year,title,pmid,lastname,forename,initials,affiliation,lab2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Feng,Qin,Q,"Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Zhang,Zheng,Z,"Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Shea,Martin J,MJ,"Lester &amp; Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Creighton,Chad J,CJ,"Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Coarfa,Cristian,C,"Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Hilsenbeck,Susan G,SG,"Lester &amp; Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Lanz,Rainer,R,"Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,He,Bin,B,"1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Department of Medicine-Hematology &amp; Oncology, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Wang,Lei,L,"Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Fu,Xiaoyong,X,"1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester &amp; Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Nardone,Agostina,A,"1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester &amp; Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Song,Yongcheng,Y,"Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Bradner,James,J,"Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Mitsiades,Nicholas,N,"1] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA [2] Department of Medicine-Hematology &amp; Oncology, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Mitsiades,Constantine S,CS,"Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Osborne,C Kent,CK,"1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester &amp; Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,Schiff,Rachel,R,"1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester &amp; Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,An epigenomic approach to therapy for tamoxifen-resistant breast cancer.,24874954,O'Malley,Bert W,BW,"1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.",2014,Brd4 Is Essential for IL-1ë_-Induced Inflammation in Human Airway Epithelial Cells.,24759736,Khan,Younis M,YM,"Airways Disease Section, National Heart &amp; Lung Institute, Imperial College London, London, United Kingdom.",2014,Brd4 Is Essential for IL-1ë_-Induced Inflammation in Human Airway Epithelial Cells.,24759736,Kirkham,Paul,P,"School of Applied Sciences, University of Wolverhampton, Wolverhampton, United Kingdom.",2014,Brd4 Is Essential for IL-1ë_-Induced Inflammation in Human Airway Epithelial Cells.,24759736,Barnes,Peter J,PJ,"Airways Disease Section, National Heart &amp; Lung Institute, Imperial College London, London, United Kingdom.",2014,Brd4 Is Essential for IL-1ë_-Induced Inflammation in Human Airway Epithelial Cells.,24759736,Adcock,Ian M,IM,"Airways Disease Section, National Heart &amp; Lung Institute, Imperial College London, London, United Kingdom.",2014,The basal transcription machinery as a target for cancer therapy.,24576043,<lastname>VillicaÌ±a</lastname>,Claudia,C,None,2014,The basal transcription machinery as a target for cancer therapy.,24576043,Cruz,Grisel,G,None,2014,The basal transcription machinery as a target for cancer therapy.,24576043,Zurita,Mario,M,"<affiliation>Departament of Developmental Genetics, Instituto de BiotecnologÌ_a, Universidad Nacional AutÌ_noma de MÌ©xico, Mexico, Mexico. marioz@ibt.unam.mx.</affiliation>",2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Fiskus,Warren,W,"Authors' Affiliations: Houston Methodist Research Institute, Houston, Texas; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and Dana-Farber Cancer Institute, Boston, Massachusetts.",2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Sharma,Sunil,S,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Qi,Jun,J,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Valenta,John A,JA,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Schaub,Leasha J,LJ,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Shah,Bhavin,B,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Peth,Karissa,K,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Portier,Bryce P,BP,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Rodriguez,Melissa,M,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Devaraj,Santhana G T,SG,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Zhan,Ming,M,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Sheng,Jianting,J,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Iyer,Swaminathan P,SP,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Bradner,James E,JE,None,2014,Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.,24435446,Bhalla,Kapil N,KN,None,2014,Emerging strategies to deplete the HIV reservoir.,24296585,Archin,Nancie M,NM,"Institute for Global Health and Infectious Diseases, and Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, USA.",2014,Emerging strategies to deplete the HIV reservoir.,24296585,Margolis,David M,DM,None,2014,Testing a new formulation for Peste des Petits Ruminants vaccine in Ethiopia.,24631085,Silva,Ana Carina,AC,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Animal Cell Technology Unit, Apartado 12, P-2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica-Universidade de Lisboa (ITQB-UNL), Animal Cell Technology Unit, Apartado 12, P-2781-901 Oeiras, Portugal.</affiliation>",2014,Testing a new formulation for Peste des Petits Ruminants vaccine in Ethiopia.,24631085,Yami,Martha,M,"National Veterinary Institute (NVI), Debre Zeit, P.O. Box 19, Ethiopia.",2014,Testing a new formulation for Peste des Petits Ruminants vaccine in Ethiopia.,24631085,Libeau,<forename>GeneviÌ¬ve</forename>,G,"CIRAD Department EMVT, Control of Exotic and Emerging Animal Diseases (UPR15), TA 30/G, Campus International de Baillarguet, 34398 Montpellier Cedex 05, France.",2014,Testing a new formulation for Peste des Petits Ruminants vaccine in Ethiopia.,24631085,Carrondo,Manuel J T,MJ,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Animal Cell Technology Unit, Apartado 12, P-2781-901 Oeiras, Portugal; FCT/UNL, LaboratÌ_rio de Engenharia BioquÌ_mica, P-2825 Monte da Caparica, Portugal.</affiliation>",2014,Testing a new formulation for Peste des Petits Ruminants vaccine in Ethiopia.,24631085,Alves,Paula M,PM,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Animal Cell Technology Unit, Apartado 12, P-2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica-Universidade de Lisboa (ITQB-UNL), Animal Cell Technology Unit, Apartado 12, P-2781-901 Oeiras, Portugal. Electronic address: marques@itqb.unl.pt.</affiliation>",2014,Analysis of cocaine and nicotine metabolites in wastewater by liquid chromatography-tandem mass spectrometry. Cross abuse index patterns on a major community.,24200094,Lopes,Alvaro,A,"<affiliation>Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal; Instituto Superior de CiÌ»ncias da SaÌ_de Egas Moniz, Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal. Electronic address: atlopes@ff.ul.pt.</affiliation>",2014,Analysis of cocaine and nicotine metabolites in wastewater by liquid chromatography-tandem mass spectrometry. Cross abuse index patterns on a major community.,24200094,Silva,Nuno,N,"iMed - Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.",2014,Analysis of cocaine and nicotine metabolites in wastewater by liquid chromatography-tandem mass spectrometry. Cross abuse index patterns on a major community.,24200094,Bronze,M R,MR,"<affiliation>iMed - Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal; IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; ITQB, Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Avenida da RepÌ_blica, EstaÌ_Ì£o AgronÌ_mica Nacional, 2780-157 Oeiras, Portugal.</affiliation>",2014,Analysis of cocaine and nicotine metabolites in wastewater by liquid chromatography-tandem mass spectrometry. Cross abuse index patterns on a major community.,24200094,Ferreira,<forename>JoÌ£o</forename>,J,"iMed - Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.",2014,Analysis of cocaine and nicotine metabolites in wastewater by liquid chromatography-tandem mass spectrometry. Cross abuse index patterns on a major community.,24200094,Morais,<forename>JosÌ©</forename>,J,"iMed - Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.",2014,Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation.,24860166,Itzen,Friederike,F,"Max Planck Institute of Molecular Physiology, Department of Physical Biochemistry, 44227 Dortmund, Germany.",2014,Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation.,24860166,Greifenberg,Ann Katrin,AK,"Max Planck Institute of Molecular Physiology, Department of Physical Biochemistry, 44227 Dortmund, Germany Center of Advanced European Studies and Research (caesar), Group Physical Biochemistry, 53175 Bonn, Germany.",2014,Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation.,24860166,<lastname>BÌ_sken</lastname>,Christian A,CA,"Max Planck Institute of Molecular Physiology, Department of Physical Biochemistry, 44227 Dortmund, Germany Center of Advanced European Studies and Research (caesar), Group Physical Biochemistry, 53175 Bonn, Germany.",2014,Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation.,24860166,Geyer,Matthias,M,"Max Planck Institute of Molecular Physiology, Department of Physical Biochemistry, 44227 Dortmund, Germany Center of Advanced European Studies and Research (caesar), Group Physical Biochemistry, 53175 Bonn, Germany matthias.geyer@caesar.de.",2014,Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.,24767840,Zhao,Hongtao,H,"Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. Electronic address: h.zhao@bioc.uzh.ch.",2014,Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.,24767840,Gartenmann,Lisa,L,"Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.",2014,Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.,24767840,Dong,Jing,J,"Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.",2014,Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.,24767840,Spiliotopoulos,Dimitrios,D,"Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.",2014,Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.,24767840,Caflisch,Amedeo,A,"Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. Electronic address: caflisch@bioc.uzh.ch.",2014,"BRD7, a tumor suppressor, interacts with p85ë± and regulates PI3K activity.",24657164,Chiu,Yu-Hsin,YH,"Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.",2014,"BRD7, a tumor suppressor, interacts with p85ë± and regulates PI3K activity.",24657164,Lee,Jennifer Y,JY,"Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.",2014,"BRD7, a tumor suppressor, interacts with p85ë± and regulates PI3K activity.",24657164,Cantley,Lewis C,LC,"Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: lcantley@med.cornell.edu.",2014,Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.,24592384,Chen,Ruichuan,R,"State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian 361005, China.",2014,Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.,24592384,Yik,Jasper H N,JH,"Department of Orthopaedic Surgery, Lawrence J. Ellison Musculoskeletal Research Center, University of California at Davis Medical Center, Sacramento, CA 95817, USA.",2014,Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.,24592384,Lew,Qiao Jing,QJ,"<affiliation>Expression Engineering Group, Bioprocessing Technology Institute, A‰öÑSTAR (Agency for Science, Technology and Research), 20 Biopolis Way, No. 06-01, Singapore 138668.</affiliation>",2014,Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.,24592384,Chao,Sheng-Hao,SH,"<affiliation>Expression Engineering Group, Bioprocessing Technology Institute, A‰öÑSTAR (Agency for Science, Technology and Research), 20 Biopolis Way, No. 06-01, Singapore 138668 ; Department of Microbiology, National University of Singapore, Block MD4, 5 Science Drive 2, Singapore 117597.</affiliation>",2014,Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells.,24520288,Wang,Ju-Bo,JB,"Department of Neurosurgery, First Affiliated Hospital of the Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.",2014,Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells.,24520288,Dong,Dan-Feng,DF,"Department of Oncology, First Affiliated Hospital of the Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.",2014,Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells.,24520288,Gao,Ke,K,"Department of Neurosurgery, First Affiliated Hospital of the Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.",2014,Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells.,24520288,Wang,Mao-DE,MD,"Department of Neurosurgery, First Affiliated Hospital of the Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.",2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Lu,Huasong,H,"School of Pharmaceutical Sciences, Innovation Center for Cell Biology, Xiamen University, Xiamen 361005, Fujian, China.",2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Li,Zichong,Z,None,2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Xue,Yuhua,Y,None,2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Schulze-Gahmen,Ursula,U,None,2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Johnson,Jeffrey R,JR,None,2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Krogan,Nevan J,NJ,None,2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Alber,Tom,T,None,2014,AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.,24367103,Zhou,Qiang,Q,None,2014,Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.,24258712,Shima,Haruko,H,"Division of Hematological Malignancy, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.",2014,Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.,24258712,Yamagata,Kazutsune,K,None,2014,Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.,24258712,Aikawa,Yukiko,Y,None,2014,Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.,24258712,Shino,Mika,M,None,2014,Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.,24258712,Koseki,Haruhiko,H,None,2014,Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.,24258712,Shimada,Hiroyuki,H,None,2014,Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.,24258712,Kitabayashi,Issay,I,None,2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,<lastname>WyspiaÅãska</lastname>,B S,BS,"Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Bannister,A J,AJ,"Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Barbieri,I,I,"Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Nangalia,J,J,"1] Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK [2] Addenbrooke's Hospital, Department of Haematology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Godfrey,A,A,"1] Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK [2] Addenbrooke's Hospital, Department of Haematology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Calero-Nieto,F J,FJ,"Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Robson,S,S,"Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Rioja,I,I,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Li,J,J,"1] Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK [2] Addenbrooke's Hospital, Department of Haematology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Wiese,M,M,"1] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK [2] Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Cannizzaro,E,E,"1] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK [2] Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Dawson,M A,MA,"1] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK [2] Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK [3] Addenbrooke's Hospital, Department of Haematology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Huntly,B,B,"Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Prinjha,R K,RK,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Green,A R,AR,"1] Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK [2] Addenbrooke's Hospital, Department of Haematology, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Gottgens,B,B,"Department of Haematology, Cambridge Institute for Medical Research and The Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.",2014,BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms.,23929215,Kouzarides,T,T,"Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK.",2014,Mechanism and factors that control HIV-1 transcription and latency activation.,24793763,Liu,Rong-Diao,RD,"School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China.",2014,Mechanism and factors that control HIV-1 transcription and latency activation.,24793763,Wu,Jun,J,None,2014,Mechanism and factors that control HIV-1 transcription and latency activation.,24793763,Shao,Rui,R,None,2014,Mechanism and factors that control HIV-1 transcription and latency activation.,24793763,Xue,Yu-Hua,YH,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Larue,Ross C,RC,"Center for Retrovirus Research and College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA, Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio 43210, Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA and Department of Pharmacology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08854, USA.",2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Plumb,Matthew R,MR,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Crowe,Brandon L,BL,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Shkriabai,Nikoloz,N,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Sharma,Amit,A,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,DiFiore,Julia,J,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Malani,Nirav,N,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Aiyer,Sriram S,SS,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Roth,Monica J,MJ,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Bushman,Frederic D,FD,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Foster,Mark P,MP,None,2014,Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.,24520112,Kvaratskhelia,Mamuka,M,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Jiang,Guochun,G,"<affiliation>aDepartment of Medical Microbiology &amp; Immunology, University of California, Davis bSection of Infectious Diseases, Department of Medicine, University of California, San Francisco cDepartment of Molecular &amp; Cellular Biology dDepartment of Internal Medicine, Division of Infectious Diseases, University of California, Davis, California, USA eInstitute of Biology and Department of Genetics, UFRJ Rio de Janeiro fKyoLab, Valinhos, SÌ£o Paulo, Brazil. *Guochun Jiang and Erica A. Mendes contributed equally to the writing of this article.</affiliation>",2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Mendes,Erica A,EA,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Kaiser,Philipp,P,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Sankaran-Walters,Sumathi,S,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Tang,Yuyang,Y,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Weber,Mariana G,MG,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Melcher,Greg P,GP,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Thompson,George R,GR,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Tanuri,Amilcar,A,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Pianowski,Luiz F,LF,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Wong,Joseph K,JK,None,2014,Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cë«-NF-ë_B signaling.,24804860,Dandekar,Satya,S,None,2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Asangani,Irfan A,IA,"1] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Dommeti,Vijaya L,VL,"Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Wang,Xiaoju,X,"1] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Malik,Rohit,R,"1] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Cieslik,Marcin,M,"Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Yang,Rendong,R,"Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia 30329, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Escara-Wilke,June,J,"Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Wilder-Romans,Kari,K,"Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Dhanireddy,Sudheer,S,"Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Engelke,Carl,C,"Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Iyer,Mathew K,MK,"Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Jing,Xiaojun,X,"Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Wu,Yi-Mi,YM,"1] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Cao,Xuhong,X,"1] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Qin,Zhaohui S,ZS,"Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia 30329, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Wang,Shaomeng,S,"1] Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Feng,Felix Y,FY,"1] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [3] Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,24759320,Chinnaiyan,Arul M,AM,"1] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2] Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [3] Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [4] Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [5] Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.",2014,BRD4: a BET(ter) target for the treatment of AML?,24526121,Valent,Peter,P,"Ludwig Boltzmann Cluster Oncology; Medical University of Vienna; Vienna, Austria; Department of Internal Medicine I; Division of Hematology &amp; Hemostaseology; Medical University of Vienna; Vienna, Austria.",2014,BRD4: a BET(ter) target for the treatment of AML?,24526121,Zuber,Johannes,J,"Research Institute of Molecular Pathology (IMP); Vienna, Austria.",2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Wienerroither,Sebastian,S,"Max F. Perutz Laboratories, University of Vienna, Vienna, Austria.",2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Rauch,Isabella,I,None,2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Rosebrock,Felix,F,None,2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Jamieson,Amanda M,AM,None,2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Bradner,James,J,None,2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Muhar,Matthias,M,None,2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Zuber,Johannes,J,None,2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,<lastname>MÌ_ller</lastname>,Mathias,M,None,2014,"Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.",24248598,Decker,Thomas,T,None,2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,Pina,Ana S,AS,"<affiliation>REQUIMTE, Departamento de QuÌ_mica, Faculdade de CiÌ»ncias e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica (Portugal); IBET-Instituto de Biologia Experimental e TecnolÌ_gica, Av. RepÌ_blica, Qta. do MarquÌ»s, 2780-157 Oeiras (Portugal); Institute of Biotechnology, Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, CB2 1QT, Cambridge (UK).</affiliation>",2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,Guilherme,<forename>MÌÁrcia</forename>,M,None,2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,Pereira,Alice S,AS,None,2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,Fernandes,<forename>ClÌÁudia S F M</forename>,CS,None,2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,Branco,Ricardo J F,RJ,None,2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,El Khoury,Graziella,G,None,2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,Lowe,Christopher R,CR,None,2014,A Tailor-Made &quot;Tag-Receptor&quot; Affinity Pair for the Purification of Fusion Proteins.,24903894,Roque,<forename>A CecÌ_lia A</forename>,AC,None,2014,Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.,24595278,Patrone,Marco,M,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Oeiras, Portugal.</affiliation>",2014,Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.,24595278,Carinhas,Nuno,N,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Oeiras, Portugal.</affiliation>",2014,Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.,24595278,Sousa,Marcos Q,MQ,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Oeiras, Portugal.</affiliation>",2014,Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.,24595278,Peixoto,Cristina,C,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Oeiras, Portugal.</affiliation>",2014,Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.,24595278,Ciferri,Claudio,C,"Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States of America.",2014,Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.,24595278,<lastname>CarfÌÂ</lastname>,Andrea,A,"Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States of America.",2014,Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.,24595278,Alves,Paula M,PM,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Oeiras, Portugal.</affiliation>",2014,The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition.,24905006,Shi,Junwei,J,"Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA; Molecular and Cellular Biology Program, Stony Brook University, Stony Brook, NY 11794, USA.",2014,The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition.,24905006,Vakoc,Christopher R,CR,"Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA. Electronic address: vakoc@cshl.edu.",2014,I-BET151 selectively regulates IL-6 production.,24859008,Barrett,Elyse,E,"Departments of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; Departments of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.",2014,I-BET151 selectively regulates IL-6 production.,24859008,Brothers,Shaun,S,"Departments of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.",2014,I-BET151 selectively regulates IL-6 production.,24859008,Wahlestedt,Claes,C,"Departments of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.",2014,I-BET151 selectively regulates IL-6 production.,24859008,Beurel,<forename>ElÌ©onore</forename>,E,"Departments of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; Departments of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. Electronic address: ebeurel@med.miami.edu.",2014,Targeting bromodomains: epigenetic readers of lysine acetylation.,24751816,Filippakopoulos,Panagis,P,"1] Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. [2] Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.",2014,Targeting bromodomains: epigenetic readers of lysine acetylation.,24751816,Knapp,Stefan,S,"1] Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. [2] Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.",2014,Expression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.,24646517,You,Linya,L,"The Rosalind &amp; Morris Goodman Cancer Research Center; Montreal, QC Canada; Department of Medicine; McGill University; Montreal, QC Canada.",2014,Expression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.,24646517,Chen,Lulu,L,"The State Key Laboratory of Reproductive Medicine; The Research Center for Bone and Stem Cells; Department of Human Anatomy; Nanjing Medical University; Nanjing, China.",2014,Expression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.,24646517,Panney,Janice,J,"The Rosalind &amp; Morris Goodman Cancer Research Center; Montreal, QC Canada.",2014,Expression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.,24646517,Miao,Dengshun,D,"The State Key Laboratory of Reproductive Medicine; The Research Center for Bone and Stem Cells; Department of Human Anatomy; Nanjing Medical University; Nanjing, China.",2014,Expression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.,24646517,Yang,Xiang-Jiao,XJ,"The Rosalind &amp; Morris Goodman Cancer Research Center; Montreal, QC Canada; Department of Medicine; McGill University; Montreal, QC Canada; Department of Biochemistry; McGill University; Montreal, QC Canada; McGill University Health Center; Montreal, QC Canada.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Ciceri,Pietro,P,"1] KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA. [2].",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,<lastname>MÌ_ller</lastname>,Susanne,S,"1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK. [3].",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,O'Mahony,Alison,A,"1] BioSeek Division of DiscoveRx Corporation, San Francisco, California, USA. [2].",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Fedorov,Oleg,O,"Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Filippakopoulos,Panagis,P,"1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research (LICR), Oxford, UK.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Hunt,Jeremy P,JP,"KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Lasater,Elisabeth A,EA,"Division of Hematology/Oncology, University of California-San Francisco, San Francisco, California, USA.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Pallares,Gabriel,G,"KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Picaud,Sarah,S,"1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research (LICR), Oxford, UK.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Wells,Christopher,C,"1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Martin,Sarah,S,"Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Wodicka,Lisa M,LM,"KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Shah,Neil P,NP,"Division of Hematology/Oncology, University of California-San Francisco, San Francisco, California, USA.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Treiber,Daniel K,DK,"KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.",2014,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,24584101,Knapp,Stefan,S,"1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.",2014,Chemical synthesis of the ATAD2 bromodomain.,24516155,Creech,Gardner S,GS,"Bioorganic Chemistry Laboratory, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.",2014,Chemical synthesis of the ATAD2 bromodomain.,24516155,Paresi,Chelsea,C,None,2014,Chemical synthesis of the ATAD2 bromodomain.,24516155,Li,Yue-Ming,YM,None,2014,Chemical synthesis of the ATAD2 bromodomain.,24516155,Danishefsky,Samuel J,SJ,None,2014,Brd4-mediated nuclear retention of the papillomavirus E2 protein contributes to its stabilization in host cells.,24448221,Li,Jing,J,"Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. jing8@mail.med.upenn.edu.",2014,Brd4-mediated nuclear retention of the papillomavirus E2 protein contributes to its stabilization in host cells.,24448221,Li,Qing,Q,"Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. sunnymaylq@hotmail.com.",2014,Brd4-mediated nuclear retention of the papillomavirus E2 protein contributes to its stabilization in host cells.,24448221,Diaz,Jason,J,"Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. jdia@mail.med.upenn.edu.",2014,Brd4-mediated nuclear retention of the papillomavirus E2 protein contributes to its stabilization in host cells.,24448221,You,Jianxin,J,"Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. jianyou@mail.med.upenn.edu.",2014,Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP.,24361270,Plotnikov,Alexander N,AN,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.",2014,Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP.,24361270,Yang,Shuai,S,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.",2014,Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP.,24361270,Zhou,Thomas Jiachi,TJ,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.",2014,Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP.,24361270,Rusinova,Elena,E,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.",2014,Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP.,24361270,Frasca,Antonio,A,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.",2014,Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP.,24361270,Zhou,Ming-Ming,MM,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA. Electronic address: ming-ming.zhou@mssm.edu.",2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Mirguet,Olivier,O,"<affiliation>Centre de Recherches FranÌ_ois Hyafil, GlaxoSmithKline R&amp;D, 25 Avenue du QuÌ©bec, 91140 Villebon-sur-Yvette (France); Current address: Institut de Recherches Servier, 11 Rue des Moulineaux, 92150 Suresnes (France). oliviermirguet@yahoo.fr.</affiliation>",2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Lamotte,Yann,Y,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Chung,Chun-Wa,CW,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Bamborough,Paul,P,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,<lastname>DelannÌ©e</lastname>,Delphine,D,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Bouillot,Anne,A,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Gellibert,<forename>FranÌ_oise</forename>,F,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Krysa,Gael,G,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Lewis,Antonia,A,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Witherington,Jason,J,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Huet,Pascal,P,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Dudit,Yann,Y,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Trottet,Lionel,L,None,2014,Naphthyridines as novel BET family bromodomain inhibitors.,24000170,Nicodeme,Edwige,E,None,2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,Wang,Ranran,R,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.",2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,Liu,Wei,W,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.",2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,Helfer,Christine M,CM,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.",2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,Bradner,James E,JE,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.",2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,Hornick,Jason L,JL,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.",2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,Janicki,Susan M,SM,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.",2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,French,Christopher A,CA,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.",2014,Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma.,24736545,You,Jianxin,J,"Authors' Affiliations: Department of Microbiology, University of Pennsylvania Perelman School of Medicine; and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Dana-Farber Cancer Institute, Dana 510D; and Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts jianyou@mail.med.upenn.edu.",2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Meng,S,S,"Division of Oral Biology, Tufts University School of Dental Medicine, Boston, MA 02111, USA.",2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Zhang,L,L,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Tang,Y,Y,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Tu,Q,Q,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Zheng,L,L,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Yu,L,L,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Murray,D,D,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Cheng,J,J,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Kim,S H,SH,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Zhou,X,X,None,2014,BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.,24799421,Chen,J,J,None,2014,Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.,24733848,Michaeloudes,Charalambos,C,"Airway Disease Section, National Heart and Lung Institute, Imperial College London and Biomedical Research Unit, Royal Brompton Hospital, London SW3 6LY, United Kingdom.",2014,Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.,24733848,Mercado,Nicolas,N,None,2014,Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.,24733848,Clarke,Colin,C,None,2014,Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.,24733848,Bhavsar,Pankaj K,PK,None,2014,Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.,24733848,Adcock,Ian M,IM,None,2014,Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.,24733848,Barnes,Peter J,PJ,None,2014,Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.,24733848,Chung,Kian Fan,KF,None,2014,Comparative drug screening in NUT midline carcinoma.,24518598,Beesley,A H,AH,"Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Western Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Stirnweiss,A,A,"Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Western Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Ferrari,E,E,"Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Western Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Endersby,R,R,"Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Western Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Howlett,M,M,"Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Western Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Failes,T W,TW,"ACRF Drug Discovery Centre for Childhood Cancer, Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW, Sydney, Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Arndt,G M,GM,"ACRF Drug Discovery Centre for Childhood Cancer, Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW, Sydney, Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Charles,A K,AK,"1] Department of Pathology, Princess Margaret Hospital for Children, Perth, Western Australia [2] School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Cole,C H,CH,"School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia.",2014,Comparative drug screening in NUT midline carcinoma.,24518598,Kees,U R,UR,"Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Western Australia.",2014,Metabolic responses of CHO cells to limitation of key amino acids.,24771076,Duarte,Tiago M,TM,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901, Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157, Oeiras, Portugal.</affiliation>",2014,Metabolic responses of CHO cells to limitation of key amino acids.,24771076,Carinhas,Nuno,N,None,2014,Metabolic responses of CHO cells to limitation of key amino acids.,24771076,Barreiro,Laura C,LC,None,2014,Metabolic responses of CHO cells to limitation of key amino acids.,24771076,Carrondo,Manuel J T,MJ,None,2014,Metabolic responses of CHO cells to limitation of key amino acids.,24771076,Alves,Paula M,PM,None,2014,Metabolic responses of CHO cells to limitation of key amino acids.,24771076,Teixeira,Ana P,AP,None,2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,Castanheira,<forename>NÌÁdia</forename>,N,"<affiliation>Instituto Nacional de InvestigaÌ_Ì£o AgrÌÁria e VeterinÌÁria, I.P., Av. da RepÌ_blica, 2780-159 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,Dourado,Ana Catarina,AC,"<affiliation>iBET-Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,Alves,Paula Isabel,PI,"<affiliation>iBET-Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,<lastname>CortÌ©s-Pallero</lastname>,<forename>AlÌ_cia Maria</forename>,AM,"<affiliation>Instituto Nacional de InvestigaÌ_Ì£o AgrÌÁria e VeterinÌÁria, I.P., Av. da RepÌ_blica, 2780-159 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,<lastname>Delgado-RodrÌ_guez</lastname>,Ana Isabel,AI,"<affiliation>Instituto Nacional de InvestigaÌ_Ì£o AgrÌÁria e VeterinÌÁria, I.P., Av. da RepÌ_blica, 2780-159 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,Prazeres,Angela,A,"<affiliation>Instituto Nacional de InvestigaÌ_Ì£o AgrÌÁria e VeterinÌÁria, I.P., Av. da RepÌ_blica, 2780-159 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,Borges,Nuno,N,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,<lastname>SÌÁnchez</lastname>,Claudia,C,"<affiliation>Instituto Nacional de InvestigaÌ_Ì£o AgrÌÁria e VeterinÌÁria, I.P., Av. da RepÌ_blica, 2780-159 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,Barreto Crespo,Maria Teresa,MT,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal; iBET-Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2014,Annual ryegrass-associated bacteria with potential for plant growth promotion.,24485300,Fareleira,Paula,P,"<affiliation>Instituto Nacional de InvestigaÌ_Ì£o AgrÌÁria e VeterinÌÁria, I.P., Av. da RepÌ_blica, 2780-159 Oeiras, Portugal. Electronic address: paula.fareleira@iniav.pt.</affiliation>",2014,Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies.,24855903,Okosun,Jessica,J,"Queen Mary University of London, Barts Cancer Institute - a Cancer Research UK Centre of Excellence, Centre for Haemato-Oncology, John Vane Science Centre , Charterhouse Square, London EC1M 6BQ , UK +44 20 7882 8780 ; +44 20 7882 3891 ; j.e.okosun@qmul.ac.uk.",2014,Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies.,24855903,Packham,Graham,G,None,2014,Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies.,24855903,Fitzgibbon,Jude,J,None,2014,Trypanosoma cruzi Bromodomain Factor 3 Binds Acetylated ë±-Tubulin and Concentrates in the Flagellum during Metacyclogenesis.,24747213,Alonso,Victoria Lucia,VL,"<affiliation>Facultad de Ciencias BioquÌ_micas y FarmacÌ©uticas, Universidad Nacional de Rosario (UNR). Rosario, Argentina Instituto de BiologÌ_a Molecular y Celular de Rosario (IBR), CONICET, Rosario, Argentina.</affiliation>",2014,Trypanosoma cruzi Bromodomain Factor 3 Binds Acetylated ë±-Tubulin and Concentrates in the Flagellum during Metacyclogenesis.,24747213,Villanova,Gabriela Vanina,GV,"<affiliation>Facultad de Ciencias BioquÌ_micas y FarmacÌ©uticas, Universidad Nacional de Rosario (UNR). Rosario, Argentina Instituto de BiologÌ_a Molecular y Celular de Rosario (IBR), CONICET, Rosario, Argentina.</affiliation>",2014,Trypanosoma cruzi Bromodomain Factor 3 Binds Acetylated ë±-Tubulin and Concentrates in the Flagellum during Metacyclogenesis.,24747213,Ritagliati,Carla,C,"<affiliation>Instituto de BiologÌ_a Molecular y Celular de Rosario (IBR), CONICET, Rosario, Argentina.</affiliation>",2014,Trypanosoma cruzi Bromodomain Factor 3 Binds Acetylated ë±-Tubulin and Concentrates in the Flagellum during Metacyclogenesis.,24747213,Machado Motta,<forename>MarÌ_a Cristina</forename>,MC,"<affiliation>LaboratÌ_rio de Ultraestrutura Celular Hertha Meyer, Instituto de BiofÌ_sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</affiliation>",2014,Trypanosoma cruzi Bromodomain Factor 3 Binds Acetylated ë±-Tubulin and Concentrates in the Flagellum during Metacyclogenesis.,24747213,Cribb,Pamela,P,"<affiliation>Facultad de Ciencias BioquÌ_micas y FarmacÌ©uticas, Universidad Nacional de Rosario (UNR). Rosario, Argentina Instituto de BiologÌ_a Molecular y Celular de Rosario (IBR), CONICET, Rosario, Argentina.</affiliation>",2014,Trypanosoma cruzi Bromodomain Factor 3 Binds Acetylated ë±-Tubulin and Concentrates in the Flagellum during Metacyclogenesis.,24747213,Serra,Esteban Carlos,EC,"<affiliation>Facultad de Ciencias BioquÌ_micas y FarmacÌ©uticas, Universidad Nacional de Rosario (UNR). Rosario, Argentina Instituto de BiologÌ_a Molecular y Celular de Rosario (IBR), CONICET, Rosario, Argentina eserra@fbioyf.unr.edu.ar.</affiliation>",2014,The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease.,24633655,Carlson,Samuel,S,"Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, Vermont.",2014,The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease.,24633655,Glass,Karen C,KC,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Wee,Susan,S,"Bristol Myers Squibb Company, Princeton, New Jersey.",2014,Targeting epigenetic regulators for cancer therapy.,24571255,Dhanak,Dash,D,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Li,Haitao,H,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Armstrong,Scott A,SA,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Copeland,Robert A,RA,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Sims,Robert,R,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Baylin,Stephen B,SB,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Liu,Xiaole Shirley,XS,None,2014,Targeting epigenetic regulators for cancer therapy.,24571255,Schweizer,Liang,L,None,2014,Bromodomains and their pharmacological inhibitors.,24497428,Gallenkamp,Daniel,D,"Bayer Pharma AG, Global Drug Discovery, 13353 Berlin (Germany).",2014,Bromodomains and their pharmacological inhibitors.,24497428,Gelato,Kathy A,KA,None,2014,Bromodomains and their pharmacological inhibitors.,24497428,Haendler,Bernard,B,None,2014,Bromodomains and their pharmacological inhibitors.,24497428,Weinmann,Hilmar,H,None,2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Rodriguez,Ramon M,RM,"<affiliation>Cancer Epigenetics Laboratory; Instituto Universitario de OncologÌ_a del Principado de Asturias (IUOPA); HUCA; Universidad de Oviedo; Oviedo, Spain; Department of Immunology; Hospital Universitario Central de Asturias; Oviedo, Spain.</affiliation>",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Suarez-Alvarez,Beatriz,B,"Department of Immunology; Hospital Universitario Central de Asturias; Oviedo, Spain.",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,<lastname>SalvanÌ©s</lastname>,Ruben,R,"Department of Immunology; Hospital Universitario Central de Asturias; Oviedo, Spain.",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Huidobro,Covadonga,C,"<affiliation>Cancer Epigenetics Laboratory; Instituto Universitario de OncologÌ_a del Principado de Asturias (IUOPA); HUCA; Universidad de Oviedo; Oviedo, Spain; MRC Human Genetics Unit; Institute of Genetics and Molecular Medicine; University of Edinburgh; Western General Hospital; Edinburgh, UK.</affiliation>",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,<lastname>ToraÌ±o</lastname>,Estela G,EG,"<affiliation>Cancer Epigenetics Laboratory; Instituto Universitario de OncologÌ_a del Principado de Asturias (IUOPA); HUCA; Universidad de Oviedo; Oviedo, Spain.</affiliation>",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Garcia-Perez,Jose L,JL,"Department of Human DNA Variability; Pfizer-University of Granada and Andalusian Government Center for Genomics and Oncology (GENYO); Granada, Spain.",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Lopez-Larrea,Carlos,C,"<affiliation>Department of Immunology; Hospital Universitario Central de Asturias; Oviedo, Spain; Fundacion Renal &quot;ÌçÌ±igo ÌÅlvarez de Toledo&quot;; Madrid, Spain.</affiliation>",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Fernandez,Agustin F,AF,"<affiliation>Cancer Epigenetics Laboratory; Instituto Universitario de OncologÌ_a del Principado de Asturias (IUOPA); HUCA; Universidad de Oviedo; Oviedo, Spain.</affiliation>",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Bueno,Clara,C,"Josep Carreras Leukemia Research Institute; Barcelona, Spain; Centre for Genomics and Oncological Research (GENYO); Pfizer/University of Granada/Andalusian Government; Granada, Spain.",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Menendez,Pablo,P,"<affiliation>Josep Carreras Leukemia Research Institute; Barcelona, Spain; InstituciÌ_ Catalana de Reserca i Estudis AvanÌ_ats (ICREA); Barcelona, Spain.</affiliation>",2014,Role of BRD4 in hematopoietic differentiation of embryonic stem cells.,24445267,Fraga,Mario F,MF,"<affiliation>Cancer Epigenetics Laboratory; Instituto Universitario de OncologÌ_a del Principado de Asturias (IUOPA); HUCA; Universidad de Oviedo; Oviedo, Spain; Department of Immunology and Oncology; Centro Nacional de BiotecnologÌ_a/CNB-CSIC; Cantoblanco; Madrid, Spain.</affiliation>",2014,An unanticipated early function of DEAD-box ATPase Prp28 during commitment to splicing is modulated by U5 snRNP protein Prp8.,24231520,Price,Argenta M,AM,None,2014,An unanticipated early function of DEAD-box ATPase Prp28 during commitment to splicing is modulated by U5 snRNP protein Prp8.,24231520,<lastname>GÌ_rnemann</lastname>,Janina,J,None,2014,An unanticipated early function of DEAD-box ATPase Prp28 during commitment to splicing is modulated by U5 snRNP protein Prp8.,24231520,Guthrie,Christine,C,None,2014,An unanticipated early function of DEAD-box ATPase Prp28 during commitment to splicing is modulated by U5 snRNP protein Prp8.,24231520,Brow,David A,DA,None,2014,CCHCR1 interacts specifically with the E2 protein of human papillomavirus type 16 on a surface overlapping BRD4 binding.,24664238,Muller,Mandy,M,"<affiliation>UnitÌ© GÌ©nÌ©tique Papillomavirus et Cancer Humain, Institut Pasteur, Paris, France; UniversitÌ© Paris Diderot, Sorbonne Paris CitÌ©, Cellule Pasteur, Paris, France.</affiliation>",2014,CCHCR1 interacts specifically with the E2 protein of human papillomavirus type 16 on a surface overlapping BRD4 binding.,24664238,Demeret,Caroline,C,"<affiliation>UnitÌ© GÌ©nÌ©tique Papillomavirus et Cancer Humain, Institut Pasteur, Paris, France.</affiliation>",2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Venkataraman,Sujatha,S,"Department of Pediatrics, Children's Hospital Colorado and University of Colorado, Denver, CO, USA.",2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Alimova,Irina,I,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Balakrishnan,Ilango,I,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Harris,Peter,P,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Birks,Diane K,DK,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Griesinger,Andrea,A,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Amani,Vladimir,V,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Cristiano,Brian,B,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Remke,Marc,M,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Taylor,Michael D,MD,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Handler,Michael,M,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Foreman,Nicholas K,NK,None,2014,Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.,24796395,Vibhakar,Rajeev,R,None,2014,New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.,24658076,Bullen,C Korin,CK,"1] Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. [2].",2014,New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.,24658076,Laird,Gregory M,GM,"1] Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. [2].",2014,New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.,24658076,Durand,Christine M,CM,"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.",2014,New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.,24658076,Siliciano,Janet D,JD,"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.",2014,New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.,24658076,Siliciano,Robert F,RF,"1] Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. [2] Howard Hughes Medical Institute, Baltimore, Maryland, USA.",2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Jung,Marie,M,"From the Global Drug Discovery, Bayer HealthCare, 13353 Berlin, Germany.",2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Philpott,Martin,M,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,<lastname>MÌ_ller</lastname>,Susanne,S,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Schulze,Jessica,J,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Badock,Volker,V,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,<lastname>EberspÌ_cher</lastname>,Uwe,U,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Moosmayer,Dieter,D,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Bader,Benjamin,B,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Schmees,Norbert,N,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,<lastname>FernÌÁndez-MontalvÌÁn</lastname>,Amaury,A,None,2014,Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.,24497639,Haendler,Bernard,B,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Roderick,Justine E,JE,"Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA;",2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Tesell,Jessica,J,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Shultz,Leonard D,LD,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Brehm,Michael A,MA,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Greiner,Dale L,DL,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Harris,Marian H,MH,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Silverman,Lewis B,LB,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Sallan,Stephen E,SE,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Gutierrez,Alejandro,A,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Look,A Thomas,AT,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Qi,Jun,J,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Bradner,James E,JE,None,2014,c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.,24394663,Kelliher,Michelle A,MA,None,2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Zou,Z,Z,"Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.",2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Huang,B,B,"Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.",2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Wu,X,X,"Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.",2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Zhang,H,H,"Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.",2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Qi,J,J,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.",2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Bradner,J,J,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.",2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Nair,S,S,"Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.",2014,Brd4 maintains constitutively active NF-ë_B in cancer cells by binding to acetylated RelA.,23686307,Chen,L-F,LF,"1] Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA [2] College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Park,Sang Won,SW,"Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: sangwon.park@childrens.harvard.edu.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Herrema,Hilde,H,"Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Salazar,Mario,M,"Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Cakir,Isin,I,"Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Cabi,Serkan,S,"Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Basibuyuk Sahin,Fatma,F,"Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Chiu,Yu-Hsin,YH,"Department of System Biology, Harvard Medical School, Boston, MA 02115, USA; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Cantley,Lewis C,LC,"Department of System Biology, Harvard Medical School, Boston, MA 02115, USA; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Department of Medicine, Weill Cornell Medical College, New York City, NY 10065, USA.",2014,BRD7 Regulates XBP1s' Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K.,24836559,Ozcan,Umut,U,"Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: umut.ozcan@childrens.harvard.edu.",2014,Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors.,24746559,Smith,Steven G,SG,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.",2014,Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors.,24746559,Sanchez,Roberto,R,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.",2014,Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors.,24746559,Zhou,Ming-Ming,MM,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA. Electronic address: ming-ming.zhou@mssm.edu.",2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,Ember,Stuart W J,SW,"<affiliation>Drug Discovery Department and å_Chemical Biology Core, H. Lee Moffitt Cancer Center and Research Institute , Tampa, Florida 33612, United States.</affiliation>",2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,Zhu,Jin-Yi,JY,None,2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,Olesen,Sanne H,SH,None,2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,Martin,Mathew P,MP,None,2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,Becker,Andreas,A,None,2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,Berndt,Norbert,N,None,2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,Georg,Gunda I,GI,None,2014,Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors.,24568369,<lastname>SchÌ_nbrunn</lastname>,Ernst,E,None,2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Pastori,Chiara,C,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Daniel,Mark,M,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Penas,Clara,C,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Volmar,Claude-Henry,CH,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Johnstone,Andrea L,AL,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Brothers,Shaun P,SP,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Graham,Regina M,RM,"Department of Neurosurgery; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Allen,Bryce,B,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Sarkaria,Jann N,JN,"Department of Radiation Oncology; Mayo Clinic; Rochester, MN USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Komotar,Ricardo J,RJ,"Department of Neurosurgery; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Wahlestedt,Claes,C,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,BET bromodomain proteins are required for glioblastoma cell proliferation.,24496381,Ayad,Nagi G,NG,"Center For Therapeutic Innovation; Department of Psychiatry and Behavioral Sciences; University of Miami Miller School of Medicine; Miami, FL USA.",2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Wilson,Boris G,BG,"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.",2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Helming,Katherine C,KC,None,2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Wang,Xiaofeng,X,None,2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Kim,Youngha,Y,None,2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Vazquez,Francisca,F,None,2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Jagani,Zainab,Z,None,2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Hahn,William C,WC,None,2014,Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.,24421395,Roberts,Charles W M,CW,None,2014,A bromodomain-containing host protein mediates the nuclear importation of a satellite RNA of Cucumber mosaic virus.,24284314,Chaturvedi,Sonali,S,"Department of Plant Pathology, University of California, Riverside, California, USA.",2014,A bromodomain-containing host protein mediates the nuclear importation of a satellite RNA of Cucumber mosaic virus.,24284314,Kalantidis,Kriton,K,None,2014,A bromodomain-containing host protein mediates the nuclear importation of a satellite RNA of Cucumber mosaic virus.,24284314,Rao,A L N,AL,None,2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Dawson,M A,MA,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK [3] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Gudgin,E J,EJ,"Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Horton,S J,SJ,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Giotopoulos,G,G,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Meduri,E,E,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Robson,S,S,"Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Cannizzaro,E,E,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Osaki,H,H,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Wiese,M,M,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Putwain,S,S,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Fong,C Y,CY,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Grove,C,C,"Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Craig,J,J,"Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Dittmann,A,A,"Discovery Research, Cellzome AG, Heidelberg, Germany.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Lugo,D,D,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Jeffrey,P,P,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Drewes,G,G,"Discovery Research, Cellzome AG, Heidelberg, Germany.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Lee,K,K,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Bullinger,L,L,"Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Prinjha,R K,RK,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Kouzarides,T,T,"Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Vassiliou,G S,GS,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.",2014,"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.",24220271,Huntly,B J P,BJ,"1] Department of Haematology, Cambridge Institute for Medical Research and Addenbrookes Hospital, University of Cambridge, Cambridge, UK [2] Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.",2014,A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.,24655834,Suzuki,Shioto,S,"Division of Pathology, Iwata City Hospital, Japan. Electronic address: shiosuzuki-path@umin.net.",2014,A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.,24655834,Kurabe,Nobuya,N,"Department of Tumor Pathology, Hamamatsu University School of Medicine, Japan.",2014,A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.,24655834,Minato,Hiroshi,H,"Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Japan.",2014,A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.,24655834,Ohkubo,Aki,A,"Division of Otolaryngology, Iwata City Hospital, Japan.",2014,A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.,24655834,Ohnishi,Ippei,I,"Division of Pathology, Iwata City Hospital, Japan.",2014,A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.,24655834,Tanioka,Fumihiko,F,"Division of Pathology, Iwata City Hospital, Japan.",2014,A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.,24655834,Sugimura,Haruhiko,H,"Department of Tumor Pathology, Hamamatsu University School of Medicine, Japan.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Chen,Chong,C,"Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Liu,Yu,Y,"Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Rappaport,Amy R,AR,"Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Kitzing,Thomas,T,"Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Schultz,Nikolaus,N,"Computational Biology Center, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Zhao,Zhen,Z,"Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Shroff,Aditya S,AS,"Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Dickins,Ross A,RA,"Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Vakoc,Christopher R,CR,"Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Bradner,James E,JE,"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02215, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Stock,Wendy,W,"Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,LeBeau,Michelle M,MM,"Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Shannon,Kevin M,KM,"Department of Pediatrics, School of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Kogan,Scott,S,"<affiliation>Department of Laboratory Medicine &amp; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, SanåÊFrancisco, CA 94158, USA.</affiliation>",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Zuber,Johannes,J,"Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA; Research Institute of Molecular Pathology, 1030 Vienna, Austria.",2014,MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.,24794707,Lowe,Scott W,SW,"Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: lowes@mskcc.org.",2014,Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.,24657799,Ray,Sutapa,S,"Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States.",2014,Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.,24657799,Zhao,Yingxin,Y,"Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX 77555, United States.",2014,Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.,24657799,Jamaluddin,Mohammad,M,"Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX 77555, United States.",2014,Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.,24657799,Edeh,Chukwudi B,CB,"Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States.",2014,Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.,24657799,Lee,Chang,C,"Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States.",2014,Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.,24657799,Brasier,Allan R,AR,"Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX 77555, United States. Electronic address: arbrasie@utmb.edu.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Fowler,Trent,T,"Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Ghatak,Payel,P,"Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Price,David H,DH,"Biochemistry Department, University of Iowa, Iowa City, Iowa, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Conaway,Ronald,R,"Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Conaway,Joan,J,"Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Chiang,Cheng-Ming,CM,"Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Bradner,James E,JE,"Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Shilatifard,Ali,A,"Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.",2014,Regulation of MYC expression and differential JQ1 sensitivity in cancer cells.,24466310,Roy,Ananda L,AL,"Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Program in Genetics, Sackler School of Biomedical Science, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Program in Immunology, Sackler School of Biomedical Science, Tufts University School of Medicine, Boston, Massachusetts, United States of America.",2014,Impact of grafting on the design of new membrane adsorbers for adenovirus purification.,24747081,Nestola,Piergiuseppe,P,"<affiliation>IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Impact of grafting on the design of new membrane adsorbers for adenovirus purification.,24747081,Villain,Louis,L,"Sartorius Stedim Biotech, August-Spindler-Strasse 11, 37079 Gottingen, Germany.",2014,Impact of grafting on the design of new membrane adsorbers for adenovirus purification.,24747081,Peixoto,Cristina,C,"<affiliation>IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal.</affiliation>",2014,Impact of grafting on the design of new membrane adsorbers for adenovirus purification.,24747081,Martins,Duarte L,DL,"<affiliation>IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Impact of grafting on the design of new membrane adsorbers for adenovirus purification.,24747081,Alves,Paula M,PM,"<affiliation>IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Impact of grafting on the design of new membrane adsorbers for adenovirus purification.,24747081,Carrondo,Manuel J T,MJ,"<affiliation>IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal; Faculdade de CiÌ»ncias e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.</affiliation>",2014,Impact of grafting on the design of new membrane adsorbers for adenovirus purification.,24747081,Mota,<forename>JosÌ© P B</forename>,JP,"<affiliation>Requimte/CQFB, Departamento de QuÌ_mica, Faculdade de CiÌ»ncias e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal; IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal. Electronic address: pmota@fct.unl.pt.</affiliation>",2014,Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange.,24333128,Fernandes,Fabiana,F,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange.,24333128,Dias,Mafalda M,MM,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange.,24333128,Vidigal,<forename>JoÌ£o</forename>,J,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange.,24333128,Sousa,Marcos F Q,MF,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange.,24333128,Patrone,Marco,M,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange.,24333128,Teixeira,Ana P,AP,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange.,24333128,Alves,Paula M,PM,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal. Electronic address: marques@itqb.unl.pt.</affiliation>",2014,The relationship between mixed microbial culture composition and PHA production performance from fermented molasses.,24025669,Carvalho,Gilda,G,"<affiliation>REQUIMTE/CQFB, Department of Chemistry, Faculdade de CiÌ»ncias e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal; IBET, Apartado 12, 2781-901 Oeiras, Portugal. Electronic address: gs.carvalho@fct.unl.pt.</affiliation>",2014,The relationship between mixed microbial culture composition and PHA production performance from fermented molasses.,24025669,Oehmen,Adrian,A,"<affiliation>REQUIMTE/CQFB, Department of Chemistry, Faculdade de CiÌ»ncias e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.</affiliation>",2014,The relationship between mixed microbial culture composition and PHA production performance from fermented molasses.,24025669,Albuquerque,Maria G E,MG,"<affiliation>REQUIMTE/CQFB, Department of Chemistry, Faculdade de CiÌ»ncias e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.</affiliation>",2014,The relationship between mixed microbial culture composition and PHA production performance from fermented molasses.,24025669,Reis,Maria A M,MA,"<affiliation>REQUIMTE/CQFB, Department of Chemistry, Faculdade de CiÌ»ncias e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.</affiliation>",2014,Pharmacological Inhibition of Bromodomain-Containing Proteins in Inflammation.,24890512,Schaefer,Uwe,U,"Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, New York 10065.",2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Rooney,Timothy P C,TP,"Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, OX1 3TA (UK) http://conway.chem.ox.ac.uk/",2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Filippakopoulos,Panagis,P,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Fedorov,Oleg,O,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Picaud,Sarah,S,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Cortopassi,Wilian A,WA,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Hay,Duncan A,DA,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Martin,Sarah,S,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Tumber,Anthony,A,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Rogers,Catherine M,CM,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Philpott,Martin,M,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Wang,Minghua,M,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Thompson,Amber L,AL,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Heightman,Tom D,TD,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Pryde,David C,DC,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Cook,Andrew,A,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Paton,Robert S,RS,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,<lastname>MÌ_ller</lastname>,Susanne,S,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Knapp,Stefan,S,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Brennan,Paul E,PE,None,2014,A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-ìÛ Interaction.,24821300,Conway,Stuart J,SJ,None,2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Moros,A,A,"<affiliation>Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,<lastname>RodrÌ_guez</lastname>,V,V,"<affiliation>Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Saborit-Villarroya,I,I,"<affiliation>Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Montraveta,A,A,"<affiliation>Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Balsas,P,P,"<affiliation>Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Sandy,P,P,"Department of Pharmacology, Constellation Pharmaceuticals, Inc., Cambridge, MA, USA.",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,<lastname>MartÌ_nez</lastname>,A,A,"<affiliation>Hematopathology Unit, Department of Pathology, Hospital ClÌ_nic, Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Wiestner,A,A,"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Normant,E,E,"Department of Pharmacology, Constellation Pharmaceuticals, Inc., Cambridge, MA, USA.",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Campo,E,E,"<affiliation>1] Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain [2] Hematopathology Unit, Department of Pathology, Hospital ClÌ_nic, Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,<lastname>PÌ©rez-GalÌÁn</lastname>,P,P,"<affiliation>Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,Colomer,D,D,"<affiliation>1] Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain [2] Hematopathology Unit, Department of Pathology, Hospital ClÌ_nic, Barcelona, Spain.</affiliation>",2014,Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.,24721791,<lastname>RouÌ©</lastname>,G,G,"<affiliation>Hemato-Oncology Department, Institut d'Investigacions BiomÌ¬diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</affiliation>",2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Das,Chandrima,C,"Department of Biochemistry and Molecular Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030.",2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Roy,Siddhartha,S,None,2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Namjoshi,Sarita,S,None,2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Malarkey,Christopher S,CS,None,2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Jones,David N M,DN,None,2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Kutateladze,Tatiana G,TG,None,2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Churchill,Mair E A,ME,None,2014,Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.,24616510,Tyler,Jessica K,JK,None,2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Kim,Hyun-Soo,HS,"Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10454, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Mukhopadhyay,Rituparna,R,"Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10454, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Rothbart,Scott B,SB,"Department of Biochemistry and Biophysics, UNC School of Medicine, Chapel Hill, NC 27599, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Silva,Andrea C,AC,"Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10454, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Vanoosthuyse,Vincent,V,"Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3QR, Scotland.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Radovani,Ernest,E,"Department of Chemistry and Biology, Ryerson University, Toronto, ON M5B 2K3, Canada.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Kislinger,Thomas,T,"Princess Margaret Cancer Center, Toronto, ON M5G 1L7, Canada.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Roguev,Assen,A,"Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA 94158, USA; California Institute for Quantitative Biosciences, San Francisco, CA 94158, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Ryan,Colm J,CJ,"Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA 94158, USA; California Institute for Quantitative Biosciences, San Francisco, CA 94158, USA; School of Medicine &amp; Medical Science, University College, Dublin 4, Ireland.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Xu,Jiewei,J,"Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA 94158, USA; California Institute for Quantitative Biosciences, San Francisco, CA 94158, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Jahari,Harlizawati,H,"<affiliation>Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA 94158, USA; California Institute for Quantitative Biosciences, San Francisco, CA 94158, USA; Malaysian Institute of Pharmaceuticals and Nutraceuticals, 11800åÊUSM Penang, Malaysia.</affiliation>",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Hardwick,Kevin G,KG,"Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3QR, Scotland.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Greenblatt,Jack F,JF,"Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 3E1, Canada.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Krogan,Nevan J,NJ,"Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA 94158, USA; California Institute for Quantitative Biosciences, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Fillingham,Jeffrey S,JS,"Department of Chemistry and Biology, Ryerson University, Toronto, ON M5B 2K3, Canada.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Strahl,Brian D,BD,"Department of Biochemistry and Biophysics, UNC School of Medicine, Chapel Hill, NC 27599, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Bouhassira,Eric E,EE,"Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10454, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Edelmann,Winfried,W,"Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10454, USA.",2014,Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.,24565511,Keogh,Michael-Christopher,MC,"Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10454, USA. Electronic address: michael.keogh@einstein.yu.edu.",2014,Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF‰ÛÉBRD/Tat-AcK50 association.,24474698,Hu,Ping,P,"Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (P.R. China).",2014,Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF‰ÛÉBRD/Tat-AcK50 association.,24474698,Wang,Xinghui,X,None,2014,Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF‰ÛÉBRD/Tat-AcK50 association.,24474698,Zhang,Baiqun,B,None,2014,Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF‰ÛÉBRD/Tat-AcK50 association.,24474698,Zhang,Shuai,S,None,2014,Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF‰ÛÉBRD/Tat-AcK50 association.,24474698,Wang,Qiang,Q,None,2014,Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF‰ÛÉBRD/Tat-AcK50 association.,24474698,Wang,Zhiyong,Z,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Chaidos,Aristeidis,A,"Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College London, London, United Kingdom;",2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Caputo,Valentina,V,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Gouvedenou,Katerina,K,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Liu,Binbin,B,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Marigo,Ilaria,I,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Chaudhry,Mohammed Suhail,MS,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Rotolo,Antonia,A,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Tough,David F,DF,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Smithers,Nicholas N,NN,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Bassil,Anna K,AK,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Chapman,Trevor D,TD,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Harker,Nicola R,NR,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Barbash,Olena,O,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Tummino,Peter,P,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Al-Mahdi,Niam,N,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Haynes,Andrea C,AC,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Cutler,Leanne,L,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Le,BaoChau,B,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Rahemtulla,Amin,A,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Roberts,Irene,I,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Kleijnen,Maurits,M,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Witherington,Jason J,JJ,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Parr,Nigel J,NJ,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Prinjha,Rab K,RK,None,2014,Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.,24335499,Karadimitris,Anastasios,A,None,2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Hsu,T-I,TI,"1] Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng-Kung University, Tainan, Taiwan [2] Center for Infection Disease and Signal Transduction, National Cheng-Kung University, Tainan, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Lin,S-C,SC,"Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng-Kung University, Tainan, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Lu,P-S,PS,"Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng-Kung University, Tainan, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Chang,W-C,WC,"1] Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng-Kung University, Tainan, Taiwan [2] Center for Infection Disease and Signal Transduction, National Cheng-Kung University, Tainan, Taiwan [3] Institute of Basic Medical Sciences, National Cheng-Kung University, Tainan, Taiwan [4] Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan, Taiwan [5] Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Hung,C-Y,CY,"Institute of Basic Medical Sciences, National Cheng-Kung University, Tainan, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Yeh,Y-M,YM,"Department of Internal Medicine, College of Medicine and Hospital, National Cheng-Kung University, Tainan, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Su,W-C,WC,"Department of Internal Medicine, College of Medicine and Hospital, National Cheng-Kung University, Tainan, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Liao,P-C,PC,"Department of Environmental and Occupational Health, National Cheng-Kung University, Tainan, Taiwan.",2014,MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.,24632608,Hung,J-J,JJ,"1] Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng-Kung University, Tainan, Taiwan [2] Center for Infection Disease and Signal Transduction, National Cheng-Kung University, Tainan, Taiwan [3] Institute of Basic Medical Sciences, National Cheng-Kung University, Tainan, Taiwan [4] Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan, Taiwan [5] Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Grayson,A R,AR,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Walsh,E M,EM,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Cameron,M J,MJ,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Godec,J,J,"1] Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA [2] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Ashworth,T,T,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Ambrose,J M,JM,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Aserlind,A B,AB,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Wang,H,H,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Evan,G I,GI,"Department of Biochemistry, University of Cambridge, Cambridge, UK.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Kluk,M J,MJ,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Bradner,J E,JE,"1] Harvard Medical School, Boston, MA, USA [2] Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,Aster,J C,JC,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.",23604113,French,C A,CA,"1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.",2014,The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.,24793789,Tsai,L-H,LH,"Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.",2014,The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.,24793789,Wu,J-Y,JY,"Department of Surgery, Buddhist Tzu Chi General Hospital, Taichung Branch, and College of Medicine, Tzu Chi University, Hualien, Taiwan.",2014,The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.,24793789,Cheng,Y-W,YW,"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.",2014,The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.,24793789,Chen,C-Y,CY,"Department of Surgery, China Medical University Hospital, Taichung, Taiwan.",2014,The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.,24793789,Sheu,G-T,GT,"Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.",2014,The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.,24793789,Wu,T-C,TC,"Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.",2014,The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.,24793789,Lee,H,H,"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Lamoureux,<forename>FranÌ_ois</forename>,F,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France [3].</affiliation>",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Baud'huin,Marc,M,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France [3] Nantes University Hospital, 1 Rue Gaston Veil, Nantes 44035, France [4].</affiliation>",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Rodriguez Calleja,Lidia,L,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France.</affiliation>",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Jacques,Camille,C,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France.</affiliation>",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Berreur,Martine,M,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France.</affiliation>",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,<lastname>RÌ©dini</lastname>,<forename>FranÌ_oise</forename>,F,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France.</affiliation>",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Lecanda,Fernando,F,"Division of Oncology, Adhesion and Metastasis Laboratory, Center for Applied Medical Research (CIMA), University of Navarra, Pio XII-55, Pamplona, Navarra 31008, Spain.",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Bradner,James E,JE,"1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA [2] Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts 02115, USA.",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Heymann,Dominique,D,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France [3] Nantes University Hospital, 1 Rue Gaston Veil, Nantes 44035, France.</affiliation>",2014,Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle.,24646477,Ory,Benjamin,B,"<affiliation>1] INSERM, UMR 957, Ìäquipe labellisÌ©e ligue 2012, 1 Rue Gaston Veil, Nantes 44035, France [2] Physiopathologie de la RÌ©sorption Osseuse et ThÌ©rapie des Tumeurs Osseuses Primitives, UniversitÌ© de Nantes, Nantes Atlantique UniversitÌ©s, EA3822, 1 Rue Gaston Veil, Nantes 44035, France.</affiliation>",2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Cho,Hyejin,H,"1Cold Spring Harbor Laboratory, Cancer Center, Cold Spring Harbor; 2Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College; 3Mount Sinai School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Unit for Laboratory Animal Medicine, Medical School, University of Michigan, Ann Arbor, Michigan.",2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Herzka,Tali,T,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Zheng,Wu,W,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Qi,Jun,J,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Wilkinson,John E,JE,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Bradner,James E,JE,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Robinson,Brian D,BD,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Castillo-Martin,Mireia,M,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Cordon-Cardo,Carlos,C,None,2014,"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.",24444712,Trotman,Lloyd C,LC,None,2014,The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis.,24319289,Belkina,Anna C,AC,"1.72 East Concord St., Rm. K520, Boston, MA 02118, USA. gdenis@bu.edu; Twitter: http://www.twitter.com/GdenisBoston.",2014,The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis.,24319289,Blanton,Wanda P,WP,None,2014,The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis.,24319289,Nikolajczyk,Barbara S,BS,None,2014,The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis.,24319289,Denis,Gerald V,GV,None,2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Almeida,<forename>AndrÌ© Martinho</forename>,AM,"<affiliation>IICT - Instituto de InvestigaÌ_Ì£o CientÌ_fica Tropical, Lisboa, Portugal; CIISA - Centro Interdisciplinar de InvestigaÌ_Ì£o em Sanidade Animal, Lisboa, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Oeiras, Portugal; IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Oeiras, Portugal. Electronic address: aalmeida@fmv.utl.pt.</affiliation>",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Plowman,Jeffrey E,JE,"AgResearch Ltd., Lincoln, New Zealand.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Harland,Duane P,DP,"AgResearch Ltd., Lincoln, New Zealand.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Thomas,Ancy,A,"AgResearch Ltd., Lincoln, New Zealand.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Kilminster,Tanya,T,"Department of Agriculture and Food Western Australia, Perth, WA, Australia.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Scanlon,Tim,T,"Department of Agriculture and Food Western Australia, Perth, WA, Australia.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Milton,John,J,"University of Western Australia, Crawley, WA, Australia.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Greeff,Johan,J,"Department of Agriculture and Food Western Australia, Perth, WA, Australia.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Oldham,Chris,C,"Department of Agriculture and Food Western Australia, Perth, WA, Australia.",2014,Influence of feed restriction on the wool proteome: A combined iTRAQ and fiber structural study.,24709639,Clerens,Stefan,S,"AgResearch Ltd., Lincoln, New Zealand.",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Martins,Isabel,I,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal; Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Garcia,Helga,H,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Varela,<forename>AdÌ©lia</forename>,A,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal; Instituto Nacional de InvestigaÌ_Ì£o AgrÌÁria e VeterinÌÁria, (INIAV), Av. da RepÌ_blica, Quinta do MarquÌ»s, 2784-505 Oeiras, Portugal.</affiliation>",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,<lastname>NÌ_Ì±ez</lastname>,Oscar,O,"Department of Analytical Chemistry, University of Barcelona, Diagonal 645, E-08028 Barcelona, Spain.",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Planchon,<forename>SÌ©bastien</forename>,S,"Proteomics Platform, Centre de Recherche Public -Gabriel Lippmann, Belvaux, Luxembourg.",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Galceran,Maria Teresa,MT,"Department of Analytical Chemistry, University of Barcelona, Diagonal 645, E-08028 Barcelona, Spain.",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Renaut,Jenny,J,"Proteomics Platform, Centre de Recherche Public -Gabriel Lippmann, Belvaux, Luxembourg.",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Rebelo,<forename>LuÌ_s P N</forename>,LP,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2014,Investigating Aspergillus nidulans secretome during colonisation of cork cell walls.,24316358,Silva Pereira,Cristina,C,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal; Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal. Electronic address: spereira@itqb.unl.pt.</affiliation>",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,French,Christopher A,CA,"Department of Pathology, Brigham and Women's Hospital/Harvard Medical School cfrench@partners.org.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Rahman,Shaila,S,"Department of Microbiology and Immunobiology, Harvard Medical School.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Walsh,Erica M,EM,"Department of Pathology, Brigham and Women's Hospital/Harvard Medical School.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Kuhnle,Simone,S,"Department of Microbiology and Immunobiology, Harvard Medical School.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Grayson,Adlai R,AR,"Department of Pathology, Brigham and Women's Hospital/Harvard Medical School.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Lemieux,Madeleine E,ME,Bioinfo.,2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Grunfeld,Noam,N,"Department of Pathology, Brigham and Women's Hospital/Harvard Medical School.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Rubin,Brian P,BP,"Robert J. Tomsich Pathology &amp; Laboratory Medicine Institute and Department of Molecular Genetics, Cleveland Clinic and Lerner Research Institute.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Antonescu,Cristina R,CR,"Department of Pathology, Memorial Sloan-Kettering Cancer Center.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Zhang,Songlin,S,"Department of Pathology &amp; Laboratory Medicine, University of Texas Health Science Center at Houston.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Venkatramani,Rajkumar,R,"Center for Cancer and Blood Diseases, Children's Hospital Los Angeles.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Dal Cin,Paola,P,"Department of Pathology, Brigham and Women's Hospital/Harvard Medical School.",2014,NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism.,24875858,Howley,Peter M,PM,"Department of Microbiology and Immunobiology, Harvard Medical School.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Shortt,Jake,J,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Hsu,Andy K,AK,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Martin,Benjamin P,BP,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Doggett,Karen,K,"Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Matthews,Geoffrey M,GM,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Doyle,Maria A,MA,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Ellul,Jason,J,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Jockel,Tina E,TE,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Andrews,Daniel M,DM,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Hogg,Simon J,SJ,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Reitsma,Andrea,A,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Faulkner,David,D,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Bergsagel,P Leif,PL,"Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ 85259, USA.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Chesi,Marta,M,"Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ 85259, USA.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Heath,Joan K,JK,"Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Denny,William A,WA,"Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Thompson,Philip E,PE,"Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Neeson,Paul J,PJ,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Ritchie,David S,DS,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,McArthur,Grant A,GA,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia.",2014,The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.,24813887,Johnstone,Ricky W,RW,"Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3002, Australia. Electronic address: ricky.johnstone@petermac.org.",2014,Pleiotrophin antagonizes Brd2 during neuronal differentiation.,24695857,Garcia-Gutierrez,Pablo,P,"<affiliation>Stem Cells Department, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) (Consejo Superior de Investigaciones Cientificas (CSIC), Junta de AndalucÌ_a, Universidad de Sevilla, Universidad Pablo de Olavide), Seville 41092, Spain.</affiliation>",2014,Pleiotrophin antagonizes Brd2 during neuronal differentiation.,24695857,Juarez-Vicente,Francisco,F,"<affiliation>Stem Cells Department, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) (Consejo Superior de Investigaciones Cientificas (CSIC), Junta de AndalucÌ_a, Universidad de Sevilla, Universidad Pablo de Olavide), Seville 41092, Spain.</affiliation>",2014,Pleiotrophin antagonizes Brd2 during neuronal differentiation.,24695857,Wolgemuth,Debra J,DJ,"Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA.",2014,Pleiotrophin antagonizes Brd2 during neuronal differentiation.,24695857,Garcia-Dominguez,Mario,M,"<affiliation>Stem Cells Department, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) (Consejo Superior de Investigaciones Cientificas (CSIC), Junta de AndalucÌ_a, Universidad de Sevilla, Universidad Pablo de Olavide), Seville 41092, Spain mario.garcia@cabimer.es.</affiliation>",2014,Genome-Scale Acetylation-Dependent Histone Eviction during Spermatogenesis.,24613302,Goudarzi,Afsaneh,A,"<affiliation>Institut National de la SantÌ© et de la Recherche MÌ©dicale U823 and UniversitÌ© Grenoble Alpes Institut Albert Bonniot, Grenoble F-38700, France.</affiliation>",2014,Genome-Scale Acetylation-Dependent Histone Eviction during Spermatogenesis.,24613302,Shiota,Hitoshi,H,"<affiliation>Institut National de la SantÌ© et de la Recherche MÌ©dicale U823 and UniversitÌ© Grenoble Alpes Institut Albert Bonniot, Grenoble F-38700, France.</affiliation>",2014,Genome-Scale Acetylation-Dependent Histone Eviction during Spermatogenesis.,24613302,Rousseaux,Sophie,S,"<affiliation>Institut National de la SantÌ© et de la Recherche MÌ©dicale U823 and UniversitÌ© Grenoble Alpes Institut Albert Bonniot, Grenoble F-38700, France.</affiliation>",2014,Genome-Scale Acetylation-Dependent Histone Eviction during Spermatogenesis.,24613302,Khochbin,Saadi,S,"<affiliation>Institut National de la SantÌ© et de la Recherche MÌ©dicale U823 and UniversitÌ© Grenoble Alpes Institut Albert Bonniot, Grenoble F-38700, France. Electronic address: khochbin@ujf-grenoble.fr.</affiliation>",2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Dittmann,Antje,A,"Cellzome GmbH , Meyerhofstrasse 1, 69117 Heidelberg, Germany.",2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Werner,Thilo,T,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Chung,Chun-Wa,CW,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Savitski,Mikhail M,MM,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,<lastname>FÌ_lth Savitski</lastname>,Maria,M,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Grandi,Paola,P,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Hopf,Carsten,C,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Lindon,Matthew,M,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Neubauer,Gitte,G,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Prinjha,Rabinder K,RK,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Bantscheff,Marcus,M,None,2014,The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.,24533473,Drewes,Gerard,G,None,2014,ChEpiMod: a knowledgebase for chemical modulators of epigenome reader domains.,24470572,Meslamani,Jamel,J,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY, 10029, USA.",2014,ChEpiMod: a knowledgebase for chemical modulators of epigenome reader domains.,24470572,Smith,Steven G,SG,None,2014,ChEpiMod: a knowledgebase for chemical modulators of epigenome reader domains.,24470572,Sanchez,Roberto,R,None,2014,ChEpiMod: a knowledgebase for chemical modulators of epigenome reader domains.,24470572,Zhou,Ming-Ming,MM,None,2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Zou,June X,JX,"UC Davis Cancer Center/Basic Sciences, University of California, Davis, UCDMC Research III, Room 1400B, 4645 2nd Avenue, Sacramento, CA 95817. hwzchen@ucdavis.edu.",2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Duan,Zhijian,Z,None,2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Wang,Junjian,J,None,2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Sokolov,Alex,A,None,2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Xu,Jianzhen,J,None,2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Chen,Christopher Z,CZ,None,2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Li,Jian Jian,JJ,None,2014,"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.",24391143,Chen,Hong-Wu,HW,None,2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Poplawski,Amanda,A,"Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Hu,Kaifeng,K,"National Magnetic Resonance Facility at Madison and Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Lee,Woonghee,W,"National Magnetic Resonance Facility at Madison and Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Natesan,Senthil,S,"Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Peng,Danni,D,"Department of Biochemistry and Molecular Biology, Division of Basic Science Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Carlson,Samuel,S,"Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Shi,Xiaobing,X,"Department of Biochemistry and Molecular Biology, Division of Basic Science Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Balaz,Stefan,S,"Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Markley,John L,JL,"National Magnetic Resonance Facility at Madison and Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.",2014,Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.,24333487,Glass,Karen C,KC,"Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA. Electronic address: karen.glass@acphs.edu.",2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Zucchelli,Chiara,C,"Dulbecco Telethon Institute, c/o Biomolecular NMR Laboratory, S. Raffaele Scientific Institute, Milano, Italy.",2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Tamburri,Simone,S,None,2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Quilici,Giacomo,G,None,2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Palagano,Eleonora,E,None,2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Berardi,Andrea,A,None,2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Saare,Mario,M,None,2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Peterson,<forename>PÌ_rt</forename>,P,None,2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Bachi,Angela,A,None,2014,Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1.,24267382,Musco,Giovanna,G,None,2014,Zinc finger protein in severe dry eye syndrome.,24215362,Lee,Seung Hoon,SH,"Department of Ophthalmology, College of Medicine, Chung-Ang University Hospital , Heukseok-dong, Dongjak-Gu, Seoul , South Korea and.",2014,Zinc finger protein in severe dry eye syndrome.,24215362,Park,Min-Yi,MY,None,2014,Zinc finger protein in severe dry eye syndrome.,24215362,Kim,Kyoung Woo,KW,None,2014,Zinc finger protein in severe dry eye syndrome.,24215362,Wee,Sung Wook,SW,None,2014,Zinc finger protein in severe dry eye syndrome.,24215362,Kim,Jae Chan,JC,None,2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Gallagher,S J,SJ,"Melanoma Research Group. Kolling Institute of Medical Research, University of Sydney, Pacific Hwy/RNSH, St Leonards, NSW, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Mijatov,B,B,"Melanoma Research Group. Kolling Institute of Medical Research, University of Sydney, Pacific Hwy/RNSH, St Leonards, NSW, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Gunatilake,D,D,"Melanoma Research Group. Kolling Institute of Medical Research, University of Sydney, Pacific Hwy/RNSH, St Leonards, NSW, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Tiffen,J C,JC,"Melanoma Research Group. Kolling Institute of Medical Research, University of Sydney, Pacific Hwy/RNSH, St Leonards, NSW, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Gowrishankar,K,K,"Melanoma Research Group. Kolling Institute of Medical Research, University of Sydney, Pacific Hwy/RNSH, St Leonards, NSW, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Jin,L,L,"Melanoma Research Group. Kolling Institute of Medical Research, University of Sydney, Pacific Hwy/RNSH, St Leonards, NSW, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Pupo,G M,GM,"Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Cullinane,C,C,"1] Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia [2] Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Prinjha,R K,RK,"Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Smithers,N,N,"Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,McArthur,G A,GA,"1] Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia [2] Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Rizos,H,H,"Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia.",2014,The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells.,24906137,Hersey,P,P,"1] Melanoma Research Group. Kolling Institute of Medical Research, University of Sydney, Pacific Hwy/RNSH, St Leonards, NSW, Australia [2] Melanoma Institute of Australia, North Sydney, NSW, Australia.",2014,"Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.",24565118,Mbonye,Uri,U,"Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, United States.",2014,"Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.",24565118,Karn,Jonathan,J,"Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, United States. Electronic address: jxk153@cwru.edu.",2014,Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV).,24185123,Salles,Paulo Guilherme de Oliveira,PG,"<affiliation>*Instituto Mario Penna and Biocor Instituto, Belo Horizonte, MG ‰ÛÊConsultoria em Patologia, Botucatu, SP, Brazil.</affiliation>",2014,Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV).,24185123,Moura,Rafael de Deus,Rde D,None,2014,Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV).,24185123,Menezes,<forename>LetÌ_cia M</forename>,LM,None,2014,Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV).,24185123,Bacchi,Carlos E,CE,None,2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Hussong,M,M,"1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany [2] Department of Biology, Chemistry and Pharmacy, Free University, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,<lastname>BÌ_rno</lastname>,S T,ST,"Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Kerick,M,M,"Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Wunderlich,A,A,"Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Franz,A,A,"1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany [2] Department of Biology, Chemistry and Pharmacy, Free University, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,<lastname>SÌ_ltmann</lastname>,H,H,"Cancer Genome Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Timmermann,B,B,"Next Generation Sequencing Group, Max Planck Institute for Molecular Genetics, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Lehrach,H,H,"Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Hirsch-Kauffmann,M,M,"Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.",2014,The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.,24763052,Schweiger,M R,MR,"1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany [2] Cologne Center for Genomics, University of Cologne, Cologne, Germany.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Knoechel,Birgit,B,"1] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [4] Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [5].",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Roderick,Justine E,JE,"1] Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. [2].",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Williamson,Kaylyn E,KE,"1] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Zhu,Jiang,J,"1] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Lohr,Jens G,JG,"1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Cotton,Matthew J,MJ,"1] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Gillespie,Shawn M,SM,"1] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Fernandez,Daniel,D,"1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Biostatistics Graduate Program, Harvard University, Cambridge, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Ku,Manching,M,"1] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Wang,Hongfang,H,"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Piccioni,Federica,F,"Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Silver,Serena J,SJ,"Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Jain,Mohit,M,"1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA. [3] Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Pearson,Daniel,D,"1] Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Biological and Biomedical Sciences Graduate Program, Harvard Medical School, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Kluk,Michael J,MJ,"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Ott,Christopher J,CJ,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Shultz,Leonard D,LD,"Jackson Laboratory, Bar Harbor, Maine, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Brehm,Michael A,MA,"Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Greiner,Dale L,DL,"Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Gutierrez,Alejandro,A,"1] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Stegmaier,Kimberly,K,"1] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Kung,Andrew L,AL,"1] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Root,David E,DE,"Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Bradner,James E,JE,"1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Aster,Jon C,JC,"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Kelliher,Michelle A,MA,"Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.",2014,An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.,24584072,Bernstein,Bradley E,BE,"1] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.",2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Liu,Suhu,S,"Authors' Affiliations: Department of Medical Oncology, Dana-Farber Cancer Institute, and Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; and Department of Immunology, Institute of Biomedical Science, University of Sao Paulo, Sao Paulo, Brazil.",2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Walker,Sarah R,SR,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Nelson,Erik A,EA,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Cerulli,Robert,R,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Xiang,Michael,M,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Toniolo,Patricia A,PA,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Qi,Jun,J,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Stone,Richard M,RM,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Wadleigh,Martha,M,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Bradner,James E,JE,None,2014,Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.,24435449,Frank,David A,DA,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Bandopadhayay,Pratiti,P,"Authors' Affiliations: Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Pediatric Neuro-Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology/Oncology, Boston Children's Hospital; Center for Cancer Genome Characterization, Dana-Farber Cancer Institute, Boston; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Departments of Neurology and Neurological Sciences and Neurosurgery, Stanford University School of Medicine; Stanford Cancer Institute, Stanford University Medical Center, Stanford; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla; Department of Neurology, Pediatrics, and Neurosurgery, University of California, San Francisco, California; and Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.",2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Bergthold,Guillaume,G,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Nguyen,Brian,B,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Schubert,Simone,S,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Gholamin,Sharareh,S,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Tang,Yujie,Y,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Bolin,Sara,S,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Schumacher,Steven E,SE,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Zeid,Rhamy,R,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Masoud,Sabran,S,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Yu,Furong,F,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Vue,Nujsaubnusi,N,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Gibson,William J,WJ,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Paolella,Brenton R,BR,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Mitra,Siddhartha S,SS,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Cheshier,Samuel H,SH,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Qi,Jun,J,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Liu,Kun-Wei,KW,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Wechsler-Reya,Robert,R,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Weiss,William A,WA,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Swartling,Fredrik J,FJ,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Kieran,Mark W,MW,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Bradner,James E,JE,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Beroukhim,Rameen,R,None,2014,BET bromodomain inhibition of MYC-amplified medulloblastoma.,24297863,Cho,Yoon-Jae,YJ,None,2014,Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.,23792448,Tolani,B,B,"Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.",2014,Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.,23792448,Gopalakrishnan,R,R,"Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.",2014,Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.,23792448,Punj,V,V,"Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.",2014,Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.,23792448,Matta,H,H,"Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.",2014,Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.,23792448,Chaudhary,P M,PM,"Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.",2014,Proteomics in farm animals: quo vadis?,24665858,de Almeida,Andre Martinho,AM,None,2014,Proteomics in farm animals: quo vadis?,24665858,Bassols,Anna,A,None,2014,Proteomics in farm animals: quo vadis?,24665858,Ceciliani,Fabrizio,F,"<affiliation>Instituto de Investigacao CientÌ_fica Tropical, Lisboa, Portugal &amp; ITQB/IBET, Oeiras, Portugal &amp; CIISA, FMV-UL, Lisboa, Portugal.</affiliation>",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Bessems,Jos G,JG,"National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands. Electronic address: jos.bessems@ec.europa.eu.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Loizou,George,G,"Health and Safety Laboratories, Mathematical Sciences Unit, Buxton, UK.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Krishnan,Kannan,K,"<affiliation>DÌ©partement de SantÌ© Environnementale et SantÌ© au Travail, FacultÌ© de MÌ©decine, UniversitÌ© de MontrÌ©al, MontrÌ©al, Canada.</affiliation>",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Clewell,Harvey J,HJ,"The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Bernasconi,Camilla,C,"Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Bois,Frederic,F,"Compiegne University of Technology, Chair of Mathematical Modelling for Systems Toxicology, Compiegne &amp; INERIS, DRC/VIVA/METO, Verneuil en Halatte, France.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Coecke,Sandra,S,"Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Collnot,Eva-Maria,EM,"<affiliation>Helmholtz Institute for Pharmaceutical Research Saarland, SaarbrÌ_cken, Germany.</affiliation>",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Diembeck,Walter,W,"Beiersdorf AG, Unnastr. 48, D-20245 Hamburg, Germany.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Farcal,Lucian Romeo,LR,"Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Geraets,Liesbeth,L,"National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Gundert-Remy,Ursula,U,"<affiliation>Department Clinical Pharmacology and Toxicology, Medical School (CharitÌ©), Berlin, Germany.</affiliation>",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Kramer,Nynke,N,"Institute for Risk Assessment Sciences, Utrecht University, Netherlands.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,<lastname>KÌ_sters</lastname>,Gabriele,G,"European Partnership for Alternative Approaches to Animal Testing (EPAA), 15b Avenue Herrmann Debroux, 1160 Bruxelles, Belgium.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Leite,Sofia B,SB,"<affiliation>Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy; Instituto de Biologia Experimental e TecnolÌ_gica (IBET)/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa (ITQB-UNL), Oeiras, Portugal.</affiliation>",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Pelkonen,Olavi R,OR,"Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,<lastname>SchrÌ_der</lastname>,Klaus,K,"BioMed-zet Life Science GmbH/Centre for Alternative and Complementary Methods to Animal Testing (ZET), Linz, Austria.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Testai,Emanuela,E,"<affiliation>Istituto Superiore di SanitÌÊ, Viale Regina Elena, 299, Rome, Italy.</affiliation>",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,Wilk-Zasadna,Iwona,I,"Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.",2014,PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.,24287156,<lastname>ZaldÌ_var-Comenges</lastname>,<forename>JosÌ©-Manuel</forename>,JM,"Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.",2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Barda,S,S,"The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel; Institute for the Study of Fertility, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.",2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Yogev,L,L,None,2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Paz,G,G,None,2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Yavetz,H,H,None,2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Lehavi,O,O,None,2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Hauser,R,R,None,2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Doniger,T,T,None,2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Breitbart,H,H,None,2014,BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility.,24865796,Kleiman,S E,SE,None,2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Sahai,Vaibhav,V,"Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University.",2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Kumar,Krishan,K,None,2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Knab,Lawrence M,LM,None,2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Chow,Christina R,CR,None,2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Raza,Sania S,SS,None,2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Bentrem,David J,DJ,None,2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Ebine,Kazumi,K,None,2014,BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.,24807963,Munshi,Hidayatullah G,HG,None,2014,The bromodomain: From epigenome reader to druggable target.,24686119,Sanchez,Roberto,R,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.",2014,The bromodomain: From epigenome reader to druggable target.,24686119,Meslamani,Jamel,J,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.",2014,The bromodomain: From epigenome reader to druggable target.,24686119,Zhou,Ming-Ming,MM,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.",2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,Liu,Ruijie,R,"Departments of Medicine and Nephrology, Mount Sinai School of Medicine, New York, NY.",2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,Zhong,Yifei,Y,None,2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,Li,Xuezhu,X,None,2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,Chen,Haibing,H,None,2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,Jim,Belinda,B,None,2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,Zhou,Ming-Ming,MM,None,2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,Chuang,Peter Y,PY,None,2014,Role of Transcription Factor Acetylation in Diabetic Kidney Disease.,24608443,He,John Cijiang,JC,None,2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Shi,Jian,J,"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Wang,Yifan,Y,"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Zeng,Lei,L,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Wu,Yadi,Y,"Department of Molecular and Biomedical Pharmacology, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Deng,Jiong,J,"Department of Pathophysiology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, and Translation Medicine Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Zhang,Qiang,Q,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Lin,Yiwei,Y,"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Li,Junlin,J,"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Kang,Tiebang,T,"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Tao,Min,M,"Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Rusinova,Elena,E,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Zhang,Guangtao,G,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Wang,Chi,C,"Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Zhu,Haining,H,"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Yao,Jun,J,"Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Zeng,Yi-Xin,YX,"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Evers,B Mark,BM,"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Department of Surgery, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Zhou,Ming-Ming,MM,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: ming-ming.zhou@mssm.edu.",2014,Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.,24525235,Zhou,Binhua P,BP,"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY 40506, USA; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China. Electronic address: peter.zhou@uky.edu.",2014,Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.,24467243,Jennings,Laura E,LE,"Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.",2014,Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.,24467243,Measures,Angelina R,AR,None,2014,Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.,24467243,Wilson,Brian G,BG,None,2014,Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.,24467243,Conway,Stuart J,SJ,None,2014,BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.,24373973,Patel,Amish J,AJ,"Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA; Cancer Biology Graduate Program, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA.",2014,BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.,24373973,Liao,Chung-Ping,CP,"Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA.",2014,BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.,24373973,Chen,Zhiguo,Z,"Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA.",2014,BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.,24373973,Liu,Chiachi,C,"Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA.",2014,BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.,24373973,Wang,Yong,Y,"Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA.",2014,BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.,24373973,Le,Lu Q,LQ,"Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA; Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA; UTSW Neurofibromatosis Clinic, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA. Electronic address: lu.le@utsouthwestern.edu.",2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Fedorov,Oleg,O,"Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.",2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Lingard,Hannah,H,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Wells,Chris,C,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Monteiro,Octovia P,OP,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Picaud,Sarah,S,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Keates,Tracy,T,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Yapp,Clarence,C,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Philpott,Martin,M,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Martin,Sarah J,SJ,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Felletar,Ildiko,I,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Marsden,Brian D,BD,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Filippakopoulos,Panagis,P,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,<lastname>MÌ_ller</lastname>,Susanne,S,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Knapp,Stefan,S,None,2014,"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.",24313754,Brennan,Paul E,PE,None,2014,BET bromodomain inhibitors: a patent review.,24261714,Garnier,Jean-Marc,JM,"The Walter and Eliza Hall Institute of Medical Research , 1G Royal Pde, Parkville, VIC, 3052 , Australia +61 3 9345 2957 ; +61 3 9347 0852 ; burns@wehi.edu.au.",2014,BET bromodomain inhibitors: a patent review.,24261714,Sharp,Phillip P,PP,None,2014,BET bromodomain inhibitors: a patent review.,24261714,Burns,Christopher J,CJ,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Park,Young-Ae,YA,"Authors' Affiliations: Department of Obstetrics &amp; Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; and Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea.",2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Lee,Jeong-Won,JW,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Kim,Hye-Sun,HS,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Lee,Yoo-Young,YY,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Kim,Tae-Joong,TJ,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Choi,Chel Hun,CH,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Choi,Jung-Joo,JJ,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Jeon,Hye-Kyung,HK,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Cho,Young Jae,YJ,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Ryu,Ji Yoon,JY,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Kim,Byoung-Gie,BG,None,2014,Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.,24198243,Bae,Duk-Soo,DS,None,2014,Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome.,24832099,Jang,Moon Kyoo,MK,"Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.",2014,Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome.,24832099,Shen,Kui,K,"Bioinformatics and Computational Biosciences Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.",2014,Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome.,24832099,McBride,Alison A,AA,"Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.",2014,Chromatin-regulating proteins as targets for cancer therapy.,24522270,Oike,Takahiro,T,"Division of Genome Biology, National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.",2014,Chromatin-regulating proteins as targets for cancer therapy.,24522270,Ogiwara,Hideaki,H,None,2014,Chromatin-regulating proteins as targets for cancer therapy.,24522270,Amornwichet,Napapat,N,None,2014,Chromatin-regulating proteins as targets for cancer therapy.,24522270,Nakano,Takashi,T,None,2014,Chromatin-regulating proteins as targets for cancer therapy.,24522270,Kohno,Takashi,T,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Shimamura,Takeshi,T,"<affiliation>Authors' Affiliations: Department of Molecular Pharmacology and Therapeutics, Oncology Research Institute, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois; Departments of Medical Oncology and Radiation Oncology; Belfer Institute for Applied Cancer Science; Ludwig Center at Dana-Farber/Harvard Cancer Center; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; Department of Medicine, Brigham and Women's Hospital; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Departament de Fisiologia, Facultat de FarmÌÊcia, Universitat de ValÌ¬ncia, Valencia, Spain; and Department of Pediatrics, Columbia University Medical Center, New York, New York.</affiliation>",2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Chen,Zhao,Z,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Soucheray,Margaret,M,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Carretero,Julian,J,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Kikuchi,Eiki,E,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Tchaicha,Jeremy H,JH,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Gao,Yandi,Y,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Cheng,Katherine A,KA,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Cohoon,Travis J,TJ,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Qi,Jun,J,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Akbay,Esra,E,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Kimmelman,Alec C,AC,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Kung,Andrew L,AL,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Bradner,James E,JE,None,2013,Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.,24045185,Wong,Kwok-Kin,KK,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Tang,Xiaoyan,X,"Inflammation Discovery Therapeutic Area, Hoffmann-La Roche Inc., Nutley, New Jersey, USA.",2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Peng,Ruoqi,R,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Phillips,Jonathan E,JE,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Deguzman,Jeremy,J,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Ren,Yonglin,Y,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Apparsundaram,Subramanium,S,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Luo,Qi,Q,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Bauer,Carla M,CM,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Fuentes,Maria E,ME,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,DeMartino,Julie A,JA,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Tyagi,Gaurav,G,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Garrido,Rosario,R,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Hogaboam,Cory M,CM,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Denton,Christopher P,CP,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Holmes,Alan M,AM,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Kitson,Christopher,C,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Stevenson,Christopher S,CS,None,2013,Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.,23759512,Budd,David C,DC,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Puissant,Alexandre,A,"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.",2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Frumm,Stacey M,SM,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Alexe,Gabriela,G,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Bassil,Christopher F,CF,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Qi,Jun,J,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Chanthery,Yvan H,YH,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Nekritz,Erin A,EA,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Zeid,Rhamy,R,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Gustafson,William Clay,WC,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Greninger,Patricia,P,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Garnett,Matthew J,MJ,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,McDermott,Ultan,U,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Benes,Cyril H,CH,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Kung,Andrew L,AL,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Weiss,William A,WA,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Bradner,James E,JE,None,2013,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,23430699,Stegmaier,Kimberly,K,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Boehm,Daniela,D,"Gladstone Institute of Virology and Immunology, San Francisco, CA, USA.",2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Calvanese,Vincenzo,V,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Dar,Roy D,RD,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Xing,Sifei,S,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Schroeder,Sebastian,S,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Martins,Laura,L,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Aull,Katherine,K,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Li,Pao-Chen,PC,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Planelles,Vicente,V,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Bradner,James E,JE,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Zhou,Ming-Ming,MM,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Siliciano,Robert F,RF,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Weinberger,Leor,L,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Verdin,Eric,E,None,2013,BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.,23255218,Ott,Melanie,M,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,Abreu,Isabel A,IA,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Genomics of Plant Stress Laboratory (GPlantS Lab), Av. da RepÌ_blica, 2780-157 Oeiras, Portugal; iBET, Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,Farinha,Ana Paula,AP,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,<lastname>NegrÌ£o</lastname>,<forename>SÌ_nia</forename>,S,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,<lastname>GonÌ_alves</lastname>,Nuno,N,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,Fonseca,<forename>CÌÁtia</forename>,C,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,Rodrigues,Mafalda,M,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,Batista,Rita,R,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,Saibo,Nelson J M,NJ,None,2013,Coping with abiotic stress: proteome changes for crop improvement.,23886779,Oliveira,M Margarida,MM,None,2013,Free chlorine inactivation of fungi in drinking water sources.,23164218,Pereira,V J,VJ,"<affiliation>IBET, Av. RepÌ_blica, Qta. do MarquÌ»s (EAN), 2784-505 Oeiras, Portugal. vanessap@itqb.unl.pt</affiliation>",2013,Free chlorine inactivation of fungi in drinking water sources.,23164218,Marques,R,R,None,2013,Free chlorine inactivation of fungi in drinking water sources.,23164218,Marques,M,M,None,2013,Free chlorine inactivation of fungi in drinking water sources.,23164218,Benoliel,M J,MJ,None,2013,Free chlorine inactivation of fungi in drinking water sources.,23164218,Barreto Crespo,M T,MT,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Parikh,Sameer A,SA,"<affiliation>*Department of Oncology, Mayo Clinic, Rochester, Minnesota; ‰ÛÊDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; ‰ÛÁDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; å_GlaxoSmithKline, Philadelphia, Pennsylvania; and ‰Û_Early Drug Development Center, Dana Farber Cancer Institute, Boston, Massachusetts.</affiliation>",2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,French,Christopher A,CA,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Costello,Brian A,BA,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Marks,Randolph S,RS,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Dronca,Roxana S,RS,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Nerby,Craig L,CL,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Roden,Anja C,AC,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Peddareddigari,Vijay G,VG,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Hilton,John,J,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Shapiro,Geoffrey I,GI,None,2013,NUT midline carcinoma: an aggressive intrathoracic neoplasm.,24457244,Molina,Julian R,JR,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Ferguson,Fleur M,FM,"Department of Chemistry, University of Cambridge , Lensfield Road, Cambridge, CB2 1EW, U.K.",2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Fedorov,Oleg,O,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Chaikuad,Apirat,A,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Philpott,Martin,M,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Muniz,Joao R C,JR,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Felletar,Ildiko,I,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,von Delft,Frank,F,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Heightman,Tom,T,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Knapp,Stefan,S,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Abell,Chris,C,None,2013,Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.,24304323,Ciulli,Alessio,A,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Zang,Kun,K,"The Key Laboratory of Molecular Medicine, Ministry of Education, Fudan University, Shanghai, PR China ; Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, PR China.",2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Wang,Jingyu,J,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Dong,Miaofang,M,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Sun,Ruixin,R,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Wang,Yuxiong,Y,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Huang,Yinong,Y,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Liu,Xiaoxia,X,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Li,Yimin,Y,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Wang,Fangnian,F,None,2013,Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.,24194944,Yu,Min,M,None,2013,Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain.,24100334,Lolli,Graziano,G,"Department of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, Italy.",2013,Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain.,24100334,Battistutta,Roberto,R,None,2013,Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.,24007471,Martin,Mathew P,MP,"Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute , 12902 Magnolia Drive, Tampa, Florida 33612, United States.",2013,Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.,24007471,Olesen,Sanne H,SH,None,2013,Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.,24007471,Georg,Gunda I,GI,None,2013,Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.,24007471,<lastname>SchÌ_nbrunn</lastname>,Ernst,E,None,2013,Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.,23796463,<lastname>GyurkÌ_</lastname>,<forename>DÌÁvid M</forename>,DM,"Semmelweis University, Department of Medical Chemistry, Tuzolto u. 37-47, H-1094 Budapest, Hungary.",2013,Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.,23796463,Veres,<forename>DÌÁniel V</forename>,DV,None,2013,Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.,23796463,<lastname>MÌ_dos</lastname>,<forename>DezsÅÔ</forename>,D,None,2013,Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.,23796463,Lenti,Katalin,K,None,2013,Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.,23796463,<lastname>KorcsmÌÁros</lastname>,<forename>TamÌÁs</forename>,T,None,2013,Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.,23796463,Csermely,Peter,P,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Qian,Min-Xian,MX,"Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, and College of Life Sciences, Beijing Normal University, 19 Xinjiekouwai Avenue, Beijing 100875, China.",2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Pang,Ye,Y,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Liu,Cui Hua,CH,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Haratake,Kousuke,K,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Du,Bo-Yu,BY,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Ji,Dan-Yang,DY,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Wang,Guang-Fei,GF,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Zhu,Qian-Qian,QQ,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Song,Wei,W,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Yu,Yadong,Y,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Zhang,Xiao-Xu,XX,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Huang,Hai-Tao,HT,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Miao,Shiying,S,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Chen,Lian-Bin,LB,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Zhang,Zi-Hui,ZH,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Liang,Ya-Nan,YN,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Liu,Shan,S,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Cha,Hwangho,H,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Yang,Dong,D,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Zhai,Yonggong,Y,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Komatsu,Takuo,T,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Tsuruta,Fuminori,F,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Li,Haitao,H,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Cao,Cheng,C,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Li,Wei,W,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Li,Guo-Hong,GH,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Cheng,Yifan,Y,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Chiba,Tomoki,T,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Wang,Linfang,L,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Goldberg,Alfred L,AL,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Shen,Yan,Y,None,2013,Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis.,23706739,Qiu,Xiao-Bo,XB,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Hewings,David S,DS,"Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.",2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Fedorov,Oleg,O,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Filippakopoulos,Panagis,P,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Martin,Sarah,S,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Picaud,Sarah,S,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Tumber,Anthony,A,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Wells,Christopher,C,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Olcina,Monica M,MM,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Freeman,Katherine,K,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Gill,Andrew,A,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Ritchie,Alison J,AJ,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Sheppard,David W,DW,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Russell,Angela J,AJ,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Hammond,Ester M,EM,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Knapp,Stefan,S,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Brennan,Paul E,PE,None,2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.",23517011,Conway,Stuart J,SJ,None,2013,Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression.,23436376,Chen,Jihong,J,"Departments of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.",2013,Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression.,23436376,Li,Qiao,Q,None,2013,The role of the double bromodomain-containing BET genes during mammalian spermatogenesis.,23287038,Berkovits,Binyamin D,BD,"Department of Genetics and Development, Columbia University Medical Center, New York, USA.",2013,The role of the double bromodomain-containing BET genes during mammalian spermatogenesis.,23287038,Wolgemuth,Debra J,DJ,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Thompson-Wicking,K,K,"Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia.",2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Francis,R W,RW,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Stirnweiss,A,A,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Ferrari,E,E,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Welch,M D,MD,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Baker,E,E,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Murch,A R,AR,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Gout,A M,AM,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Carter,K W,KW,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Charles,A K,AK,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Phillips,M B,MB,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Kees,U R,UR,None,2013,Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.,23128391,Beesley,A H,AH,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Vidler,Lewis R,LR,"Division of Cancer Therapeutics, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research , 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom.",2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Filippakopoulos,Panagis,P,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Fedorov,Oleg,O,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Picaud,Sarah,S,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Martin,Sarah,S,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Tomsett,Michael,M,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Woodward,Hannah,H,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Brown,Nathan,N,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Knapp,Stefan,S,None,2013,Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.,24090311,Hoelder,Swen,S,None,2013,Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle.,23722886,McBride,Alison A,AA,"Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. amcbride@nih.gov",2013,Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle.,23722886,Jang,Moon Kyoo,MK,None,2013,Anything but simple: a phosphorylation-driven toggle within Brd4 triggers gene-specific transcriptional activation.,23473602,Laptenko,Oleg,O,"Department of Biological Sciences, Columbia University, New York, NY 10027, USA.",2013,Anything but simple: a phosphorylation-driven toggle within Brd4 triggers gene-specific transcriptional activation.,23473602,Prives,Carol,C,None,2013,Reactivation of latent HIV: do all roads go through P-TEFb?,24409197,Budhiraja,Sona,S,"Department of Molecular Microbiology &amp; Virology, Baylor College of Medicine, Houston, TX 77030, USA.",2013,Reactivation of latent HIV: do all roads go through P-TEFb?,24409197,Rice,Andrew P,AP,"Department of Molecular Microbiology &amp; Virology, Baylor College of Medicine, Houston, TX 77030, USA.",2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,Spiltoir,Jessica I,JI,"Department of Medicine, Division of Cardiology, University of Colorado Denver, Aurora, CO, USA; Department of Pharmacology, University of Colorado Denver, Aurora, CO, USA.",2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,Stratton,Matthew S,MS,None,2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,Cavasin,Maria A,MA,None,2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,Demos-Davies,Kim,K,None,2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,Reid,Brian G,BG,None,2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,Qi,Jun,J,None,2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,Bradner,James E,JE,None,2013,BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.,23939492,McKinsey,Timothy A,TA,None,2013,The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.,23752591,Proserpio,Valentina,V,"Department of Biosciences, University of Milan, 20133 Milan, Italy.",2013,The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.,23752591,Fittipaldi,Raffaella,R,None,2013,The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.,23752591,Ryall,James G,JG,None,2013,The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.,23752591,Sartorelli,Vittorio,V,None,2013,The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.,23752591,Caretti,Giuseppina,G,None,2013,BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.,23420887,Belkina,Anna C,AC,"Cancer Research Center, Boston University School of Medicine, Boston, MA 02118, USA.",2013,BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.,23420887,Nikolajczyk,Barbara S,BS,None,2013,BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.,23420887,Denis,Gerald V,GV,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Vidigal,<forename>JoÌ£o</forename>,J,"<affiliation>IBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Dias,Mafalda M,MM,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Fernandes,Fabiana,F,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Patrone,Marco,M,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Bispo,<forename>ClÌÁudia</forename>,C,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Andrade,<forename>ClÌÁudia</forename>,C,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Gardner,Rui,R,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Carrondo,Manuel J T,MJ,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Alves,Paula M,PM,None,2013,A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five‰ã¢ cells.,24161917,Teixeira,Ana P,AP,None,2013,Metabolic signatures of GS-CHO cell clones associated with butyrate treatment and culture phase transition.,23794452,Carinhas,Nuno,N,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901, Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157, Oeiras, Portugal.</affiliation>",2013,Metabolic signatures of GS-CHO cell clones associated with butyrate treatment and culture phase transition.,23794452,Duarte,Tiago M,TM,None,2013,Metabolic signatures of GS-CHO cell clones associated with butyrate treatment and culture phase transition.,23794452,Barreiro,Laura C,LC,None,2013,Metabolic signatures of GS-CHO cell clones associated with butyrate treatment and culture phase transition.,23794452,Carrondo,Manuel J T,MJ,None,2013,Metabolic signatures of GS-CHO cell clones associated with butyrate treatment and culture phase transition.,23794452,Alves,Paula M,PM,None,2013,Metabolic signatures of GS-CHO cell clones associated with butyrate treatment and culture phase transition.,23794452,Teixeira,Ana P,AP,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,<lastname>NegrÌ£o</lastname>,<forename>SÌ_nia</forename>,S,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Oeiras, Portugal; iBET, Oeiras, Portugal.</affiliation>",2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,Almadanim,<forename>M CecÌ_lia</forename>,MC,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,Pires,<forename>InÌ»s S</forename>,IS,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,Abreu,Isabel A,IA,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,Maroco,<forename>JoÌ£o</forename>,J,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,Courtois,Brigitte,B,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,Gregorio,Glenn B,GB,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,McNally,Kenneth L,KL,None,2013,New allelic variants found in key rice salt-tolerance genes: an association study.,23116435,Oliveira,M Margarida,MM,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Wyce,Anastasia,A,"Cancer Epigenetics DPU, Oncology R and D GlaxoSmithKline, Collegeville, PA, USA.",2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Degenhardt,Yan,Y,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Bai,Yuchen,Y,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Le,BaoChau,B,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Korenchuk,Susan,S,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Crouthame,Ming-Chih,MC,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,McHugh,Charles F,CF,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Vessella,Robert,R,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Creasy,Caretha L,CL,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Tummino,Peter J,PJ,None,2013,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,24293458,Barbash,Olena,O,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Picaud,Sarah,S,"Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.",2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Wells,Christopher,C,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Felletar,Ildiko,I,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Brotherton,Deborah,D,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Martin,Sarah,S,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Savitsky,Pavel,P,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Diez-Dacal,Beatriz,B,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Philpott,Martin,M,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Bountra,Chas,C,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Lingard,Hannah,H,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Fedorov,Oleg,O,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,<lastname>MÌ_ller</lastname>,Susanne,S,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Brennan,Paul E,PE,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Knapp,Stefan,S,None,2013,"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.",24248379,Filippakopoulos,Panagis,P,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,De Rijck,Jan,J,"Laboratory for Molecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.",2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,de Kogel,Christine,C,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Demeulemeester,Jonas,J,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Vets,Sofie,S,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,El Ashkar,Sara,S,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Malani,Nirav,N,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Bushman,Frederic D,FD,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Landuyt,Bart,B,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Husson,Steven J,SJ,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Busschots,Katrien,K,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Gijsbers,Rik,R,None,2013,The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.,24183673,Debyser,Zeger,Z,None,2013,Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.,24091140,Lee,Woonghee,W,"National Magnetic Resonance Facility at Madison, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA; Biochemistry Department, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA. Electronic address: whlee@nmrfam.wisc.edu.",2013,Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.,24091140,Hu,Kaifeng,K,None,2013,Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.,24091140,Tonelli,Marco,M,None,2013,Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.,24091140,Bahrami,Arash,A,None,2013,Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.,24091140,Neuhardt,Elizabeth,E,None,2013,Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.,24091140,Glass,Karen C,KC,None,2013,Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.,24091140,Markley,John L,JL,None,2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Sarai,Naoyuki,N,"Program in Genomics of Differentiation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.",2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Nimura,Keisuke,K,None,2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Tamura,Tomohiko,T,None,2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Kanno,Tomohiko,T,None,2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Patel,Mira C,MC,None,2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Heightman,Tom D,TD,None,2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Ura,Kiyoe,K,None,2013,WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.,23921552,Ozato,Keiko,K,None,2013,Bromodomain proteins in HIV infection.,23793227,Boehm,Daniela,D,"Gladstone Institute of Virology and Immunology, San Francisco, CA 94158, USA.",2013,Bromodomain proteins in HIV infection.,23793227,Conrad,Ryan J,RJ,None,2013,Bromodomain proteins in HIV infection.,23793227,Ott,Melanie,M,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Panagopoulos,Ioannis,I,"Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. ioannis.panagopoulos@rr-research.no",2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Micci,Francesca,F,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Thorsen,Jim,J,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Haugom,Lisbeth,L,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Buechner,Jochen,J,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Kerndrup,Gitte,G,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Tierens,Anne,A,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Zeller,Bernward,B,None,2013,Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.,23667654,Heim,Sverre,S,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Hu,Kaishun,K,"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.",2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Liao,Dan,D,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Wu,Wenjing,W,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Han,An-Jia,AJ,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Shi,Hui-Juan,HJ,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Wang,Fen,F,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Wang,Xin,X,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Zhong,Li,L,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Duan,Tingmei,T,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Wu,Yuanzhong,Y,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Cao,Jingying,J,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Tang,Jianjun,J,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Sang,Yi,Y,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Wang,Li,L,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Lv,Xiaobin,X,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Xu,Shuangbing,S,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Zhang,Ru-Hua,RH,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Deng,Wu-Guo,WG,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Li,Sheng-Ping,SP,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Zeng,Yi-Xin,YX,None,2013,Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.,24840027,Kang,Tiebang,T,None,2013,Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins.,23425632,Li,Junlin,J,"Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Northwest University, Xi'an 710069, People's Republic of China. xcgao@nwu.edu.cn.",2013,Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins.,23425632,Zhao,Guifang,G,None,2013,Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins.,23425632,Gao,Xiaocai,X,None,2013,"Three calcium-sensitive genes, fus, brd3 and wdr5, are highly expressed in neural and renal territories during amphibian development.",23287019,Bibonne,A,A,"<affiliation>UniversitÌ© Toulouse 3, Centre de Biologie du DÌ©veloppement, Toulouse, France.</affiliation>",2013,"Three calcium-sensitive genes, fus, brd3 and wdr5, are highly expressed in neural and renal territories during amphibian development.",23287019,<lastname>NÌ©ant</lastname>,I,I,None,2013,"Three calcium-sensitive genes, fus, brd3 and wdr5, are highly expressed in neural and renal territories during amphibian development.",23287019,Batut,J,J,None,2013,"Three calcium-sensitive genes, fus, brd3 and wdr5, are highly expressed in neural and renal territories during amphibian development.",23287019,Leclerc,C,C,None,2013,"Three calcium-sensitive genes, fus, brd3 and wdr5, are highly expressed in neural and renal territories during amphibian development.",23287019,Moreau,M,M,None,2013,"Three calcium-sensitive genes, fus, brd3 and wdr5, are highly expressed in neural and renal territories during amphibian development.",23287019,Gilbert,T,T,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Tang,Xiaoyan,X,"Inflammation Discovery Therapeutic Area, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, NJ 07110-1199, USA.",2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Peng,Ruoqi,R,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Ren,Yonglin,Y,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Apparsundaram,Subramanium,S,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Deguzman,Jeremy,J,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Bauer,Carla M,CM,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Hoffman,Ann F,AF,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Hamilton,Shannon,S,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Liang,Zhenmin,Z,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Zeng,Hang,H,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Fuentes,Maria E,ME,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Demartino,Julie A,JA,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Kitson,Christopher,C,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Stevenson,Christopher S,CS,None,2013,BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.,23115324,Budd,David C,DC,None,2013,Pre-Clinical Studies of Epigenetic Therapies Targeting Histone Modifiers in Lung Cancer.,24058902,Huffman,Kenneth,K,"Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center , Dallas, TX , USA.",2013,Pre-Clinical Studies of Epigenetic Therapies Targeting Histone Modifiers in Lung Cancer.,24058902,Martinez,Elisabeth D,ED,None,2013,Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin.,23667520,Mughal,Nouman,N,"Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.",2013,Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin.,23667520,Coppotelli,Giuseppe,G,None,2013,Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin.,23667520,Callegari,Simone,S,None,2013,Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin.,23667520,Gastaldello,Stefano,S,None,2013,Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin.,23667520,Masucci,Maria G,MG,None,2013,Combined approaches for HIV cure.,23446138,Margolis,David M,DM,"Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7042, USA. dmargo@med.unc.edu",2013,Combined approaches for HIV cure.,23446138,Hazuda,Daria J,DJ,None,2013,BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.,24403256,Stewart,Helen Jayne Susan,HJ,"Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, BN1 9PS, U.K; Department of Haematology, Royal Sussex County Hospital, Brighton, East Sussex, BN2 5BE, U.K.",2013,BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.,24403256,Horne,Gillian Abigail,GA,None,2013,BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.,24403256,Bastow,Sarah,S,None,2013,BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.,24403256,Chevassut,Timothy James Telfer,TJ,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Henssen,Anton,A,"<affiliation>Istituto Superiore di SanitÌÊ, Rome, Italy.</affiliation>",2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Thor,Theresa,T,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Odersky,Andrea,A,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Heukamp,Lukas,L,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,El-Hindy,Nicolai,N,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Beckers,Anneleen,A,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Speleman,Frank,F,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Althoff,Kristina,K,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,<lastname>SchÌ_fers</lastname>,Simon,S,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Schramm,Alexander,A,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Sure,Ulrich,U,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Fleischhack,Gudrun,G,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Eggert,Angelika,A,None,2013,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,24231268,Schulte,Johannes H,JH,None,2013,Testis specific gene expression drives disease progression and Rituximab resistance in lymphoma.,23918227,Knapp,Stefan,S,"Nuffield Department of Clinical Medicine, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), University of Oxford, Oxford, UK. stefan.knapp@sgc.ox.ac.uk",2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Gao,Lina,L,"Division of Hematology/Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, United States of America.",2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Schwartzman,Jacob,J,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Gibbs,Angela,A,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Lisac,Robert,R,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Kleinschmidt,Richard,R,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Wilmot,Beth,B,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Bottomly,Daniel,D,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Coleman,Ilsa,I,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Nelson,Peter,P,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,McWeeney,Shannon,S,None,2013,Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.,23704919,Alumkal,Joshi,J,None,2013,Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.,24120735,Rodrigues,A F,AF,"<affiliation>IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal; Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Avenida RepÌ_blica, 2780-157 Oeiras, Portugal.</affiliation>",2013,Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.,24120735,Formas-Oliveira,A S,AS,None,2013,Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.,24120735,Bandeira,V S,VS,None,2013,Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.,24120735,Alves,P M,PM,None,2013,Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.,24120735,Hu,W S,WS,None,2013,Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.,24120735,Coroadinha,A S,AS,None,2013,SAD phasing towards structure determination of a thermostable Rieske ferredoxin with a novel stabilizing disulfide bridge.,23695576,Bandeiras,Tiago M,TM,"<affiliation>IBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal.</affiliation>",2013,SAD phasing towards structure determination of a thermostable Rieske ferredoxin with a novel stabilizing disulfide bridge.,23695576,Freitas,Micael C,MC,None,2013,SAD phasing towards structure determination of a thermostable Rieske ferredoxin with a novel stabilizing disulfide bridge.,23695576,Petrasch,Dennis,D,None,2013,SAD phasing towards structure determination of a thermostable Rieske ferredoxin with a novel stabilizing disulfide bridge.,23695576,Kletzin,Arnulf,A,None,2013,SAD phasing towards structure determination of a thermostable Rieske ferredoxin with a novel stabilizing disulfide bridge.,23695576,<lastname>FrazÌ£o</lastname>,Carlos,C,None,2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Gehling,Victor S,VS,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Hewitt,Michael C,MC,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Vaswani,Rishi G,RG,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Leblanc,Yves,Y,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,<lastname>CÌ«tÌ©</lastname>,Alexandre,A,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Nasveschuk,Christopher G,CG,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Taylor,Alexander M,AM,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Harmange,Jean-Christophe,JC,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Audia,James E,JE,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Pardo,Eneida,E,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Joshi,Shivangi,S,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Sandy,Peter,P,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Mertz,Jennifer A,JA,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Sims,Robert J,RJ,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Bergeron,Louise,L,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Bryant,Barbara M,BM,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Bellon,Steve,S,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Poy,Florence,F,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Jayaram,Hariharan,H,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Sankaranarayanan,Ravichandran,R,"Jubilant Biosys Limited , #96, Industrial Suburb, Second Stage, Yeshwantpur, Bangalore 560 022, India.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Yellapantula,Sreegouri,S,"Jubilant Biosys Limited , #96, Industrial Suburb, Second Stage, Yeshwantpur, Bangalore 560 022, India.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Bangalore Srinivasamurthy,Nandana,N,"Jubilant Biosys Limited , #96, Industrial Suburb, Second Stage, Yeshwantpur, Bangalore 560 022, India.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Birudukota,Swarnakumari,S,"Jubilant Biosys Limited , #96, Industrial Suburb, Second Stage, Yeshwantpur, Bangalore 560 022, India.",2013,"Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.",24900758,Albrecht,Brian K,BK,"Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Liu,Wen,W,"<affiliation>Howard Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, LaåÊJolla, CA 92093, USA; School of Pharmaceutical Science, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China. Electronic address: w2liu@xmu.edu.cn.</affiliation>",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Ma,Qi,Q,"<affiliation>Howard Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, LaåÊJolla, CA 92093, USA; Graduate Program in Bioinformatics and System Biology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.</affiliation>",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Wong,Kaki,K,"<affiliation>Howard Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, LaåÊJolla, CA 92093, USA.</affiliation>",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Li,Wenbo,W,"<affiliation>Howard Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, LaåÊJolla, CA 92093, USA.</affiliation>",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Ohgi,Kenny,K,"<affiliation>Howard Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, LaåÊJolla, CA 92093, USA.</affiliation>",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Zhang,Jie,J,"<affiliation>Howard Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, LaåÊJolla, CA 92093, USA.</affiliation>",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Aggarwal,Aneel K,AK,"<affiliation>Department of Structural and Chemical Biology, Mount Sinai School of Medicine, Box 1677, 1425 Madison Avenue, New York, NYåÊ10029,åÊUSA.</affiliation>",2013,Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.,24360279,Rosenfeld,Michael G,MG,"<affiliation>Howard Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, LaåÊJolla, CA 92093, USA. Electronic address: mrosenfeld@ucsd.edu.</affiliation>",2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Fisher,Kate,K,"Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK.",2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Gee,Fiona,F,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Wang,Siyao,S,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Xue,Feng,F,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Knapp,Stefan,S,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Philpott,Martin,M,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Wells,Christopher,C,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Rodriguez,Miriam,M,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Snoek,L Basten,LB,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Kammenga,Jan,J,None,2013,Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation.,24285704,Poulin,Gino B,GB,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Correia,Bruno,B,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Oeiras, Portugal.</affiliation>",2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Cerqueira,Sofia A,SA,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Beauchemin,Chantal,C,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Pires de Miranda,Marta,M,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Li,Shijun,S,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Ponnusamy,Rajesh,R,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Rodrigues,<forename>LÌ©nia</forename>,L,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Schneider,Thomas R,TR,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Carrondo,Maria A,MA,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Kaye,Kenneth M,KM,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,Simas,J Pedro,JP,None,2013,Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.,24146618,McVey,Colin E,CE,None,2013,Cardiology: Bromodomain inhibition halts heart failure.,24080694,Flemming,Alexandra,A,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Largeot,Anne,A,"<affiliation>Inserm U866, Labex LipSTIC team, FacultÌ© de MÌ©decine, UniversitÌ© de Bourgogne, 21000 Dijon, France.</affiliation>",2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Paggetti,<forename>JÌ©rÌ«me</forename>,J,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,<lastname>BrosÌ©us</lastname>,Julien,J,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Aucagne,Romain,R,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Lagrange,Brice,B,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Martin,Romain Z,RZ,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Berthelet,Jean,J,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,<lastname>QuÌ©rÌ©</lastname>,Ronan,R,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Lucchi,<forename>GÌ©raldine</forename>,G,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Ducoroy,Patrick,P,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Bastie,<forename>Jean-NoÌÇl</forename>,JN,None,2013,"Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.",23994619,Delva,Laurent,L,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Anand,Priti,P,"Case Cardiovascular Research Institute, Department of Medicine, Case Western Reserve University School of Medicine, and Harrington Heart &amp; Vascular Institute, University Hospitals Case Medical Center, Cleveland, OH 44106, USA.",2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Brown,Jonathan D,JD,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Lin,Charles Y,CY,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Qi,Jun,J,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Zhang,Rongli,R,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Artero,Pedro Calderon,PC,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Alaiti,M Amer,MA,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Bullard,Jace,J,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Alazem,Kareem,K,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Margulies,Kenneth B,KB,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Cappola,Thomas P,TP,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Lemieux,Madeleine,M,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Plutzky,Jorge,J,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Bradner,James E,JE,None,2013,BET bromodomains mediate transcriptional pause release in heart failure.,23911322,Haldar,Saptarsi M,SM,None,2013,Analysis of rice Snf2 family proteins and their potential roles in epigenetic regulation.,23770592,Hu,Yongfeng,Y,"Jingchu University of Technology, 448000 Jingmen, China. feng2602@sina.com",2013,Analysis of rice Snf2 family proteins and their potential roles in epigenetic regulation.,23770592,Zhu,Ning,N,None,2013,Analysis of rice Snf2 family proteins and their potential roles in epigenetic regulation.,23770592,Wang,Xuemin,X,None,2013,Analysis of rice Snf2 family proteins and their potential roles in epigenetic regulation.,23770592,Yi,Qingping,Q,None,2013,Analysis of rice Snf2 family proteins and their potential roles in epigenetic regulation.,23770592,Zhu,Deyan,D,None,2013,Analysis of rice Snf2 family proteins and their potential roles in epigenetic regulation.,23770592,Lai,Yan,Y,None,2013,Analysis of rice Snf2 family proteins and their potential roles in epigenetic regulation.,23770592,Zhao,Yu,Y,None,2013,Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.,23658523,Mbonye,Uri R,UR,"Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.",2013,Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.,23658523,Gokulrangan,Giridharan,G,None,2013,Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.,23658523,Datt,Manish,M,None,2013,Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.,23658523,Dobrowolski,Curtis,C,None,2013,Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.,23658523,Cooper,Maxwell,M,None,2013,Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.,23658523,Chance,Mark R,MR,None,2013,Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.,23658523,Karn,Jonathan,J,None,2013,Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex.,23479607,Ozturk,Nuri,N,"Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.",2013,Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex.,23479607,VanVickle-Chavez,Sarah J,SJ,None,2013,Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex.,23479607,Akileswaran,Lakshmi,L,None,2013,Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex.,23479607,Van Gelder,Russell N,RN,None,2013,Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex.,23479607,Sancar,Aziz,A,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Raeder,Maria B,MB,"Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway. Maria.Rader@uib.no",2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Birkeland,Even,E,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Trovik,Jone,J,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Krakstad,Camilla,C,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Shehata,Shyemaa,S,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Schumacher,Steven,S,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Zack,Travis I,TI,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Krohn,Antje,A,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Werner,Henrica Mj,HM,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Moody,Susan E,SE,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Wik,Elisabeth,E,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Stefansson,Ingunn M,IM,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Holst,Frederik,F,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Oyan,Anne M,AM,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Tamayo,Pablo,P,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Mesirov,Jill P,JP,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Kalland,Karl H,KH,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Akslen,Lars A,LA,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Simon,Ronald,R,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Beroukhim,Rameen,R,None,2013,Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.,23393560,Salvesen,Helga B,HB,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Shi,Junwei,J,"Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA;",2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Whyte,Warren A,WA,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Zepeda-Mendoza,Cinthya J,CJ,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Milazzo,Joseph P,JP,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Shen,Chen,C,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Roe,Jae-Seok,JS,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Minder,Jessica L,JL,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Mercan,Fatih,F,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Wang,Eric,E,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Eckersley-Maslin,Melanie A,MA,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Campbell,Amy E,AE,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Kawaoka,Shinpei,S,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Shareef,Sarah,S,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Zhu,Zhu,Z,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Kendall,Jude,J,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Muhar,Matthias,M,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Haslinger,Christian,C,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Yu,Ming,M,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Roeder,Robert G,RG,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Wigler,Michael H,MH,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Blobel,Gerd A,GA,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Zuber,Johannes,J,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Spector,David L,DL,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Young,Richard A,RA,None,2013,Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.,24285714,Vakoc,Christopher R,CR,None,2013,Brd4 shields chromatin from ATM kinase signaling storms.,24045152,Choi,Serah,S,"1UPMC Medical Education Transitional Year Residency Program, University of Pittsburgh School of Medicine, Hillman Cancer Center, Research Pavilion, Pittsburgh, PA 15213, USA.",2013,Brd4 shields chromatin from ATM kinase signaling storms.,24045152,Bakkenist,Christopher J,CJ,None,2013,Oncogene interference through targeting of chromatin regulators.,23624838,Roe,Jae-Seok,JS,None,2013,Oncogene interference through targeting of chromatin regulators.,23624838,Vakoc,Christopher R,CR,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Brait,Mariana,M,"Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.",2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Munari,Enrico,E,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,LeBron,Cynthia,C,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Noordhuis,Maartje G,MG,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Begum,Shahnaz,S,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Michailidi,Christina,C,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Gonzalez-Roibon,Nilda,N,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Maldonado,Leonel,L,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Sen,Tanusree,T,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Guerrero-Preston,Rafael,R,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Cope,Leslie,L,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Parrella,Paola,P,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Fazio,Vito Michele,VM,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Ha,Patrick K,PK,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Netto,George J,GJ,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Sidransky,David,D,None,2013,Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.,23435205,Hoque,Mohammad O,MO,None,2013,Analysis of the papillomavirus E2 and bromodomain protein Brd4 interaction using bimolecular fluorescence complementation.,24205059,Helfer,Christine M,CM,"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.",2013,Analysis of the papillomavirus E2 and bromodomain protein Brd4 interaction using bimolecular fluorescence complementation.,24205059,Wang,Ranran,R,None,2013,Analysis of the papillomavirus E2 and bromodomain protein Brd4 interaction using bimolecular fluorescence complementation.,24205059,You,Jianxin,J,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Da Costa,D,D,"School of Cancer Sciences, University of Birmingham, Birmingham, UK.",2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Agathanggelou,A,A,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Perry,T,T,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Weston,V,V,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Petermann,E,E,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Zlatanou,A,A,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Oldreive,C,C,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Wei,W,W,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Stewart,G,G,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Longman,J,J,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Smith,E,E,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Kearns,P,P,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Knapp,S,S,None,2013,BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.,23872705,Stankovic,T,T,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Cheng,Zhixiang,Z,"Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.",2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Gong,Yuanying,Y,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Ma,Yufang,Y,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Lu,Kaihua,K,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Lu,Xiang,X,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Pierce,Larry A,LA,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Thompson,Reid C,RC,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Muller,Susanne,S,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Knapp,Stefan,S,None,2013,Inhibition of BET bromodomain targets genetically diverse glioblastoma.,23403638,Wang,Jialiang,J,None,2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Visagie,C M,CM,"Department of Microbiology, University of Stellenbosch, Private Bag X1, Stellenbosch 7600, South Africa. ; CBS-KNAW Fungal Biodiversity Centre, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands; ; Biodiversity (Mycology), Eastern Cereal and Oilseed Research Centre, 960 Carling Ave., Ottawa, Ontario, K1A 0C6, Canada.",2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Houbraken,J,J,"CBS-KNAW Fungal Biodiversity Centre, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands;",2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Rodriques,C,C,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB-UNL), Apartado 127, 2780-901, Oeiras, Portugal.</affiliation>",2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Silva Pereira,C,C,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB-UNL), Apartado 127, 2780-901, Oeiras, Portugal. ; Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901, Oeiras, Portugal.</affiliation>",2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Dijksterhuis,J,J,"CBS-KNAW Fungal Biodiversity Centre, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands;",2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Seifert,K A,KA,"Biodiversity (Mycology), Eastern Cereal and Oilseed Research Centre, 960 Carling Ave., Ottawa, Ontario, K1A 0C6, Canada.",2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Jacobs,K,K,"Department of Microbiology, University of Stellenbosch, Private Bag X1, Stellenbosch 7600, South Africa.",2013,Five new Penicillium species in section Sclerotiora: a tribute to the Dutch Royal family.,24761034,Samson,R A,RA,"CBS-KNAW Fungal Biodiversity Centre, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands;",2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,Martins,Isabel,I,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal; Instituto de Biologia Experimental e TecnolÌ_gica, IBET, Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,Hartmann,Diego O,DO,None,2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,Alves,Paula C,PC,None,2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,Planchon,<forename>SÌ©bastien</forename>,S,None,2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,Renaut,Jenny,J,None,2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,<lastname>LeitÌ£o</lastname>,M Cristina,MC,None,2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,Rebelo,<forename>LuÌ_s P N</forename>,LP,None,2013,Proteomic alterations induced by ionic liquids in Aspergillus nidulans and Neurospora crassa.,24120530,Silva Pereira,Cristina,C,None,2013,Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.,23565229,Fernandes,Paulo,P,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Oeiras, Portugal.</affiliation>",2013,Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.,23565229,Santiago,<forename>VirgÌ_nia M</forename>,VM,None,2013,Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.,23565229,Rodrigues,Ana F,AF,None,2013,Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.,23565229,<lastname>TomÌÁs</lastname>,<forename>HÌ©lio</forename>,H,None,2013,Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.,23565229,Kremer,Eric J,EJ,None,2013,Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.,23565229,Alves,Paula M,PM,None,2013,Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.,23565229,Coroadinha,Ana S,AS,None,2013,An RNAi-based dimorphic genetic screen identified the double bromodomain protein BET-1 as a sumo-dependent attenuator of RAS-mediated signalling.,24349540,Gee,Fiona,F,"Faculty of Life Sciences, The University of Manchester, Manchester, Greater Manchester, United Kingdom.",2013,An RNAi-based dimorphic genetic screen identified the double bromodomain protein BET-1 as a sumo-dependent attenuator of RAS-mediated signalling.,24349540,Fisher,Kate,K,"Faculty of Life Sciences, The University of Manchester, Manchester, Greater Manchester, United Kingdom.",2013,An RNAi-based dimorphic genetic screen identified the double bromodomain protein BET-1 as a sumo-dependent attenuator of RAS-mediated signalling.,24349540,Klemstein,Ulrike,U,"Faculty of Life Sciences, The University of Manchester, Manchester, Greater Manchester, United Kingdom.",2013,An RNAi-based dimorphic genetic screen identified the double bromodomain protein BET-1 as a sumo-dependent attenuator of RAS-mediated signalling.,24349540,Poulin,Gino B,GB,"Faculty of Life Sciences, The University of Manchester, Manchester, Greater Manchester, United Kingdom.",2013,Developing epigenetic diagnostics and therapeutics for brain disorders.,24145019,Qureshi,Irfan A,IA,"Roslyn and Leslie Goldstein Laboratory for Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Institute for Brain Disorders and Neural Regeneration, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Rose F. Kennedy Center for Research on Intellectual and Developmental Disabilities, Albert Einstein College of Medicine, Bronx, NY 10461, USA.",2013,Developing epigenetic diagnostics and therapeutics for brain disorders.,24145019,Mehler,Mark F,MF,None,2013,Spliceosome-mediated decay (SMD) regulates expression of nonintronic genes in budding yeast.,24065768,Volanakis,Adam,A,"Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom;",2013,Spliceosome-mediated decay (SMD) regulates expression of nonintronic genes in budding yeast.,24065768,Passoni,Monica,M,None,2013,Spliceosome-mediated decay (SMD) regulates expression of nonintronic genes in budding yeast.,24065768,Hector,Ralph D,RD,None,2013,Spliceosome-mediated decay (SMD) regulates expression of nonintronic genes in budding yeast.,24065768,Shah,Sneha,S,None,2013,Spliceosome-mediated decay (SMD) regulates expression of nonintronic genes in budding yeast.,24065768,Kilchert,Cornelia,C,None,2013,Spliceosome-mediated decay (SMD) regulates expression of nonintronic genes in budding yeast.,24065768,Granneman,Sander,S,None,2013,Spliceosome-mediated decay (SMD) regulates expression of nonintronic genes in budding yeast.,24065768,Vasiljeva,Lidia,L,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Sismani,C,C,"Department of Cytogenetics and Genomics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.",2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Donoghue,J,J,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Alexandrou,A,A,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Karkaletsi,M,M,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Christopoulou,S,S,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Konstantinidou,A E,AE,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Livanos,P,P,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Patsalis,P C,PC,None,2013,"A prenatally ascertained, maternally inherited 14.8 Mb duplication of chromosomal bands Xq13.2-q21.31 associated with multiple congenital abnormalities in a male fetus.",23973723,Velissariou,V,V,None,2013,Logic of the inflammation-associated transcriptional response.,23886066,Tarakhovsky,Alexander,A,"Rockefeller University, New York, New York, USA. tarakho@mail.rockefeller.edu",2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Flajollet,<forename>SÌ©bastien</forename>,S,"European Genomic Institute for Diabetes-EGID, FR 3508, Lille, France.",2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Rachez,Christophe,C,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Ploton,Maheul,M,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Schulz,<forename>CÌ©line</forename>,C,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Gallais,Rozenn,R,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,<lastname>MÌ©tivier</lastname>,<forename>RaphaÌÇl</forename>,R,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Pawlak,Michal,M,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Leray,Aymeric,A,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Issulahi,Al Amine,AA,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,<lastname>HÌ©liot</lastname>,Laurent,L,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Staels,Bart,B,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Salbert,Gilles,G,None,2013,The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.,23762261,Lefebvre,Philippe,P,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Tian,Bing,B,"Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.",2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Zhao,Yingxin,Y,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Kalita,Mridul,M,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Edeh,Chukwudi B,CB,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Paessler,Slobodan,S,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Casola,Antonella,A,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Teng,Michael N,MN,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Garofalo,Roberto P,RP,None,2013,CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.,23596302,Brasier,Allan R,AR,None,2013,Targeting MYCN: a good BET for improving neuroblastoma therapy?,23475876,Schnepp,Robert W,RW,"Division of Oncology and the Center for Childhood Cancer Research. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.",2013,Targeting MYCN: a good BET for improving neuroblastoma therapy?,23475876,Maris,John M,JM,None,2013,Brd2 gene disruption causes &quot;metabolically healthy&quot; obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes.,23374712,Wang,Fangnian,F,"IQuum Inc, Marlborough, MA 01752, USA.",2013,Brd2 gene disruption causes &quot;metabolically healthy&quot; obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes.,23374712,Deeney,Jude T,JT,None,2013,Brd2 gene disruption causes &quot;metabolically healthy&quot; obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes.,23374712,Denis,Gerald V,GV,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Wu,Wen-Jing,WJ,"State Key Laboratory of Oncology in Southern China, Guangzhou, China.",2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Hu,Kai-Shun,KS,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Chen,Dong-Liang,DL,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Zeng,Zhao-Lei,ZL,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Luo,Hui-Yan,HY,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Wang,Feng,F,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Wang,De-Shen,DS,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Wang,Zhi-Qiang,ZQ,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,He,Fan,F,None,2013,Prognostic relevance of BRD7 expression in colorectal carcinoma.,23215825,Xu,Rui-Hua,RH,None,2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,Sakakibara,Nozomi,N,"Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.",2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,Chen,Dan,D,None,2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,Jang,Moon Kyoo,MK,None,2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,Kang,Dong Wook,DW,None,2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,Luecke,Hans F,HF,None,2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,Wu,Shwu-Yuan,SY,None,2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,Chiang,Cheng-Ming,CM,None,2013,Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.,24278023,McBride,Alison A,AA,None,2013,Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence.,24040311,Verma,Subhash C,SC,"Department of Microbiology and Immunology, School of Medicine, University of Nevada, Reno, Nevada, United States of America.",2013,Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence.,24040311,Cai,Qiliang,Q,None,2013,Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence.,24040311,Kreider,Edward,E,None,2013,Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence.,24040311,Lu,Jie,J,None,2013,Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence.,24040311,Robertson,Erle S,ES,None,2013,Transcriptional control by NF-ë_B: elongation in focus.,23624258,Diamant,Gil,G,"Dept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot , Israel.",2013,Transcriptional control by NF-ë_B: elongation in focus.,23624258,Dikstein,Rivka,R,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Russell,Sarah M,SM,"Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.",2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Lechner,Melissa G,MG,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Mokashi,Anusuya,A,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Megiel,Carolina,C,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Jang,Julie K,JK,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Taylor,Clive R,CR,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Looijenga,Leendert H J,LH,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,French,Christopher A,CA,None,2013,"Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.",23374840,Epstein,Alan L,AL,None,2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Chapuy,Bjoern,B,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,McKeown,Michael R,MR,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Lin,Charles Y,CY,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Monti,Stefano,S,"Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Roemer,Margaretha G M,MG,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Qi,Jun,J,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Rahl,Peter B,PB,"Whitehead Institute of Genome Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Sun,Heather H,HH,"Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Yeda,Kelly T,KT,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Doench,John G,JG,"Broad Institute, Cambridge, MA 02142, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Reichert,Elaine,E,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Kung,Andrew L,AL,"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Rodig,Scott J,SJ,"Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Young,Richard A,RA,"Whitehead Institute of Genome Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Shipp,Margaret A,MA,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: margaret_shipp@dfci.harvard.edu.",2013,Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.,24332044,Bradner,James E,JE,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: james_bradner@dfci.harvard.edu.",2013,Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor ë_B (NF-ë_B) signaling.,24189064,Wu,Xuewei,X,From the Department of Biochemistry and.,2013,Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor ë_B (NF-ë_B) signaling.,24189064,Qi,Jun,J,None,2013,Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor ë_B (NF-ë_B) signaling.,24189064,Bradner,James E,JE,None,2013,Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor ë_B (NF-ë_B) signaling.,24189064,Xiao,Gutian,G,None,2013,Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor ë_B (NF-ë_B) signaling.,24189064,Chen,Lin-Feng,LF,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Emadali,Anouk,A,"<affiliation>CEA, iRTSV, Biologie ÌÊ Grande Echelle, Grenoble, France.</affiliation>",2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Rousseaux,Sophie,S,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Bruder-Costa,Juliana,J,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Rome,Claire,C,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Duley,Samuel,S,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Hamaidia,Sieme,S,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Betton,Patricia,P,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Debernardi,Alexandra,A,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Leroux,Dominique,D,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Bernay,Benoit,B,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Kieffer-Jaquinod,Sylvie,S,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Combes,Florence,F,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Ferri,Elena,E,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,McKenna,Charles E,CE,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Petosa,Carlo,C,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Bruley,Christophe,C,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Garin,<forename>JÌ©rÌ«me</forename>,J,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Ferro,Myriam,M,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Gressin,<forename>RÌ©my</forename>,R,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Callanan,Mary B,MB,None,2013,"Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.",23828858,Khochbin,Saadi,S,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Patel,Mira C,MC,"Program in Genomics of Differentiation, NICHD, National Institutes of Health, Bethesda, Maryland, USA.",2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Debrosse,Maxime,M,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Smith,Matthew,M,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Dey,Anup,A,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Huynh,Walter,W,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Sarai,Naoyuki,N,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Heightman,Tom D,TD,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Tamura,Tomohiko,T,None,2013,BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.,23589332,Ozato,Keiko,K,None,2013,A new BET on the control of HIV latency.,23370386,Karn,Jonathan,J,"Department of Molecular Biology and Microbiology, Case School of Medicine, Cleveland, OH, USA. jonathan.karn@case.edu",2013,Normalizing gene expression by quantitative PCR during somatic embryogenesis in two representative conifer species: Pinus pinaster and Picea abies.,23529547,de Vega-Bartol,<forename>JosÌ© J</forename>,JJ,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (iBET), Apartado 12, 2780-901, Oeiras, Portugal.</affiliation>",2013,Normalizing gene expression by quantitative PCR during somatic embryogenesis in two representative conifer species: Pinus pinaster and Picea abies.,23529547,Santos,Raquen Raissa,RR,None,2013,Normalizing gene expression by quantitative PCR during somatic embryogenesis in two representative conifer species: Pinus pinaster and Picea abies.,23529547,<lastname>SimÌµes</lastname>,Marta,M,None,2013,Normalizing gene expression by quantitative PCR during somatic embryogenesis in two representative conifer species: Pinus pinaster and Picea abies.,23529547,Miguel,<forename>CÌ©lia M</forename>,CM,None,2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,McLure,Kevin G,KG,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Gesner,Emily M,EM,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Tsujikawa,Laura,L,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Kharenko,Olesya A,OA,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Attwell,Sarah,S,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Campeau,Eric,E,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Wasiak,Sylwia,S,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Stein,Adam,A,"Xtal BioStructures Inc., Natick, Maryland, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,White,Andre,A,"Xtal BioStructures Inc., Natick, Maryland, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Fontano,Eric,E,"Xtal BioStructures Inc., Natick, Maryland, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Suto,Robert K,RK,"Xtal BioStructures Inc., Natick, Maryland, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Wong,Norman C W,NC,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Wagner,Gregory S,GS,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Hansen,Henrik C,HC,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.",24391744,Young,Peter R,PR,"Resverlogix Corp., Calgary, Alberta, Canada, or San Francisco, California, United States of America.",2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,Lucas,Xavier,X,"<affiliation>Pharmazeutische Bioinformatik, Institut fÌ_r Pharmazeutische, Wissenschaften, Albert-Ludwigs-UniversitÌ_t, Hermann-Herder-Strasse 9, 79104 Freiburg (Germany) http://www.pharmaceutical-bioinformatics.org.</affiliation>",2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,Wohlwend,Daniel,D,None,2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,<lastname>HÌ_gle</lastname>,Martin,M,None,2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,Schmidtkunz,Karin,K,None,2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,Gerhardt,Stefan,S,None,2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,<lastname>SchÌ_le</lastname>,Roland,R,None,2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,Jung,Manfred,M,None,2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,Einsle,Oliver,O,None,2013,4-Acyl pyrroles: mimicking acetylated lysines in histone code reading.,24272870,<lastname>GÌ_nther</lastname>,Stefan,S,None,2013,The p38-interacting protein (p38IP) regulates G2/M progression by promoting ë±-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.,24220028,Liu,Xin,X,"From the Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275 and.",2013,The p38-interacting protein (p38IP) regulates G2/M progression by promoting ë±-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.,24220028,Xiao,Wei,W,None,2013,The p38-interacting protein (p38IP) regulates G2/M progression by promoting ë±-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.,24220028,Wang,Xu-Dong,XD,None,2013,The p38-interacting protein (p38IP) regulates G2/M progression by promoting ë±-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.,24220028,Li,Yue-Fang,YF,None,2013,The p38-interacting protein (p38IP) regulates G2/M progression by promoting ë±-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.,24220028,Han,Jiahuai,J,None,2013,The p38-interacting protein (p38IP) regulates G2/M progression by promoting ë±-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.,24220028,Li,Yingqiu,Y,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Zhang,Guangtao,G,"Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai , 1425 Madison Avenue, New York, New York 10029, United States.",2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Plotnikov,Alexander N,AN,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Rusinova,Elena,E,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Shen,Tong,T,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Morohashi,Keita,K,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Joshua,Jennifer,J,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Zeng,Lei,L,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Mujtaba,Shiraz,S,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Ohlmeyer,Michael,M,None,2013,Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.,24144283,Zhou,Ming-Ming,MM,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Chen,Chong,C,"Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;",2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Liu,Yu,Y,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Lu,Chao,C,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Cross,Justin R,JR,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Morris,John P,JP,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Shroff,Aditya S,AS,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Ward,Patrick S,PS,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Bradner,James E,JE,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Thompson,Craig,C,None,2013,Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.,24065765,Lowe,Scott W,SW,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Segura,Miguel F,MF,"<affiliation>Authors' Affiliations: Departments of Pathology and Dermatology, New York University School of Medicine; Interdisciplinary Melanoma Cooperative Group, New York University Cancer Institute, New York University Langone Medical Center; Departments of Structural and Chemical Biology and Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Instituto de Salud Carlos III, Majadahonda, Madrid; and Laboratory of Translational Research in Childhood Cancer, Vall d'HebrÌ_n Institut de Recerca (VHIR), Barcelona, Spain.</affiliation>",2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Fontanals-Cirera,<forename>BÌÁrbara</forename>,B,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Gaziel-Sovran,Avital,A,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Guijarro,<forename>MarÌ_a V</forename>,MV,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Hanniford,Doug,D,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Zhang,Guangtao,G,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,<lastname>GonzÌÁlez-Gomez</lastname>,Pilar,P,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Morante,Marta,M,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Jubierre,Luz,L,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Zhang,Weijia,W,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Darvishian,Farbod,F,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Ohlmeyer,Michael,M,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Osman,Iman,I,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Zhou,Ming-Ming,MM,None,2013,BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.,23950209,Hernando,Eva,E,None,2013,Malignant genome reprogramming by ATAD2.,23831842,Boussouar,<forename>FayÌ_al</forename>,F,"<affiliation>INSERM, U823, UniversitÌ© Joseph Fourier - Grenoble 1, Institut Albert Bonniot, Grenoble, F-38700, France.</affiliation>",2013,Malignant genome reprogramming by ATAD2.,23831842,Jamshidikia,Mahya,M,None,2013,Malignant genome reprogramming by ATAD2.,23831842,Morozumi,Yuichi,Y,None,2013,Malignant genome reprogramming by ATAD2.,23831842,Rousseaux,Sophie,S,None,2013,Malignant genome reprogramming by ATAD2.,23831842,Khochbin,Saadi,S,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Schmidt,J,J,"Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA.",2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Braggio,E,E,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Kortuem,K M,KM,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Egan,J B,JB,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Zhu,Y X,YX,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Xin,C S,CS,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Tiedemann,R E,RE,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Palmer,S E,SE,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Garbitt,V M,VM,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,McCauley,D,D,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Kauffman,M,M,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Shacham,S,S,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Chesi,M,M,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Bergsagel,P L,PL,None,2013,Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.,23752175,Stewart,A K,AK,None,2013,Conference scene: 2nd cancer epigenetics conference.,23566090,Smith,Cassandra L,CL,"Boston University, Boston, MA 02215, USA. clsmith@bu.edu",2013,The importance of diagnosing NUT midline carcinoma.,23463074,French,Christopher A,CA,"Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02115, USA. cfrench@partners.org",2013,"[BRPF2, a novel transcript of BRPF1 and their expression in mice tissues].",23357268,Guo,Fen,F,"Guangdong Pharmaceutical University, Guangzhou, China. guofenjnu@gmail.com",2013,"[BRPF2, a novel transcript of BRPF1 and their expression in mice tissues].",23357268,Lin,Pi-Rong,PR,None,2013,"[BRPF2, a novel transcript of BRPF1 and their expression in mice tissues].",23357268,Li,Yue-Qin,YQ,None,2013,"[BRPF2, a novel transcript of BRPF1 and their expression in mice tissues].",23357268,Su,Xian-Li,XL,None,2013,"[BRPF2, a novel transcript of BRPF1 and their expression in mice tissues].",23357268,Wang,Ding-Ding,DD,None,2013,"[BRPF2, a novel transcript of BRPF1 and their expression in mice tissues].",23357268,Zhou,Tian-Hong,TH,None,2013,Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.,23038103,Duan,Zhijian,Z,"Cancer Center/Basic Sciences, University of California at Davis, Sacramento, California 95817, USA.",2013,Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.,23038103,Zou,June X,JX,None,2013,Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.,23038103,Yang,Ping,P,None,2013,Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.,23038103,Wang,Yuzhuo,Y,None,2013,Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.,23038103,Borowsky,Alexander D,AD,None,2013,Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.,23038103,Gao,Allen C,AC,None,2013,Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.,23038103,Chen,Hong-Wu,HW,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Alsarraj,Jude,J,"Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.",2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Faraji,Farhoud,F,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Geiger,Thomas R,TR,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Mattaini,Katherine R,KR,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Williams,Mia,M,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Wu,Josephine,J,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Ha,Ngoc-Han,NH,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Merlino,Tyler,T,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Walker,Renard C,RC,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Bosley,Allen D,AD,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Xiao,Zhen,Z,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Andresson,Thorkell,T,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Esposito,Dominic,D,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Smithers,Nicholas,N,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Lugo,Dave,D,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Prinjha,Rab,R,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Day,Anup,A,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Crawford,Nigel P S,NP,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Ozato,Keiko,K,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Gardner,Kevin,K,None,2013,"BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.",24260471,Hunter,Kent W,KW,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Mirguet,Olivier,O,"<affiliation>Centre de Recherches FranÌ_ois Hyafil, GlaxoSmithKline R&amp;D , 25 Avenue du QuÌ©bec, 91140 Villebon-sur-Yvette, France.</affiliation>",2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Gosmini,Romain,R,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Toum,<forename>JÌ©rÌ«me</forename>,J,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,<lastname>ClÌ©ment</lastname>,Catherine A,CA,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Barnathan,<forename>MÌ©lanie</forename>,M,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Brusq,Jean-Marie,JM,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Mordaunt,Jacqueline E,JE,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Grimes,Richard M,RM,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Crowe,Miriam,M,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Pineau,Olivier,O,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Ajakane,Myriam,M,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Daugan,Alain,A,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Jeffrey,Phillip,P,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Cutler,Leanne,L,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Haynes,Andrea C,AC,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Smithers,Nicholas N,NN,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Chung,Chun-wa,CW,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Bamborough,Paul,P,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Uings,Iain J,IJ,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Lewis,Antonia,A,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Witherington,Jason,J,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Parr,Nigel,N,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,Prinjha,Rab K,RK,None,2013,Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.,24015967,<lastname>NicodÌ¬me</lastname>,Edwige,E,None,2013,Macrophages: the neglected barrier to eradication.,24152764,Watters,Sarah A,SA,"Department of Infection and Immunity, University College London, London, UK.",2013,Macrophages: the neglected barrier to eradication.,24152764,Mlcochova,Petra,P,None,2013,Macrophages: the neglected barrier to eradication.,24152764,Gupta,Ravindra K,RK,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Sharma,Amit,A,"Center for Retrovirus Research, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.",2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Larue,Ross C,RC,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Plumb,Matthew R,MR,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Malani,Nirav,N,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Male,Frances,F,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Slaughter,Alison,A,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Kessl,Jacques J,JJ,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Shkriabai,Nikolozi,N,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Coward,Elizabeth,E,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Aiyer,Sriram S,SS,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Green,Patrick L,PL,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Wu,Li,L,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Roth,Monica J,MJ,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Bushman,Frederic D,FD,None,2013,BET proteins promote efficient murine leukemia virus integration at transcription start sites.,23818621,Kvaratskhelia,Mamuka,M,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,<lastname>LovÌ©n</lastname>,Jakob,J,"Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.",2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Hoke,Heather A,HA,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Lin,Charles Y,CY,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Lau,Ashley,A,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Orlando,David A,DA,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Vakoc,Christopher R,CR,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Bradner,James E,JE,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Lee,Tong Ihn,TI,None,2013,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,23582323,Young,Richard A,RA,None,2013,Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA.,23365439,Wang,Xin,X,"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.",2013,Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA.,23365439,Helfer,Christine M,CM,None,2013,Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA.,23365439,Pancholi,Neha,N,None,2013,Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA.,23365439,Bradner,James E,JE,None,2013,Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA.,23365439,You,Jianxin,J,None,2013,New insights concerning the occurrence of fungi in water sources and their potential pathogenicity.,24011405,Oliveira,B R,BR,"<affiliation>iBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal.</affiliation>",2013,New insights concerning the occurrence of fungi in water sources and their potential pathogenicity.,24011405,Crespo,M T Barreto,MT,None,2013,New insights concerning the occurrence of fungi in water sources and their potential pathogenicity.,24011405,<lastname>San RomÌ£o</lastname>,M V,MV,None,2013,New insights concerning the occurrence of fungi in water sources and their potential pathogenicity.,24011405,Benoliel,M J,MJ,None,2013,New insights concerning the occurrence of fungi in water sources and their potential pathogenicity.,24011405,Samson,R A,RA,None,2013,New insights concerning the occurrence of fungi in water sources and their potential pathogenicity.,24011405,Pereira,V J,VJ,None,2013,"Patulibacter medicamentivorans sp. nov., isolated from activated sludge of a wastewater treatment plant.",23264500,Almeida,<forename>BÌÁrbara</forename>,B,"IBET - Apartado 12, 2781-901 Oeiras, Portugal.",2013,"Patulibacter medicamentivorans sp. nov., isolated from activated sludge of a wastewater treatment plant.",23264500,Vaz-Moreira,Ivone,I,None,2013,"Patulibacter medicamentivorans sp. nov., isolated from activated sludge of a wastewater treatment plant.",23264500,Schumann,Peter,P,None,2013,"Patulibacter medicamentivorans sp. nov., isolated from activated sludge of a wastewater treatment plant.",23264500,Nunes,Olga C,OC,None,2013,"Patulibacter medicamentivorans sp. nov., isolated from activated sludge of a wastewater treatment plant.",23264500,Carvalho,Gilda,G,None,2013,"Patulibacter medicamentivorans sp. nov., isolated from activated sludge of a wastewater treatment plant.",23264500,Barreto Crespo,Maria T,MT,None,2013,"The making of I-BET762, a BET bromodomain inhibitor now in clinical development.",24107192,Zhao,Yujun,Y,"Comprehensive Cancer Center and Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan , Ann Arbor, Michigan 48109, United States.",2013,"The making of I-BET762, a BET bromodomain inhibitor now in clinical development.",24107192,Yang,Chao-Yie,CY,None,2013,"The making of I-BET762, a BET bromodomain inhibitor now in clinical development.",24107192,Wang,Shaomeng,S,None,2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,<lastname>HnilicovÌÁ</lastname>,Jarmila,J,"Department of RNA Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague 142 20, Czech Republic Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague 142 20, Czech Republic Max Planck Institute for Molecular Cell Biology and Genetics, Dresden 01307, Germany J. Heyrovsky Institute of Physical Chemistry, Academy of Sciences of the Czech Republic, Prague 182 23, Czech Republic.",2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,Hozeifi,Samira,S,None,2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,<lastname>StejskalovÌÁ</lastname>,Eva,E,None,2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,<lastname>DuÅÁkovÌÁ</lastname>,Eva,E,None,2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,Poser,Ina,I,None,2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,<lastname>HumpolÌ_€çkovÌÁ</lastname>,Jana,J,None,2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,Hof,Martin,M,None,2013,The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.,24048450,<lastname>Stan€_k</lastname>,David,D,None,2013,"Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites.",23945939,Kellner,Wendy A,WA,"Department of Biology, Emory University, Atlanta, GA 30322, USA and Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322, USA.",2013,"Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites.",23945939,Van Bortle,Kevin,K,None,2013,"Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites.",23945939,Li,Li,L,None,2013,"Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites.",23945939,Ramos,Edward,E,None,2013,"Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites.",23945939,Takenaka,Naomi,N,None,2013,"Distinct isoforms of the Drosophila Brd4 homologue are present at enhancers, promoters and insulator sites.",23945939,Corces,Victor G,VG,None,2013,The CH2 domain of CBP/p300 is a novel zinc finger.,23831576,Park,Sangho,S,"Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.",2013,The CH2 domain of CBP/p300 is a novel zinc finger.,23831576,Martinez-Yamout,Maria A,MA,None,2013,The CH2 domain of CBP/p300 is a novel zinc finger.,23831576,Dyson,H Jane,HJ,None,2013,The CH2 domain of CBP/p300 is a novel zinc finger.,23831576,Wright,Peter E,PE,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Floyd,Scott R,SR,"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.",2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Pacold,Michael E,ME,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Huang,Qiuying,Q,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Clarke,Scott M,SM,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Lam,Fred C,FC,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Cannell,Ian G,IG,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Bryson,Bryan D,BD,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Rameseder,Jonathan,J,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Lee,Michael J,MJ,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Blake,Emily J,EJ,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Fydrych,Anna,A,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Ho,Richard,R,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Greenberger,Benjamin A,BA,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Chen,Grace C,GC,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Maffa,Amanda,A,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Del Rosario,Amanda M,AM,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Root,David E,DE,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Carpenter,Anne E,AE,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Hahn,William C,WC,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Sabatini,David M,DM,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Chen,Clark C,CC,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,White,Forest M,FM,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Bradner,James E,JE,None,2013,The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.,23728299,Yaffe,Michael B,MB,None,2013,Bromodomains as therapeutic targets in cancer.,23543289,Barbieri,Isaia,I,"Kouzarides laboratory, University of Cambridge.",2013,Bromodomains as therapeutic targets in cancer.,23543289,Cannizzaro,Ester,E,None,2013,Bromodomains as therapeutic targets in cancer.,23543289,Dawson,Mark A,MA,None,2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Fu,Jiafang,J,"State Key Laboratory of Microbial Technology, Shandong University, Jinan, China.",2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Hou,Jin,J,None,2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Liu,Liangyu,L,None,2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Chen,Lei,L,None,2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Wang,Mingpeng,M,None,2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Shen,Yu,Y,None,2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Zhang,Zhaojie,Z,None,2013,Interplay between BDF1 and BDF2 and their roles in regulating the yeast salt stress response.,23452060,Bao,Xiaoming,X,None,2013,Cancers with wrong HATs: the impact of acetylation.,23325510,Di Cerbo,Vincenzo,V,"Max-Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany.",2013,Cancers with wrong HATs: the impact of acetylation.,23325510,Schneider,Robert,R,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Wyce,Anastasia,A,"Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, Collegeville, Pennsylvania, USA.",2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Ganji,Gopinath,G,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Smitheman,Kimberly N,KN,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Chung,Chun-Wa,CW,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Korenchuk,Susan,S,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Bai,Yuchen,Y,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Barbash,Olena,O,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Le,BaoChau,B,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Craggs,Peter D,PD,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,McCabe,Michael T,MT,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Kennedy-Wilson,Karen M,KM,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Sanchez,Lydia V,LV,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Gosmini,Romain L,RL,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Parr,Nigel,N,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,McHugh,Charles F,CF,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Dhanak,Dashyant,D,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Prinjha,Rab K,RK,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Auger,Kurt R,KR,None,2013,BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.,24009722,Tummino,Peter J,PJ,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Picaud,Sarah,S,"Structural Genomics Consortium and Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, USA.",2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Da Costa,David,D,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Thanasopoulou,Angeliki,A,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Filippakopoulos,Panagis,P,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Fish,Paul V,PV,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Philpott,Martin,M,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Fedorov,Oleg,O,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Brennan,Paul,P,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Bunnage,Mark E,ME,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Owen,Dafydd R,DR,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Bradner,James E,JE,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Taniere,Philippe,P,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,O'Sullivan,Brendan,B,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,<lastname>MÌ_ller</lastname>,Susanne,S,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Schwaller,Juerg,J,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Stankovic,Tatjana,T,None,2013,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.",23576556,Knapp,Stefan,S,None,2013,Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.,22777717,Fang,Wei,W,"Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.",2013,Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.,22777717,French,Christopher A,CA,None,2013,Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.,22777717,Cameron,Michael J,MJ,None,2013,Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.,22777717,Han,Yiding,Y,None,2013,Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.,22777717,Liu,Honggang,H,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Gupta,Saumya Shree,SS,"Institute of Virology, Hannover Medical School, Hannover, Germany.",2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Maetzig,Tobias,T,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Maertens,Goedele N,GN,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Sharif,Azar,A,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Rothe,Michael,M,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Weidner-Glunde,Magdalena,M,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Galla,Melanie,M,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Schambach,Axel,A,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Cherepanov,Peter,P,None,2013,Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.,24049186,Schulz,Thomas F,TF,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Zhao,X,X,"Department of Malignant Hematology and Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.",2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Lwin,T,T,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Zhang,X,X,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Huang,A,A,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Wang,J,J,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Marquez,V E,VE,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Chen-Kiang,S,S,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Dalton,W S,WS,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Sotomayor,E,E,None,2013,Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.,23538750,Tao,J,J,None,2013,P-TEFb as a target to reactivate latent HIV: two Brds are now in hand.,23324342,Rice,Andrew P,AP,"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA. arice@bcm.edu",2013,The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.,23087374,Li,Zichong,Z,"Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.",2013,The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.,23087374,Guo,Jia,J,None,2013,The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.,23087374,Wu,Yuntao,Y,None,2013,The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.,23087374,Zhou,Qiang,Q,None,2013,Transcriptomic analysis highlights epigenetic and transcriptional regulation during zygotic embryo development of Pinus pinaster.,23987738,de Vega-Bartol,<forename>JosÌ© J</forename>,JJ,"<affiliation>iBET - Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal. cmiguel@itqb.unl.pt.</affiliation>",2013,Transcriptomic analysis highlights epigenetic and transcriptional regulation during zygotic embryo development of Pinus pinaster.,23987738,<lastname>SimÌµes</lastname>,Marta,M,None,2013,Transcriptomic analysis highlights epigenetic and transcriptional regulation during zygotic embryo development of Pinus pinaster.,23987738,Lorenz,W Walter,WW,None,2013,Transcriptomic analysis highlights epigenetic and transcriptional regulation during zygotic embryo development of Pinus pinaster.,23987738,Rodrigues,Andreia S,AS,None,2013,Transcriptomic analysis highlights epigenetic and transcriptional regulation during zygotic embryo development of Pinus pinaster.,23987738,Alba,Rob,R,None,2013,Transcriptomic analysis highlights epigenetic and transcriptional regulation during zygotic embryo development of Pinus pinaster.,23987738,Dean,Jeffrey F D,JF,None,2013,Transcriptomic analysis highlights epigenetic and transcriptional regulation during zygotic embryo development of Pinus pinaster.,23987738,Miguel,<forename>CÌ©lia M</forename>,CM,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Almeida,B,B,"IBET, Apartado 12, 2781-901, Oeiras, Portugal.",2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Kjeldal,H,H,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Lolas,I,I,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Knudsen,A D,AD,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Carvalho,G,G,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Nielsen,K L,KL,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Barreto Crespo,M T,MT,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Stensballe,A,A,None,2013,Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11.,23212173,Nielsen,J L,JL,None,2013,BET bromodomain inhibition suppresses TH17-mediated pathology.,24101376,Mele,Deanna A,DA,"Constellation Pharmaceuticals, Inc., Cambridge, MA.",2013,BET bromodomain inhibition suppresses TH17-mediated pathology.,24101376,Salmeron,Andres,A,None,2013,BET bromodomain inhibition suppresses TH17-mediated pathology.,24101376,Ghosh,Srimoyee,S,None,2013,BET bromodomain inhibition suppresses TH17-mediated pathology.,24101376,Huang,Hon-Ren,HR,None,2013,BET bromodomain inhibition suppresses TH17-mediated pathology.,24101376,Bryant,Barbara M,BM,None,2013,BET bromodomain inhibition suppresses TH17-mediated pathology.,24101376,Lora,Jose M,JM,None,2013,Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.,24013502,Wang,Jiyong,J,"Department of Biological Sciences, Columbia University, New York, New York 10027, USA;",2013,Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.,24013502,Tadeo,Xavier,X,None,2013,Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.,24013502,Hou,Haitong,H,None,2013,Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.,24013502,Tu,Patricia G,PG,None,2013,Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.,24013502,Thompson,James,J,None,2013,Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.,24013502,Yates,John R,JR,None,2013,Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.,24013502,Jia,Songtao,S,None,2013,Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.,23934153,Delvecchio,Manuela,M,"1] European Molecular Biology Laboratory, Grenoble, France. [2] Unit for Virus Host-Cell Interactions, University of Grenoble Alpes, European Molecular Biology Laboratory-Centre National de la Recherche Scientifique, Grenoble, France. [3].",2013,Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.,23934153,Gaucher,Jonathan,J,None,2013,Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.,23934153,Aguilar-Gurrieri,Carmen,C,None,2013,Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.,23934153,Ortega,Esther,E,None,2013,Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.,23934153,Panne,Daniel,D,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,He,Minghao,M,"Center for AIDS Research, College of Life Sciences, Nankai University, Tianjin, China.",2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Zhang,Linlin,L,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Wang,Xincheng,X,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Huo,Lihong,L,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Sun,Lei,L,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Feng,Chengye,C,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Jing,Xutian,X,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Du,Danyao,D,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Liang,Huabin,H,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Liu,Min,M,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Hong,Zhangyong,Z,None,2013,Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.,23826228,Zhou,Jun,J,None,2013,Does bromodomain flexibility influence histone recognition?,23711371,Steiner,Sandra,S,"Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.",2013,Does bromodomain flexibility influence histone recognition?,23711371,Magno,Andrea,A,None,2013,Does bromodomain flexibility influence histone recognition?,23711371,Huang,Danzhi,D,None,2013,Does bromodomain flexibility influence histone recognition?,23711371,Caflisch,Amedeo,A,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Zhao,Lele,L,"Department of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , 555 Zuchongzhi Road, Shanghai 201203, China.",2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Cao,Danyan,D,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Chen,Tiantian,T,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Wang,Yingqing,Y,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Miao,Zehong,Z,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Xu,Yechun,Y,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Chen,Wuyan,W,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Wang,Xin,X,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Li,Yanlian,Y,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Du,Zhiyan,Z,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Xiong,Bing,B,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Li,Jian,J,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Xu,Chunyan,C,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Zhang,Naixia,N,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,He,Jianhua,J,None,2013,Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.,23530754,Shen,Jingkang,J,None,2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Kockmann,Tobias,T,"ETH Zurich, Department of Biosystems Science and Engineering (D-BSSE), Mattenstrasse 26, 4058 Basel, Switzerland. renato.paro@bsse.ethz.ch.",2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Gerstung,Moritz,M,None,2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Schlumpf,Tommy,T,None,2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Xhinzhou,Zhu,Z,None,2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Hess,Daniel,D,None,2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Beerenwinkel,Niko,N,None,2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Beisel,Christian,C,None,2013,The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila.,23442797,Paro,Renato,R,None,2013,Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.,23317504,Wu,Shwu-Yuan,SY,"Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.",2013,Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.,23317504,Lee,A-Young,AY,None,2013,Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.,23317504,Lai,Hsien-Tsung,HT,None,2013,Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.,23317504,Zhang,Hong,H,None,2013,Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.,23317504,Chiang,Cheng-Ming,CM,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Hellert,Jan,J,"Department of Structural Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.",2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Weidner-Glunde,Magdalena,M,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Krausze,Joern,J,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Richter,Ulrike,U,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Adler,Heiko,H,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Fedorov,Roman,R,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Pietrek,Marcel,M,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,<lastname>RÌ_ckert</lastname>,Jessica,J,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Ritter,Christiane,C,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,Schulz,Thomas F,TF,None,2013,A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.,24146614,<lastname>LÌ_hrs</lastname>,Thorsten,T,None,2013,Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-ë± gene in acute kidney injury.,23936185,Bomsztyk,Karol,K,"Department of Medicine, University of Washington, Seattle, Washington, USA. karolb@u.washington.edu",2013,Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-ë± gene in acute kidney injury.,23936185,Flanagin,Steve,S,None,2013,Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-ë± gene in acute kidney injury.,23936185,Mar,Daniel,D,None,2013,Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-ë± gene in acute kidney injury.,23936185,Mikula,Michal,M,None,2013,Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-ë± gene in acute kidney injury.,23936185,Johnson,Ali,A,None,2013,Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-ë± gene in acute kidney injury.,23936185,Zager,Richard,R,None,2013,Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-ë± gene in acute kidney injury.,23936185,Denisenko,Oleg,O,None,2013,Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell.,23521829,Bhar,Anirban,A,"Institute of Bioinformatics, University Medical Center Goettingen, University of Goettingen, Goldschmidtstrasse 1, Goettingen, D-37077, Germany. anirban.bhar@bioinf.med.uni-goettingen.de.",2013,Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell.,23521829,Haubrock,Martin,M,None,2013,Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell.,23521829,Mukhopadhyay,Anirban,A,None,2013,Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell.,23521829,Maulik,Ujjwal,U,None,2013,Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell.,23521829,Bandyopadhyay,Sanghamitra,S,None,2013,Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell.,23521829,Wingender,Edgar,E,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Zhang,Weishi,W,"Laboratory of Gene Regulation and Inflammation, SIgN (Singapore Immunology Network), A*STAR (Agency for Science, Technology and Research), Biopolis, Immunos 04-00, 8A Biomedical Grove, Singapore.",2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Prakash,Celine,C,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Sum,Calvin,C,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Gong,Yue,Y,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Li,Yinghui,Y,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Kwok,Jeffrey J T,JJ,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Thiessen,Nina,N,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Pettersson,Sven,S,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Jones,Steven J M,SJ,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Knapp,Stefan,S,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Yang,Henry,H,None,2012,Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.,23086925,Chin,Keh-Chuang,KC,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Banerjee,Camellia,C,"Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.",2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Archin,Nancie,N,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Michaels,Daniel,D,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Belkina,Anna C,AC,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Denis,Gerald V,GV,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Bradner,James,J,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Sebastiani,Paola,P,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Margolis,David M,DM,None,2012,BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.,22802445,Montano,Monty,M,None,2012,Step-by-step strategy for protein enrichment and proteome characterisation of extracellular polymeric substances in wastewater treatment systems.,22622841,Silva,Ana F,AF,"IBET, 2781-901 Oeiras, Portugal.",2012,Step-by-step strategy for protein enrichment and proteome characterisation of extracellular polymeric substances in wastewater treatment systems.,22622841,Carvalho,Gilda,G,None,2012,Step-by-step strategy for protein enrichment and proteome characterisation of extracellular polymeric substances in wastewater treatment systems.,22622841,Soares,Renata,R,None,2012,Step-by-step strategy for protein enrichment and proteome characterisation of extracellular polymeric substances in wastewater treatment systems.,22622841,Coelho,Ana V,AV,None,2012,Step-by-step strategy for protein enrichment and proteome characterisation of extracellular polymeric substances in wastewater treatment systems.,22622841,Barreto Crespo,M Teresa,MT,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Marcelino,Isabel,I,"IBET, Apartado 12, 2780-901 Oeiras, Portugal. isabel_m31@hotmail.com",2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,de Almeida,<forename>AndrÌ© Martinho</forename>,AM,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Brito,Catarina,C,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Meyer,Damien F,DF,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Barreto,<forename>MÌ_nica</forename>,M,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Sheikboudou,Christian,C,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Franco,Catarina F,CF,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Martinez,Dominique,D,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,<lastname>LefranÌ_ois</lastname>,Thierry,T,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,<lastname>VachiÌ©ry</lastname>,Nathalie,N,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Carrondo,Manuel J T,MJ,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Coelho,Ana Varela,AV,None,2012,Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins.,22204792,Alves,Paula M,PM,None,2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Hewings,David S,DS,"Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, U.K.",2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Rooney,Timothy P C,TP,None,2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Jennings,Laura E,LE,None,2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Hay,Duncan A,DA,None,2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Schofield,Christopher J,CJ,None,2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Brennan,Paul E,PE,None,2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Knapp,Stefan,S,None,2012,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.,22924434,Conway,Stuart J,SJ,None,2012,"No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways.",22864638,Penkert,Judith,J,"Institute of Cell and Molecular Pathology, Hannover Medical School, Carl-Neuberg-Strasse 1, Hannover, Germany.",2012,"No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways.",22864638,Schlegelberger,Brigitte,B,None,2012,"No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways.",22864638,Steinemann,Doris,D,None,2012,"No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways.",22864638,Gadzicki,Dorothea,D,None,2012,"Lysine acetylation: enzymes, bromodomains and links to different diseases.",22708559,You,Linya,L,"<affiliation>The Rosalind &amp; Morris Goodman Cancer Research Center, McGill University, MontrÌ©al, QuÌ©bec, Canada.</affiliation>",2012,"Lysine acetylation: enzymes, bromodomains and links to different diseases.",22708559,Nie,Jianyun,J,None,2012,"Lysine acetylation: enzymes, bromodomains and links to different diseases.",22708559,Sun,Wei-Jian,WJ,None,2012,"Lysine acetylation: enzymes, bromodomains and links to different diseases.",22708559,Zheng,Zhi-Qiang,ZQ,None,2012,"Lysine acetylation: enzymes, bromodomains and links to different diseases.",22708559,Yang,Xiang-Jiao,XJ,None,2012,The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3'-UTR truncation in round spermatids.,22570411,Berkovits,Binyamin D,BD,"Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA.",2012,The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3'-UTR truncation in round spermatids.,22570411,Wang,Li,L,None,2012,The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3'-UTR truncation in round spermatids.,22570411,Guarnieri,Paolo,P,None,2012,The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3'-UTR truncation in round spermatids.,22570411,Wolgemuth,Debra J,DJ,None,2012,MYC on the path to cancer.,22464321,Dang,Chi V,CV,"Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. dangvchi@upenn.edu",2012,Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.,22334664,Wang,Ranran,R,"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.",2012,Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.,22334664,Li,Qing,Q,None,2012,Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.,22334664,Helfer,Christine M,CM,None,2012,Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.,22334664,Jiao,Jing,J,None,2012,Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.,22334664,You,Jianxin,J,None,2012,The role of bromodomain proteins in regulating gene expression.,24704920,Josling,Gabrielle A,GA,"Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Australia. gjosling@student.unimelb.edu.au.",2012,The role of bromodomain proteins in regulating gene expression.,24704920,Selvarajah,Shamista A,SA,"Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Australia. s.selvarajah@student.unimelb.edu.au.",2012,The role of bromodomain proteins in regulating gene expression.,24704920,Petter,Michaela,M,"Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Australia. mpetter@unimelb.edu.au.",2012,The role of bromodomain proteins in regulating gene expression.,24704920,Duffy,Michael F,MF,"Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Australia. mduffy@unimelb.edu.au.",2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Garabedian,Mikael V,MV,"Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, USA.",2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Noguchi,Chiaki,C,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Ziegler,Melissa A,MA,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Das,Mukund M,MM,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Singh,Tanu,T,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Harper,Logan J,LJ,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Leman,Adam R,AR,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Khair,Lyne,L,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Moser,Bettina A,BA,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Nakamura,Toru M,TM,None,2012,The double-bromodomain proteins Bdf1 and Bdf2 modulate chromatin structure to regulate S-phase stress response in Schizosaccharomyces pombe.,22095079,Noguchi,Eishi,E,None,2012,Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.,23027873,Devaiah,Ballachanda N,BN,"Experimental Immunology Branch, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA.",2012,Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.,23027873,Singer,Dinah S,DS,None,2012,HEXIM1-binding elements on mRNAs identified through transcriptomic SELEX and computational screening.,22609015,Fujimoto,Yuki,Y,"Department of Basic Medical Sciences, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.",2012,HEXIM1-binding elements on mRNAs identified through transcriptomic SELEX and computational screening.,22609015,Nakamura,Yoshikazu,Y,None,2012,HEXIM1-binding elements on mRNAs identified through transcriptomic SELEX and computational screening.,22609015,Ohuchi,Shoji,S,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Herrmann,Harald,H,"Ludwig Boltzmann Cluster Oncology, Vienna, Austria.",2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Blatt,Katharina,K,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Shi,Junwei,J,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Gleixner,Karoline V,KV,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Cerny-Reiterer,Sabine,S,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,<lastname>MÌ_llauer</lastname>,Leonhard,L,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Vakoc,Christopher R,CR,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Sperr,Wolfgang R,WR,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Horny,Hans-Peter,HP,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Bradner,James E,JE,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Zuber,Johannes,J,None,2012,Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.,23249862,Valent,Peter,P,None,2012,Parsing the potential of a new male contraceptive.,23042348,Wolgemuth,Debra J,DJ,"Columbia University Medical Center, New York, New York, USA.",2012,Parsing the potential of a new male contraceptive.,23042348,Griswold,Michael D,MD,None,2012,Parsing the potential of a new male contraceptive.,23042348,Grimes,David A,DA,None,2012,RNA fingerprinting analysis of Oenococcus oeni strains under wine conditions.,22608229,Marques,Ana Paula,AP,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal. amarques@itqb.unl.pt</affiliation>",2012,RNA fingerprinting analysis of Oenococcus oeni strains under wine conditions.,22608229,<lastname>San RomÌ£o</lastname>,<forename>Maria VitÌ_ria</forename>,MV,None,2012,RNA fingerprinting analysis of Oenococcus oeni strains under wine conditions.,22608229,Tenreiro,<forename>RogÌ©rio</forename>,R,None,2012,Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production.,22179842,Rodrigues,A F,AF,"<affiliation>Animal Cell Technology Laboratory, Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Oeiras, Portugal.</affiliation>",2012,Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production.,22179842,Amaral,A I,AI,None,2012,Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production.,22179842,<lastname>VerÌ_ssimo</lastname>,V,V,None,2012,Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production.,22179842,Alves,P M,PM,None,2012,Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production.,22179842,Coroadinha,A S,AS,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Gaucher,Jonathan,J,"<affiliation>INSERM, U823, UniversitÌ© Joseph Fourier-Grenoble 1, Institut Albert Bonniot, Grenoble, France.</affiliation>",2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Boussouar,<forename>FayÌ_al</forename>,F,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Montellier,Emilie,E,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Curtet,Sandrine,S,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Buchou,Thierry,T,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Bertrand,Sarah,S,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Hery,Patrick,P,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Jounier,Sylvie,S,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Depaux,Arnaud,A,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Vitte,Anne-Laure,AL,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Guardiola,Philippe,P,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Pernet,Karin,K,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Debernardi,Alexandra,A,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Lopez,Fabrice,F,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Holota,<forename>HÌ©lÌ¬ne</forename>,H,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Imbert,Jean,J,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Wolgemuth,Debra J,DJ,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,<lastname>GÌ©rard</lastname>,Matthieu,M,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Rousseaux,Sophie,S,None,2012,Bromodomain-dependent stage-specific male genome programming by Brdt.,22922464,Khochbin,Saadi,S,None,2012,Menin as a hub controlling mixed lineage leukemia.,22829075,Thiel,Austin T,AT,"Department of Cancer Biology, Abramson Family Cancer Research Institute, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.",2012,Menin as a hub controlling mixed lineage leukemia.,22829075,Huang,Jing,J,None,2012,Menin as a hub controlling mixed lineage leukemia.,22829075,Lei,Ming,M,None,2012,Menin as a hub controlling mixed lineage leukemia.,22829075,Hua,Xianxin,X,None,2012,Genome-wide screen of human bromodomain-containing proteins identifies Cecr2 as a novel DNA damage response protein.,22699752,Lee,Seul-Ki,SK,"Department of Life Science, Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul 120-750, Korea.",2012,Genome-wide screen of human bromodomain-containing proteins identifies Cecr2 as a novel DNA damage response protein.,22699752,Park,Eun-Jung,EJ,None,2012,Genome-wide screen of human bromodomain-containing proteins identifies Cecr2 as a novel DNA damage response protein.,22699752,Lee,Han-Sae,HS,None,2012,Genome-wide screen of human bromodomain-containing proteins identifies Cecr2 as a novel DNA damage response protein.,22699752,Lee,Ye Seul,YS,None,2012,Genome-wide screen of human bromodomain-containing proteins identifies Cecr2 as a novel DNA damage response protein.,22699752,Kwon,Jongbum,J,None,2012,Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress.,22567088,Nishiyama,Akira,A,"Program in Genomics of Differentiation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.",2012,Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress.,22567088,Dey,Anup,A,None,2012,Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress.,22567088,Tamura,Tomohiko,T,None,2012,Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress.,22567088,Ko,Minoru,M,None,2012,Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress.,22567088,Ozato,Keiko,K,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Chesi,Marta,M,"Comprehensive Cancer Center, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA.",2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Matthews,Geoffrey M,GM,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Garbitt,Victoria M,VM,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Palmer,Stephen E,SE,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Shortt,Jake,J,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Lefebure,Marcus,M,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Stewart,A Keith,AK,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Johnstone,Ricky W,RW,None,2012,Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.,22451422,Bergsagel,P Leif,PL,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Tanaka,Mio,M,"Kanagawa Children's Medical Center, Division of Pathology, Yokohama, Japan. mio@zc4.so-net.ne.jp",2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Kato,Keisuke,K,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Gomi,Kiyoshi,K,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Yoshida,Mariko,M,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Niwa,Tetsu,T,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Aida,Noriko,N,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Kigasawa,Hisato,H,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Ohama,Yokatsu,Y,None,2012,NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.,22301500,Tanaka,Yukichi,Y,None,2012,ECSASB2 mediates MLL degradation during hematopoietic differentiation.,22174154,Wang,Jingya,J,"Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.",2012,ECSASB2 mediates MLL degradation during hematopoietic differentiation.,22174154,Muntean,Andrew G,AG,None,2012,ECSASB2 mediates MLL degradation during hematopoietic differentiation.,22174154,Hess,Jay L,JL,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,<lastname>SchrÌ_der</lastname>,Sebastian,S,"Gladstone Institute of Virology and Immunology, University of California, San Francisco, California 94158, USA.",2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Cho,Sungyoo,S,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Zeng,Lei,L,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Zhang,Qiang,Q,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Kaehlcke,Katrin,K,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Mak,Lily,L,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Lau,Joann,J,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Bisgrove,Dwayne,D,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,<lastname>SchnÌ_lzer</lastname>,Martina,M,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Verdin,Eric,E,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Zhou,Ming-Ming,MM,None,2012,Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.,22084242,Ott,Melanie,M,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Winter,Georg E,GE,"CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.",2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Rix,Uwe,U,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Carlson,Scott M,SM,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Gleixner,Karoline V,KV,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Grebien,Florian,F,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Gridling,Manuela,M,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,<lastname>MÌ_ller</lastname>,<forename>AndrÌ© C</forename>,AC,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Breitwieser,Florian P,FP,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Bilban,Martin,M,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Colinge,Jacques,J,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Valent,Peter,P,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Bennett,Keiryn L,KL,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,White,Forest M,FM,None,2012,Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.,23023260,Superti-Furga,Giulio,G,None,2012,The histone code and treatments for acute myeloid leukemia.,22397660,Godley,Lucy A,LA,"Section of Hematology and Oncology and the Comprehensive Cancer Center, University of Chicago, Chicago, USA.",2012,The histone code and treatments for acute myeloid leukemia.,22397660,Le Beau,Michelle M,MM,None,2012,Editorial: JQ1: giving HIV-1 expression a boost by blocking bromodomains?,23204259,Zinchenko,Michelle Kim,MK,None,2012,Editorial: JQ1: giving HIV-1 expression a boost by blocking bromodomains?,23204259,Siliciano,Robert F,RF,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Zhu,Jian,J,"Department of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02127, USA.",2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Gaiha,Gaurav D,GD,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,John,Sinu P,SP,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Pertel,Thomas,T,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Chin,Christopher R,CR,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Gao,Geng,G,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Qu,Hongjing,H,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Walker,Bruce D,BD,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Elledge,Stephen J,SJ,None,2012,Reactivation of latent HIV-1 by inhibition of BRD4.,23041316,Brass,Abraham L,AL,None,2012,Downstream Processing of Lentiviral Vectors: releasing bottlenecks.,23075104,Bandeira,Vanessa Sofia,VS,"IBET, Animal Cell Technology Unit, Oeiras, Portugal; vbandeira@itqb.unl.pt.",2012,Downstream Processing of Lentiviral Vectors: releasing bottlenecks.,23075104,Peixoto,Cristina,C,None,2012,Downstream Processing of Lentiviral Vectors: releasing bottlenecks.,23075104,Rodrigues,Ana Filipa,AF,None,2012,Downstream Processing of Lentiviral Vectors: releasing bottlenecks.,23075104,Cruz,Pedro,P,None,2012,Downstream Processing of Lentiviral Vectors: releasing bottlenecks.,23075104,Alves,Paula,P,None,2012,Downstream Processing of Lentiviral Vectors: releasing bottlenecks.,23075104,Coroadinha,Ana Sofia,AS,None,2012,Downstream Processing of Lentiviral Vectors: releasing bottlenecks.,23075104,Carrondo,Manuel,M,None,2012,Carbon monoxide targeting mitochondria.,22536507,Queiroga,<forename>ClÌÁudia S F</forename>,CS,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2012,Carbon monoxide targeting mitochondria.,22536507,Almeida,Ana S,AS,None,2012,Carbon monoxide targeting mitochondria.,22536507,Vieira,Helena L A,HL,None,2012,Putative molecular mechanism underlying sperm chromatin remodelling is regulated by reproductive hormones.,23241214,Gill-Sharma,Manjeet Kaur,MK,"Department of Neuroendocrinology, National Institute for Research in Reproductive Health, J,M, Street, Parel, Mumbai 400012, India. manjitgill_sharma@hotmail.com.",2012,Putative molecular mechanism underlying sperm chromatin remodelling is regulated by reproductive hormones.,23241214,Choudhuri,Jyoti,J,None,2012,Putative molecular mechanism underlying sperm chromatin remodelling is regulated by reproductive hormones.,23241214,Ansari,Mukhtar Aleem,MA,None,2012,Putative molecular mechanism underlying sperm chromatin remodelling is regulated by reproductive hormones.,23241214,D'Souza,Serena,S,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Fish,Paul V,PV,"Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&amp;D , Ramsgate Road, Sandwich CT13 9NJ, United Kingdom.",2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Filippakopoulos,Panagis,P,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Bish,Gerwyn,G,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Brennan,Paul E,PE,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Bunnage,Mark E,ME,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Cook,Andrew S,AS,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Federov,Oleg,O,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Gerstenberger,Brian S,BS,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Jones,Hannah,H,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Knapp,Stefan,S,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Marsden,Brian,B,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Nocka,Karl,K,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Owen,Dafydd R,DR,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Philpott,Martin,M,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Picaud,Sarah,S,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Primiano,Michael J,MJ,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Ralph,Michael J,MJ,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Sciammetta,Nunzio,N,None,2012,Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.,23095041,Trzupek,John D,JD,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Bandukwala,Hozefa S,HS,"La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.",2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Gagnon,John,J,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Togher,Susan,S,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Greenbaum,Jason A,JA,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Lamperti,Edward D,ED,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Parr,Nigel J,NJ,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Molesworth,Amy M H,AM,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Smithers,Nicholas,N,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Lee,Kevin,K,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Witherington,Jason,J,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Tough,David F,DF,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Prinjha,Rab K,RK,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Peters,Bjoern,B,None,2012,Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.,22912406,Rao,Anjana,A,None,2012,Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA.,22820306,Liu,Lei,L,"Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230026, PR China.",2012,Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA.,22820306,Qin,Su,S,None,2012,Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA.,22820306,Zhang,Jiahai,J,None,2012,Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA.,22820306,Ji,Peng,P,None,2012,Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA.,22820306,Shi,Yunyu,Y,None,2012,Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA.,22820306,Wu,Jihui,J,None,2012,Electroconvulsive seizures regulates the Brd1 gene in the frontal cortex and hippocampus of the adult rat.,22675730,Fryland,Tue,T,"Department of Biomedicine, Aarhus University, Aarhus, Denmark. tue@humgen.au.dk",2012,Electroconvulsive seizures regulates the Brd1 gene in the frontal cortex and hippocampus of the adult rat.,22675730,Elfving,Betina,B,None,2012,Electroconvulsive seizures regulates the Brd1 gene in the frontal cortex and hippocampus of the adult rat.,22675730,Christensen,Jane H,JH,None,2012,Electroconvulsive seizures regulates the Brd1 gene in the frontal cortex and hippocampus of the adult rat.,22675730,Mors,Ole,O,None,2012,Electroconvulsive seizures regulates the Brd1 gene in the frontal cortex and hippocampus of the adult rat.,22675730,Wegener,Gregers,G,None,2012,Electroconvulsive seizures regulates the Brd1 gene in the frontal cortex and hippocampus of the adult rat.,22675730,<lastname>BÌürglum</lastname>,Anders D,AD,None,2012,Small molecule bromodomain inhibitors: extending the druggable genome.,22520470,Chung,Chun-Wa,CW,"Computational and Structural Sciences, GlaxoSmithKline R&amp;D, Stevenage, SG1 2NY, UK.",2012,SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.,22442726,Middeljans,Evelien,E,"Department of Molecular Biology, Nijmegen Centre for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands.",2012,SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.,22442726,Wan,Xi,X,None,2012,SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.,22442726,Jansen,Pascal W,PW,None,2012,SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.,22442726,Sharma,Vikram,V,None,2012,SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.,22442726,Stunnenberg,Hendrik G,HG,None,2012,SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.,22442726,Logie,Colin,C,None,2012,Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix.,22295248,Alsarraj,Jude,J,"Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.",2012,Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix.,22295248,Hunter,Kent W,KW,None,2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Filippakopoulos,Panagis,P,"University of Oxford, Nuffield Department of Clinical Medicine, Structural Genomics Consortium, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK.",2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Picaud,Sarah,S,None,2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Fedorov,Oleg,O,None,2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Keller,Marco,M,None,2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Wrobel,Matthias,M,None,2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Morgenstern,Olaf,O,None,2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Bracher,Franz,F,None,2012,Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.,22137933,Knapp,Stefan,S,None,2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,Du,Chao,C,"Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, People's Republic of China.",2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,Jin,Ya-Qiong,YQ,None,2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,Qi,Jun-Juan,JJ,None,2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,Ji,Zhen-Xing,ZX,None,2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,Li,Shu-Yan,SY,None,2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,An,Guo-Shun,GS,None,2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,Jia,Hong-Ti,HT,None,2012,Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.,22814845,Ni,Ju-Hua,JH,None,2012,Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication.,23144621,Wang,Xin,X,"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.",2012,Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication.,23144621,Li,Jing,J,None,2012,Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication.,23144621,Schowalter,Rachel M,RM,None,2012,Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication.,23144621,Jiao,Jing,J,None,2012,Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication.,23144621,Buck,Christopher B,CB,None,2012,Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication.,23144621,You,Jianxin,J,None,2012,Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.,22952229,Bartholomeeusen,Koen,K,"Department of Medicine, University of California, San Francisco, California 94143-0703, USA.",2012,Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.,22952229,Xiang,Yanhui,Y,None,2012,Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.,22952229,Fujinaga,Koh,K,None,2012,Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.,22952229,Peterlin,B Matija,BM,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Carrondo,Manuel J T,MJ,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Oeiras, Portugal.</affiliation>",2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Alves,Paula M,PM,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Carinhas,Nuno,N,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Glassey,Jarka,J,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Hesse,Friedemann,F,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Merten,Otto-Wilhelm,OW,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Micheletti,Martina,M,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Noll,Thomas,T,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Oliveira,Rui,R,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Reichl,Udo,U,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Staby,Arne,A,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Teixeira,Ana P,AP,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Weichert,Henry,H,None,2012,"How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology?",22949408,Mandenius,Carl-Fredrik,CF,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,Marcelino,Isabel,I,"IBET, Apartado 12, 2780-901 Oeiras, Portugal. marcelino@itqb.unl.pt",2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,de Almeida,<forename>AndrÌ© Martinho</forename>,AM,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,Ventosa,Miguel,M,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,Pruneau,Ludovic,L,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,Meyer,Damien F,DF,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,Martinez,Dominique,D,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,<lastname>LefranÌ_ois</lastname>,Thierry,T,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,<lastname>VachiÌ©ry</lastname>,Nathalie,N,None,2012,Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines.,22480908,Coelho,Ana Varela,AV,None,2012,Microbial population analysis of nutrient removal-related organisms in membrane bioreactors.,21826414,Silva,Ana F,AF,"<affiliation>Microbiology Laboratory, Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Av. RepÌ_blica, Qta. do MarquÌ»s, 2780-157, Oeiras, Portugal.</affiliation>",2012,Microbial population analysis of nutrient removal-related organisms in membrane bioreactors.,21826414,Carvalho,Gilda,G,None,2012,Microbial population analysis of nutrient removal-related organisms in membrane bioreactors.,21826414,Oehmen,Adrian,A,None,2012,Microbial population analysis of nutrient removal-related organisms in membrane bioreactors.,21826414,Lousada-Ferreira,Maria,M,None,2012,Microbial population analysis of nutrient removal-related organisms in membrane bioreactors.,21826414,van Nieuwenhuijzen,Arjen,A,None,2012,Microbial population analysis of nutrient removal-related organisms in membrane bioreactors.,21826414,Reis,Maria A M,MA,None,2012,Microbial population analysis of nutrient removal-related organisms in membrane bioreactors.,21826414,Crespo,M Teresa Barreto,MT,None,2012,Disordered epigenetic regulation in MLL-related leukemia.,23054645,Zhang,Yue,Y,"Division of Pathology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Room S7.607, MLC 7013, Cincinnati, OH 45229-3039, USA.",2012,Disordered epigenetic regulation in MLL-related leukemia.,23054645,Chen,Aili,A,None,2012,Disordered epigenetic regulation in MLL-related leukemia.,23054645,Yan,Xiao-Mei,XM,None,2012,Disordered epigenetic regulation in MLL-related leukemia.,23054645,Huang,Gang,G,None,2012,Contraception for men: a breakthrough new approach.,22901799,Bremner,William J,WJ,"Department of Medicine, University of Washington, Seattle, WA 98195, USA. wbremner@uw.edu",2012,Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.,22788793,Vidler,Lewis R,LR,"Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom.",2012,Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.,22788793,Brown,Nathan,N,None,2012,Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.,22788793,Knapp,Stefan,S,None,2012,Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.,22788793,Hoelder,Swen,S,None,2012,Heterochromatin protein 1 gamma and Ië_B kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages.,22649058,Thorne,James L,JL,"Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, Wellcome Trust Brenner Building, St. James's University Hospital, Leeds LS9 7TF, UK.",2012,Heterochromatin protein 1 gamma and Ië_B kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages.,22649058,Ouboussad,Lylia,L,None,2012,Heterochromatin protein 1 gamma and Ië_B kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages.,22649058,Lefevre,Pascal F,PF,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Devaiah,Ballachanda N,BN,"Experimental Immunology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.",2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Lewis,Brian A,BA,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Cherman,Natasha,N,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Hewitt,Michael C,MC,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Albrecht,Brian K,BK,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Robey,Pamela G,PG,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Ozato,Keiko,K,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Sims,Robert J,RJ,None,2012,BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.,22509028,Singer,Dinah S,DS,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Seal,Jonathan,J,"Epinova DPU, GlaxoSmithKline R&amp;D, Medicines Research Centre, Stevenage, Hertfordshire, UK. jon.t.seal@gsk.com",2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Lamotte,Yann,Y,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Donche,<forename>FrÌ©dÌ©ric</forename>,F,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Bouillot,Anne,A,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Mirguet,Olivier,O,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Gellibert,<forename>FranÌ_oise</forename>,F,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Nicodeme,Edwige,E,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Krysa,Gael,G,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Kirilovsky,Jorge,J,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Beinke,Soren,S,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,McCleary,Scott,S,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Rioja,Inma,I,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Bamborough,Paul,P,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Chung,Chun-Wa,CW,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Gordon,Laurie,L,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Lewis,Toni,T,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Walker,Ann L,AL,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Cutler,Leanne,L,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Lugo,David,D,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Wilson,David M,DM,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Witherington,Jason,J,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Lee,Kevin,K,None,2012,Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).,22437115,Prinjha,Rab K,RK,None,2012,Place your BETs: the therapeutic potential of bromodomains.,22277300,Prinjha,R K,RK,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline PLC, Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK.",2012,Place your BETs: the therapeutic potential of bromodomains.,22277300,Witherington,J,J,None,2012,Place your BETs: the therapeutic potential of bromodomains.,22277300,Lee,K,K,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Bamborough,Paul,P,"Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline R&amp;D, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK. Paul.a.Bamborough@gsk.com",2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Diallo,Hawa,H,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Goodacre,Jonathan D,JD,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Gordon,Laurie,L,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Lewis,Antonia,A,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Seal,Jonathan T,JT,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Wilson,David M,DM,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Woodrow,Michael D,MD,None,2012,Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.,22136469,Chung,Chun-Wa,CW,None,2012,Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.,22024541,Suh,Eui Jin,EJ,"BRI, Korea Institute of Science and Technology Seoul, Korea University of Science and Technology Daejeon, Korea.",2012,Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.,22024541,Kabir,Mohammad Humayun,MH,None,2012,Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.,22024541,Kang,Un Beom,UB,None,2012,Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.,22024541,Lee,Jong Won,JW,None,2012,Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.,22024541,Yu,Jonghan,J,None,2012,Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.,22024541,Noh,Dong Young,DY,None,2012,Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.,22024541,Lee,Cheolju,C,None,2012,NUT midline carcinoma with cutaneous metastases.,22794811,Young,Michelle R,MR,None,2012,NUT midline carcinoma with cutaneous metastases.,22794811,Millington,Karmaine,K,None,2012,NUT midline carcinoma with cutaneous metastases.,22794811,Clarke,Loren E,LE,None,2012,NUT midline carcinoma with cutaneous metastases.,22794811,Helm,Klaus,K,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Barda,Shimi,S,"The Mina and Everard Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.",2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Paz,Gedalia,G,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Yogev,Leah,L,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Yavetz,Haim,H,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Lehavi,Ofer,O,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Hauser,Ron,R,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Botchan,Amnon,A,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Breitbart,Haim,H,None,2012,Expression of BET genes in testis of men with different spermatogenic impairments.,22035730,Kleiman,Sandra E,SE,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,Goupille,Olivier,O,"CEA, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses, France.",2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,Penglong,Tipparat,T,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,<lastname>LefÌ¬vre</lastname>,Carine,C,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,Granger,Marine,M,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,Kadri,Zahra,Z,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,Fucharoen,Suthat,S,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,<lastname>Maouche-ChrÌ©tien</lastname>,Leila,L,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,Leboulch,Philippe,P,None,2012,BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.,23137537,<lastname>ChrÌ©tien</lastname>,Stany,S,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Ott,Christopher J,CJ,"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.",2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Kopp,Nadja,N,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Bird,Liat,L,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Paranal,Ronald M,RM,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Qi,Jun,J,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Bowman,Teresa,T,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Rodig,Scott J,SJ,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Kung,Andrew L,AL,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Bradner,James E,JE,None,2012,BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.,22904298,Weinstock,David M,DM,None,2012,Downstream processing of lentiviral vectors: releasing bottlenecks.,22934827,Bandeira,Vanessa,V,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), 2781-901 Oeiras, Portugal.</affiliation>",2012,Downstream processing of lentiviral vectors: releasing bottlenecks.,22934827,Peixoto,Cristina,C,None,2012,Downstream processing of lentiviral vectors: releasing bottlenecks.,22934827,Rodrigues,Ana F,AF,None,2012,Downstream processing of lentiviral vectors: releasing bottlenecks.,22934827,Cruz,Pedro E,PE,None,2012,Downstream processing of lentiviral vectors: releasing bottlenecks.,22934827,Alves,Paula M,PM,None,2012,Downstream processing of lentiviral vectors: releasing bottlenecks.,22934827,Coroadinha,Ana S,AS,None,2012,Downstream processing of lentiviral vectors: releasing bottlenecks.,22934827,Carrondo,Manuel J T,MJ,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Brito,Catarina,C,"<affiliation>iBET, Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2780-901 Oeiras, Portugal.</affiliation>",2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,<lastname>SimÌ£o</lastname>,Daniel,D,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Costa,<forename>InÌ»s</forename>,I,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Malpique,Rita,R,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Pereira,Cristina I,CI,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Fernandes,Paulo,P,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Serra,Margarida,M,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Schwarz,Sigrid C,SC,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Schwarz,Johannes,J,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Kremer,Eric J,EJ,None,2012,3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].,22433395,Alves,Paula M,PM,None,2012,The bromodomain-containing protein tBRD-1 is specifically expressed in spermatocytes and is essential for male fertility.,23213453,Leser,Katja,K,"<affiliation>Philipps-UniversitÌ_t Marburg, Fachbereich Biologie, Entwicklungsbiologie , Karl-von-Frisch Strasse 8, 35043 Marburg , Germany.</affiliation>",2012,The bromodomain-containing protein tBRD-1 is specifically expressed in spermatocytes and is essential for male fertility.,23213453,Awe,Stephan,S,None,2012,The bromodomain-containing protein tBRD-1 is specifically expressed in spermatocytes and is essential for male fertility.,23213453,Barckmann,Bridlin,B,None,2012,The bromodomain-containing protein tBRD-1 is specifically expressed in spermatocytes and is essential for male fertility.,23213453,Renkawitz-Pohl,Renate,R,None,2012,The bromodomain-containing protein tBRD-1 is specifically expressed in spermatocytes and is essential for male fertility.,23213453,Rathke,Christina,C,None,2012,Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins.,22897906,Leroy,Gary,G,"Department of Molecular Biology, Princeton University, 415 Schultz Laboratory, Princeton NJ 08544, USA. bagarcia@princeton.edu.",2012,Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins.,22897906,Chepelev,Iouri,I,None,2012,Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins.,22897906,Dimaggio,Peter A,PA,None,2012,Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins.,22897906,Blanco,Mario A,MA,None,2012,Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins.,22897906,Zee,Barry M,BM,None,2012,Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins.,22897906,Zhao,Keji,K,None,2012,Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins.,22897906,Garcia,Benjamin A,BA,None,2012,Bromodomain-containing protein 2 gene in photosensitive epilepsy.,22766109,Yavuz,Ebru Nur,EN,"Istanbul University, Istanbul Faculty of Medicine, Department of Neurology and Istanbul University Epilepsy Center, Turkey.",2012,Bromodomain-containing protein 2 gene in photosensitive epilepsy.,22766109,Ozdemir,Ozkan,O,None,2012,Bromodomain-containing protein 2 gene in photosensitive epilepsy.,22766109,Catal,Suzin,S,None,2012,Bromodomain-containing protein 2 gene in photosensitive epilepsy.,22766109,Bebek,Nerses,N,None,2012,Bromodomain-containing protein 2 gene in photosensitive epilepsy.,22766109,Ozbek,Ugur,U,None,2012,Bromodomain-containing protein 2 gene in photosensitive epilepsy.,22766109,Baykan,Betul,B,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Yang,Ping,P,"UC Davis Cancer Center/Basic Sciences, University of California at Davis, Sacramento, California, USA.",2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Guo,Linlang,L,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Duan,Zhijian J,ZJ,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Tepper,Clifford G,CG,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Xue,Ling,L,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Chen,Xinbin,X,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Kung,Hsing-Jien,HJ,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Gao,Allen C,AC,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Zou,June X,JX,None,2012,"Histone methyltransferase NSD2/MMSET mediates constitutive NF-ë_B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.",22645312,Chen,Hong-Wu,HW,None,2012,Epigenetic protein families: a new frontier for drug discovery.,22498752,Arrowsmith,Cheryl H,CH,"Structural Genomics Consortium, University of Toronto, 101 College Street, Toronto, Ontario M5G 1L7, Canada. carrow@uhnresearch.ca",2012,Epigenetic protein families: a new frontier for drug discovery.,22498752,Bountra,Chas,C,None,2012,Epigenetic protein families: a new frontier for drug discovery.,22498752,Fish,Paul V,PV,None,2012,Epigenetic protein families: a new frontier for drug discovery.,22498752,Lee,Kevin,K,None,2012,Epigenetic protein families: a new frontier for drug discovery.,22498752,Schapira,Matthieu,M,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Petrini,Petrini,P,"Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.",2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,French,Christopher A,CA,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Rajan,Arun,A,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Cameron,Michael J,MJ,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Jaffe,Elaine S,ES,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Zucali,Paolo A,PA,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Xie,Jianwu,J,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Wang,Yisong,Y,None,2012,NUT rearrangement is uncommon in human thymic epithelial tumors.,22425924,Giaccone,Giuseppe,G,None,2012,Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery.,22136404,Chung,Chun-Wa,CW,"Computational &amp; Structural Chemistry, Molecular Discovery Research, GlaxoSmithKline R&amp;D, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK. Chun-wa.chung@gsk.com",2012,Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery.,22136404,Dean,Anthony W,AW,None,2012,Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery.,22136404,Woolven,James M,JM,None,2012,Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery.,22136404,Bamborough,Paul,P,None,2012,[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].,23157742,Fang,Wei,W,"Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.",2012,[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].,23157742,French,Christopher A,CA,None,2012,[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].,23157742,Cameron,Michael J,MJ,None,2012,[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].,23157742,Han,Yi-Ding,YD,None,2012,[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].,23157742,Liu,Hong-Gang,HG,None,2012,Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.,22790861,Evans,Andrew G,AG,"Department of Pathology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA 02115, USA.",2012,Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.,22790861,French,Christopher A,CA,None,2012,Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.,22790861,Cameron,Michael J,MJ,None,2012,Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.,22790861,Fletcher,Christopher D M,CD,None,2012,Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.,22790861,Jackman,David M,DM,None,2012,Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.,22790861,Lathan,Christopher S,CS,None,2012,Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.,22790861,Sholl,Lynette M,LM,None,2012,NUT midline carcinoma: an imaging case series and review of literature.,22033856,Polsani,Aruna,A,"Department of Radiology &amp; Imaging Sciences, Children's Healthcare of Atlanta, Emory University, 1405 Clifton Road NE, Atlanta, GA 30322, USA. aruna_polsani@yahoo.com",2012,NUT midline carcinoma: an imaging case series and review of literature.,22033856,Braithwaite,Kiery A,KA,None,2012,NUT midline carcinoma: an imaging case series and review of literature.,22033856,Alazraki,Adina L,AL,None,2012,NUT midline carcinoma: an imaging case series and review of literature.,22033856,Abramowsky,Carlos,C,None,2012,NUT midline carcinoma: an imaging case series and review of literature.,22033856,Shehata,Bahig M,BM,None,2012,Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins.,23129625,Lockwood,William W,WW,"Cancer Biology and Genetics Section, Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. william.lockwood@nih.gov",2012,Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins.,23129625,Zejnullahu,Kreshnik,K,None,2012,Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins.,23129625,Bradner,James E,JE,None,2012,Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins.,23129625,Varmus,Harold,H,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Matzuk,Martin M,MM,"Department of Pathology &amp; Immunology, Baylor College of Medicine, Houston, TX 77030, USA. mmatzuk@bcm.edu",2012,Small-molecule inhibition of BRDT for male contraception.,22901802,McKeown,Michael R,MR,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Filippakopoulos,Panagis,P,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Li,Qinglei,Q,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Ma,Lang,L,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Agno,Julio E,JE,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Lemieux,Madeleine E,ME,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Picaud,Sarah,S,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Yu,Richard N,RN,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Qi,Jun,J,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Knapp,Stefan,S,None,2012,Small-molecule inhibition of BRDT for male contraception.,22901802,Bradner,James E,JE,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,Malpique,Rita,R,"Animal Cell Technology, IBET, Oeiras, Portugal.",2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,<lastname>TostÌµes</lastname>,Rui,R,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,Beier,Axel F J,AF,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,Serra,Margarida,M,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,Brito,Catarina,C,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,Schulz,Julia C,JC,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,<lastname>BjÌ_rquist</lastname>,Petter,P,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,Zimmermann,Heiko,H,None,2012,Surface-based cryopreservation strategies for human embryonic stem cells: a comparative study.,22718690,Alves,Paula M,PM,None,2012,A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.,23144632,Draker,Ryan,R,"Ontario Cancer Institute, Toronto, Canada.",2012,A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.,23144632,Ng,Marlee K,MK,None,2012,A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.,23144632,Sarcinella,Elizabeth,E,None,2012,A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.,23144632,Ignatchenko,Vladimir,V,None,2012,A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.,23144632,Kislinger,Thomas,T,None,2012,A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.,23144632,Cheung,Peter,P,None,2012,The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal.,22971749,Fukazawa,Hidesuke,H,"<affiliation>Department of Bioactive Molecules, National Institute of Infectious Diseases, 1‰ÛÒ23‰ÛÒ1 Toyama, Tokyo162‰ÛÒ8640, Japan. fukazawa@nih.go.jp</affiliation>",2012,The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal.,22971749,Masumi,Atsuko,A,None,2012,Application of an omonasteine ligation strategy for the total chemical synthesis of the BRD7 bromodomain.,22889936,Van de Vijver,Pieter,P,"Laboratory for Chemical Protein Synthesis, Department of Biochemistry, Maastricht University, Universiteitssingel 50, 6200 MD, Maastricht, The Netherlands. p.vandevijver@maastrichtuniversity.nl",2012,Application of an omonasteine ligation strategy for the total chemical synthesis of the BRD7 bromodomain.,22889936,Scheer,Liesbeth,L,None,2012,Application of an omonasteine ligation strategy for the total chemical synthesis of the BRD7 bromodomain.,22889936,van Beijnum,Judy,J,None,2012,Application of an omonasteine ligation strategy for the total chemical synthesis of the BRD7 bromodomain.,22889936,Griffioen,Arjan,A,None,2012,Application of an omonasteine ligation strategy for the total chemical synthesis of the BRD7 bromodomain.,22889936,Hackeng,Tilman M,TM,None,2012,"BET domain co-regulators in obesity, inflammation and cancer.",22722403,Belkina,Anna C,AC,"Cancer Research Center, Nutrition Obesity Research Center, Departments of Medicine and Pharmacology, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA.",2012,"BET domain co-regulators in obesity, inflammation and cancer.",22722403,Denis,Gerald V,GV,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Zhang,Guangtao,G,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, New York 10029, USA.",2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Liu,Ruijie,R,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Zhong,Yifei,Y,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Plotnikov,Alexander N,AN,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Zhang,Weijia,W,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Zeng,Lei,L,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Rusinova,Elena,E,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Gerona-Nevarro,Guillermo,G,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Moshkina,Natasha,N,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Joshua,Jennifer,J,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Chuang,Peter Y,PY,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Ohlmeyer,Michael,M,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,He,John Cijiang,JC,None,2012,Down-regulation of NF-ë_B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.,22645123,Zhou,Ming-Ming,MM,None,2012,Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27.,22493065,Tie,Feng,F,"Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, USA.",2012,Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27.,22493065,Banerjee,Rakhee,R,None,2012,Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27.,22493065,Conrad,Patricia A,PA,None,2012,Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27.,22493065,Scacheri,Peter C,PC,None,2012,Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27.,22493065,Harte,Peter J,PJ,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Mirguet,Olivier,O,"Lipid Metabolism Discovery Performance Unit, GlaxoSmithKline, Les Ulis Cedex, France. olivier.x.mirguet@gsk.com",2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Lamotte,Yann,Y,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Donche,<forename>FrÌ©dÌ©ric</forename>,F,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Toum,<forename>JÌ©rÌ«me</forename>,J,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Gellibert,<forename>FranÌ_oise</forename>,F,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Bouillot,Anne,A,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Gosmini,Romain,R,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Nguyen,Van-Loc,VL,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,<lastname>DelannÌ©e</lastname>,Delphine,D,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Seal,Jonathan,J,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Blandel,Florence,F,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Boullay,<forename>Anne-BÌ©nÌ©dicte</forename>,AB,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Boursier,Eric,E,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Martin,Sandrine,S,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Brusq,Jean-Marie,JM,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Krysa,Gael,G,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Riou,Alizon,A,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Tellier,<forename>RÌ©mi</forename>,R,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Costaz,<forename>AgnÌ¬s</forename>,A,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Huet,Pascal,P,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Dudit,Yann,Y,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Trottet,Lionel,L,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Kirilovsky,Jorge,J,None,2012,From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.,22386529,Nicodeme,Edwige,E,None,2012,"Insights into role of bromodomain, testis-specific (Brdt) in acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesis.",22215678,Dhar,Surbhi,S,"Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore 560064, India.",2012,"Insights into role of bromodomain, testis-specific (Brdt) in acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesis.",22215678,Thota,Anusha,A,None,2012,"Insights into role of bromodomain, testis-specific (Brdt) in acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesis.",22215678,Rao,Manchanahalli Rangaswamy Satyanarayana,MR,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Rodriguez,R M,RM,"<affiliation>Cancer Epigenetics Laboratory, Instituto Universitario de OncologÌ_a del Principado de Asturias (IUOPA), HUCA, Universidad de Oviedo, Oviedo, Spain.</affiliation>",2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Huidobro,C,C,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Urdinguio,R G,RG,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Mangas,C,C,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Soldevilla,B,B,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,<lastname>DomÌ_nguez</lastname>,G,G,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Bonilla,F,F,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Fernandez,A F,AF,None,2012,Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.,22120039,Fraga,M F,MF,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Okamura,Daiji,D,"Cell Resource Center for Biomedical Research, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Miyagi, Japan.",2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Maeda,Ikuma,I,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Taniguchi,Hirofumi,H,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Tokitake,Yuko,Y,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Ikeda,Makiko,M,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Ozato,Keiko,K,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Mise,Nathan,N,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Abe,Kuniya,K,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Noce,Toshiaki,T,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Izpisua Belmonte,Juan Carlos,JC,None,2012,Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells.,23154982,Matsui,Yasuhisa,Y,None,2012,Identification and analysis of papillomavirus E2 protein binding sites in the human genome.,22031941,<lastname>VÌµsa</lastname>,Liisi,L,"Center of Biomedical Technology, Institute of Technology, University of Tartu, Tartu, Estonia.",2012,Identification and analysis of papillomavirus E2 protein binding sites in the human genome.,22031941,Sudakov,Aleksander,A,None,2012,Identification and analysis of papillomavirus E2 protein binding sites in the human genome.,22031941,Remm,Maido,M,None,2012,Identification and analysis of papillomavirus E2 protein binding sites in the human genome.,22031941,Ustav,Mart,M,None,2012,Identification and analysis of papillomavirus E2 protein binding sites in the human genome.,22031941,Kurg,Reet,R,None,2012,Cancer research: Open ambition.,22874946,Maxmen,Amy,A,None,2012,Cold acclimation and floral development in almond bud break: insights into the regulatory pathways.,22685307,Barros,Pedro M,PM,"<affiliation>Genomics of Plant Stress Laboratory (GPlantS), Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa, Av. da RepÌ_blica, 2780-157 Oeiras, Portugal andåÊIBET, Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2012,Cold acclimation and floral development in almond bud break: insights into the regulatory pathways.,22685307,<lastname>GonÌ_alves</lastname>,Nuno,N,None,2012,Cold acclimation and floral development in almond bud break: insights into the regulatory pathways.,22685307,Saibo,Nelson J M,NJ,None,2012,Cold acclimation and floral development in almond bud break: insights into the regulatory pathways.,22685307,Oliveira,M Margarida,MM,None,2012,Bromodomains: are readers right for epigenetic therapy?,24900532,Conway,Stuart J,SJ,"Department of Chemistry, Chemistry Research Laboratory, University of Oxford , Mansfield Road, Oxford, OX2 8JQ, United Kingdom.",2012,Chromatin modifications as therapeutic targets in MLL-rearranged leukemia.,22867873,Deshpande,Aniruddha J,AJ,"Division of Hematology/Oncology, Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.",2012,Chromatin modifications as therapeutic targets in MLL-rearranged leukemia.,22867873,Bradner,James,J,None,2012,Chromatin modifications as therapeutic targets in MLL-rearranged leukemia.,22867873,Armstrong,Scott A,SA,None,2012,The bromodomain interaction module.,22710155,Filippakopoulos,Panagis,P,"Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK. panagis.filippakopoulos@sgc.ox.ac.uk",2012,The bromodomain interaction module.,22710155,Knapp,Stefan,S,None,2012,Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B.,22595521,Garcia-Gutierrez,Pablo,P,"<affiliation>Stem Cells Department, Centro Andaluz de BiologÌ_a Molecular y Medicina Regenerativa and Consejo Superior de Investigaciones CientÌ_ficas, Av Americo Vespucio, Spain.</affiliation>",2012,Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B.,22595521,Mundi,Maria,M,None,2012,Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B.,22595521,Garcia-Dominguez,Mario,M,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Filippakopoulos,Panagis,P,"Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK. panagis.filippakopoulos@sgc.ox.ac.uk",2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Picaud,Sarah,S,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Mangos,Maria,M,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Keates,Tracy,T,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Lambert,Jean-Philippe,JP,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Barsyte-Lovejoy,Dalia,D,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Felletar,Ildiko,I,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Volkmer,Rudolf,R,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,<lastname>MÌ_ller</lastname>,Susanne,S,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Pawson,Tony,T,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Gingras,Anne-Claude,AC,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Arrowsmith,Cheryl H,CH,None,2012,Histone recognition and large-scale structural analysis of the human bromodomain family.,22464331,Knapp,Stefan,S,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Christensen,Jane H,JH,"Department of Biomedicine, Aarhus University, Denmark. jhc@humgen.au.dk",2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Elfving,Betina,B,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,<lastname>MÌ_ller</lastname>,Heidi K,HK,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Fryland,Tue,T,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Nyegaard,Mette,M,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Corydon,Thomas J,TJ,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Nielsen,Anders Lade,AL,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Mors,Ole,O,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,Wegener,Gregers,G,None,2012,The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.,22341945,<lastname>BÌürglum</lastname>,Anders D,AD,None,2012,HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods.,24832227,Quy,Vo Cam,VC,"<affiliation>Computational Biophysics, German Research School for Simulation Sciences, Computational Biomedicine, Institute for Advanced Simulation (IAS-5), Forschungszentrum JÌ_lich, JÌ_lich D-52425, Germany. v.c.quy@grs-sim.de.</affiliation>",2012,HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods.,24832227,Pantano,Sergio,S,"Institut Pasteur de Montevideo, Mataojo 2020, Montevideo CP 11400, Uruguay. spantano@pasteur.edu.uy.",2012,HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods.,24832227,Rossetti,Giulia,G,"<affiliation>Computational Biophysics, German Research School for Simulation Sciences, Computational Biomedicine, Institute for Advanced Simulation (IAS-5), Forschungszentrum JÌ_lich, JÌ_lich D-52425, Germany. g.rossetti@grs-sim.de.</affiliation>",2012,HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods.,24832227,Giacca,Mauro,M,"International Centre for Genetic Engineering and Biotechnology, Trieste 34149, Italy. giacca@icgeb.org.",2012,HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods.,24832227,Carloni,Paolo,P,"<affiliation>Computational Biophysics, German Research School for Simulation Sciences, Computational Biomedicine, Institute for Advanced Simulation (IAS-5), Forschungszentrum JÌ_lich, JÌ_lich D-52425, Germany. p.carloni@grs-sim.de.</affiliation>",2012,Comparative kinome analysis to identify putative colon tumor biomarkers.,22095101,Hennig,Ewa E,EE,"Department of Gastroenterology and Hepatology, Medical Center for Postgraduate Education, Warsaw, Poland.",2012,Comparative kinome analysis to identify putative colon tumor biomarkers.,22095101,Mikula,Michal,M,None,2012,Comparative kinome analysis to identify putative colon tumor biomarkers.,22095101,Rubel,Tymon,T,None,2012,Comparative kinome analysis to identify putative colon tumor biomarkers.,22095101,Dadlez,Michal,M,None,2012,Comparative kinome analysis to identify putative colon tumor biomarkers.,22095101,Ostrowski,Jerzy,J,None,2012,&quot;Remembering&quot; tissue-specific transcription patterns through mitosis.,23032269,Kadauke,Stephan,S,None,2012,&quot;Remembering&quot; tissue-specific transcription patterns through mitosis.,23032269,Blobel,Gerd A,GA,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Toyoshima,Masafumi,M,"Department of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.",2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Howie,Heather L,HL,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Imakura,Maki,M,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Walsh,Ryan M,RM,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Annis,James E,JE,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Chang,Aaron N,AN,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Frazier,Jason,J,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Chau,B Nelson,BN,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Loboda,Andrey,A,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Linsley,Peter S,PS,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Cleary,Michele A,MA,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Park,Julie R,JR,None,2012,Functional genomics identifies therapeutic targets for MYC-driven cancer.,22623531,Grandori,Carla,C,None,2012,Pathogenesis of NUT midline carcinoma.,22017582,French,Christopher A,CA,"Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. cfrench@partners.org",2011,Synchronous fluorescence spectroscopy as a novel tool to enable PAT applications in bioprocesses.,21391211,Teixeira,Ana P,AP,"IBET, Apartado 12, 2781-901 Oeiras, Portugal. anat@itqb.unl.pt",2011,Synchronous fluorescence spectroscopy as a novel tool to enable PAT applications in bioprocesses.,21391211,Duarte,Tiago M,TM,None,2011,Synchronous fluorescence spectroscopy as a novel tool to enable PAT applications in bioprocesses.,21391211,Carrondo,M J T,MJ,None,2011,Synchronous fluorescence spectroscopy as a novel tool to enable PAT applications in bioprocesses.,21391211,Alves,Paula M,PM,None,2011,Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions.,21956175,Chung,Chun-Wa,CW,"PTS, GlaxoSmithKline R&amp;D, Stevenage, UK. Chun-wa.h.Chung@gsk.com",2011,Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions.,21956175,Witherington,Jason,J,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Hewings,David S,DS,"Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.",2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Wang,Minghua,M,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Philpott,Martin,M,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Fedorov,Oleg,O,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Uttarkar,Sagar,S,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Filippakopoulos,Panagis,P,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Picaud,Sarah,S,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Vuppusetty,Chaitanya,C,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Marsden,Brian,B,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Knapp,Stefan,S,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Conway,Stuart J,SJ,None,2011,"3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.",21851057,Heightman,Tom D,TD,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Ruthenburg,Alexander J,AJ,"Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.",2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Li,Haitao,H,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Milne,Thomas A,TA,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Dewell,Scott,S,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,McGinty,Robert K,RK,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Yuen,Melanie,M,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Ueberheide,Beatrix,B,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Dou,Yali,Y,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Muir,Tom W,TW,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Patel,Dinshaw J,DJ,None,2011,Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.,21596426,Allis,C David,CD,None,2011,"Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.",21447565,Tae,Sookil,S,"Department of Molecular and Cellular Biochemistry, College of Medicine, The Ohio State University, Columbus, Ohio, OH 43210, USA.",2011,"Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.",21447565,Karkhanis,Vrajesh,V,None,2011,"Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.",21447565,Velasco,Kevin,K,None,2011,"Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.",21447565,Yaneva,Mariana,M,None,2011,"Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.",21447565,Erdjument-Bromage,Hediye,H,None,2011,"Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.",21447565,Tempst,Paul,P,None,2011,"Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.",21447565,Sif,<forename>SaÌød</forename>,S,None,2011,NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl.,21922980,Rutt,Amy L,AL,"Department of Otolaryngology, Children's Hospital of Michigan, Detroit, MI 48201, USA.",2011,NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl.,21922980,Poulik,Janet,J,None,2011,NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl.,21922980,Siddiqui,Abdul Hafeez,AH,None,2011,NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl.,21922980,Konski,Andre,A,None,2011,NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl.,21922980,Kalaf,Majid,M,None,2011,NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl.,21922980,Madgy,David N,DN,None,2011,NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl.,21922980,Wang,Zhihong J,ZJ,None,2011,SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.,21321083,Kapoor-Vazirani,Priya,P,"Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.",2011,SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.,21321083,Kagey,Jacob D,JD,None,2011,SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.,21321083,Vertino,Paula M,PM,None,2011,First drugs found to inhibit elusive cancer target.,22064391,Moyer,Melinda Wenner,MW,None,2011,Carbon monoxide prevents hepatic mitochondrial membrane permeabilization.,21388535,Queiroga,<forename>ClÌÁudia S F</forename>,CS,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2011,Carbon monoxide prevents hepatic mitochondrial membrane permeabilization.,21388535,Almeida,Ana S,AS,None,2011,Carbon monoxide prevents hepatic mitochondrial membrane permeabilization.,21388535,Alves,Paula M,PM,None,2011,Carbon monoxide prevents hepatic mitochondrial membrane permeabilization.,21388535,Brenner,Catherine,C,None,2011,Carbon monoxide prevents hepatic mitochondrial membrane permeabilization.,21388535,Vieira,Helena L A,HL,None,2011,"Elucidating the biochemical overwintering adaptations of Larval Cucujus clavipes puniceus, a nonmodel organism, via high throughput proteomics.",21923194,Carrasco,Martin A,MA,"Department of Applied and Computational Mathematics and Statistics, University of Notre Dame , Notre Dame, Indiana 46556, United States. mcarrasc@nd.edu",2011,"Elucidating the biochemical overwintering adaptations of Larval Cucujus clavipes puniceus, a nonmodel organism, via high throughput proteomics.",21923194,Buechler,Steven A,SA,None,2011,"Elucidating the biochemical overwintering adaptations of Larval Cucujus clavipes puniceus, a nonmodel organism, via high throughput proteomics.",21923194,Arnold,Randy J,RJ,None,2011,"Elucidating the biochemical overwintering adaptations of Larval Cucujus clavipes puniceus, a nonmodel organism, via high throughput proteomics.",21923194,Sformo,Todd,T,None,2011,"Elucidating the biochemical overwintering adaptations of Larval Cucujus clavipes puniceus, a nonmodel organism, via high throughput proteomics.",21923194,Barnes,Brian M,BM,None,2011,"Elucidating the biochemical overwintering adaptations of Larval Cucujus clavipes puniceus, a nonmodel organism, via high throughput proteomics.",21923194,Duman,John G,JG,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Philpott,Martin,M,"Structural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, UK.",2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Yang,Jing,J,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Tumber,Tony,T,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Fedorov,Oleg,O,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Uttarkar,Sagar,S,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Filippakopoulos,Panagis,P,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Picaud,Sarah,S,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Keates,Tracy,T,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Felletar,Ildiko,I,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Ciulli,Alessio,A,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Knapp,Stefan,S,None,2011,Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.,21804994,Heightman,Tom D,TD,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Chung,Chun-Wa,CW,"Molecular Discovery Research, GlaxoSmithKline R&amp;D, Stevenage SG5 4HT, UK. Chun-Wa.H.Chung@gsk.com",2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Coste,Herve,H,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,White,Julia H,JH,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Mirguet,Olivier,O,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Wilde,Jonathan,J,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Gosmini,Romain L,RL,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Delves,Chris,C,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Magny,Sylvie M,SM,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Woodward,Robert,R,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Hughes,Stephen A,SA,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Boursier,Eric V,EV,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Flynn,Helen,H,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Bouillot,Anne M,AM,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Bamborough,Paul,P,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Brusq,Jean-Marie G,JM,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Gellibert,Francoise J,FJ,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Jones,Emma J,EJ,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Riou,Alizon M,AM,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Homes,Paul,P,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Martin,Sandrine L,SL,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Uings,Iain J,IJ,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Toum,Jerome,J,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Clement,Catherine A,CA,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Boullay,Anne-Benedicte,AB,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Grimley,Rachel L,RL,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Blandel,Florence M,FM,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Prinjha,Rab K,RK,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Lee,Kevin,K,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Kirilovsky,Jorge,J,None,2011,Discovery and characterization of small molecule inhibitors of the BET family bromodomains.,21568322,Nicodeme,Edwige,E,None,2011,"Prp8, the pivotal protein of the spliceosomal catalytic center, evolved from a retroelement-encoded reverse transcriptase.",21441348,<lastname>Dlaki€à</lastname>,Mensur,M,"Department of Microbiology, Montana State University, Bozeman, Montana 59717, USA. mdlakic@montana.edu",2011,"Prp8, the pivotal protein of the spliceosomal catalytic center, evolved from a retroelement-encoded reverse transcriptase.",21441348,Mushegian,Arcady,A,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Robinson,Blaine W,BW,"Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.",2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Germano,Giuseppe,G,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Song,Yuanquan,Y,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Abrams,Joshua,J,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Scott,Marion,M,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Guariento,Ilaria,I,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Tiso,Natascia,N,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Argenton,Francesco,F,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Basso,Giuseppe,G,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Rhodes,Jennifer,J,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Kanki,John P,JP,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Look,A Thomas,AT,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Balice-Gordon,Rita J,RJ,None,2011,mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.,21155757,Felix,Carolyn A,CA,None,2011,FDG PET/CT imaging of NUT midline carcinoma.,21825839,Niederkohr,Ryan D,RD,"Department of Nuclear Medicine, Kaiser Permanente Medical Center, Santa Clara, CA 95051, USA. rniederkohr@gmail.com",2011,FDG PET/CT imaging of NUT midline carcinoma.,21825839,Cameron,Michael J,MJ,None,2011,FDG PET/CT imaging of NUT midline carcinoma.,21825839,French,Christopher A,CA,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Shimizu,Yosuke,Y,"Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.",2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Hamazaki,Yoko,Y,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Hattori,Masakazu,M,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Doi,Keiko,K,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Terada,Naoki,N,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Kobayashi,Takashi,T,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Toda,Yoshinobu,Y,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Yamasaki,Toshinari,T,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Inoue,Takahiro,T,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Kajita,Yoichiro,Y,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Maeno,Atsushi,A,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Kamba,Tomomi,T,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Mikami,Yoshiki,Y,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Kamoto,Toshiyuki,T,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Yamada,Tomomi,T,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Kanno,Toru,T,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Yoshikawa,Kiyotsugu,K,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Ogawa,Osamu,O,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Minato,Nagahiro,N,None,2011,SPA-1 controls the invasion and metastasis of human prostate cancer.,21251160,Nakamura,Eijiro,E,None,2011,NUT midline carcinoma: case report and review of the literature.,20034986,Hsieh,Min-Shu,MS,"Department of Pathology, National Taiwan University Hospital Yun-Lin branch, Yunlin, Taiwan.",2011,NUT midline carcinoma: case report and review of the literature.,20034986,French,Christopher A,CA,None,2011,NUT midline carcinoma: case report and review of the literature.,20034986,Liang,Cher-Wei,CW,None,2011,NUT midline carcinoma: case report and review of the literature.,20034986,Hsiao,Cheng-Hsiang,CH,None,2011,RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.,22046134,Palermo,Richard D,RD,"School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.",2011,RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.,22046134,Webb,Helen M,HM,None,2011,RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.,22046134,West,Michelle J,MJ,None,2011,Genomic diversity of Oenococcus oeni from different winemaking regions of Portugal.,22101413,Marques,Ana P,AP,"Institute of Experimental Biology and Technology-IBET and Institute of Chemical and Biological Technology-ITQB, New University of Lisbon, Oeiras, Portugal. amarques@itqb.unl.pt",2011,Genomic diversity of Oenococcus oeni from different winemaking regions of Portugal.,22101413,Duarte,Ana J,AJ,None,2011,Genomic diversity of Oenococcus oeni from different winemaking regions of Portugal.,22101413,Chambel,<forename>LÌ©lia</forename>,L,None,2011,Genomic diversity of Oenococcus oeni from different winemaking regions of Portugal.,22101413,Teixeira,Maria F,MF,None,2011,Genomic diversity of Oenococcus oeni from different winemaking regions of Portugal.,22101413,<lastname>San RomÌ£o</lastname>,Maria V,MV,None,2011,Genomic diversity of Oenococcus oeni from different winemaking regions of Portugal.,22101413,Tenreiro,<forename>RogÌ©rio</forename>,R,None,2011,Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification.,21294110,Vicente,Tiago,T,"IBET, Oeiras, Portugal.",2011,Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification.,21294110,<lastname>FÌÁber</lastname>,<forename>RenÌ©</forename>,R,None,2011,Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification.,21294110,Alves,Paula M,PM,None,2011,Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification.,21294110,Carrondo,Manuel J T,MJ,None,2011,Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification.,21294110,Mota,<forename>JosÌ© P B</forename>,JP,None,2011,Direct regulation of nucleosome density by the conserved AAA-ATPase Yta7.,22074782,Lombardi,Laura M,LM,"Department of Molecular and Cell Biology, and California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720, USA.",2011,Direct regulation of nucleosome density by the conserved AAA-ATPase Yta7.,22074782,Ellahi,Aisha,A,None,2011,Direct regulation of nucleosome density by the conserved AAA-ATPase Yta7.,22074782,Rine,Jasper,J,None,2011,Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemia.,21907920,Blobel,Gerd A,GA,"Division of Hematology, The Children's Hospital of Philadelphia, PA 19104, USA.",2011,Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemia.,21907920,Kalota,Anna,A,None,2011,Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemia.,21907920,Sanchez,Patricia V,PV,None,2011,Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemia.,21907920,Carroll,Martin,M,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Mishima,Yuta,Y,"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Graduate School of Pharmaceutical, Sciences, Chiba University, Chiba, Japan.",2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Miyagi,Satoru,S,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Saraya,Atsunori,A,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Negishi,Masamitsu,M,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Endoh,Mitsuhiro,M,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Endo,Takaho A,TA,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Toyoda,Tetsuro,T,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Shinga,Jun,J,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Katsumoto,Takuo,T,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Chiba,Tetsuhiro,T,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Yamaguchi,Naoto,N,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Kitabayashi,Issay,I,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Koseki,Haruhiko,H,None,2011,The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.,21753189,Iwama,Atsushi,A,None,2011,"The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.",21555454,Rahman,Shaila,S,"Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.",2011,"The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.",21555454,Sowa,Mathew E,ME,None,2011,"The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.",21555454,Ottinger,Matthias,M,None,2011,"The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.",21555454,Smith,Jennifer A,JA,None,2011,"The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.",21555454,Shi,Yang,Y,None,2011,"The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.",21555454,Harper,J Wade,JW,None,2011,"The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.",21555454,Howley,Peter M,PM,None,2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Alsarraj,Jude,J,"Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.",2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Walker,Renard C,RC,None,2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Webster,Joshua D,JD,None,2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Geiger,Thomas R,TR,None,2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Crawford,Nigel P S,NP,None,2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Simpson,R Mark,RM,None,2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Ozato,Keiko,K,None,2011,Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.,21389092,Hunter,Kent W,KW,None,2011,Isolation and functional characterization of P-TEFb-associated factors that control general and HIV-1 transcriptional elongation.,20385240,Chen,Ruichuan,R,"Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen 361005, Fujian, China.",2011,Isolation and functional characterization of P-TEFb-associated factors that control general and HIV-1 transcriptional elongation.,20385240,Liu,Min,M,None,2011,Isolation and functional characterization of P-TEFb-associated factors that control general and HIV-1 transcriptional elongation.,20385240,Zhang,Kai,K,None,2011,Isolation and functional characterization of P-TEFb-associated factors that control general and HIV-1 transcriptional elongation.,20385240,Zhou,Qiang,Q,None,2011,BRD4 jump-starts transcription after mitotic silencing.,22126464,Voigt,Philipp,P,"Howard Hughes Medical Institute, New York University School of Medicine, Department of Biochemistry, New York, NY 10016, USA.",2011,BRD4 jump-starts transcription after mitotic silencing.,22126464,Reinberg,Danny,D,None,2011,Peptoid ligands that bind selectively to phosphoproteins.,21742492,Cai,Di,D,"Department of Chemistry, The Scripps Research Institute, Scripps Florida, 130 Scripps Way, Jupiter, FL 33458, USA.",2011,Peptoid ligands that bind selectively to phosphoproteins.,21742492,Lee,A-Young,AY,None,2011,Peptoid ligands that bind selectively to phosphoproteins.,21742492,Chiang,Cheng-Ming,CM,None,2011,Peptoid ligands that bind selectively to phosphoproteins.,21742492,Kodadek,Thomas,T,None,2011,"New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.",21238915,Bhaijee,Feriyl,F,"Department of Pathology, The University of Mississippi Medical Center, Jackson, MS 39216, USA.",2011,"New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.",21238915,Pepper,Dominique J,DJ,None,2011,"New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.",21238915,Pitman,Karen T,KT,None,2011,"New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.",21238915,Bell,Diana,D,None,2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Mertz,Jennifer A,JA,"Constellation Pharmaceuticals, Inc, Cambridge, MA 02142, USA.",2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Conery,Andrew R,AR,None,2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Bryant,Barbara M,BM,None,2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Sandy,Peter,P,None,2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Balasubramanian,Srividya,S,None,2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Mele,Deanna A,DA,None,2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Bergeron,Louise,L,None,2011,Targeting MYC dependence in cancer by inhibiting BET bromodomains.,21949397,Sims,Robert J,RJ,None,2011,Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species.,21251953,Vieira,Helena L A,HL,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal. hvieira@itqb.unl.pt</affiliation>",2011,Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species.,21251953,Alves,Paula M,PM,None,2011,Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species.,21251953,Vercelli,Alessandro,A,None,2011,RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.,21900162,Brasier,Allan R,AR,"MRB 8.126, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1060, USA. arbrasie@utmb.edu",2011,RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.,21900162,Tian,B,B,None,2011,RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.,21900162,Jamaluddin,M,M,None,2011,RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.,21900162,Kalita,Mridul K,MK,None,2011,RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.,21900162,Garofalo,Roberto P,RP,None,2011,RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.,21900162,Lu,Muping,M,None,2011,Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms.,21749977,Chatterjee,Nilanjana,N,"Department of Biochemistry and Molecular Biology, Southern Illinois University School of Medicine, Carbondale, IL 62901-4413, USA.",2011,Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms.,21749977,Sinha,Divya,D,None,2011,Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms.,21749977,Lemma-Dechassa,Mekonnen,M,None,2011,Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms.,21749977,Tan,Song,S,None,2011,Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms.,21749977,Shogren-Knaak,Michael A,MA,None,2011,Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms.,21749977,Bartholomew,Blaine,B,None,2011,Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.,21555453,Gamsjaeger,Roland,R,"School of Molecular Bioscience, University of Sydney, Sydney, NSW 2006, Australia.",2011,Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.,21555453,Webb,Sarah R,SR,None,2011,Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.,21555453,Lamonica,Janine M,JM,None,2011,Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.,21555453,Billin,Andrew,A,None,2011,Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.,21555453,Blobel,Gerd A,GA,None,2011,Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.,21555453,Mackay,Joel P,JP,None,2011,Chromatin remodeling complex NURF regulates thymocyte maturation.,21289071,Landry,Joseph W,JW,"Laboratory of Biochemistry and Molecular Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. jwlandry2@vcu.edu",2011,Chromatin remodeling complex NURF regulates thymocyte maturation.,21289071,Banerjee,Subhadra,S,None,2011,Chromatin remodeling complex NURF regulates thymocyte maturation.,21289071,Taylor,Barbara,B,None,2011,Chromatin remodeling complex NURF regulates thymocyte maturation.,21289071,Aplan,Peter D,PD,None,2011,Chromatin remodeling complex NURF regulates thymocyte maturation.,21289071,Singer,Alfred,A,None,2011,Chromatin remodeling complex NURF regulates thymocyte maturation.,21289071,Wu,Carl,C,None,2011,Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.,21652721,Yan,Junpeng,J,"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.",2011,Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.,21652721,Diaz,Jason,J,None,2011,Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.,21652721,Jiao,Jing,J,None,2011,Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.,21652721,Wang,Ranran,R,None,2011,Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.,21652721,You,Jianxin,J,None,2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Wang,Jiangfang,J,"Division of Rheumatology, The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA.",2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Reuschel,Emma L,EL,None,2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Shackelford,Jason M,JM,None,2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Jeang,Lauren,L,None,2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Shivers,Debra K,DK,None,2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Diehl,J Alan,JA,None,2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Yu,Xiao-Fang,XF,None,2011,HIV-1 Vif promotes the G‰âÅ- to S-phase cell-cycle transition.,21149631,Finkel,Terri H,TH,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Delmore,Jake E,JE,"Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.",2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Issa,Ghayas C,GC,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Lemieux,Madeleine E,ME,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Rahl,Peter B,PB,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Shi,Junwei,J,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Jacobs,Hannah M,HM,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Kastritis,Efstathios,E,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Gilpatrick,Timothy,T,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Paranal,Ronald M,RM,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Qi,Jun,J,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Chesi,Marta,M,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Schinzel,Anna C,AC,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,McKeown,Michael R,MR,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Heffernan,Timothy P,TP,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Vakoc,Christopher R,CR,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Bergsagel,P Leif,PL,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Ghobrial,Irene M,IM,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Richardson,Paul G,PG,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Young,Richard A,RA,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Hahn,William C,WC,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Anderson,Kenneth C,KC,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Kung,Andrew L,AL,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Bradner,James E,JE,None,2011,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,21889194,Mitsiades,Constantine S,CS,None,2011,Large-scale production and purification of VLP-based vaccines.,21784230,Vicente,Tiago,T,"Animal Cell Technology Unit, IBET, Apartado 12, P-2781-901 Oeiras, Portugal.",2011,Large-scale production and purification of VLP-based vaccines.,21784230,<lastname>RoldÌ£o</lastname>,<forename>AntÌ_nio</forename>,A,None,2011,Large-scale production and purification of VLP-based vaccines.,21784230,Peixoto,Cristina,C,None,2011,Large-scale production and purification of VLP-based vaccines.,21784230,Carrondo,Manuel J T,MJ,None,2011,Large-scale production and purification of VLP-based vaccines.,21784230,Alves,Paula M,PM,None,2011,The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic background.,22020252,Berkovits,Binyamin D,BD,"Department of Genetics and Development, Columbia University Medical Center, New York, New York 10032, USA.",2011,The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic background.,22020252,Wolgemuth,Debra J,DJ,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Ai,Nanping,N,"State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361005, Fujian, China.",2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Hu,Xiangming,X,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Ding,Feng,F,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Yu,Bingfei,B,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Wang,Huiping,H,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Lu,Xiaodong,X,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Zhang,Kai,K,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Li,Yannan,Y,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Han,Aidong,A,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Lin,Wen,W,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Liu,Runzhong,R,None,2011,Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.,21890894,Chen,Ruichuan,R,None,2011,Recruitment of TIF1ë_ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities.,21726812,Agricola,Eleonora,E,"Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.",2011,Recruitment of TIF1ë_ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities.,21726812,Randall,Rebecca A,RA,None,2011,Recruitment of TIF1ë_ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities.,21726812,Gaarenstroom,Tessa,T,None,2011,Recruitment of TIF1ë_ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities.,21726812,Dupont,Sirio,S,None,2011,Recruitment of TIF1ë_ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities.,21726812,Hill,Caroline S,CS,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Lamonica,Janine M,JM,"Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.",2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Deng,Wulan,W,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Kadauke,Stephan,S,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Campbell,Amy E,AE,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Gamsjaeger,Roland,R,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Wang,Hongxin,H,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Cheng,Yong,Y,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Billin,Andrew N,AN,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Hardison,Ross C,RC,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Mackay,Joel P,JP,None,2011,Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes.,21536911,Blobel,Gerd A,GA,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Gerona-Navarro,Guillermo,G,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1677, New York, New York 10029, United States.",2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,<lastname>Yoel-RodrÌ_guez</lastname>,None,None,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Mujtaba,Shiraz,S,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Frasca,Antonio,A,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Patel,Jigneshkumar,J,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Zeng,Lei,L,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Plotnikov,Alexander N,AN,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Osman,Roman,R,None,2011,Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.,21271695,Zhou,Ming-Ming,MM,None,2011,"HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation.",21599968,<lastname>RamÌ_rez-Salazar</lastname>,Eric,E,"Department of Genetics and Molecular Biology, CINVESTAV-IPN, Mexico City, Mexico.",2011,"HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation.",21599968,Centeno,Federico,F,None,2011,"HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation.",21599968,Nieto,Karen,K,None,2011,"HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation.",21599968,<lastname>Valencia-HernÌÁndez</lastname>,Armando,A,None,2011,"HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation.",21599968,Salcedo,Mauricio,M,None,2011,"HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation.",21599968,Garrido,<forename>EfraÌ_n</forename>,E,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Zuber,Johannes,J,"Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA.",2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Shi,Junwei,J,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Wang,Eric,E,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Rappaport,Amy R,AR,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Herrmann,Harald,H,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Sison,Edward A,EA,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Magoon,Daniel,D,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Qi,Jun,J,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Blatt,Katharina,K,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Wunderlich,Mark,M,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Taylor,Meredith J,MJ,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Johns,Christopher,C,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Chicas,Agustin,A,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Mulloy,James C,JC,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Kogan,Scott C,SC,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Brown,Patrick,P,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Valent,Peter,P,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Bradner,James E,JE,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Lowe,Scott W,SW,None,2011,RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.,21814200,Vakoc,Christopher R,CR,None,2011,Fluorescence-based tools to improve biopharmaceutical process development.,22373314,Duarte,Tiago M,TM,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal. anat@itqb.unl.pt.</affiliation>",2011,Fluorescence-based tools to improve biopharmaceutical process development.,22373314,Carrondo,Manuel Jt,MJ,None,2011,Fluorescence-based tools to improve biopharmaceutical process development.,22373314,Alves,Paula M,PM,None,2011,Fluorescence-based tools to improve biopharmaceutical process development.,22373314,Teixeira,Ana P,AP,None,2011,[Expression and clinical significance of bromodomain-containing protein 7 in non-small cell lung cancer].,22008115,Chen,Long,L,"Department of Cardiothoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, China.",2011,[Expression and clinical significance of bromodomain-containing protein 7 in non-small cell lung cancer].,22008115,Yu,Fenglei,F,None,2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,<lastname>VelÌ_ÅÁek</lastname>,Libor,L,"Department of Cell Biology &amp; Anatomy, New York College of Medicine, Valhalla, New York, United States of America. libor_velisek@nymc.edu",2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,Shang,Enyuan,E,None,2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,<lastname>VelÌ_ÅÁkovÌÁ</lastname>,Jana,J,None,2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,Chachua,Tamar,T,None,2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,Macchiarulo,Stephania,S,None,2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,Maglakelidze,Giorgi,G,None,2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,Wolgemuth,Debra J,DJ,None,2011,GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy.,21887291,Greenberg,David A,DA,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Charles,Georgette M,GM,"Department of Biochemistry and Biophysics, University of California, San Francisco, CA, 94158, USA.",2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Chen,Changbin,C,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Shih,Susan C,SC,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Collins,Sean R,SR,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Beltrao,Pedro,P,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Zhang,Xin,X,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Sharma,Tanu,T,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Tan,Song,S,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Burlingame,Alma L,AL,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Krogan,Nevan J,NJ,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Madhani,Hiten D,HD,None,2011,Site-specific acetylation mark on an essential chromatin-remodeling complex promotes resistance to replication stress.,21673141,Narlikar,Geeta J,GJ,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Borah,Jagat C,JC,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.",2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Mujtaba,Shiraz,S,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Karakikes,Ioannis,I,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Zeng,Lei,L,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Muller,Michaela,M,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Patel,Jigneshkumar,J,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Moshkina,Natasha,N,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Morohashi,Keita,K,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Zhang,Weijia,W,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Gerona-Navarro,Guillermo,G,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Hajjar,Roger J,RJ,None,2011,A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.,21513889,Zhou,Ming-Ming,MM,None,2011,[Midline carcinoma with rearrangement of nuclear protein in testis gene].,21575402,FANG,Wei,W,None,2011,[Midline carcinoma with rearrangement of nuclear protein in testis gene].,21575402,LIU,Hong-gang,HG,None,2011,Disrupting the reader of histone language.,21618372,Oliver,Samuel S,SS,"University of Wisconsin, Department of Biomolecular Chemistry and the Wisconsin Institute for Discovery, 330 North Orchard Street, Madison, WI 53715, USA.",2011,Disrupting the reader of histone language.,21618372,Denu,John M,JM,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Rodrigues,Ana F,AF,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (IBET/ITQB-UNL), Apartado 12, P-2781-901 Oeiras, Portugal. avalente@itqb.unl.pt.</affiliation>",2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Guerreiro,Miguel R,MR,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Castro,Rute,R,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,<lastname>TomÌÁs</lastname>,<forename>HÌ©lio A</forename>,HA,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Dalba,Charlotte,C,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Klatzmann,David,D,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Alves,Paula M,PM,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Carrondo,Manuel J T,MJ,None,2011,Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.,22373065,Coroadinha,Ana S,AS,None,2011,Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression.,21674167,Real,<forename>GonÌ_alo</forename>,G,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica Instituto (IBET), Apartado 12, 2781-901, Oeiras, Portugal. real@itqb.unl.pt</affiliation>",2011,Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression.,21674167,Monteiro,Francisca,F,None,2011,Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression.,21674167,Burger,Christa,C,None,2011,Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression.,21674167,Alves,Paula M,PM,None,2011,Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation.,21983563,Zhao,Rui,R,"Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA.",2011,Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation.,21983563,Nakamura,Tetsuya,T,None,2011,Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation.,21983563,Fu,Yu,Y,None,2011,Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation.,21983563,Lazar,Zsolt,Z,None,2011,Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation.,21983563,Spector,David L,DL,None,2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Qin,Su,S,"Hefei National Laboratory for Physical Sciences at the Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230026, China.",2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Jin,Lei,L,None,2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Zhang,Jiahai,J,None,2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Liu,Lei,L,None,2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Ji,Peng,P,None,2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Wu,Mian,M,None,2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Wu,Jihui,J,None,2011,Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).,21880731,Shi,Yunyu,Y,None,2011,"The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels.",21608014,Shang,Enyuan,E,"Division of Statistical Genetics, Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, New York 10032, USA.",2011,"The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels.",21608014,Cui,Qingping,Q,None,2011,"The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels.",21608014,Wang,Xiangyuan,X,None,2011,"The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels.",21608014,Beseler,Cheryl,C,None,2011,"The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels.",21608014,Greenberg,David A,DA,None,2011,"The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels.",21608014,Wolgemuth,Debra J,DJ,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Ito,Tamaki,T,"Chemical Genetics Laboratory, RIKEN Advanced Science Institute, Wako, Saitama 351-0198, Japan.",2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Umehara,Takashi,T,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Sasaki,Kazuki,K,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Nakamura,Yoshihiro,Y,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Nishino,Norikazu,N,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Terada,Takaho,T,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Shirouzu,Mikako,M,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Padmanabhan,Balasundaram,B,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Yokoyama,Shigeyuki,S,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Ito,Akihiro,A,None,2011,Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.,21513886,Yoshida,Minoru,M,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Schwartz,Brian E,BE,"Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.",2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Hofer,Matthias D,MD,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Lemieux,Madeleine E,ME,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Bauer,Daniel E,DE,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Cameron,Michael J,MJ,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,West,Nathan H,NH,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Agoston,Elin S,ES,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Reynoird,Nicolas,N,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Khochbin,Saadi,S,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Ince,Tan A,TA,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Christie,Amanda,A,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Janeway,Katherine A,KA,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Vargas,Sara O,SO,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Perez-Atayde,Antonio R,AR,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Aster,Jon C,JC,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Sallan,Stephen E,SE,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Kung,Andrew L,AL,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,Bradner,James E,JE,None,2011,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,21447744,French,Christopher A,CA,None,2010,Selective inhibition of BET bromodomains.,20871596,Filippakopoulos,Panagis,P,"Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford OX3 7DQ, UK.",2010,Selective inhibition of BET bromodomains.,20871596,Qi,Jun,J,None,2010,Selective inhibition of BET bromodomains.,20871596,Picaud,Sarah,S,None,2010,Selective inhibition of BET bromodomains.,20871596,Shen,Yao,Y,None,2010,Selective inhibition of BET bromodomains.,20871596,Smith,William B,WB,None,2010,Selective inhibition of BET bromodomains.,20871596,Fedorov,Oleg,O,None,2010,Selective inhibition of BET bromodomains.,20871596,Morse,Elizabeth M,EM,None,2010,Selective inhibition of BET bromodomains.,20871596,Keates,Tracey,T,None,2010,Selective inhibition of BET bromodomains.,20871596,Hickman,Tyler T,TT,None,2010,Selective inhibition of BET bromodomains.,20871596,Felletar,Ildiko,I,None,2010,Selective inhibition of BET bromodomains.,20871596,Philpott,Martin,M,None,2010,Selective inhibition of BET bromodomains.,20871596,Munro,Shonagh,S,None,2010,Selective inhibition of BET bromodomains.,20871596,McKeown,Michael R,MR,None,2010,Selective inhibition of BET bromodomains.,20871596,Wang,Yuchuan,Y,None,2010,Selective inhibition of BET bromodomains.,20871596,Christie,Amanda L,AL,None,2010,Selective inhibition of BET bromodomains.,20871596,West,Nathan,N,None,2010,Selective inhibition of BET bromodomains.,20871596,Cameron,Michael J,MJ,None,2010,Selective inhibition of BET bromodomains.,20871596,Schwartz,Brian,B,None,2010,Selective inhibition of BET bromodomains.,20871596,Heightman,Tom D,TD,None,2010,Selective inhibition of BET bromodomains.,20871596,La Thangue,Nicholas,N,None,2010,Selective inhibition of BET bromodomains.,20871596,French,Christopher A,CA,None,2010,Selective inhibition of BET bromodomains.,20871596,Wiest,Olaf,O,None,2010,Selective inhibition of BET bromodomains.,20871596,Kung,Andrew L,AL,None,2010,Selective inhibition of BET bromodomains.,20871596,Knapp,Stefan,S,None,2010,Selective inhibition of BET bromodomains.,20871596,Bradner,James E,JE,None,2010,Assessment of the presence and dynamics of fungi in drinking water sources using cultural and molecular methods.,20705315,Pereira,V J,VJ,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Av. RepÌ_blica, Qta. do MarquÌ»s (EAN), 2784-505 Oeiras, Portugal. vanessap@itqb.unl.pt</affiliation>",2010,Assessment of the presence and dynamics of fungi in drinking water sources using cultural and molecular methods.,20705315,Fernandes,D,D,None,2010,Assessment of the presence and dynamics of fungi in drinking water sources using cultural and molecular methods.,20705315,Carvalho,G,G,None,2010,Assessment of the presence and dynamics of fungi in drinking water sources using cultural and molecular methods.,20705315,Benoliel,M J,MJ,None,2010,Assessment of the presence and dynamics of fungi in drinking water sources using cultural and molecular methods.,20705315,<lastname>San RomÌ£o</lastname>,M V,MV,None,2010,Assessment of the presence and dynamics of fungi in drinking water sources using cultural and molecular methods.,20705315,Barreto Crespo,M T,MT,None,2010,ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.,21158754,Leachman,Nathaniel T,NT,"Department of Cell Biology and Human Anatomy, University of California at Davis, Davis, California 95616, USA.",2010,ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.,21158754,Brellier,Florence,F,None,2010,ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.,21158754,Ferralli,Jacqueline,J,None,2010,ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.,21158754,Chiquet-Ehrismann,Ruth,R,None,2010,ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.,21158754,Tucker,Richard P,RP,None,2010,Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.,20855524,Revenko,Alexey S,AS,"Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, CA 95817, USA.",2010,Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.,20855524,Kalashnikova,Ekaterina V,EV,None,2010,Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.,20855524,Gemo,Abigael T,AT,None,2010,Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.,20855524,Zou,June X,JX,None,2010,Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.,20855524,Chen,Hong-Wu,HW,None,2010,Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors.,20589882,Fairbridge,Nicholas A,NA,"Department of Biological Sciences, University of Alberta, Edmonton, Canada.",2010,Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors.,20589882,Dawe,Christine E,CE,None,2010,Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors.,20589882,Niri,Farshad H,FH,None,2010,Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors.,20589882,Kooistra,Megan K,MK,None,2010,Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors.,20589882,King-Jones,Kirst,K,None,2010,Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors.,20589882,McDermid,Heather E,HE,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Bergner,Laura M,LM,"Department of Biology, Davidson College , Davidson, NC 28035, USA.",2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Hickman,F Edward,FE,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Wood,Kathleen H,KH,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Wakeman,Carolyn M,CM,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Stone,Hunter H,HH,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Campbell,Tessa J,TJ,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Lightcap,Samantha B,SB,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Favors,Sheena M,SM,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Aldridge,Amanda C,AC,None,2010,A novel predicted bromodomain-related protein affects coordination between meiosis and spermiogenesis in Drosophila and is required for male meiotic cytokinesis.,20491580,Hales,Karen G,KG,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Drost,Jarno,J,"The Netherlands Cancer Institute, Division of Gene Regulation, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.",2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Mantovani,Fiamma,F,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Tocco,Francesca,F,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Elkon,Ran,R,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Comel,Anna,A,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Holstege,Henne,H,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Kerkhoven,Ron,R,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Jonkers,Jos,J,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Voorhoeve,P Mathijs,PM,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Agami,Reuven,R,None,2010,BRD7 is a candidate tumour suppressor gene required for p53 function.,20228809,Del Sal,Giannino,G,None,2010,C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.,20051959,Yamaguchi,K,K,"Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.",2010,C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.,20051959,Sakai,M,M,None,2010,C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.,20051959,Shimokawa,T,T,None,2010,C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.,20051959,Yamada,Y,Y,None,2010,C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.,20051959,Nakamura,Y,Y,None,2010,C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.,20051959,Furukawa,Y,Y,None,2010,The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.,20808803,Krueger,Brian J,BJ,"Molecular and Cellular Biology Program, University of Iowa, Iowa City, Iowa, United States of America.",2010,The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.,20808803,Varzavand,Katayoun,K,None,2010,The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.,20808803,Cooper,Jeffrey J,JJ,None,2010,The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.,20808803,Price,David H,DH,None,2010,CDK8 is a positive regulator of transcriptional elongation within the serum response network.,20098423,Donner,Aaron J,AJ,"Howard Hughes Medical Institute, The University of Colorado at Boulder, Boulder, Colorado, USA.",2010,CDK8 is a positive regulator of transcriptional elongation within the serum response network.,20098423,Ebmeier,Christopher C,CC,None,2010,CDK8 is a positive regulator of transcriptional elongation within the serum response network.,20098423,Taatjes,Dylan J,DJ,None,2010,CDK8 is a positive regulator of transcriptional elongation within the serum response network.,20098423,Espinosa,<forename>JoaquÌ_n M</forename>,JM,None,2010,A novel molecular method for identification of Oenococcus oeni and its specific detection in wine.,20598766,Marques,Ana P,AP,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Universidade Nova de Lisboa, Oeiras, Portugal.</affiliation>",2010,A novel molecular method for identification of Oenococcus oeni and its specific detection in wine.,20598766,<lastname>ZÌ©-ZÌ©</lastname>,<forename>LÌ_bia</forename>,L,None,2010,A novel molecular method for identification of Oenococcus oeni and its specific detection in wine.,20598766,<lastname>San-RomÌ£o</lastname>,<forename>Maria VitÌ_ria</forename>,MV,None,2010,A novel molecular method for identification of Oenococcus oeni and its specific detection in wine.,20598766,Tenreiro,<forename>RogÌ©rio</forename>,R,None,2010,Systematic screen reveals new functional dynamics of histones H3 and H4 during gametogenesis.,20713519,Govin,<forename>JÌ©rÌ«me</forename>,J,"Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.",2010,Systematic screen reveals new functional dynamics of histones H3 and H4 during gametogenesis.,20713519,Dorsey,Jean,J,None,2010,Systematic screen reveals new functional dynamics of histones H3 and H4 during gametogenesis.,20713519,Gaucher,Jonathan,J,None,2010,Systematic screen reveals new functional dynamics of histones H3 and H4 during gametogenesis.,20713519,Rousseaux,Sophie,S,None,2010,Systematic screen reveals new functional dynamics of histones H3 and H4 during gametogenesis.,20713519,Khochbin,Saadi,S,None,2010,Systematic screen reveals new functional dynamics of histones H3 and H4 during gametogenesis.,20713519,Berger,Shelley L,SL,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Caron,C,C,"INSERM, U823, France. cecile.caron@ujf-grenoble.fr",2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Lestrat,C,C,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Marsal,S,S,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Escoffier,E,E,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Curtet,S,S,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Virolle,V,V,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Barbry,P,P,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Debernardi,A,A,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Brambilla,C,C,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Brambilla,E,E,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Rousseaux,S,S,None,2010,Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers.,20581866,Khochbin,S,S,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Akai,Yusuke,Y,"Biomedicinal Information Research Center, National Institute of Advanced Industrial Science and Technology, 2-4-7 Aomi, Koto-ku, Tokyo 135-0064, Japan.",2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Adachi,Naruhiko,N,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Hayashi,Yohei,Y,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Eitoku,Masamitsu,M,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Sano,Norihiko,N,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Natsume,Ryo,R,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Kudo,Norio,N,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Tanokura,Masaru,M,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Senda,Toshiya,T,None,2010,Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction.,20393127,Horikoshi,Masami,M,None,2010,"A cooperative activation loop among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair.",20224553,Lee,Han-Sae,HS,"Division of Life and Pharmaceutical Sciences, Department of Life Science, Ewha Womans University, Seoul, Republic of Korea.",2010,"A cooperative activation loop among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair.",20224553,Park,Ji-Hye,JH,None,2010,"A cooperative activation loop among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair.",20224553,Kim,So-Jung,SJ,None,2010,"A cooperative activation loop among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair.",20224553,Kwon,Su-Jung,SJ,None,2010,"A cooperative activation loop among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair.",20224553,Kwon,Jongbum,J,None,2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Umehara,Takashi,T,"RIKEN Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama 230-0045, Japan.",2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Nakamura,Yoshihiro,Y,None,2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Jang,Moon Kyoo,MK,None,2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Nakano,Kazumi,K,None,2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Tanaka,Akiko,A,None,2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Ozato,Keiko,K,None,2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Padmanabhan,Balasundaram,B,None,2010,Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.,20048151,Yokoyama,Shigeyuki,S,None,2010,Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.,19846528,Yan,Junpeng,J,"Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.",2010,Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.,19846528,Li,Qing,Q,None,2010,Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.,19846528,Lievens,Sam,S,None,2010,Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.,19846528,Tavernier,Jan,J,None,2010,Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.,19846528,You,Jianxin,J,None,2010,Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains.,20715035,Vollmuth,Friederike,F,"<affiliation>Abteilung Physikalische Biochemie, Max-Planck-Institut fÌ_r molekulare Physiologie, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.</affiliation>",2010,Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains.,20715035,Geyer,Matthias,M,None,2010,Demystified molecular pathology of NUT midline carcinomas.,18552174,French,Christopher A,CA,"Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Cfrench@partners.org",2010,Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance.,20566345,Vicente,Tiago,T,"IBET, Apartado 12, P-2781-901 Oeiras, Portugal.",2010,Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance.,20566345,Mota,<forename>JosÌ© P B</forename>,JP,None,2010,Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance.,20566345,Peixoto,Cristina,C,None,2010,Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance.,20566345,Alves,Paula M,PM,None,2010,Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance.,20566345,Carrondo,Manuel J T,MJ,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Nicodeme,Edwige,E,"<affiliation>Centre de Recherche GSK, 27 Avenue du QuÌ©bec, 91140 Villebon Sur Yvette, France.</affiliation>",2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Jeffrey,Kate L,KL,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Schaefer,Uwe,U,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Beinke,Soren,S,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Dewell,Scott,S,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Chung,Chun-Wa,CW,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Chandwani,Rohit,R,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Marazzi,Ivan,I,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Wilson,Paul,P,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Coste,<forename>HervÌ©</forename>,H,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,White,Julia,J,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Kirilovsky,Jorge,J,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Rice,Charles M,CM,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Lora,Jose M,JM,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Prinjha,Rab K,RK,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Lee,Kevin,K,None,2010,Suppression of inflammation by a synthetic histone mimic.,21068722,Tarakhovsky,Alexander,A,None,2010,Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.,20709061,Umehara,Takashi,T,"RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama, Japan.",2010,Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.,20709061,Nakamura,Yoshihiro,Y,None,2010,Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.,20709061,Wakamori,Masatoshi,M,None,2010,Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.,20709061,Ozato,Keiko,K,None,2010,Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.,20709061,Yokoyama,Shigeyuki,S,None,2010,Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.,20709061,Padmanabhan,Balasundaram,B,None,2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,Steilmann,Cornelia,C,"Department of Urology, Pediatric Urology and Andrology, Rudolf Buchheim-Strasse 7, Justus Liebig University, 35385 Giessen, Germany. cornelia.steilmann@chiru.med.uni-giessen.de",2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,Cavalcanti,<forename>MÌÁrcia C O</forename>,MC,None,2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,Bartkuhn,Marek,M,None,2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,<lastname>Pons-KÌ_hnemann</lastname>,<forename>JÌ_rn</forename>,J,None,2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,Schuppe,Hans-Christian,HC,None,2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,Weidner,Wolfgang,W,None,2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,Steger,Klaus,K,None,2010,The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men.,20538714,Paradowska,Agnieszka,A,None,2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,Harte,Mary T,MT,"Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, Northern Ireland, United Kingdom. m.harte@qub.ac.uk",2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,O'Brien,Garrett J,GJ,None,2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,Ryan,Niamh M,NM,None,2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,Gorski,Julia J,JJ,None,2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,Savage,Kienan I,KI,None,2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,Crawford,Nyree T,NT,None,2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,Mullan,Paul B,PB,None,2010,"BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.",20215511,Harkin,D Paul,DP,None,2010,WHAT do viruses BET on?,20036832,Weidner-Glunde,Magdalena,M,"Hannover Medical School, Institute of Virology, Hannover, Germany. weidner-glunde.magdalena@MHHannover.de",2010,WHAT do viruses BET on?,20036832,Ottinger,Matthias,M,None,2010,WHAT do viruses BET on?,20036832,Schulz,Thomas F,TF,None,2010,Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.,19846509,Sekhar,Vandana,V,"Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA.",2010,Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.,19846509,Reed,Shawna C,SC,None,2010,Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.,19846509,McBride,Alison A,AA,None,2010,The energetics of the acetylation switch in p53-mediated transcriptional activation.,19731376,Eichenbaum,Kenneth D,KD,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York University, New York, New York 10029, USA.",2010,The energetics of the acetylation switch in p53-mediated transcriptional activation.,19731376,<lastname>RodrÌ_guez</lastname>,Yoel,Y,None,2010,The energetics of the acetylation switch in p53-mediated transcriptional activation.,19731376,Mezei,Mihaly,M,None,2010,The energetics of the acetylation switch in p53-mediated transcriptional activation.,19731376,Osman,Roman,R,None,2010,Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.,20542002,Jha,Sudhakar,S,"Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.",2010,Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.,20542002,Vande Pol,Scott,S,None,2010,Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.,20542002,Banerjee,Nilam Sanjib,NS,None,2010,Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.,20542002,Dutta,Arun Brendan,AB,None,2010,Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.,20542002,Chow,Louise T,LT,None,2010,Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.,20542002,Dutta,Anindya,A,None,2010,Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development.,20444457,Vicente,Tiago,T,"IBET, Apartado 12, P-2781-901 Oeiras, Portugal; ITQB-UNL, P-2780-157 Oeiras, Portugal.",2010,Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development.,20444457,Peixoto,Cristina,C,None,2010,Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development.,20444457,Alves,Paula M,PM,None,2010,Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development.,20444457,Carrondo,Manuel J T,MJ,None,2010,Alteration of nuclear protein profiling for NIH-3T3 cells exposed to H‰ââO‰ââ.,20941747,Liu,Yawei,Y,"Department of Pathophysiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.",2010,Alteration of nuclear protein profiling for NIH-3T3 cells exposed to H‰ââO‰ââ.,20941747,He,Minyi,M,None,2010,Alteration of nuclear protein profiling for NIH-3T3 cells exposed to H‰ââO‰ââ.,20941747,Sun,Xuegang,X,None,2010,Alteration of nuclear protein profiling for NIH-3T3 cells exposed to H‰ââO‰ââ.,20941747,Peng,Kang,K,None,2010,Alteration of nuclear protein profiling for NIH-3T3 cells exposed to H‰ââO‰ââ.,20941747,Zhao,Liang,L,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Reynoird,Nicolas,N,"<affiliation>INSERM, U823, UniversitÌ© Joseph Fourier-Grenoble 1, Institut Albert Bonniot, Grenoble, France.</affiliation>",2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Schwartz,Brian E,BE,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Delvecchio,Manuela,M,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Sadoul,Karin,K,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Meyers,David,D,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Mukherjee,Chandrani,C,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Caron,<forename>CÌ©cile</forename>,C,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Kimura,Hiroshi,H,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Rousseaux,Sophie,S,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Cole,Philip A,PA,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Panne,Daniel,D,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,French,Christopher A,CA,None,2010,Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.,20676058,Khochbin,Saadi,S,None,2010,Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.,20505343,Chen,Jihong,J,"Department of 1Pathology and Laboratory Medicine, University of Ottawa, Ontario, Canada.",2010,Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.,20505343,Ghazawi,Feras M,FM,None,2010,Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.,20505343,Li,Qiao,Q,None,2010,Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2.,20368734,Charlop-Powers,Zachary,Z,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1677, New York, NY 10029, USA.",2010,Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2.,20368734,Zeng,Lei,L,None,2010,Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2.,20368734,Zhang,Qiang,Q,None,2010,Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2.,20368734,Zhou,Ming-Ming,MM,None,2010,Double bromodomain protein BET-1 and MYST HATs establish and maintain stable cell fates in C. elegans.,20181741,Shibata,Yukimasa,Y,"Laboratory for Cell Fate Decision, Riken, Center for Developmental Biology, Kobe, Hyogo, 650-0047, Japan.",2010,Double bromodomain protein BET-1 and MYST HATs establish and maintain stable cell fates in C. elegans.,20181741,Takeshita,Hisako,H,None,2010,Double bromodomain protein BET-1 and MYST HATs establish and maintain stable cell fates in C. elegans.,20181741,Sasakawa,Noriko,N,None,2010,Double bromodomain protein BET-1 and MYST HATs establish and maintain stable cell fates in C. elegans.,20181741,Sawa,Hitoshi,H,None,2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Airoldi,Chiara A,CA,"<affiliation>Dipartimento di Scienze Biomolecolari e Biotecnologie, UniversitÌÊ degli Studi di Milano, 20133 Milan, Italy.</affiliation>",2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Rovere,Federica Della,FD,None,2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Falasca,Giuseppina,G,None,2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Marino,Giada,G,None,2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Kooiker,Maarten,M,None,2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Altamura,Maria Maddalena,MM,None,2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Citterio,Sandra,S,None,2010,The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development.,20032077,Kater,Martin M,MM,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Nyegaard,Mette,M,"Institute of Human Genetics, University of Aarhus, Aarhus, Denmark.",2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Severinsen,Jacob E,JE,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Als,Thomas D,TD,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Hedemand,Anne,A,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Straarup,Steen,S,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Nordentoft,Merete,M,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,McQuillin,Andrew,A,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Bass,Nicholas,N,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Lawrence,Jacob,J,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Thirumalai,Srinivasa,S,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Pereira,Ana C P,AC,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Kandaswamy,Radhika,R,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Lydall,Gregory J,GJ,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Sklar,Pamela,P,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Scolnick,Edward,E,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Purcell,Shaun,S,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Curtis,David,D,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Gurling,Hugh M D,HM,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Mortensen,Preben B,PB,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,Mors,Ole,O,None,2010,Support of association between BRD1 and both schizophrenia and bipolar affective disorder.,19693800,<lastname>BÌürglum</lastname>,Anders D,AD,None,2010,Single cell analysis of transcriptional activation dynamics.,20422051,Rafalska-Metcalf,Ilona U,IU,"Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, Pennsylvania, United States of America.",2010,Single cell analysis of transcriptional activation dynamics.,20422051,Powers,Sara Lawrence,SL,None,2010,Single cell analysis of transcriptional activation dynamics.,20422051,Joo,Lucy M,LM,None,2010,Single cell analysis of transcriptional activation dynamics.,20422051,LeRoy,Gary,G,None,2010,Single cell analysis of transcriptional activation dynamics.,20422051,Janicki,Susan M,SM,None,2010,The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.,19828607,Bellanger,Sophie,S,"Papillomavirus Regulation and Cancer, Institute of Medical Biology, A*Star, Biopolis, Immunos, Singapore 138648. sophie.bellanger@imb.a-star.edu.sg",2010,The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.,19828607,Tan,Chye Ling,CL,None,2010,The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.,19828607,Nei,Wenlong,W,None,2010,The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.,19828607,He,Ping Ping,PP,None,2010,The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.,19828607,Thierry,<forename>FranÌ_oise</forename>,F,None,2010,Production of retroviral vectors: review.,21054246,Coroadinha,Ana S,AS,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica-Universidade Nova de Lisboa/Instituto de Biologia Experimental e TecnolÌ_gica (ITQB-UNL/IBET), P-2781-901 Oeiras, Portugal.</affiliation>",2010,Production of retroviral vectors: review.,21054246,Gama-Norton,Leonor,L,None,2010,Production of retroviral vectors: review.,21054246,Amaral,Ana I,AI,None,2010,Production of retroviral vectors: review.,21054246,Hauser,Hansjorg,H,None,2010,Production of retroviral vectors: review.,21054246,Alves,Paula M,PM,None,2010,Production of retroviral vectors: review.,21054246,Cruz,Pedro E,PE,None,2010,Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance.,20171645,Vicente,Tiago,T,"IBET, Apartado 12, P-2781-901 Oeiras, Portugal.",2010,Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance.,20171645,Mota,<forename>JosÌ© P B</forename>,JP,None,2010,Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance.,20171645,Peixoto,Cristina,C,None,2010,Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance.,20171645,Alves,Paula M,PM,None,2010,Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance.,20171645,Carrondo,Manuel J T,MJ,None,2010,"Maintenance of neuronal laterality in Caenorhabditis elegans through MYST histone acetyltransferase complex components LSY-12, LSY-13 and LIN-49.",20923973,O'Meara,M Maggie,MM,"Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, New York 10032, USA.",2010,"Maintenance of neuronal laterality in Caenorhabditis elegans through MYST histone acetyltransferase complex components LSY-12, LSY-13 and LIN-49.",20923973,Zhang,Feifan,F,None,2010,"Maintenance of neuronal laterality in Caenorhabditis elegans through MYST histone acetyltransferase complex components LSY-12, LSY-13 and LIN-49.",20923973,Hobert,Oliver,O,None,2010,Gene regulation and tumor suppression by the bromodomain-containing protein BRD7.,20647772,Mantovani,Fiamma,F,"Laboratorio Nazionale CIB, Area Science Park, Trieste, Italy.",2010,Gene regulation and tumor suppression by the bromodomain-containing protein BRD7.,20647772,Drost,Jarno,J,None,2010,Gene regulation and tumor suppression by the bromodomain-containing protein BRD7.,20647772,Voorhoeve,P Mathijs,PM,None,2010,Gene regulation and tumor suppression by the bromodomain-containing protein BRD7.,20647772,Del Sal,Giannino,G,None,2010,Gene regulation and tumor suppression by the bromodomain-containing protein BRD7.,20647772,Agami,Reuven,R,None,2010,Molecular cloning of chicken Cecr2 and its expression during chicken embryo development.,20336606,Chen,Jingchen,J,"Department of Molecular Embryology, Institute of Anatomy and Cell Biology, University of Freiburg, Germany.",2010,Molecular cloning of chicken Cecr2 and its expression during chicken embryo development.,20336606,Morosan-Puopolo,Gabriela,G,None,2010,Molecular cloning of chicken Cecr2 and its expression during chicken embryo development.,20336606,Dai,Fangping,F,None,2010,Molecular cloning of chicken Cecr2 and its expression during chicken embryo development.,20336606,Wang,Jianlin,J,None,2010,Molecular cloning of chicken Cecr2 and its expression during chicken embryo development.,20336606,Brand-Saberi,Beate,B,None,2010,"Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.",20133580,Smith,Jennifer A,JA,"Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.",2010,"Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.",20133580,White,Elizabeth A,EA,None,2010,"Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.",20133580,Sowa,Mathew E,ME,None,2010,"Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.",20133580,Powell,Maria L C,ML,None,2010,"Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.",20133580,Ottinger,Matthias,M,None,2010,"Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.",20133580,Harper,J Wade,JW,None,2010,"Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.",20133580,Howley,Peter M,PM,None,2010,NUT midline carcinoma.,20951314,French,Christopher Alexander,CA,"Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. cfrench@partners.org",2010,BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.,20395873,Nelson,Benjamin A,BA,"Department of Pediatrics, Pulmonary Division, Massachusetts General Hospital, Boston, MA, USA.",2010,BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.,20395873,Lee,Edward Y,EY,None,2010,BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.,20395873,French,Christopher A,CA,None,2010,BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.,20395873,Bauer,Daniel E,DE,None,2010,BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.,20395873,Vargas,Sara O,SO,None,2010,Improvement of recombinant protein production by an anti-apoptotic protein from hemolymph of Lonomia obliqua.,20936342,Vieira,Helena L A,HL,"<affiliation>Instituto de Biologia Experimental e Tecnologia/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica IBET/ITQB -UNL, Apartado 12, 2781-901, Oeiras, Portugal.</affiliation>",2010,Improvement of recombinant protein production by an anti-apoptotic protein from hemolymph of Lonomia obliqua.,20936342,Pereira,Ana C P,AC,None,2010,Improvement of recombinant protein production by an anti-apoptotic protein from hemolymph of Lonomia obliqua.,20936342,Peixoto,Cristina C,CC,None,2010,Improvement of recombinant protein production by an anti-apoptotic protein from hemolymph of Lonomia obliqua.,20936342,Moraes,Roberto H P,RH,None,2010,Improvement of recombinant protein production by an anti-apoptotic protein from hemolymph of Lonomia obliqua.,20936342,Alves,Paula M,PM,None,2010,Improvement of recombinant protein production by an anti-apoptotic protein from hemolymph of Lonomia obliqua.,20936342,<lastname>MendonÌ_a</lastname>,Ronaldo Z,RZ,None,2010,"Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.",21189220,Denis,Gerald V,GV,"Cancer Research Center, Boston University School of Medicine, 72 East Concord Street, K520, Boston, Massachusetts 02118, USA. gdenis@bu.edu",2010,Features of cryptic promoters and their varied reliance on bromodomain-containing factors.,20886085,Pattenden,Samantha G,SG,"Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.",2010,Features of cryptic promoters and their varied reliance on bromodomain-containing factors.,20886085,Gogol,Madelaine M,MM,None,2010,Features of cryptic promoters and their varied reliance on bromodomain-containing factors.,20886085,Workman,Jerry L,JL,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Huang,Rong,R,"Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.",2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Holbert,Marc A,MA,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Tarrant,Mary Katherine,MK,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Curtet,Sandrine,S,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Colquhoun,David R,DR,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Dancy,Beverley M,BM,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Dancy,Blair C,BC,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Hwang,Yousang,Y,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Tang,Yong,Y,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Meeth,Katrina,K,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Marmorstein,Ronen,R,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Cole,Robert N,RN,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Khochbin,Saadi,S,None,2010,Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.,20608637,Cole,Philip A,PA,None,2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Della Rovere,Federica,F,"<affiliation>Dipartimento di Biologia Vegetale, Sapienza UniversitÌÊ di Roma, Rome, Italy.</affiliation>",2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Airoldi,Chiara A,CA,None,2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Falasca,Giuseppina,G,None,2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Ghiani,Alessandra,A,None,2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Fattorini,Laura,L,None,2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Citterio,Sandra,S,None,2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Kater,Martin,M,None,2010,The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle.,20495359,Altamura,Maria Maddalena,MM,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Altaf,Mohammed,M,"<affiliation>Laval University Cancer Research Center, HÌ«tel-Dieu de QuÌ©bec, CHUQ, Quebec City, Quebec G1R 2J6, Canada.</affiliation>",2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Auger,<forename>AndrÌ©anne</forename>,A,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Monnet-Saksouk,Julie,J,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Brodeur,<forename>JoÌÇlle</forename>,J,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Piquet,Sandra,S,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Cramet,Myriam,M,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Bouchard,Nathalie,N,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Lacoste,Nicolas,N,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Utley,Rhea T,RT,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,Gaudreau,Luc,L,None,2010,NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex.,20332092,<lastname>CÌ«tÌ©</lastname>,Jacques,J,None,2010,Biochemical profiling of histone binding selectivity of the yeast bromodomain family.,20126658,Zhang,Qiang,Q,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, New York, United States of America.",2010,Biochemical profiling of histone binding selectivity of the yeast bromodomain family.,20126658,Chakravarty,Suvobrata,S,None,2010,Biochemical profiling of histone binding selectivity of the yeast bromodomain family.,20126658,Ghersi,Dario,D,None,2010,Biochemical profiling of histone binding selectivity of the yeast bromodomain family.,20126658,Zeng,Lei,L,None,2010,Biochemical profiling of histone binding selectivity of the yeast bromodomain family.,20126658,Plotnikov,Alexander N,AN,None,2010,Biochemical profiling of histone binding selectivity of the yeast bromodomain family.,20126658,Sanchez,Roberto,R,None,2010,Biochemical profiling of histone binding selectivity of the yeast bromodomain family.,20126658,Zhou,Ming-Ming,MM,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Kushima,Itaru,I,"Department of Psychiatry, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-ku, Nagoya, Aichi 466-8550, Japan. kushima.itaru@a.mbox.nagoya-u.ac.jp",2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Aleksic,Branko,B,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Ikeda,Masashi,M,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Yamanouchi,Yoshio,Y,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Kinoshita,Yoko,Y,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Ito,Yoshihito,Y,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Nakamura,Yukako,Y,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Inada,Toshiya,T,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Iwata,Nakao,N,None,2010,Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.,19908236,Ozaki,Norio,N,None,2010,Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.,20926576,Cho,Won-Kyung,WK,"Virus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, 41 Medlars Dr., Bethesda, MD 20892, USA. wonkyungc@gmail.com",2010,Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.,20926576,Jang,Moon Kyoo,MK,None,2010,Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.,20926576,Huang,Keven,K,None,2010,Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.,20926576,Pise-Masison,Cynthia A,CA,None,2010,Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.,20926576,Brady,John N,JN,None,2010,NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.,20352379,Ziai,James,J,"Department of Pathology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.",2010,NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.,20352379,French,Chris A,CA,None,2010,NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.,20352379,Zambrano,Eduardo,E,None,2010,"An integrated analysis of enzyme activities, cofactor pools and metabolic fluxes in baculovirus-infected Spodoptera frugiperda Sf9 cells.",20933551,Bernal,Vicente,V,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Instituto de Biologia Experimental e TecnolÌ_gica, Universidade Nova de Lisboa (ITQB/IBET-UNL), Av. da RepÌ_blica - EAN, 2780-157 Oeiras, Portugal.</affiliation>",2010,"An integrated analysis of enzyme activities, cofactor pools and metabolic fluxes in baculovirus-infected Spodoptera frugiperda Sf9 cells.",20933551,Monteiro,Francisca,F,None,2010,"An integrated analysis of enzyme activities, cofactor pools and metabolic fluxes in baculovirus-infected Spodoptera frugiperda Sf9 cells.",20933551,Carinhas,Nuno,N,None,2010,"An integrated analysis of enzyme activities, cofactor pools and metabolic fluxes in baculovirus-infected Spodoptera frugiperda Sf9 cells.",20933551,<lastname>AmbrÌ_sio</lastname>,Raquel,R,None,2010,"An integrated analysis of enzyme activities, cofactor pools and metabolic fluxes in baculovirus-infected Spodoptera frugiperda Sf9 cells.",20933551,Alves,Paula M,PM,None,2010,Improving baculovirus production at high cell density through manipulation of energy metabolism.,19732849,Carinhas,Nuno,N,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa/Instituto de Biologia Experimental e TecnolÌ_gica (ITQB-UNL/IBET), Apartado 12, P-2781-901 Oeiras, Portugal.</affiliation>",2010,Improving baculovirus production at high cell density through manipulation of energy metabolism.,19732849,Bernal,Vicente,V,None,2010,Improving baculovirus production at high cell density through manipulation of energy metabolism.,19732849,Monteiro,Francisca,F,None,2010,Improving baculovirus production at high cell density through manipulation of energy metabolism.,19732849,Carrondo,Manuel J T,MJ,None,2010,Improving baculovirus production at high cell density through manipulation of energy metabolism.,19732849,Oliveira,Rui,R,None,2010,Improving baculovirus production at high cell density through manipulation of energy metabolism.,19732849,Alves,Paula M,PM,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Tsai,Wen-Wei,WW,"Department of Biochemistry and Molecular Biology, Program in Genes and Development, Graduate School of Biomedical Sciences, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.",2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Wang,Zhanxin,Z,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Yiu,Teresa T,TT,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Akdemir,Kadir C,KC,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Xia,Weiya,W,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Winter,Stefan,S,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Tsai,Cheng-Yu,CY,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Shi,Xiaobing,X,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Schwarzer,Dirk,D,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Plunkett,William,W,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Aronow,Bruce,B,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Gozani,Or,O,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Fischle,Wolfgang,W,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Hung,Mien-Chie,MC,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Patel,Dinshaw J,DJ,None,2010,TRIM24 links a non-canonical histone signature to breast cancer.,21164480,Barton,Michelle Craig,MC,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Kalashnikova,Ekaterina V,EV,"Department of Biochemistry and Molecular Medicine, School of Medicine, and UC Davis Cancer Center/Basic Sciences, University of California at Davis, Sacramento, California 95817, USA.",2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Revenko,Alexey S,AS,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Gemo,Abigael T,AT,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Andrews,Nicolas P,NP,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Tepper,Clifford G,CG,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Zou,June X,JX,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Cardiff,Robert D,RD,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Borowsky,Alexander D,AD,None,2010,"ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.",20864510,Chen,Hong-Wu,HW,None,2010,Flipping MLL1's switch one proline at a time.,20602992,Grow,Edward J,EJ,"Department of Genetics, Stanford University, Stanford, CA 94305, USA.",2010,Flipping MLL1's switch one proline at a time.,20602992,Wysocka,Joanna,J,None,2010,An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.,20493850,Denis,Gerald V,GV,"Cancer Research Center, Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA. gdenis@bu.edu",2010,An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.,20493850,Nikolajczyk,Barbara S,BS,None,2010,An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.,20493850,Schnitzler,Gavin R,GR,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Buganim,Yosef,Y,"Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.",2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Goldstein,Ido,I,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Lipson,Doron,D,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Milyavsky,Michael,M,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Polak-Charcon,Sylvie,S,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Mardoukh,Corine,C,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Solomon,Hilla,H,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Kalo,Eyal,E,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Madar,Shalom,S,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Brosh,Ran,R,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Perelman,Marina,M,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Navon,Roy,R,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Goldfinger,Naomi,N,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Barshack,Iris,I,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Yakhini,Zohar,Z,None,2010,A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.,20300178,Rotter,Varda,V,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Harikrishnan,K N,KN,"Epigenetics in Human Health and Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.",2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Bayles,Richard,R,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Ciccotosto,Giuseppe D,GD,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Maxwell,Scott,S,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Cappai,Roberto,R,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Pelka,Gregory J,GJ,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Tam,Patrick P L,PP,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,Christodoulou,John,J,None,2010,Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons.,20107077,El-Osta,Assam,A,None,2010,Brd2 disruption in mice causes severe obesity without Type 2 diabetes.,19883376,Wang,Fangnian,F,"Cancer Research Center, Boston University School of Medicine, Boston, MA 02118, USA.",2010,Brd2 disruption in mice causes severe obesity without Type 2 diabetes.,19883376,Liu,Hongsheng,H,None,2010,Brd2 disruption in mice causes severe obesity without Type 2 diabetes.,19883376,Blanton,Wanda P,WP,None,2010,Brd2 disruption in mice causes severe obesity without Type 2 diabetes.,19883376,Belkina,Anna,A,None,2010,Brd2 disruption in mice causes severe obesity without Type 2 diabetes.,19883376,Lebrasseur,Nathan K,NK,None,2010,Brd2 disruption in mice causes severe obesity without Type 2 diabetes.,19883376,Denis,Gerald V,GV,None,2010,Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division.,20810736,Silla,Toomas,T,"Department of Biomedical Technology, Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.",2010,Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division.,20810736,<lastname>MÌ_nnik</lastname>,Andres,A,None,2010,Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division.,20810736,Ustav,Mart,M,None,2010,T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.,20201073,Dow,Eugene C,EC,"Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.",2010,T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.,20201073,Liu,Hongbing,H,None,2010,T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.,20201073,Rice,Andrew P,AP,None,2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Gaspar,<forename>FrÌ©dÌ©ric</forename>,F,"<affiliation>IBET and ITQB-UNL, Quinta do marquÌ»s, Av da RepÌ_blica, 2781-901 Oeiras, Portugal.</affiliation>",2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Teixeira,Neuza,N,None,2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Rigottier-Gois,Lionel,L,None,2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Marujo,Paulo,P,None,2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Nielsen-LeRoux,Christina,C,None,2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Crespo,Maria Teresa Barreto,MT,None,2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Lopes,<forename>Maria de FÌÁtima Silva</forename>,Mde F,None,2009,Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE.,19696101,Serror,Pascale,P,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Byun,Jung S,JS,"Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, Bethesda, MD 20892, USA.",2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Wong,Madeline M,MM,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Cui,Wenwu,W,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Idelman,Gila,G,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Li,Quentin,Q,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,De Siervi,Adriana,A,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Bilke,Sven,S,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Haggerty,Cynthia M,CM,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Player,Audrey,A,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Wang,Yong Hong,YH,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Thirman,Michael J,MJ,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Kaberlein,Joseph J,JJ,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Petrovas,Constantinos,C,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Koup,Richard A,RA,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Longo,Dan,D,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Ozato,Keiko,K,None,2009,Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.,19880750,Gardner,Kevin,K,None,2009,Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.,19766566,Zippo,Alessio,A,"<affiliation>Dipartimento di Biologia Molecolare UniversitÌÊ di Siena, Siena, Italy.</affiliation>",2009,Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.,19766566,Serafini,Riccardo,R,None,2009,Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.,19766566,Rocchigiani,Marina,M,None,2009,Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.,19766566,Pennacchini,Susanna,S,None,2009,Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.,19766566,Krepelova,Anna,A,None,2009,Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.,19766566,Oliviero,Salvatore,S,None,2009,Control of inducible gene expression by signal-dependent transcriptional elongation.,19596240,Hargreaves,Diana C,DC,"Howard Hughes Medical Institute and Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06510, USA.",2009,Control of inducible gene expression by signal-dependent transcriptional elongation.,19596240,Horng,Tiffany,T,None,2009,Control of inducible gene expression by signal-dependent transcriptional elongation.,19596240,Medzhitov,Ruslan,R,None,2009,Unbiased proteomic screen for binding proteins to modified lysines on histone H3.,19337993,Chan,Doug W,DW,"ProTech Laboratory Inc., Houston, TX 77054, USA. dchan@protechlaboratory.com",2009,Unbiased proteomic screen for binding proteins to modified lysines on histone H3.,19337993,Wang,Yi,Y,None,2009,Unbiased proteomic screen for binding proteins to modified lysines on histone H3.,19337993,Wu,Meng,M,None,2009,Unbiased proteomic screen for binding proteins to modified lysines on histone H3.,19337993,Wong,Jiemin,J,None,2009,Unbiased proteomic screen for binding proteins to modified lysines on histone H3.,19337993,Qin,Jun,J,None,2009,Unbiased proteomic screen for binding proteins to modified lysines on histone H3.,19337993,Zhao,Yingming,Y,None,2009,Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.,19211738,Gagnon,David,D,"<affiliation>Laboratory of Molecular Virology, Institut de Recherches Cliniques de MontrÌ©al, Montreal, Quebec, Canada.</affiliation>",2009,Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.,19211738,Joubert,Simon,S,None,2009,Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.,19211738,<lastname>SÌ©nÌ©chal</lastname>,<forename>HÌ©lÌ¬ne</forename>,H,None,2009,Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.,19211738,Fradet-Turcotte,<forename>AmÌ©lie</forename>,A,None,2009,Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.,19211738,Torre,Sabrina,S,None,2009,Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.,19211738,Archambault,Jacques,J,None,2009,Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability.,19038968,Lee,A-Young,AY,"Simmons Comprehensive Cancer Center and the Departments of Pharmacology and Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8807, USA.",2009,Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability.,19038968,Chiang,Cheng-Ming,CM,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Haack,Herbert,H,"Cell Signaling Technology Inc., Danvers, MA, USA.",2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Johnson,Laura A,LA,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Fry,Christopher J,CJ,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Crosby,Katherine,K,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Polakiewicz,Roberto D,RD,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Stelow,Edward B,EB,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Hong,Seung-Mo,SM,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Schwartz,Brian E,BE,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Cameron,Michael J,MJ,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Rubin,Mark A,MA,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Chang,Martin C,MC,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,Aster,Jon C,JC,None,2009,Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.,19363441,French,Christopher A,CA,None,2009,Flow cytometric and morphological analyses of Pinus pinaster somatic embryogenesis.,19665503,Marum,Liliana,L,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET)/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica-Universidade Nova de Lisboa (ITQB-UNL), Av. RepÌ_blica (EAN) 2784-505 Oeiras, Portugal.</affiliation>",2009,Flow cytometric and morphological analyses of Pinus pinaster somatic embryogenesis.,19665503,Loureiro,<forename>JoÌ£o</forename>,J,None,2009,Flow cytometric and morphological analyses of Pinus pinaster somatic embryogenesis.,19665503,Rodriguez,Eleazar,E,None,2009,Flow cytometric and morphological analyses of Pinus pinaster somatic embryogenesis.,19665503,Santos,<forename>ConceiÌ_Ì£o</forename>,C,None,2009,Flow cytometric and morphological analyses of Pinus pinaster somatic embryogenesis.,19665503,Oliveira,M Margarida,MM,None,2009,Flow cytometric and morphological analyses of Pinus pinaster somatic embryogenesis.,19665503,Miguel,<forename>CÌ©lia</forename>,C,None,2009,Analysis of genetic stability at SSR loci during somatic embryogenesis in maritime pine (Pinus pinaster).,19153739,Marum,Liliana,L,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Oeiras, Portugal.</affiliation>",2009,Analysis of genetic stability at SSR loci during somatic embryogenesis in maritime pine (Pinus pinaster).,19153739,Rocheta,Margarida,M,None,2009,Analysis of genetic stability at SSR loci during somatic embryogenesis in maritime pine (Pinus pinaster).,19153739,Maroco,<forename>JoÌ£o</forename>,J,None,2009,Analysis of genetic stability at SSR loci during somatic embryogenesis in maritime pine (Pinus pinaster).,19153739,Oliveira,M Margarida,MM,None,2009,Analysis of genetic stability at SSR loci during somatic embryogenesis in maritime pine (Pinus pinaster).,19153739,Miguel,<forename>CÌ©lia</forename>,C,None,2009,The role of human bromodomains in chromatin biology and gene transcription.,19736624,Sanchez,Roberto,R,"Mount Sinai School of Medicine, Department of Structural and Chemical Biology, New York, NY 10029, USA. roberto.sanchez@mssm.edu",2009,The role of human bromodomains in chromatin biology and gene transcription.,19736624,Zhou,Ming-Ming,MM,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Gradolatto,Angeline,A,"University of Arkansas for Medical Sciences, Department of Biochemistry and Molecular Biology, Little Rock, Arkansas 72205, USA.",2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Smart,Sherri K,SK,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Byrum,Stephanie,S,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Blair,Lauren P,LP,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Rogers,Richard S,RS,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Kolar,Elizabeth A,EA,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Lavender,Heather,H,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Larson,Signe K,SK,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Aitchison,John D,JD,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Taverna,Sean D,SD,None,2009,A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity.,19581291,Tackett,Alan J,AJ,None,2009,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,19318566,Zou,June X,JX,"Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, California, USA. jxzou@ucdavis.edu",2009,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,19318566,Guo,Linlang,L,None,2009,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,19318566,Revenko,Alexey S,AS,None,2009,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,19318566,Tepper,Clifford G,CG,None,2009,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,19318566,Gemo,Abigael T,AT,None,2009,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,19318566,Kung,Hsing-Jien,HJ,None,2009,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,19318566,Chen,Hong-Wu,HW,None,2009,Arabidopsis ING and Alfin1-like protein families localize to the nucleus and bind to H3K4me3/2 via plant homeodomain fingers.,19154204,Lee,Woo Yong,WY,"Department of Biological Sciences, KAIST, Daejeon 305-701, Korea.",2009,Arabidopsis ING and Alfin1-like protein families localize to the nucleus and bind to H3K4me3/2 via plant homeodomain fingers.,19154204,Lee,Daeyoup,D,None,2009,Arabidopsis ING and Alfin1-like protein families localize to the nucleus and bind to H3K4me3/2 via plant homeodomain fingers.,19154204,Chung,Won-Il,WI,None,2009,Arabidopsis ING and Alfin1-like protein families localize to the nucleus and bind to H3K4me3/2 via plant homeodomain fingers.,19154204,Kwon,Chang Seob,CS,None,2009,"Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.",19297489,Kapasi,Anokhi J,AJ,"Department of Cellular and Molecular Medicine and School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093-0712, USA.",2009,"Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.",19297489,Clark,Charles L,CL,None,2009,"Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.",19297489,Tran,Karen,K,None,2009,"Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.",19297489,Spector,Deborah H,DH,None,2009,Virus production for clinical gene therapy.,19565917,Vicente,Tiago,T,"<affiliation>Instituto de Biologia Experimental e TenolÌ_gica (IBET), Oeiras, Portugal.</affiliation>",2009,Virus production for clinical gene therapy.,19565917,Peixoto,Cristina,C,None,2009,Virus production for clinical gene therapy.,19565917,Carrondo,Manuel J T,MJ,None,2009,Virus production for clinical gene therapy.,19565917,Alves,Paula M,PM,None,2009,Stirred bioreactors for the expansion of adult pancreatic stem cells.,19054658,Serra,Margarida,M,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica-Universidade Nova de Lisboa/Instituto de Biologia Experimental e TecnolÌ_gica (ITQB-UNL/IBET), Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2009,Stirred bioreactors for the expansion of adult pancreatic stem cells.,19054658,Brito,Catarina,C,None,2009,Stirred bioreactors for the expansion of adult pancreatic stem cells.,19054658,Leite,Sofia B,SB,None,2009,Stirred bioreactors for the expansion of adult pancreatic stem cells.,19054658,Gorjup,Erwin,E,None,2009,Stirred bioreactors for the expansion of adult pancreatic stem cells.,19054658,von Briesen,Hagen,H,None,2009,Stirred bioreactors for the expansion of adult pancreatic stem cells.,19054658,Carrondo,Manuel J T,MJ,None,2009,Stirred bioreactors for the expansion of adult pancreatic stem cells.,19054658,Alves,Paula M,PM,None,2009,Brd4 regulation of papillomavirus protein E2 stability.,19553317,Zheng,Gang,G,"Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.",2009,Brd4 regulation of papillomavirus protein E2 stability.,19553317,Schweiger,Michal-Ruth,MR,None,2009,Brd4 regulation of papillomavirus protein E2 stability.,19553317,Martinez-Noel,Gustavo,G,None,2009,Brd4 regulation of papillomavirus protein E2 stability.,19553317,Zheng,Leon,L,None,2009,Brd4 regulation of papillomavirus protein E2 stability.,19553317,Smith,Jennifer A,JA,None,2009,Brd4 regulation of papillomavirus protein E2 stability.,19553317,Harper,J Wade,JW,None,2009,Brd4 regulation of papillomavirus protein E2 stability.,19553317,Howley,Peter M,PM,None,2009,Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse.,19301389,Shang,Enyuan,E,"Division of Statistical Genetics, Department of Biostatistics, Mailman School of Public Health and Department of Psychiatry, Columbia University Medical Center, New York, New York 10032, USA.",2009,Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse.,19301389,Wang,Xiangyuan,X,None,2009,Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse.,19301389,Wen,Duancheng,D,None,2009,Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse.,19301389,Greenberg,David A,DA,None,2009,Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse.,19301389,Wolgemuth,Debra J,DJ,None,2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Villanova,Gabriela Vanina,GV,"<affiliation>Instituto de BiologÌ_a Molecular y Celular de Rosario, Facultad de Ciencias BioquÌ_micas y FarmacÌ©uticas, Suipacha 351, 2000, Rosario, Argentina.</affiliation>",2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Nardelli,Sheila Cristina,SC,None,2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Cribb,Pamela,P,None,2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Magdaleno,<forename>AnahÌ_</forename>,A,None,2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Silber,Ariel Mariano,AM,None,2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Motta,Maria Cristina M,MC,None,2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Schenkman,Sergio,S,None,2009,Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation.,19136002,Serra,Esteban,E,None,2009,Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.,19152411,Wang,Wei-Sheng,WS,"Department of Life Science, Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan ROC.",2009,Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.,19152411,Lee,Moon-Sing,MS,None,2009,Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.,19152411,Tseng,Chih-En,CE,None,2009,Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.,19152411,Liao,I-Huan,IH,None,2009,Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.,19152411,Huang,Shu-Ping,SP,None,2009,Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.,19152411,Lin,Ru-Inn,RI,None,2009,Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.,19152411,Li,Chin,C,None,2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,Pereira,V J,VJ,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Oeiras, Portugal.</affiliation>",2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,<lastname>BasÌ_lio</lastname>,M C,MC,None,2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,Fernandes,D,D,None,2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,Domingues,M,M,None,2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,Paiva,J M,JM,None,2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,Benoliel,M J,MJ,None,2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,Crespo,M T,MT,None,2009,Occurrence of filamentous fungi and yeasts in three different drinking water sources.,19560184,<lastname>San RomÌ£o</lastname>,M V,MV,None,2009,The effect of the cell death suppressor vMIA on the production of a recombinant protein in the adenovirus-293 expression system.,19041945,Vieira,Helena L A,HL,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB-UNL), Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2009,The effect of the cell death suppressor vMIA on the production of a recombinant protein in the adenovirus-293 expression system.,19041945,Cunha,Liliana,L,None,2009,The effect of the cell death suppressor vMIA on the production of a recombinant protein in the adenovirus-293 expression system.,19041945,Goldmacher,Victor S,VS,None,2009,The effect of the cell death suppressor vMIA on the production of a recombinant protein in the adenovirus-293 expression system.,19041945,Alves,Paula M,PM,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,<lastname>CirÌ_</lastname>,Marco,M,"Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.",2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Prosperini,Elena,E,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Quarto,Micaela,M,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Grazini,Ursula,U,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Walfridsson,Julian,J,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,McBlane,Fraser,F,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Nucifero,Paolo,P,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Pacchiana,Giovanni,G,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Capra,Maria,M,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Christensen,Jesper,J,None,2009,"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.",19843847,Helin,Kristian,K,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Rousseaux,S,S,"<affiliation>Inserm U823, universitÌ© Joseph-Fourier, institut Albert-Bonniot, domaine de la Merci, 38706 Grenoble, France. sophie.rousseaux@ujf-grenoble.fr</affiliation>",2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Gaucher,J,J,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Thevenon,J,J,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Caron,C,C,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Vitte,A-L,AL,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Curtet,S,S,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Derobertis,C,C,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Faure,A-K,AK,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Levy,R,R,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Aknin-Seifer,I,I,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Ravel,C,C,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Siffroi,J-P,JP,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Mc Elreavey,K,K,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Lejeune,H,H,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Jimenez,C,C,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Hennebicq,S,S,None,2009,[Spermiogenesis: histone acetylation triggers male genome reprogramming].,19447664,Khochbin,S,S,None,2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Archacki,Rafal,R,"Laboratory of Plant Molecular Biology, University of Warsaw, Pawinskiego 5A, 02-106, Warsaw, Poland.",2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Sarnowski,Tomasz J,TJ,None,2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Halibart-Puzio,Joanna,J,None,2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Brzeska,Katarzyna,K,None,2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Buszewicz,Daniel,D,None,2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Prymakowska-Bosak,Marta,M,None,2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Koncz,Csaba,C,None,2009,Genetic analysis of functional redundancy of BRM ATPase and ATSWI3C subunits of Arabidopsis SWI/SNF chromatin remodelling complexes.,19301030,Jerzmanowski,Andrzej,A,None,2009,Thermodynamic and kinetic analysis of bromodomain-histone interactions.,21609869,Thompson,Martin,M,"Department of Chemistry, Michigan Technological University, Houghton, Michigan, USA.",2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Zhou,Meisheng,M,"Virus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.",2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Huang,Keven,K,None,2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Jung,Kyung-Jin,KJ,None,2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Cho,Won-Kyung,WK,None,2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Klase,Zach,Z,None,2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Kashanchi,Fatah,F,None,2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Pise-Masison,Cynthia A,CA,None,2009,Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.,18971272,Brady,John N,JN,None,2009,Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin.,19129460,Jang,Moon Kyoo,MK,"Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Building 4, Room 137, 4 Center Drive MSC 0445, Bethesda, MD 20892-0445, USA.",2009,Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin.,19129460,Kwon,Deukwoo,D,None,2009,Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin.,19129460,McBride,Alison A,AA,None,2009,Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.,19537947,Carmo,M,M,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica-Universidade Nova de Lisboa/Instituto de Biologia Experimental e TecnolÌ_gica (ITQB-UNL/IBET), P-2781-901 Oeiras, Portugal.</affiliation>",2009,Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.,19537947,Dias,J D,JD,None,2009,Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.,19537947,Panet,A,A,None,2009,Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.,19537947,Coroadinha,A S,AS,None,2009,Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.,19537947,Carrondo,M J T,MJ,None,2009,Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.,19537947,Alves,P M,PM,None,2009,Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.,19537947,Cruz,P E,PE,None,2009,Dual role for the tyrosine decarboxylation pathway in Enterococcus faecium E17: response to an acid challenge and generation of a proton motive force.,19011061,Pereira,C I,CI,"<affiliation>IBET-Instituto de Biologia Experimental e TecnolÌ_gica, Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2009,Dual role for the tyrosine decarboxylation pathway in Enterococcus faecium E17: response to an acid challenge and generation of a proton motive force.,19011061,Matos,D,D,None,2009,Dual role for the tyrosine decarboxylation pathway in Enterococcus faecium E17: response to an acid challenge and generation of a proton motive force.,19011061,<lastname>San RomÌ£o</lastname>,M V,MV,None,2009,Dual role for the tyrosine decarboxylation pathway in Enterococcus faecium E17: response to an acid challenge and generation of a proton motive force.,19011061,Crespo,M T Barreto,MT,None,2009,Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4.,20495683,Chiang,Cheng-Ming,CM,"Simmons Comprehensive Cancer Center, Department of Biochemistry, and Department of Pharmacology, University of Texas Southwestern Medical Center 5323 Harry Hines Boulevard, Dallas, Texas 75390 USA.",2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Kikuchi,Misato,M,"Department of Biochemistry, Hokkaido University Graduate School of Medicine, N15, W7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.",2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Okumura,Fumihiko,F,None,2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Tsukiyama,Tadasuke,T,None,2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Watanabe,Masashi,M,None,2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Miyajima,Naoto,N,None,2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Tanaka,Junji,J,None,2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Imamura,Masahiro,M,None,2009,"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.",19909775,Hatakeyama,Shigetsugu,S,None,2009,Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.,19812244,Dey,Anup,A,"Laboratory of Molecular Growth Regulation, Program in Genomics of Differentiation, National Institute of Child Health and Human Development and Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.",2009,Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.,19812244,Nishiyama,Akira,A,None,2009,Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.,19812244,Karpova,Tatiana,T,None,2009,Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.,19812244,McNally,James,J,None,2009,Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.,19812244,Ozato,Keiko,K,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Fillingham,Jeffrey,J,"Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Canada.",2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Kainth,Pinay,P,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Lambert,Jean-Philippe,JP,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,van Bakel,Harm,H,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Tsui,Kyle,K,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,<lastname>PeÌ±a-Castillo</lastname>,Lourdes,L,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Nislow,Corey,C,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Figeys,Daniel,D,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Hughes,Timothy R,TR,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Greenblatt,Jack,J,None,2009,Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression.,19683497,Andrews,Brenda J,BJ,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Siegel,T Nicolai,TN,"Laboratory of Molecular Parasitology, The Rockefeller University, New York, New York 10065, USA.",2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Hekstra,Doeke R,DR,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Kemp,Louise E,LE,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Figueiredo,Luisa M,LM,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Lowell,Joanna E,JE,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Fenyo,David,D,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Wang,Xuning,X,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Dewell,Scott,S,None,2009,Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei.,19369410,Cross,George A M,GA,None,2009,The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.,19244327,Ottinger,Matthias,M,"<affiliation>Institut fÌ_r Virologie, Medizinische Hochschule Hannover, Hannover, Germany.</affiliation>",2009,The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.,19244327,Pliquet,Daniel,D,None,2009,The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.,19244327,Christalla,Thomas,T,None,2009,The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.,19244327,Frank,Ronald,R,None,2009,The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.,19244327,Stewart,James P,JP,None,2009,The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.,19244327,Schulz,Thomas F,TF,None,2009,Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution.,19828451,Vollmuth,Friederike,F,"<affiliation>Abteilung Physikalische Biochemie, Max-Planck-Institut fÌ_r Molekulare Physiologie, Otto-Hahn-Strasse 11, D-44227 Dortmund, Germany.</affiliation>",2009,Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution.,19828451,Blankenfeldt,Wulf,W,None,2009,Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution.,19828451,Geyer,Matthias,M,None,2009,Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.,19103749,Huang,Bo,B,"Department of Biochemistry, College of Medicine, MC-714, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.",2009,Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.,19103749,Yang,Xiao-Dong,XD,None,2009,Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.,19103749,Zhou,Ming-Ming,MM,None,2009,Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.,19103749,Ozato,Keiko,K,None,2009,Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.,19103749,Chen,Lin-Feng,LF,None,2009,Identification of Sinorhizobium (Ensifer) medicae based on a specific genomic sequence unveiled by M13-PCR fingerprinting.,20112226,Dourado,Ana Catarina,AC,"Institute of Experimental and Technological Biology (IBET), Oeiras, Portugal.",2009,Identification of Sinorhizobium (Ensifer) medicae based on a specific genomic sequence unveiled by M13-PCR fingerprinting.,20112226,Alves,Paula I L,PI,None,2009,Identification of Sinorhizobium (Ensifer) medicae based on a specific genomic sequence unveiled by M13-PCR fingerprinting.,20112226,Tenreiro,Tania,T,None,2009,Identification of Sinorhizobium (Ensifer) medicae based on a specific genomic sequence unveiled by M13-PCR fingerprinting.,20112226,Ferreira,<forename>EugÌ©nio M</forename>,EM,None,2009,Identification of Sinorhizobium (Ensifer) medicae based on a specific genomic sequence unveiled by M13-PCR fingerprinting.,20112226,Tenreiro,<forename>RogÌ©rio</forename>,R,None,2009,Identification of Sinorhizobium (Ensifer) medicae based on a specific genomic sequence unveiled by M13-PCR fingerprinting.,20112226,Fareleira,Paula,P,None,2009,Identification of Sinorhizobium (Ensifer) medicae based on a specific genomic sequence unveiled by M13-PCR fingerprinting.,20112226,Crespo,M Teresa Barreto,MT,None,2009,Weissella halotolerans W22 combines arginine deiminase and ornithine decarboxylation pathways and converts arginine to putrescine.,19486212,Pereira,C I,CI,"Instituto de Biologia Experimental e Tecnologica (IBET), Universidade Nova de Lisboa, Oeiras, Portugal. cpereira@itqb.unl.pt",2009,Weissella halotolerans W22 combines arginine deiminase and ornithine decarboxylation pathways and converts arginine to putrescine.,19486212,<lastname>San RomÌ£o</lastname>,M V,MV,None,2009,Weissella halotolerans W22 combines arginine deiminase and ornithine decarboxylation pathways and converts arginine to putrescine.,19486212,Lolkema,J S,JS,None,2009,Weissella halotolerans W22 combines arginine deiminase and ornithine decarboxylation pathways and converts arginine to putrescine.,19486212,Crespo,M T Barreto,MT,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,<lastname>MoriniÌ¬re</lastname>,Jeanne,J,"European Molecular Biology Laboratory, Grenoble Outstation, 6 rue Jules Horowitz, BP 181, 38042 Grenoble Cedex 9, France.",2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Rousseaux,Sophie,S,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Steuerwald,Ulrich,U,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,<lastname>Soler-LÌ_pez</lastname>,Montserrat,M,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Curtet,Sandrine,S,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Vitte,Anne-Laure,AL,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Govin,<forename>JÌ©rÌ«me</forename>,J,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Gaucher,Jonathan,J,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Sadoul,Karin,K,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Hart,Darren J,DJ,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Krijgsveld,Jeroen,J,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Khochbin,Saadi,S,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,<lastname>MÌ_ller</lastname>,Christoph W,CW,None,2009,Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.,19794495,Petosa,Carlo,C,None,2009,Alternative splicing of NURF301 generates distinct NURF chromatin remodeling complexes with altered modified histone binding specificities.,19629165,Kwon,So Yeon,SY,"Institute of Biomedical Research, University of Birmingham, Edgbaston, United Kingdom.",2009,Alternative splicing of NURF301 generates distinct NURF chromatin remodeling complexes with altered modified histone binding specificities.,19629165,Xiao,Hua,H,None,2009,Alternative splicing of NURF301 generates distinct NURF chromatin remodeling complexes with altered modified histone binding specificities.,19629165,Wu,Carl,C,None,2009,Alternative splicing of NURF301 generates distinct NURF chromatin remodeling complexes with altered modified histone binding specificities.,19629165,Badenhorst,Paul,P,None,2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Gyuris,Aron,A,"Department of Molecular and Cell Biology and Biochemistry, Brown University, 70 Ship St., Providence, RI 02903, USA.",2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Donovan,Diana J,DJ,None,2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Seymour,Kimberly A,KA,None,2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Lovasco,Lindsay A,LA,None,2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Smilowitz,Nathaniel R,NR,None,2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Halperin,Anthony L P,AL,None,2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Klysik,Jan E,JE,None,2009,The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.,19362612,Freiman,Richard N,RN,None,2009,Bdf1p deletion affects mitochondrial function and causes apoptotic cell death under salt stress.,19220868,Liu,Xiangyong,X,"State Key Laboratory of Microbial Technology, Shandong University, Jinan, China.",2009,Bdf1p deletion affects mitochondrial function and causes apoptotic cell death under salt stress.,19220868,Yang,Hui,H,None,2009,Bdf1p deletion affects mitochondrial function and causes apoptotic cell death under salt stress.,19220868,Zhang,Xiaohua,X,None,2009,Bdf1p deletion affects mitochondrial function and causes apoptotic cell death under salt stress.,19220868,Liu,Liangyu,L,None,2009,Bdf1p deletion affects mitochondrial function and causes apoptotic cell death under salt stress.,19220868,Lei,Ming,M,None,2009,Bdf1p deletion affects mitochondrial function and causes apoptotic cell death under salt stress.,19220868,Zhang,Zhaojie,Z,None,2009,Bdf1p deletion affects mitochondrial function and causes apoptotic cell death under salt stress.,19220868,Bao,Xiaoming,X,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Kadota,Mitsutaka,M,"Laboratory of Population Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.",2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Sato,Misako,M,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Duncan,Beverly,B,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Ooshima,Akira,A,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Yang,Howard H,HH,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Diaz-Meyer,Natacha,N,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Gere,Sheryl,S,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Kageyama,Shun-Ichiro,S,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Fukuoka,Junya,J,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Nagata,Takuya,T,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Tsukada,Kazuhiro,K,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Dunn,Barbara K,BK,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Wakefield,Lalage M,LM,None,2009,Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.,19706770,Lee,Maxwell P,MP,None,2009,Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism.,19459142,Bernal,Vicente,V,"<affiliation>Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Universidade Nova de Lisboa (ITQB-UNL/IBET), Oeiras, Portugal.</affiliation>",2009,Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism.,19459142,Carinhas,Nuno,N,None,2009,Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism.,19459142,Yokomizo,Adriana Y,AY,None,2009,Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism.,19459142,Carrondo,Manuel J T,MJ,None,2009,Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism.,19459142,Alves,Paula M,PM,None,2009,BRD8 is a potential chemosensitizing target for spindle poisons in colorectal cancer therapy.,19787264,Yamada,Hiroshi Y,HY,"Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center (OUHSC), BRC1207, Oklahoma City, OK 73104, USA. hiroshi-yamada@ouhsc.edu",2009,BRD8 is a potential chemosensitizing target for spindle poisons in colorectal cancer therapy.,19787264,Rao,Chinthalapally V,CV,None,2009,Regulation of aurora B expression by the bromodomain protein Brd4.,19596781,You,Jianxin,J,"Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.",2009,Regulation of aurora B expression by the bromodomain protein Brd4.,19596781,Li,Qing,Q,None,2009,Regulation of aurora B expression by the bromodomain protein Brd4.,19596781,Wu,Chong,C,None,2009,Regulation of aurora B expression by the bromodomain protein Brd4.,19596781,Kim,Jina,J,None,2009,Regulation of aurora B expression by the bromodomain protein Brd4.,19596781,Ottinger,Matthias,M,None,2009,Regulation of aurora B expression by the bromodomain protein Brd4.,19596781,Howley,Peter M,PM,None,2009,The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.,19342595,Zhou,Jiliang,J,"Department of Cellular and Integrative Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202-5120, USA.",2009,The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.,19342595,Zhang,Min,M,None,2009,The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.,19342595,Fang,Hong,H,None,2009,The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.,19342595,El-Mounayri,Omar,O,None,2009,The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.,19342595,Rodenberg,Jennifer M,JM,None,2009,The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.,19342595,Imbalzano,Anthony N,AN,None,2009,The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.,19342595,Herring,B Paul,BP,None,2009,The Gcn5 bromodomain of the SAGA complex facilitates cooperative and cross-tail acetylation of nucleosomes.,19218239,Li,Shanshan,S,"Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, Iowa 50011, USA.",2009,The Gcn5 bromodomain of the SAGA complex facilitates cooperative and cross-tail acetylation of nucleosomes.,19218239,Shogren-Knaak,Michael A,MA,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Wu,Wei-Hua,WH,"Laboratory of Biochemistry and Molecular Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA. wuwe@mail.nih.gov",2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Wu,Chwen-Huey,CH,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Ladurner,Andreas,A,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Mizuguchi,Gaku,G,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Wei,Debbie,D,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Xiao,Hua,H,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Luk,Ed,E,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Ranjan,Anand,A,None,2009,N terminus of Swr1 binds to histone H2AZ and provides a platform for subunit assembly in the chromatin remodeling complex.,19088068,Wu,Carl,C,None,2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,den Bakker,Michael A,MA,"Department of Pathology, Erasmus MC, 3000 CA Rotterdam, The Netherlands. m.denbakker@erasmusmc.nl",2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,Beverloo,Berna H,BH,None,2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,van den Heuvel-Eibrink,Marry M,MM,None,2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,Meeuwis,Cees A,CA,None,2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,Tan,Liane M,LM,None,2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,Johnson,Laura A,LA,None,2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,French,Christopher A,CA,None,2009,NUT midline carcinoma of the parotid gland with mesenchymal differentiation.,19561446,van Leenders,Geert J L H,GJ,None,2009,The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.,19004936,Poddar,Atasi,A,"Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland 20892, USA.",2009,The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.,19004936,Reed,Shawna C,SC,None,2009,The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.,19004936,McPhillips,Maria G,MG,None,2009,The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.,19004936,Spindler,Jonathan E,JE,None,2009,The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.,19004936,McBride,Alison A,AA,None,2008,Predicting sporulation events in a bioreactor using an electronic nose.,18435482,Clemente,J J,JJ,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, P-2781-901 Oeiras, Portugal.</affiliation>",2008,Predicting sporulation events in a bioreactor using an electronic nose.,18435482,Monteiro,S M S,SM,None,2008,Predicting sporulation events in a bioreactor using an electronic nose.,18435482,Carrondo,M J T,MJ,None,2008,Predicting sporulation events in a bioreactor using an electronic nose.,18435482,Cunha,A E,AE,None,2008,The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.,18782771,Hou,Tieying,T,"Department of Biochemistry, University of Texas Medical Branch, Galveston, Texas 77555-1060, USA.",2008,The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.,18782771,Ray,Sutapa,S,None,2008,The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.,18782771,Lee,Chang,C,None,2008,The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.,18782771,Brasier,Allan R,AR,None,2008,Kinetic analysis of acetylation-dependent Pb1 bromodomain-histone interactions.,18508185,Kupitz,Christopher,C,"Department of Chemistry, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, United States.",2008,Kinetic analysis of acetylation-dependent Pb1 bromodomain-histone interactions.,18508185,Chandrasekaran,Renu,R,None,2008,Kinetic analysis of acetylation-dependent Pb1 bromodomain-histone interactions.,18508185,Thompson,Martin,M,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Chen,Ruichuan,R,"Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen 361005, Fujian, China. chenrc@xmu.edu.cn",2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Liu,Min,M,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Li,Huan,H,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Xue,Yuhua,Y,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Ramey,Wanichaya N,WN,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,He,Nanhai,N,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Ai,Nanping,N,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Luo,Haohong,H,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Zhu,Ying,Y,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Zhou,Nan,N,None,2008,PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.,18483222,Zhou,Qiang,Q,None,2008,Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300.,18400184,Zeng,Lei,L,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York University, New York, NY 10029, USA.",2008,Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300.,18400184,Zhang,Qiang,Q,None,2008,Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300.,18400184,Gerona-Navarro,Guillermo,G,None,2008,Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300.,18400184,Moshkina,Natalia,N,None,2008,Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300.,18400184,Zhou,Ming-Ming,MM,None,2008,The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.,18922874,Lin,Ammy,A,"Department of Molecular Genetics, University of Toronto, 1 Kings College Circle, Toronto, Canada M5S 1A8.",2008,The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.,18922874,Wang,Shan,S,None,2008,The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.,18922874,Nguyen,Tin,T,None,2008,The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.,18922874,Shire,Kathy,K,None,2008,The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.,18922874,Frappier,Lori,L,None,2008,Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.,18092921,Carrondo,Manuel J T,MJ,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica, Universidade Nova de Lisboa (IBET/ITQB/UNL), P-2781-901 Oeiras, Portugal.</affiliation>",2008,Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.,18092921,Merten,Otto-Wilhelm,OW,None,2008,Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.,18092921,Haury,Matthias,M,None,2008,Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.,18092921,Alves,Paula M,PM,None,2008,Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.,18092921,Coroadinha,Ana S,AS,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Urano,Emiko,E,"National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.",2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Kariya,Yumi,Y,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Futahashi,Yuko,Y,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Ichikawa,Reiko,R,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Hamatake,Makiko,M,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Fukazawa,Hidesuke,H,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Morikawa,Yuko,Y,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Yoshida,Takeshi,T,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Koyanagi,Yoshio,Y,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Yamamoto,Naoki,N,None,2008,Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.,18996376,Komano,Jun,J,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Liu,Huaying,H,"Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, Changsha, Hunan, PR China. huayingcsu@yahoo.com.cn",2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Zhang,Liming,L,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Niu,Zhaoxia,Z,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Zhou,Ming,M,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Peng,Cong,C,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Li,Xiayu,X,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Deng,Tan,T,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Shi,Lei,L,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Tan,Yixin,Y,None,2008,Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.,18778484,Li,Guiyuan,G,None,2008,The PHD domain of plant PIAS proteins mediates sumoylation of bromodomain GTE proteins.,18502747,Garcia-Dominguez,Mario,M,"<affiliation>Centro Andaluz de BiologÌ_a Molecular y Medicina Regenerativa Consejo Superior de Investigaciones CientÌ_ficas-Universidad de Sevilla, Seville, Spain. mario.garcia@cabimer.es</affiliation>",2008,The PHD domain of plant PIAS proteins mediates sumoylation of bromodomain GTE proteins.,18502747,March-Diaz,Rosana,R,None,2008,The PHD domain of plant PIAS proteins mediates sumoylation of bromodomain GTE proteins.,18502747,Reyes,Jose C,JC,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Berro,Reem,R,"Department of Biochemistry and Microbiology, The George Washington University Medical Center, 2300 I St. NW, Washington, DC 20037, USA.",2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Pedati,Caitlin,C,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Kehn-Hall,Kylene,K,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Wu,Weilin,W,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Klase,Zachary,Z,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Even,Yasmine,Y,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,<lastname>GeneviÌ¬re</lastname>,Anne-Marie,AM,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Ammosova,Tatiana,T,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Nekhai,Sergei,S,None,2008,"CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.",18480452,Kashanchi,Fatah,F,None,2008,Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.,18396160,Nishiyama,Akira,A,"Laboratory of Molecular Growth Regulation, Genomics and Differentiation Program, National Institutes of Child Health and Human Development, National Institutes of Health, Building 6, Room 2A01, 6 Center Drive, Bethesda, MD 20892-2753, United States.",2008,Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.,18396160,Mochizuki,Kazuki,K,None,2008,Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.,18396160,Mueller,Florian,F,None,2008,Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.,18396160,Karpova,Tatiana,T,None,2008,Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.,18396160,McNally,James G,JG,None,2008,Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.,18396160,Ozato,Keiko,K,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Liu,Huaying,H,"Cancer Research Institute, Central South University, Changsha, Hunan, People's Republic of China.",2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Li,Xiaoling,X,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Niu,Zhaoxia,Z,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Zhang,Liming,L,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Zhou,Ming,M,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Huang,He,H,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,He,Jiajin,J,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Zhang,Wenling,W,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Xiao,Lan,L,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Tang,Yunlian,Y,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Wang,Li,L,None,2008,Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.,18071067,Li,Guiyuan,G,None,2008,Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells.,18040715,Zou,Yanming,Y,"Saban Research Institute, Childrens Hospital Los Angeles, Los Angeles, CA, 90027, USA.",2008,Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells.,18040715,He,Lina,L,None,2008,Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells.,18040715,Chi,Feng,F,None,2008,Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells.,18040715,Jong,Ambrose,A,None,2008,Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells.,18040715,Huang,Sheng-He,SH,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Landry,Joseph,J,"Laboratory of Biochemistry and Molecular Cell Biology, National Cancer Institute, National Institutes of Heath, Bethesda, MD, USA. landrjos@mail.nih.gov",2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Sharov,Alexei A,AA,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Piao,Yulan,Y,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Sharova,Lioudmila V,LV,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Xiao,Hua,H,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Southon,Eileen,E,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Matta,Jennifer,J,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Tessarollo,Lino,L,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Zhang,Ying E,YE,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Ko,Minoru S H,MS,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Kuehn,Michael R,MR,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Yamaguchi,Terry P,TP,None,2008,Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.,18974875,Wu,Carl,C,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Lange,Martin,M,"Group Cardiovascular Genetics, Department Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin 14195, Germany.",2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Kaynak,Bogac,B,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Forster,Ulrike B,UB,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,<lastname>TÌ_njes</lastname>,Martje,M,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Fischer,Jenny J,JJ,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Grimm,Christina,C,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Schlesinger,Jenny,J,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Just,Steffen,S,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Dunkel,Ilona,I,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Krueger,Tammo,T,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Mebus,Siegrun,S,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Lehrach,Hans,H,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Lurz,Rudi,R,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Gobom,Johan,J,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Rottbauer,Wolfgang,W,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Abdelilah-Seyfried,Salim,S,None,2008,"Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex.",18765789,Sperling,Silke,S,None,2008,Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.,18500820,Liu,Ying,Y,None,2008,Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.,18500820,Wang,Xiqing,X,None,2008,Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.,18500820,Zhang,Jiahai,J,None,2008,Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.,18500820,Huang,Hongda,H,None,2008,Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.,18500820,Ding,Bo,B,None,2008,Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.,18500820,Wu,Jihui,J,None,2008,Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.,18500820,Shi,Yunyu,Y,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Laue,Kathrin,K,"Georges-Koehler-Laboratory, Max-Planck-Institute of Immunobiology, Freiburg, Germany.",2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Daujat,Sylvain,S,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Crump,Justin Gage,JG,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Plaster,Nikki,N,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Roehl,Henry H,HH,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,None,None,None,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Kimmel,Charles B,CB,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Schneider,Robert,R,None,2008,The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.,18469222,Hammerschmidt,Matthias,M,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Philipps,Dana L,DL,"Cornell University, College of Veterinary Medicine, Ithaca, NY 14850, USA.",2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Wigglesworth,Karen,K,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Hartford,Suzanne A,SA,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Sun,Fengyun,F,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Pattabiraman,Shrivatsav,S,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Schimenti,Kerry,K,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Handel,MaryAnn,M,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Eppig,John J,JJ,None,2008,The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition.,18353305,Schimenti,John C,JC,None,2008,Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression.,18039861,Yang,Zhiyuan,Z,"Department of Molecular and Cell Biology, University of California, 622 Barker Hall, Room 3202, Berkeley, CA 94720, USA.",2008,Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression.,18039861,He,Nanhai,N,None,2008,Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression.,18039861,Zhou,Qiang,Q,None,2008,Breast cancer metastasis: do variations in inherited genes make a difference?,18505960,McBride,Gail,G,None,2008,Brd4 associates with mitotic chromosomes throughout early zebrafish embryogenesis.,18498094,Toyama,Reiko,R,"Laboratory of Molecular Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA. toyamar@mail.nih.gov",2008,Brd4 associates with mitotic chromosomes throughout early zebrafish embryogenesis.,18498094,Rebbert,Martha L,ML,None,2008,Brd4 associates with mitotic chromosomes throughout early zebrafish embryogenesis.,18498094,Dey,Anup,A,None,2008,Brd4 associates with mitotic chromosomes throughout early zebrafish embryogenesis.,18498094,Ozato,Keiko,K,None,2008,Brd4 associates with mitotic chromosomes throughout early zebrafish embryogenesis.,18498094,Dawid,Igor B,IB,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Crawford,Nigel P S,NP,"Laboratory of Cancer Biology and Genetics and Laboratory of Population Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.",2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Alsarraj,Jude,J,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Lukes,Luanne,L,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Walker,Renard C,RC,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Officewala,Jennifer S,JS,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Yang,Howard H,HH,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Lee,Maxwell P,MP,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Ozato,Keiko,K,None,2008,Bromodomain 4 activation predicts breast cancer survival.,18427120,Hunter,Kent W,KW,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Sun,Jing,J,"State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.",2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Nie,Jing,J,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Hao,Bingtao,B,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Li,Lu,L,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Xing,Guichun,G,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Wang,Zhaoqing,Z,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Zhou,Ying,Y,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Sun,Qihong,Q,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Li,Guiyuan,G,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,Zhang,Lingqiang,L,None,2008,Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.,18329849,He,Fuchu,F,None,2008,Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength.,18025106,Koutroubas,George,G,"Institute of Molecular Biology, Genetics, and Biotechnology, Foundation for Biomedical Research of the Academy of Athens, 4 Soranou Efesiou Street, Athens 11527, Greece.",2008,Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength.,18025106,Merika,Menie,M,None,2008,Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength.,18025106,Thanos,Dimitris,D,None,2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,Stelow,Edward B,EB,"Department of Pathology, University of Virginia, Charlottesville, VA, USA.",2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,Bellizzi,Andrew M,AM,None,2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,Taneja,Krishan,K,None,2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,Mills,Stacey E,SE,None,2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,Legallo,Robin D,RD,None,2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,Kutok,Jeffery L,JL,None,2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,Aster,Jon C,JC,None,2008,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,18391746,French,Christopher A,CA,None,2008,Combining metabolic flux analysis tools and 13C NMR to estimate intracellular fluxes of cultured astrocytes.,17904693,Teixeira,Ana P,AP,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia Quimica e BiolÌ_gica (IBET/ITQB), Apartado 12, P-2781-901 Oeiras, Portugal.</affiliation>",2008,Combining metabolic flux analysis tools and 13C NMR to estimate intracellular fluxes of cultured astrocytes.,17904693,Santos,<forename>SÌ_nia SÌÁ</forename>,SS,None,2008,Combining metabolic flux analysis tools and 13C NMR to estimate intracellular fluxes of cultured astrocytes.,17904693,Carinhas,Nuno,N,None,2008,Combining metabolic flux analysis tools and 13C NMR to estimate intracellular fluxes of cultured astrocytes.,17904693,Oliveira,Rui,R,None,2008,Combining metabolic flux analysis tools and 13C NMR to estimate intracellular fluxes of cultured astrocytes.,17904693,Alves,Paula M,PM,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Liu,Huaying,H,"Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, Changsha, Hunan 410078, People's Republic of China. huayingcsu@yahoo.com",2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Zhou,Ming,M,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Luo,Xiaomin,X,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Zhang,Liming,L,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Niu,Zhaoxia,Z,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Peng,Cong,C,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Ma,Jian,J,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Peng,Shuping,S,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Zhou,Houde,H,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Xiang,Bo,B,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Li,Xiayu,X,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Li,Shufang,S,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,He,Jiajin,J,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Li,Xiaoling,X,None,2008,Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.,19111069,Li,Guiyuan,G,None,2008,The Swi2/Snf2 bromodomain is important for the full binding and remodeling activity of the SWI/SNF complex on H3- and H4-acetylated nucleosomes.,18837912,Awad,Salma,S,"Faculty of Medicine and Health Sciences, Department of Biochemistry, UAE University, Al Ain, United Arab Emirates.",2008,The Swi2/Snf2 bromodomain is important for the full binding and remodeling activity of the SWI/SNF complex on H3- and H4-acetylated nucleosomes.,18837912,Hassan,Ahmed H,AH,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Benhamed,Moussa,M,"<affiliation>Institut de Biotechnologie des Plantes, UMR 8618, Centre National de la Recherche Scientifique, UniversitÌ© de Paris Sud 11, 91405 Orsay, France.</affiliation>",2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Martin-Magniette,Marie-Laure,ML,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Taconnat,Ludivine,L,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Bitton,<forename>FrÌ©dÌ©rique</forename>,F,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Servet,Caroline,C,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,De Clercq,Rebecca,R,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,De Meyer,<forename>BjÌ_rn</forename>,B,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Buysschaert,Caroline,C,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Rombauts,<forename>StÌ©phane</forename>,S,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Villarroel,Raimundo,R,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Aubourg,<forename>SÌ©bastien</forename>,S,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Beynon,Jim,J,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Bhalerao,Rishikesh P,RP,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Coupland,George,G,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Gruissem,Wilhelm,W,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Menke,Frank L H,FL,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Weisshaar,Bernd,B,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Renou,Jean-Pierre,JP,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Zhou,Dao-Xiu,DX,None,2008,Genome-scale Arabidopsis promoter array identifies targets of the histone acetyltransferase GCN5.,18644002,Hilson,Pierre,P,None,2008,Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding.,18495759,Cardenas-Mora,Juan,J,"Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 208920-0455, USA.",2008,Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding.,18495759,Spindler,Jonathan E,JE,None,2008,Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding.,18495759,Jang,Moon Kyoo,MK,None,2008,Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding.,18495759,McBride,Alison A,AA,None,2008,The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.,18406326,LeRoy,Gary,G,"Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.",2008,The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.,18406326,Rickards,Brenden,B,None,2008,The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.,18406326,Flint,S J,SJ,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Mochizuki,Kazuki,K,"Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, 6 Center Drive, Bethesda, MD 20892, USA.",2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Nishiyama,Akira,A,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Jang,Moon Kyoo,MK,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Dey,Anup,A,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Ghosh,Anu,A,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Tamura,Tomohiko,T,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Natsume,Hiroko,H,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Yao,Hongjie,H,None,2008,The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.,18223296,Ozato,Keiko,K,None,2008,The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.,18301994,Crawford,Nigel P S,NP,"Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.",2008,The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.,18301994,Walker,Renard C,RC,None,2008,The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.,18301994,Lukes,Luanne,L,None,2008,The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.,18301994,Officewala,Jennifer S,JS,None,2008,The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.,18301994,Williams,Robert W,RW,None,2008,The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.,18301994,Hunter,Kent W,KW,None,2008,Envelope-like retrotransposons in the plant kingdom: evidence of their presence in gymnosperms (Pinus pinaster).,18925379,Miguel,<forename>CÌ©lia</forename>,C,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica, Univ. Nova de Lisboa (IBET/ITQB-UNL), Quinta do MarquÌ»s, 2784-505, Oeiras, Portugal. cmiguel@itqb.unl.pt</affiliation>",2008,Envelope-like retrotransposons in the plant kingdom: evidence of their presence in gymnosperms (Pinus pinaster).,18925379,<lastname>SimÌµes</lastname>,Marta,M,None,2008,Envelope-like retrotransposons in the plant kingdom: evidence of their presence in gymnosperms (Pinus pinaster).,18925379,Oliveira,Maria Margarida,MM,None,2008,Envelope-like retrotransposons in the plant kingdom: evidence of their presence in gymnosperms (Pinus pinaster).,18925379,Rocheta,Margarida,M,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Ashe,Alyson,A,"Epigenetics Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, Queensland 4006, Australia. alyson.ashe@qimr.edu.au",2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Morgan,Daniel K,DK,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Whitelaw,Nadia C,NC,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Bruxner,Timothy J,TJ,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Vickaryous,Nicola K,NK,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Cox,Liza L,LL,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Butterfield,Natalie C,NC,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Wicking,Carol,C,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Blewitt,Marnie E,ME,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Wilkins,Sarah J,SJ,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Anderson,Gregory J,GJ,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Cox,Timothy C,TC,None,2008,A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development.,19099580,Whitelaw,Emma,E,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Lin,Yi-Jan,YJ,"1Tatsuo Miyazawa Memorial Program, RIKEN Genomic Sciences Center, Yokohama 230-0045, Japan.",2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Umehara,Takashi,T,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Inoue,Makoto,M,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Saito,Kohei,K,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Kigawa,Takanori,T,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Jang,Moon-Kyoo,MK,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Ozato,Keiko,K,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Yokoyama,Shigeyuki,S,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,Padmanabhan,Balasundaram,B,None,2008,Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.,18815416,<lastname>GÌ_ntert</lastname>,Peter,P,None,2008,Quantitative FRET analysis by fast acquisition time domain FLIM at high spatial resolution in living cells.,18539634,Padilla-Parra,Sergi,S,"<affiliation>Institut Jacques Monod, UMR 7592, Centre National de la Recherche Scientifique, UniversitÌ© Paris-Diderot, Paris, France.</affiliation>",2008,Quantitative FRET analysis by fast acquisition time domain FLIM at high spatial resolution in living cells.,18539634,<lastname>AudugÌ©</lastname>,Nicolas,N,None,2008,Quantitative FRET analysis by fast acquisition time domain FLIM at high spatial resolution in living cells.,18539634,Coppey-Moisan,<forename>MaÌøtÌ©</forename>,M,None,2008,Quantitative FRET analysis by fast acquisition time domain FLIM at high spatial resolution in living cells.,18539634,Tramier,Marc,M,None,2008,Saccharomyces cerevisiae Yta7 regulates histone gene expression.,18493054,Gradolatto,Angeline,A,"Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.",2008,Saccharomyces cerevisiae Yta7 regulates histone gene expression.,18493054,Rogers,Richard S,RS,None,2008,Saccharomyces cerevisiae Yta7 regulates histone gene expression.,18493054,Lavender,Heather,H,None,2008,Saccharomyces cerevisiae Yta7 regulates histone gene expression.,18493054,Taverna,Sean D,SD,None,2008,Saccharomyces cerevisiae Yta7 regulates histone gene expression.,18493054,Allis,C David,CD,None,2008,Saccharomyces cerevisiae Yta7 regulates histone gene expression.,18493054,Aitchison,John D,JD,None,2008,Saccharomyces cerevisiae Yta7 regulates histone gene expression.,18493054,Tackett,Alan J,AJ,None,2008,It takes a PHD to SUMO.,18406149,Peng,Jamy,J,"Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.",2008,It takes a PHD to SUMO.,18406149,Wysocka,Joanna,J,None,2008,Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD.,18222173,Wei,Lanlan,L,"Department of Chemistry, University of Akron, 109 East Buchtel Commons, Akron, OH 44325, USA.",2008,Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD.,18222173,Jamonnak,Nuttara,N,None,2008,Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD.,18222173,Choy,Jeremy,J,None,2008,Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD.,18222173,Wang,Zhenghe,Z,None,2008,Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD.,18222173,Zheng,Weiping,W,None,2008,Molecular correlates of laminar differences in the macaque dorsal lateral geniculate nucleus.,19005066,Murray,Karl D,KD,"Center for Neuroscience and Department of Psychiatry and Behavioral Sciences, University of California, Davis, Davis, California 95616, USA.",2008,Molecular correlates of laminar differences in the macaque dorsal lateral geniculate nucleus.,19005066,Rubin,Carol M,CM,None,2008,Molecular correlates of laminar differences in the macaque dorsal lateral geniculate nucleus.,19005066,Jones,Edward G,EG,None,2008,Molecular correlates of laminar differences in the macaque dorsal lateral geniculate nucleus.,19005066,Chalupa,Leo M,LM,None,2008,Inhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome.,17942543,Kapasi,Anokhi J,AJ,"Skaggs School of Pharmacy and Pharmaceutical Sciences, Room 3254, Mail Code 0712, 9500 Gilman Drive, University of California, San Diego, La Jolla, CA 92093-0712, USA.",2008,Inhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome.,17942543,Spector,Deborah H,DH,None,2008,Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.,18591231,Cortes,<forename>MÌ©lanie A M</forename>,MA,"<affiliation>INRA, UR 1282 Infectiologie Animale et SantÌ© Publique, Laboratoire de PathogÌ©nie BactÌ©rienne, Nouzilly, France.</affiliation>",2008,Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.,18591231,Gibon,Julien,J,None,2008,Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.,18591231,Chanteloup,Nathalie K,NK,None,2008,Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.,18591231,Moulin-Schouleur,Maryvonne,M,None,2008,Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.,18591231,Gilot,Philippe,P,None,2008,Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.,18591231,Germon,Pierre,P,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Ullah,Mukta,M,"<affiliation>Department of Medicine, McGill University Health Centre, MontrÌ©al, QuÌ©bec H3G 0B1, Canada.</affiliation>",2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Pelletier,Nadine,N,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Xiao,Lin,L,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Zhao,Song Ping,SP,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Wang,Kainan,K,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Degerny,Cindy,C,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Tahmasebi,Soroush,S,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Cayrou,Christelle,C,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Doyon,Yannick,Y,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Goh,Siew-Lee,SL,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Champagne,Nathalie,N,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,<lastname>CÌ«tÌ©</lastname>,Jacques,J,None,2008,Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.,18794358,Yang,Xiang-Jiao,XJ,None,2008,The multi-tasking P-TEFb complex.,18513937,<lastname>BrÌ¬s</lastname>,Vanessa,V,"Regulatory Biology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, USA.",2008,The multi-tasking P-TEFb complex.,18513937,Yoh,Sunnie M,SM,None,2008,The multi-tasking P-TEFb complex.,18513937,Jones,Katherine A,KA,None,2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Zeng,Lei,L,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York University, 1425 Madison Avenue, New York, New York 10029, USA.",2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Yap,Kyoko L,KL,None,2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Ivanov,Alexey V,AV,None,2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Wang,Xueqi,X,None,2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Mujtaba,Shiraz,S,None,2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Plotnikova,Olga,O,None,2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Rauscher,Frank J,FJ,None,2008,Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.,18488044,Zhou,Ming-Ming,MM,None,2008,Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence.,18402692,Dibenedetto,Angela J,AJ,"Department of Biology, Villanova University, Villanova, PA, USA. angela.dibenedetto@villanova.edu",2008,Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence.,18402692,Guinto,Jake B,JB,None,2008,Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence.,18402692,Ebert,Timothy D,TD,None,2008,Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence.,18402692,Bee,Katharine J,KJ,None,2008,Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence.,18402692,Schmidt,Michael M,MM,None,2008,Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence.,18402692,Jackman,Todd R,TR,None,2008,Thermodynamic analysis of acetylation-dependent Pb1 bromodomain-histone H3 interactions.,18191465,Thompson,Martin,M,"Department of Chemistry, Michigan Technological University, Houghton, MI 49931, USA. mthomps@mtu.edu",2008,Thermodynamic analysis of acetylation-dependent Pb1 bromodomain-histone H3 interactions.,18191465,Chandrasekaran,Renu,R,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,French,C A,CA,"Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.",2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Ramirez,C L,CL,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Kolmakova,J,J,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Hickman,T T,TT,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Cameron,M J,MJ,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Thyne,M E,ME,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Kutok,J L,JL,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Toretsky,J A,JA,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Tadavarthy,A K,AK,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Kees,U R,UR,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Fletcher,J A,JA,None,2008,BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.,17934517,Aster,J C,JC,None,2007,"PpRab1, a Rab GTPase from maritime pine is differentially expressed during embryogenesis.",17562081,<lastname>GonÌ_alves</lastname>,<forename>SÌ_nia</forename>,S,"<affiliation>Forest Biotech Lab, Instituto de Biologia Experimental e TecnolÌ_gica (IBET)/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Quinta do MarquÌ»s, 2784-505 Oeiras, Portugal.</affiliation>",2007,"PpRab1, a Rab GTPase from maritime pine is differentially expressed during embryogenesis.",17562081,Cairney,John,J,None,2007,"PpRab1, a Rab GTPase from maritime pine is differentially expressed during embryogenesis.",17562081,<lastname>RodrÌ_guez</lastname>,<forename>MarÌ_a PÌ©rez</forename>,MP,None,2007,"PpRab1, a Rab GTPase from maritime pine is differentially expressed during embryogenesis.",17562081,<lastname>CÌÁnovas</lastname>,Francisco,F,None,2007,"PpRab1, a Rab GTPase from maritime pine is differentially expressed during embryogenesis.",17562081,Oliveira,Margarida,M,None,2007,"PpRab1, a Rab GTPase from maritime pine is differentially expressed during embryogenesis.",17562081,Miguel,<forename>CÌ©lia</forename>,C,None,2007,The effect of heat shock on paclitaxel production in Taxus yunnanensis cell suspension cultures: role of abscisic acid pretreatment.,16868922,Zhang,Changhe,C,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal. zhang@itqb.unl.pt</affiliation>",2007,The effect of heat shock on paclitaxel production in Taxus yunnanensis cell suspension cultures: role of abscisic acid pretreatment.,16868922,Fevereiro,Pedro S,PS,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Ivanov,Alexey V,AV,"The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.",2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Peng,Hongzhuang,H,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Yurchenko,Vyacheslav,V,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Yap,Kyoko L,KL,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Negorev,Dmitri G,DG,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Schultz,David C,DC,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Psulkowski,Elyse,E,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Fredericks,William J,WJ,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,White,David E,DE,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Maul,Gerd G,GG,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Sadofsky,Moshe J,MJ,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Zhou,Ming-Ming,MM,None,2007,PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.,18082607,Rauscher,Frank J,FJ,None,2007,Virp1 is a host protein with a major role in Potato spindle tuber viroid infection in Nicotiana plants.,17898061,Kalantidis,K,K,"Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, Heraklion, Crete, Greece. kriton@imbb.forth.gr",2007,Virp1 is a host protein with a major role in Potato spindle tuber viroid infection in Nicotiana plants.,17898061,Denti,M A,MA,None,2007,Virp1 is a host protein with a major role in Potato spindle tuber viroid infection in Nicotiana plants.,17898061,Tzortzakaki,S,S,None,2007,Virp1 is a host protein with a major role in Potato spindle tuber viroid infection in Nicotiana plants.,17898061,Marinou,E,E,None,2007,Virp1 is a host protein with a major role in Potato spindle tuber viroid infection in Nicotiana plants.,17898061,Tabler,M,M,None,2007,Virp1 is a host protein with a major role in Potato spindle tuber viroid infection in Nicotiana plants.,17898061,Tsagris,M,M,None,2007,Structure and acetyl-lysine recognition of the bromodomain.,17694091,Mujtaba,S,S,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY 10029, USA.",2007,Structure and acetyl-lysine recognition of the bromodomain.,17694091,Zeng,L,L,None,2007,Structure and acetyl-lysine recognition of the bromodomain.,17694091,Zhou,M-M,MM,None,2007,The bromodomain protein LEX-1 acts with TAM-1 to modulate gene expression in C. elegans.,17618463,Tseng,Rong-Jeng,RJ,"Department of Molecular Genetics, Ohio State University, 938 Biological Sciences Building, 484 West 12th Avenue, Columbus, OH 43210, USA.",2007,The bromodomain protein LEX-1 acts with TAM-1 to modulate gene expression in C. elegans.,17618463,Armstrong,Kristin R,KR,None,2007,The bromodomain protein LEX-1 acts with TAM-1 to modulate gene expression in C. elegans.,17618463,Wang,Xiaodong,X,None,2007,The bromodomain protein LEX-1 acts with TAM-1 to modulate gene expression in C. elegans.,17618463,Chamberlin,Helen M,HM,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Sun,Hongbin,H,"Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, PR China.",2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Liu,Jiangxin,J,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Zhang,Jiahai,J,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Shen,Weiqun,W,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Huang,Hongda,H,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Xu,Chao,C,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Dai,Haiming,H,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Wu,Jihui,J,None,2007,Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.,17498659,Shi,Yunyu,Y,None,2007,Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4.,17293877,Natsume,Ryo,R,"Japan Biological Information Research Centre (JBIRC), Japan Biological Informatics Consortium (JBIC), 2-42 Aomi, Koto-ku, Tokyo 135-0064, Japan.",2007,Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4.,17293877,Eitoku,Masamitsu,M,None,2007,Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4.,17293877,Akai,Yusuke,Y,None,2007,Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4.,17293877,Sano,Norihiko,N,None,2007,Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4.,17293877,Horikoshi,Masami,M,None,2007,Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4.,17293877,Senda,Toshiya,T,None,2007,Transcriptional and subcellular regulation of the TRIP-Br family.,17141982,Lai,I-Lu,IL,"Institute of Molecular Biology, National Chung Hsing University, 250 Kuo-Kuang Road, Taichung 40227, Taiwan.",2007,Transcriptional and subcellular regulation of the TRIP-Br family.,17141982,Wang,Shi-Yun,SY,None,2007,Transcriptional and subcellular regulation of the TRIP-Br family.,17141982,Yao,Ya-Li,YL,None,2007,Transcriptional and subcellular regulation of the TRIP-Br family.,17141982,Yang,Wen-Ming,WM,None,2007,Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.,17686863,Cho,Won-Kyung,WK,"Virus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 41 Medlars Dr., Bldg. 41, Rm. B201, Bethesda, MD 20892, USA.",2007,Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.,17686863,Zhou,Meisheng,M,None,2007,Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.,17686863,Jang,Moon Kyoo,MK,None,2007,Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.,17686863,Huang,Keven,K,None,2007,Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.,17686863,Jeong,Soo-Jin,SJ,None,2007,Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.,17686863,Ozato,Keiko,K,None,2007,Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.,17686863,Brady,John N,JN,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Istrate,C,C,"IBET/ITQB Instituto de Biologia Experimental e Tecnologica/ Instituto de Tecnologica Quimica e Biologica, Oeiras, Portugal.",2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Douagi,I,I,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Charpilienne,A,A,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,McInerney,G M,GM,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Hidmark,A,A,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Johansen,K,K,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Larsson,M,M,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Magnusson,K-E,KE,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Poncet,D,D,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Svensson,L,L,None,2007,Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.,17523941,Hinkula,J,J,None,2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,Keuling,Angela,A,"Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.",2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,Yang,Fang,F,None,2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,Hanna,Scott,S,None,2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,Wang,Huaien,H,None,2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,Tully,Tim,T,None,2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,Burnham,Amanda,A,None,2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,Locke,John,J,None,2007,"Mutation analysis of Drosophila dikar/CG32394, homologue of the chromatin-remodelling gene CECR2.",17893736,McDermid,Heather E,HE,None,2007,"MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.",17694082,Yang,X-J,XJ,"<affiliation>Molecular Oncology Group, Department of Medicine, McGill University Health Center, MontrÌ©al, QuÌ©bec, Canada. xiang.jiao.yang@mcgill.ca</affiliation>",2007,"MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.",17694082,Ullah,M,M,None,2007,"Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.",17582821,Singh,Mahavir,M,"Max-Planck-Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.",2007,"Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.",17582821,Popowicz,Grzegorz M,GM,None,2007,"Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.",17582821,Krajewski,Marcin,M,None,2007,"Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.",17582821,Holak,Tad A,TA,None,2007,"[KAP-1, a scaffold protein in transcription regulation].",17369165,Yang,Dong,D,"Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China. yangdong@hupo.org.cn",2007,"[KAP-1, a scaffold protein in transcription regulation].",17369165,Jiang,Ying,Y,None,2007,"[KAP-1, a scaffold protein in transcription regulation].",17369165,He,Fu-Chu,FC,None,2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Shen,Weiqun,W,"School of Life Sciences, and Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, 230026, People's Republic of China.",2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Xu,Chao,C,None,2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Huang,Wei,W,None,2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Zhang,Jiahai,J,None,2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Carlson,Justin E,JE,None,2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Tu,Xiaoming,X,None,2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Wu,Jihui,J,None,2007,Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.,17274598,Shi,Yunyu,Y,None,2007,Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.,17111193,Peng,Jinhong,J,"National Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, Hubei, People's Republic of China.",2007,Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.,17111193,Dong,Wei,W,None,2007,Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.,17111193,Chen,Lu,L,None,2007,Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.,17111193,Zou,Tingting,T,None,2007,Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.,17111193,Qi,Yipeng,Y,None,2007,Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.,17111193,Liu,Yingle,Y,None,2007,Regulation of transcript elongation through cooperative and ordered recruitment of cofactors.,17535807,Sharma,Manish,M,"Immunology Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India.",2007,Regulation of transcript elongation through cooperative and ordered recruitment of cofactors.,17535807,George,Anuja A,AA,None,2007,Regulation of transcript elongation through cooperative and ordered recruitment of cofactors.,17535807,Singh,Badri N,BN,None,2007,Regulation of transcript elongation through cooperative and ordered recruitment of cofactors.,17535807,Sahoo,Naresh C,NC,None,2007,Regulation of transcript elongation through cooperative and ordered recruitment of cofactors.,17535807,Rao,Kanury V S,KV,None,2007,Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.,17881376,Nightingale,Karl P,KP,"Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.",2007,Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.,17881376,Baumann,Matthias,M,None,2007,Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.,17881376,Eberharter,Anton,A,None,2007,Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.,17881376,Mamais,Adamantios,A,None,2007,Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.,17881376,Becker,Peter B,PB,None,2007,Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.,17881376,Boyes,Joan,J,None,2007,Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription.,17690245,Bisgrove,Dwayne A,DA,"Gladstone Institute of Virology and Immunology, University of California, San Francisco, CA 94158, USA.",2007,Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription.,17690245,Mahmoudi,Tokameh,T,None,2007,Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription.,17690245,Henklein,Peter,P,None,2007,Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription.,17690245,Verdin,Eric,E,None,2007,"A double-bromodomain protein, FSH-S, activates the homeotic gene ultrabithorax through a critical promoter-proximal region.",17526731,Chang,Yuh-Long,YL,"Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan 115, Republic of China.",2007,"A double-bromodomain protein, FSH-S, activates the homeotic gene ultrabithorax through a critical promoter-proximal region.",17526731,King,Balas,B,None,2007,"A double-bromodomain protein, FSH-S, activates the homeotic gene ultrabithorax through a critical promoter-proximal region.",17526731,Lin,Shu-Chun,SC,None,2007,"A double-bromodomain protein, FSH-S, activates the homeotic gene ultrabithorax through a critical promoter-proximal region.",17526731,Kennison,James A,JA,None,2007,"A double-bromodomain protein, FSH-S, activates the homeotic gene ultrabithorax through a critical promoter-proximal region.",17526731,Huang,Der-Hwa,DH,None,2007,"Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC.",17368181,Kato,Shigeaki,S,"The Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan. uskato@mail.ecc.u-tokyo.ac.jp",2007,"Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC.",17368181,Fujiki,Ryoji,R,None,2007,"Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC.",17368181,Kim,Mi-Sun,MS,None,2007,"Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC.",17368181,Kitagawa,Hirochika,H,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Nagashima,Takashi,T,"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.",2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Maruyama,Tetsuo,T,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Furuya,Masataka,M,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Kajitani,Takashi,T,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Uchida,Hiroshi,H,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Masuda,Hirotaka,H,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Ono,Masanori,M,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Arase,Toru,T,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Ozato,Keiko,K,None,2007,Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.,17267518,Yoshimura,Yasunori,Y,None,2007,Paternity analysis in Excel.,17928093,Rocheta,Margarida,M,"<affiliation>Centro de BotÌ¢nica Aplicada ÌÊ Agricultura, SecÌ_Ì£o de GenÌ©tica, Instituto Superior de Agronomia (ISA), TU Lisbon, Portugal. rocheta@isa.utl.pt</affiliation>",2007,Paternity analysis in Excel.,17928093,<lastname>DionÌ_sio</lastname>,F Miguel,FM,None,2007,Paternity analysis in Excel.,17928093,Fonseca,<forename>LuÌ_s</forename>,L,None,2007,Paternity analysis in Excel.,17928093,Pires,Ana M,AM,None,2007,Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes.,17140688,Ribeiro,<forename>TÌ¢nia</forename>,T,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET)/ Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2007,Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes.,17140688,Abrantes,Marta,M,None,2007,Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes.,17140688,Lopes,<forename>Maria de FÌÁtima Silva</forename>,Mde F,None,2007,Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes.,17140688,Crespo,Maria Teresa Barreto,MT,None,2007,Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.,17848202,Huang,Hongda,H,"Hefei National Laboratory for Physical Sciences at Microscale and School of Life Science, University of Science and Technology of China, Hefei, Anhui 230026, People's Republic of China. hhd075@mail.ustc.edu.cn",2007,Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.,17848202,Zhang,Jiahai,J,None,2007,Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.,17848202,Shen,Weiqun,W,None,2007,Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.,17848202,Wang,Xingsheng,X,None,2007,Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.,17848202,Wu,Jiawen,J,None,2007,Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.,17848202,Wu,Jihui,J,None,2007,Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.,17848202,Shi,Yunyu,Y,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Lan,Fei,F,"Department of Pathology, Harvard Medical School, 77 Ave Louis Pasteur, Boston, Massachusetts 02115, USA.",2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Collins,Robert E,RE,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,De Cegli,Rossella,R,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Alpatov,Roman,R,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Horton,John R,JR,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Shi,Xiaobing,X,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Gozani,Or,O,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Cheng,Xiaodong,X,None,2007,Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.,17687328,Shi,Yang,Y,None,2007,NuA4-directed chromatin transactions throughout the Saccharomyces cerevisiae genome.,17526728,Durant,Melissa,M,"Center for Gene Regulation, Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA.",2007,NuA4-directed chromatin transactions throughout the Saccharomyces cerevisiae genome.,17526728,Pugh,B Franklin,BF,None,2007,N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine.,17340003,Jamonnak,Nuttara,N,"Department of Chemistry, University of Akron, 190 E. Buchtel Commons, Akron, OH 44325, USA.",2007,N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine.,17340003,Fatkins,David G,DG,None,2007,N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine.,17340003,Wei,Lanlan,L,None,2007,N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine.,17340003,Zheng,Weiping,W,None,2007,Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2.,17267510,Griffiths,Rhoswyn,R,"Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, United Kingdom.",2007,Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2.,17267510,Whitehouse,Adrian,A,None,2007,"Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.",17406891,Micci,Francesca,F,"Department of Medical Genetics, Rikshospitalet-Radiumhospitalet Medical Centre (Montebello), 0310, Oslo, Norway. francesca.micci@labmed.uio.no",2007,"Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.",17406891,Panagopoulos,Ioannis,I,None,2007,"Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.",17406891,<lastname>TjÌünnfjord</lastname>,Geir E,GE,None,2007,"Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.",17406891,Kolstad,Arne,A,None,2007,"Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.",17406891,Delabie,Jan,J,None,2007,"Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.",17406891,Beiske,Klaus,K,None,2007,"Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.",17406891,Heim,Sverre,S,None,2007,"ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.",17998543,Zou,June X,JX,"Department of Biochemistry and Molecular Medicine, School of Medicine, and University of California at Davis Cancer Center/Basic Science, University of California at Davis, Sacramento, CA 95817, USA. jxzou@ucdavis.edu",2007,"ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.",17998543,Revenko,Alexey S,AS,None,2007,"ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.",17998543,Li,Li B,LB,None,2007,"ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.",17998543,Gemo,Abigael T,AT,None,2007,"ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.",17998543,Chen,Hong-Wu,HW,None,2007,A nucleosome interaction module is required for normal function of Arabidopsis thaliana BRAHMA.,17825834,Farrona,S,S,"<affiliation>Centro Andaluz de BiologÌ_a Molecular y Medicina Regenerativa and Instituto de BioquÌ_mica Vegetal y FotosÌ_ntesis, Consejo Superior de Investigaciones CientÌ_ficas, AmÌ©rico Vespucio s/n, E-41092 Sevilla, Spain.</affiliation>",2007,A nucleosome interaction module is required for normal function of Arabidopsis thaliana BRAHMA.,17825834,Hurtado,L,L,None,2007,A nucleosome interaction module is required for normal function of Arabidopsis thaliana BRAHMA.,17825834,Reyes,J C,JC,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Field,Michael,M,"GOLD Service, Hunter Genetics, Waratah, Australia.",2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Tarpey,Patrick S,PS,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Smith,Raffaella,R,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Edkins,Sarah,S,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,O'Meara,Sarah,S,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Stevens,Claire,C,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Tofts,Calli,C,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Teague,Jon,J,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Butler,Adam,A,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Dicks,Ed,E,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Barthorpe,Syd,S,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Buck,Gemma,G,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Cole,Jennifer,J,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Gray,Kristian,K,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Halliday,Kelly,K,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Hills,Katy,K,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Jenkinson,Andrew,A,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Jones,David,D,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Menzies,Andrew,A,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Mironenko,Tatiana,T,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Perry,Janet,J,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Raine,Keiran,K,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Richardson,David,D,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Shepherd,Rebecca,R,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Small,Alexandra,A,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Varian,Jennifer,J,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,West,Sofie,S,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Widaa,Sara,S,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Mallya,Uma,U,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Wooster,Richard,R,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Moon,Jenny,J,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Luo,Ying,Y,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Hughes,Helen,H,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Shaw,Marie,M,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Friend,Kathryn L,KL,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Corbett,Mark,M,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Turner,Gillian,G,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Partington,Michael,M,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Mulley,John,J,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Bobrow,Martin,M,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Schwartz,Charles,C,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Stevenson,Roger,R,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Gecz,Jozef,J,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Stratton,Michael R,MR,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Futreal,P Andrew,PA,None,2007,Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.,17668385,Raymond,F Lucy,FL,None,2007,Genetic and comparative transcriptome analysis of bromodomain factor 1 in the salt stress response of Saccharomyces cerevisiae.,17334841,Liu,Xiangyong,X,"State Key Laboratory of Microbial Technology, Shandong University, Jinan, 250100, P.R. China, bxm@sdu.edu.cn.",2007,Genetic and comparative transcriptome analysis of bromodomain factor 1 in the salt stress response of Saccharomyces cerevisiae.,17334841,Zhang,Xiaohua,X,None,2007,Genetic and comparative transcriptome analysis of bromodomain factor 1 in the salt stress response of Saccharomyces cerevisiae.,17334841,Wang,Chao,C,None,2007,Genetic and comparative transcriptome analysis of bromodomain factor 1 in the salt stress response of Saccharomyces cerevisiae.,17334841,Liu,Liangyu,L,None,2007,Genetic and comparative transcriptome analysis of bromodomain factor 1 in the salt stress response of Saccharomyces cerevisiae.,17334841,Lei,Ming,M,None,2007,Genetic and comparative transcriptome analysis of bromodomain factor 1 in the salt stress response of Saccharomyces cerevisiae.,17334841,Bao,Xiaoming,X,None,2007,"Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4.",17049203,Paillisson,<forename>AmÌ©lie</forename>,A,"<affiliation>Physiologie de la Reproduction et des Comportements, UMR 6175 INRA-CNRS-UniversitÌ© FranÌ_ois Rabelais de Tours-Haras Nationaux, 37380 Nouzilly, France.</affiliation>",2007,"Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4.",17049203,Levasseur,Anthony,A,None,2007,"Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4.",17049203,Gouret,Philippe,P,None,2007,"Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4.",17049203,Callebaut,Isabelle,I,None,2007,"Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4.",17049203,Bontoux,Martine,M,None,2007,"Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4.",17049203,Pontarotti,Pierre,P,None,2007,"Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4.",17049203,Monget,Philippe,P,None,2007,Novel culture strategy for human stem cell proliferation and neuronal differentiation.,17868148,Serra,Margarida,M,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (IBET/ITQB), Oeiras, Portugal.</affiliation>",2007,Novel culture strategy for human stem cell proliferation and neuronal differentiation.,17868148,Leite,Sofia B,SB,None,2007,Novel culture strategy for human stem cell proliferation and neuronal differentiation.,17868148,Brito,Catarina,C,None,2007,Novel culture strategy for human stem cell proliferation and neuronal differentiation.,17868148,Costa,<forename>JÌ_lia</forename>,J,None,2007,Novel culture strategy for human stem cell proliferation and neuronal differentiation.,17868148,Carrondo,Manuel J T,MJ,None,2007,Novel culture strategy for human stem cell proliferation and neuronal differentiation.,17868148,Alves,Paula M,PM,None,2007,An acetylation switch in p53 mediates holo-TFIID recruitment.,17996705,Li,Andrew G,AG,"Department of Biochemistry, University of California, Riverside, 900 University Avenue, Riverside, CA 92521, USA.",2007,An acetylation switch in p53 mediates holo-TFIID recruitment.,17996705,Piluso,Landon G,LG,None,2007,An acetylation switch in p53 mediates holo-TFIID recruitment.,17996705,Cai,Xin,X,None,2007,An acetylation switch in p53 mediates holo-TFIID recruitment.,17996705,Gadd,Brian J,BJ,None,2007,An acetylation switch in p53 mediates holo-TFIID recruitment.,17996705,Ladurner,Andreas G,AG,None,2007,An acetylation switch in p53 mediates holo-TFIID recruitment.,17996705,Liu,Xuan,X,None,2007,Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation.,17803945,VanDemark,Andrew P,AP,"Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.",2007,Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation.,17803945,Kasten,Margaret M,MM,None,2007,Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation.,17803945,Ferris,Elliott,E,None,2007,Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation.,17803945,Heroux,Annie,A,None,2007,Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation.,17803945,Hill,Christopher P,CP,None,2007,Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation.,17803945,Cairns,Bradley R,BR,None,2007,Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.,17626100,Schweiger,Michal-Ruth,MR,"Harvard Medical School, Department of Pathology, 77 Avenue Louis Pasteur, Room 950, Boston, MA 02115, USA.",2007,Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.,17626100,Ottinger,Matthias,M,None,2007,Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.,17626100,You,Jianxin,J,None,2007,Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.,17626100,Howley,Peter M,PM,None,2007,Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.,17507796,Zang,Zhi Jiang,ZJ,"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.",2007,Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.,17507796,Sim,Khe Guan,KG,None,2007,Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.,17507796,Cheong,Jit Kong,JK,None,2007,Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.,17507796,Yang,Christopher Maolin,CM,None,2007,Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.,17507796,Yap,Chui Sun,CS,None,2007,Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.,17507796,Hsu,Stephen I-Hong,SI,None,2007,The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.,17329240,Wu,Shwu-Yuan,SY,"Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.",2007,The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.,17329240,Chiang,Cheng-Ming,CM,None,2007,Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.,17166848,Lenburg,Marc E,ME,"Department of Genetics and Genomics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.",2007,Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.,17166848,Sinha,Anupama,A,None,2007,Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.,17166848,Faller,Douglas V,DV,None,2007,Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.,17166848,Denis,Gerald V,GV,None,2007,Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.,17049045,Hassan,Ahmed H,AH,"Department of Biochemistry, Faculty of Medicine and Health Sciences, UAE University, P.O. Box 17666, Al-Ain, United Arab Emirates. ahmedh@uaeu.ac.ae",2007,Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.,17049045,Awad,Salma,S,None,2007,Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.,17049045,Al-Natour,Zeina,Z,None,2007,Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.,17049045,Othman,Samah,S,None,2007,Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.,17049045,Mustafa,Farah,F,None,2007,Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.,17049045,Rizvi,Tahir A,TA,None,2007,Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics.,17628504,Santos,<forename>SÌ_nia SÌÁ</forename>,SS,"<affiliation>Animal Cell Technology Laboratory, Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (IBET/ITQB), Oeiras, Portugal.</affiliation>",2007,Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics.,17628504,Leite,Sofia B,SB,None,2007,Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics.,17628504,Sonnewald,Ursula,U,None,2007,Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics.,17628504,Carrondo,Manuel J T,MJ,None,2007,Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics.,17628504,Alves,Paula M,PM,None,2007,PpRT1: the first complete gypsy-like retrotransposon isolated in Pinus pinaster.,17008993,Rocheta,Margarida,M,"<affiliation>Forest Biotech Lab, Instituto de Biologia Experimental e TecnolÌ_gica (IBET/ITQB), Quinta do MarquÌ»s, 2784-505 Oeiras, Portugal. rocheta@itqb.unl.pt</affiliation>",2007,PpRT1: the first complete gypsy-like retrotransposon isolated in Pinus pinaster.,17008993,Cordeiro,Jorge,J,None,2007,PpRT1: the first complete gypsy-like retrotransposon isolated in Pinus pinaster.,17008993,Oliveira,M,M,None,2007,PpRT1: the first complete gypsy-like retrotransposon isolated in Pinus pinaster.,17008993,Miguel,<forename>CÌ©lia</forename>,C,None,2007,Pspace: a program that assesses protein space.,17956630,Mezei,Mihaly,M,"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York University, One Gustave L, Levy Place, New York, New York 10029, USA. Mihaly.Mezei@mssm.edu.",2007,Pspace: a program that assesses protein space.,17956630,Zhou,Ming-Ming,MM,None,2007,"The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation.",17728347,Shang,Enyuan,E,"The Institute of Human Nutrition, Columbia University Medical Center, New York, NY 10032, USA.",2007,"The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation.",17728347,Nickerson,Helen D,HD,None,2007,"The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation.",17728347,Wen,Duancheng,D,None,2007,"The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation.",17728347,Wang,Xiangyuan,X,None,2007,"The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation.",17728347,Wolgemuth,Debra J,DJ,None,2007,"Purification, crystallization and preliminary X-ray diffraction of the C-terminal bromodomain from human BRD2.",17620725,Umehara,Takashi,T,"Genomic Sciences Center, Yokohama Institute, RIKEN, 1-7-22 Suehiro-cho, Tsurumi, Yokohama 230-0045, Japan.",2007,"Purification, crystallization and preliminary X-ray diffraction of the C-terminal bromodomain from human BRD2.",17620725,Wakamori,Masatoshi,M,None,2007,"Purification, crystallization and preliminary X-ray diffraction of the C-terminal bromodomain from human BRD2.",17620725,Tanaka,Akiko,A,None,2007,"Purification, crystallization and preliminary X-ray diffraction of the C-terminal bromodomain from human BRD2.",17620725,Padmanabhan,Balasundaram,B,None,2007,"Purification, crystallization and preliminary X-ray diffraction of the C-terminal bromodomain from human BRD2.",17620725,Yokoyama,Shigeyuki,S,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Rong,Hui,H,"Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230026, People's Republic of China.",2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Li,Yan,Y,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Shi,Xiaowei,X,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Zhang,Xiao,X,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Gao,Yongxiang,Y,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Dai,Haiming,H,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Teng,Maikun,M,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Niu,Liwen,L,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Liu,Qun,Q,None,2007,Structure of human upstream binding factor HMG box 5 and site for binding of the cell-cycle regulatory factor TAF1.,17505112,Hao,Quan,Q,None,2007,Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions.,17320048,Chandrasekaran,Renu,R,"Department of Chemistry, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, USA.",2007,Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions.,17320048,Thompson,Martin,M,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Nakamura,Yoshihiro,Y,"RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama 230-0045, Japan.",2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Umehara,Takashi,T,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Nakano,Kazumi,K,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Jang,Moon Kyoo,MK,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Shirouzu,Mikako,M,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Morita,Satoshi,S,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Uda-Tochio,Hiroko,H,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Hamana,Hiroaki,H,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Terada,Takaho,T,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Adachi,Naruhiko,N,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Matsumoto,Takehisa,T,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Tanaka,Akiko,A,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Horikoshi,Masami,M,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Ozato,Keiko,K,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Padmanabhan,Balasundaram,B,None,2007,Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.,17148447,Yokoyama,Shigeyuki,S,None,2007,Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4.,17023018,<lastname>SÌ©nÌ©chal</lastname>,<forename>HÌ©lÌ¬ne</forename>,H,"<affiliation>Laboratory of Molecular Virology, Institut de recherches cliniques de MontrÌ©al, 110 Pine Avenue West, Montreal, Quebec, Canada H2W 1R7.</affiliation>",2007,Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4.,17023018,Poirier,Guy G,GG,None,2007,Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4.,17023018,Coulombe,Benoit,B,None,2007,Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4.,17023018,Laimins,Laimonis A,LA,None,2007,Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4.,17023018,Archambault,Jacques,J,None,2007,Successful treatment of a child with t(15;19)-positive tumor.,16435379,Mertens,Fredrik,F,"Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. fredrik.mertens@med.lu.se",2007,Successful treatment of a child with t(15;19)-positive tumor.,16435379,Wiebe,Thomas,T,None,2007,Successful treatment of a child with t(15;19)-positive tumor.,16435379,Adlercreutz,Catharina,C,None,2007,Successful treatment of a child with t(15;19)-positive tumor.,16435379,Mandahl,Nils,N,None,2007,Successful treatment of a child with t(15;19)-positive tumor.,16435379,French,Christopher A,CA,None,2006,SWI/SNF displaces SAGA-acetylated nucleosomes.,17030999,Chandy,Mark,M,"Stowers Institute for Medical Research, 1000 E 50th St., Kansas City, MO 64110, USA.",2006,SWI/SNF displaces SAGA-acetylated nucleosomes.,17030999,<lastname>GutiÌ©rrez</lastname>,<forename>JosÌ© L</forename>,JL,None,2006,SWI/SNF displaces SAGA-acetylated nucleosomes.,17030999,Prochasson,Philippe,P,None,2006,SWI/SNF displaces SAGA-acetylated nucleosomes.,17030999,Workman,Jerry L,JL,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Severinsen,J E,JE,"Institute of Human Genetics, University of Aarhus, Aarhus, Denmark.",2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Bjarkam,C R,CR,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Kiaer-Larsen,S,S,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Olsen,I M,IM,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Nielsen,M M,MM,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Blechingberg,J,J,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Nielsen,A L,AL,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Holm,I E,IE,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Foldager,L,L,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Young,B D,BD,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Muir,W J,WJ,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Blackwood,D H R,DH,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Corydon,T J,TJ,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,Mors,O,O,None,2006,Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.,16924267,<lastname>BÌürglum</lastname>,A D,AD,None,2006,The Swi2/Snf2 bromodomain is required for the displacement of SAGA and the octamer transfer of SAGA-acetylated nucleosomes.,16648632,Hassan,Ahmed H,AH,"Faculty of Medicine and Health Sciences, Department of Biochemistry, United Arab Emirates University, P. O. Box 17666, Al-Ain, United Arab Emirates. ahmedh@uaeu.ac.ae",2006,The Swi2/Snf2 bromodomain is required for the displacement of SAGA and the octamer transfer of SAGA-acetylated nucleosomes.,16648632,Awad,Salma,S,None,2006,The Swi2/Snf2 bromodomain is required for the displacement of SAGA and the octamer transfer of SAGA-acetylated nucleosomes.,16648632,Prochasson,Philippe,P,None,2006,Cloning and developmental expression of WSTF during Xenopus laevis embryogenesis.,16448863,Cus,Robert,R,"Department of Biochemistry, University of Ulm, Albert-Einstein-Allee 11, D-89081 Ulm, Germany.",2006,Cloning and developmental expression of WSTF during Xenopus laevis embryogenesis.,16448863,Maurus,Daniel,D,None,2006,Cloning and developmental expression of WSTF during Xenopus laevis embryogenesis.,16448863,<lastname>KÌ_hl</lastname>,Michael,M,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Peng,Cong,C,"Cancer Research Institution, Central of South University, Changsha, Hunan, China.",2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Zhou,Jie,J,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Liu,Hua Ying,HY,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Zhou,Ming,M,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Wang,Li Li,LL,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Zhang,Qiu Hong,QH,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Yang,Yi Xin,YX,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Xiong,Wei,W,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Shen,Shou Rong,SR,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Li,Xiao Ling,XL,None,2006,The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.,16265664,Li,Gui Yuan,GY,None,2006,Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation.,16980611,He,Nanhai,N,"Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.",2006,Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation.,16980611,Pezda,Andrea C,AC,None,2006,Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation.,16980611,Zhou,Qiang,Q,None,2006,The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.,16529836,Coroadinha,A S,AS,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (IBET/ITQB), Oeiras, Portugal.</affiliation>",2006,The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.,16529836,Schucht,R,R,None,2006,The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.,16529836,Gama-Norton,L,L,None,2006,The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.,16529836,Wirth,D,D,None,2006,The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.,16529836,Hauser,H,H,None,2006,The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.,16529836,Carrondo,M J T,MJ,None,2006,BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.,17023429,Ooi,Lezanne,L,"Institute of Membrane and Systems Biology, University of Leeds, Leeds LS2 9JT, United Kingdom. L.Ooi@leeds.ac.uk",2006,BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.,17023429,Belyaev,Nikolai D,ND,None,2006,BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.,17023429,Miyake,Katsuhide,K,None,2006,BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.,17023429,Wood,Ian C,IC,None,2006,BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.,17023429,Buckley,Noel J,NJ,None,2006,Brd4 links chromatin targeting to HPV transcriptional silencing.,16921027,Wu,Shwu-Yuan,SY,"Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.",2006,Brd4 links chromatin targeting to HPV transcriptional silencing.,16921027,Lee,A-Young,AY,None,2006,Brd4 links chromatin targeting to HPV transcriptional silencing.,16921027,Hou,Samuel Y,SY,None,2006,Brd4 links chromatin targeting to HPV transcriptional silencing.,16921027,Kemper,Jongsook Kim,JK,None,2006,Brd4 links chromatin targeting to HPV transcriptional silencing.,16921027,Erdjument-Bromage,Hediye,H,None,2006,Brd4 links chromatin targeting to HPV transcriptional silencing.,16921027,Tempst,Paul,P,None,2006,Brd4 links chromatin targeting to HPV transcriptional silencing.,16921027,Chiang,Cheng-Ming,CM,None,2006,Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.,16611886,Schweiger,Michal-Ruth,MR,"Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.",2006,Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.,16611886,You,Jianxin,J,None,2006,Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.,16611886,Howley,Peter M,PM,None,2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Sachchidanand,None,None,"Structural Biology Program, Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York University, New York 10029, USA.",2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Resnick-Silverman,Lois,L,None,2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Yan,Sherry,S,None,2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Mutjaba,Shiraz,S,None,2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Liu,Wen-Jun,WJ,None,2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Zeng,Lei,L,None,2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Manfredi,James J,JJ,None,2006,Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.,16426974,Zhou,Ming-Ming,MM,None,2006,Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.,16943289,Kurg,Reet,R,"Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia. rkurg@ebc.ee",2006,Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.,16943289,Tekkel,Helena,H,None,2006,Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.,16943289,Abroi,Aare,A,None,2006,Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.,16943289,Ustav,Mart,M,None,2006,Chiral separation and identification of beta-aminoketones of pharmacological interest by high performance liquid chromatography and capillary electrophoresis.,16442551,<lastname>SimplÌ_cio</lastname>,<forename>Ana LuÌ_sa</forename>,AL,"School of Pharmacy, Trinity College, Dublin 2, Ireland. anas@ibet.pt",2006,Chiral separation and identification of beta-aminoketones of pharmacological interest by high performance liquid chromatography and capillary electrophoresis.,16442551,Matias,Pedro,P,None,2006,Chiral separation and identification of beta-aminoketones of pharmacological interest by high performance liquid chromatography and capillary electrophoresis.,16442551,Gilmer,John F,JF,None,2006,Chiral separation and identification of beta-aminoketones of pharmacological interest by high performance liquid chromatography and capillary electrophoresis.,16442551,Clancy,John M,JM,None,2006,RSC exploits histone acetylation to abrogate the nucleosomal block to RNA polymerase II elongation.,17081996,Carey,Michael,M,"Stowers Medical Research Institute, 1000 East 50th Street, Kansas City, Missouri 64110, USA.",2006,RSC exploits histone acetylation to abrogate the nucleosomal block to RNA polymerase II elongation.,17081996,Li,Bing,B,None,2006,RSC exploits histone acetylation to abrogate the nucleosomal block to RNA polymerase II elongation.,17081996,Workman,Jerry L,JL,None,2006,Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.,16973557,McPhillips,M G,MG,"Laboratory of Viral Diseases, NIAID, NIH, Building 4, Room 137, 4 Center Dr., MSC 0455, Bethesda, MD 20892-0455, USA.",2006,Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.,16973557,Oliveira,J G,JG,None,2006,Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.,16973557,Spindler,J E,JE,None,2006,Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.,16973557,Mitra,R,R,None,2006,Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.,16973557,McBride,A A,AA,None,2006,The Drosophila ramshackle gene encodes a chromatin-associated protein required for cell morphology in the developing eye.,16904300,D'Costa,Allison,A,"Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322-3030, USA.",2006,The Drosophila ramshackle gene encodes a chromatin-associated protein required for cell morphology in the developing eye.,16904300,Reifegerste,Rita,R,None,2006,The Drosophila ramshackle gene encodes a chromatin-associated protein required for cell morphology in the developing eye.,16904300,Sierra,Scott,S,None,2006,The Drosophila ramshackle gene encodes a chromatin-associated protein required for cell morphology in the developing eye.,16904300,Moses,Kevin,K,None,2006,Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.,16568954,Govin,J,J,"<affiliation>Laboratoire de Biologie MolÌ©culaire et Cellulaire de la DiffÌ©renciation, INSERM U 309, Equipe Chromatine et Expression des GÌ¬nes, Institut Albert Bonniot, FacultÌ© de MÌ©decine, La Tronche, France.</affiliation>",2006,Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.,16568954,Lestrat,C,C,None,2006,Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.,16568954,Caron,C,C,None,2006,Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.,16568954,Pivot-Pajot,C,C,None,2006,Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.,16568954,Rousseaux,S,S,None,2006,Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.,16568954,Khochbin,S,S,None,2006,Differentiation-dependent expression of hypothetical proteins in the neuroblastoma cell line N1E-115.,16425288,Oh,Ji-eun,JE,"Department of Pediatrics, Medical University of Vienna, Austria.",2006,Differentiation-dependent expression of hypothetical proteins in the neuroblastoma cell line N1E-115.,16425288,Karlmark,Karlin Raja,KR,None,2006,Differentiation-dependent expression of hypothetical proteins in the neuroblastoma cell line N1E-115.,16425288,Shin,Jooho,J,None,2006,Differentiation-dependent expression of hypothetical proteins in the neuroblastoma cell line N1E-115.,16425288,<lastname>HengstschlÌ_ger</lastname>,Markus,M,None,2006,Differentiation-dependent expression of hypothetical proteins in the neuroblastoma cell line N1E-115.,16425288,Lubec,Gert,G,None,2006,Recurrent fusion oncogenes in carcinomas.,17425505,Teixeira,Manuel R,MR,"<affiliation>Department of Genetics, Portuguese Oncology Institute, Rua Dr. AntÌ_nio Bernardino de Almeida, 4200-072 Porto, Portugal. mteixeir@ipoporto.min-saude.pt</affiliation>",2006,Mechanisms controlling CDK9 activity.,16720337,Marshall,Renee M,RM,"Fels Institute for Cancer Research and Molecular Biology, Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA.",2006,Mechanisms controlling CDK9 activity.,16720337,Grana,Xavier,X,None,2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Santos,<forename>SÌ_nia SÌÁ</forename>,SS,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (IBET/ITQB), Oeiras, Portugal.</affiliation>",2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Gibson,Gary E,GE,None,2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Cooper,Arthur J L,AJ,None,2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Denton,Travis T,TT,None,2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Thompson,Charles M,CM,None,2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Bunik,Victoria I,VI,None,2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Alves,Paula M,PM,None,2006,Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons.,16416424,Sonnewald,Ursula,U,None,2006,The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation.,16959964,Zhou,Qiang,Q,"Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3202, USA. qzhou@uclink4.berkeley.edu",2006,The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation.,16959964,Yik,Jasper H N,JH,None,2006,Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.,16893449,Agbottah,Emmanuel,E,"The George Washington University Medical Center, Department of Biochemistry and Molecular Biology, Washington, DC 20037, USA. etagbottah@yahoo.com",2006,Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.,16893449,Deng,Longwen,L,None,2006,Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.,16893449,Dannenberg,Luke O,LO,None,2006,Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.,16893449,Pumfery,Anne,A,None,2006,Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.,16893449,Kashanchi,Fatah,F,None,2006,Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).,16546331,Bennetts,Jennifer S,JS,"Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, QLD 4072, Australia.",2006,Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).,16546331,Fowles,Lindsay F,LF,None,2006,Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).,16546331,Berkman,Jennifer L,JL,None,2006,Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).,16546331,van Bueren,Kelly Lammerts,KL,None,2006,Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).,16546331,Richman,Joy M,JM,None,2006,Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).,16546331,Simpson,Fiona,F,None,2006,Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).,16546331,Wicking,Carol,C,None,2006,Reconstitution of chromatin transcription with purified components reveals a chromatin-specific repressive activity of p300.,16415879,Santoso,Buyung,B,"Section of Molecular Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0347, USA.",2006,Reconstitution of chromatin transcription with purified components reveals a chromatin-specific repressive activity of p300.,16415879,Kadonaga,James T,JT,None,2006,Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.,16641272,Dao,Luan D,LD,"Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.",2006,Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.,16641272,Duffy,Aaron,A,None,2006,Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.,16641272,Van Tine,Brian A,BA,None,2006,Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.,16641272,Wu,Shwu-Yuan,SY,None,2006,Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.,16641272,Chiang,Cheng-Ming,CM,None,2006,Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.,16641272,Broker,Thomas R,TR,None,2006,Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.,16641272,Chow,Louise T,LT,None,2006,Catalase effect on cell death for the improvement of recombinant protein production in baculovirus-insect cell system.,17082911,Vieira,Helena L A,HL,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901, Oeiras, Portugal.</affiliation>",2006,Catalase effect on cell death for the improvement of recombinant protein production in baculovirus-insect cell system.,17082911,Pereira,Ana C P,AC,None,2006,Catalase effect on cell death for the improvement of recombinant protein production in baculovirus-insect cell system.,17082911,Carrondo,Manuel J T,MJ,None,2006,Catalase effect on cell death for the improvement of recombinant protein production in baculovirus-insect cell system.,17082911,Alves,Paula M,PM,None,2006,Process development for the mass production of Ehrlichia ruminantium.,16257480,Marcelino,Isabel,I,"IBET, Apartado 12, 2781-901 Oeiras, Portugal.",2006,Process development for the mass production of Ehrlichia ruminantium.,16257480,Sousa,Marcos F Q,MF,None,2006,Process development for the mass production of Ehrlichia ruminantium.,16257480,<lastname>VerÌ_ssimo</lastname>,<forename>CÌ©lia</forename>,C,None,2006,Process development for the mass production of Ehrlichia ruminantium.,16257480,Cunha,<forename>AntÌ_nio E</forename>,AE,None,2006,Process development for the mass production of Ehrlichia ruminantium.,16257480,Carrondo,Manuel J T,MJ,None,2006,Process development for the mass production of Ehrlichia ruminantium.,16257480,Alves,Paula M,PM,None,2006,"KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.",17178852,White,David E,DE,"The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.",2006,"KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.",17178852,Negorev,Dmitri,D,None,2006,"KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.",17178852,Peng,Hongzhuang,H,None,2006,"KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.",17178852,Ivanov,Alexey V,AV,None,2006,"KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.",17178852,Maul,Gerd G,GG,None,2006,"KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.",17178852,Rauscher,Frank J,FJ,None,2006,The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression.,16954381,Sripathy,Smitha P,SP,"Case Western Reserve University, Department of Pharmacology and Case Comprehensive Cancer Center, Cleveland, Ohio 44106-4965, USA.",2006,The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression.,16954381,Stevens,Jessica,J,None,2006,The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression.,16954381,Schultz,David C,DC,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Liu,Huaying,H,"Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, Hunan, People's Republic of China.",2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Peng,Cong,C,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Zhou,Ming,M,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Zhou,Jie,J,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Shen,Shourong,S,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Zhou,Houde,H,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Xiong,Wei,W,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Luo,Xiaomin,X,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Peng,Shuping,S,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Niu,Zhaoxia,Z,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Ouyang,Jue,J,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Li,Xiaoling,X,None,2006,Cloning and characterization of the BRD7 gene promoter.,16792505,Li,Guiyuan,G,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Lorenz,Susanne,S,"<affiliation>Gene Mapping Center, Max-DelbrÌ_ck-Center for Molecular Medicine, Robert-RÌ_ssle-Str. 10, 13125 Berlin, Germany.</affiliation>",2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Taylor,Kirsten P,KP,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Gehrmann,Anne,A,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Becker,Tim,T,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Muhle,Hiltrud,H,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Gresch,Meike,M,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Tauer,Ulrike,U,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Sander,Thomas,T,None,2006,Association of BRD2 polymorphisms with photoparoxysmal response.,16516380,Stephani,Ulrich,U,None,2006,The Epc-N domain: a predicted protein-protein interaction domain found in select chromatin associated proteins.,16412250,Perry,Jason,J,"Division of Biological Sciences, University of California at San Diego, La Jolla, USA. jmperry@biomail.ucsd.edu",2006,Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.,17189190,Abbate,Eric A,EA,"Department of Molecular and Cell Biology, Division of Biochemistry and Molecular Biology, University of California, Berkeley, Berkeley, California 94720, USA.",2006,Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.,17189190,Voitenleitner,Christian,C,None,2006,Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.,17189190,Botchan,Michael R,MR,None,2006,Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.,16542442,Engleson,Jens,J,"Department of Oncology, Lund University Hospital, SE-221 85, Lund, Sweden. jens.engleson@skane.se",2006,Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.,16542442,Soller,Maria,M,None,2006,Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.,16542442,Panagopoulos,Ioannis,I,None,2006,Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.,16542442,<lastname>DahlÌ©n</lastname>,Anna,A,None,2006,Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.,16542442,Dictor,Michael,M,None,2006,Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.,16542442,Jerkeman,Mats,M,None,2006,"Activity and expression of a virulence factor, gelatinase, in dairy enterococci.",17046092,Lopes,<forename>Maria de FÌÁtima Silva</forename>,Mde F,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET)/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Universidade Nova de Lisboa, Apartado 12, 2781-901 Oeiras, Portugal. flopes@itqb.unl.pt</affiliation>",2006,"Activity and expression of a virulence factor, gelatinase, in dairy enterococci.",17046092,<lastname>SimÌµes</lastname>,<forename>Ana PatrÌ_cia</forename>,AP,None,2006,"Activity and expression of a virulence factor, gelatinase, in dairy enterococci.",17046092,Tenreiro,<forename>RogÌ©rio</forename>,R,None,2006,"Activity and expression of a virulence factor, gelatinase, in dairy enterococci.",17046092,Marques,<forename>JosÌ© Joaquim Figueiredo</forename>,JJ,None,2006,"Activity and expression of a virulence factor, gelatinase, in dairy enterococci.",17046092,Crespo,Maria Teresa Barreto,MT,None,2006,Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.,16940503,You,Jianxin,J,"Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.",2006,Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.,16940503,Srinivasan,Viswanathan,V,None,2006,Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.,16940503,Denis,Gerald V,GV,None,2006,Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.,16940503,Harrington,William J,WJ,None,2006,Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.,16940503,Ballestas,Mary E,ME,None,2006,Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.,16940503,Kaye,Kenneth M,KM,None,2006,Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.,16940503,Howley,Peter M,PM,None,2006,Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.,16728978,Li,Haitao,H,"Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.",2006,Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.,16728978,Ilin,Serge,S,None,2006,Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.,16728978,Wang,Wooikoon,W,None,2006,Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.,16728978,Duncan,Elizabeth M,EM,None,2006,Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.,16728978,Wysocka,Joanna,J,None,2006,Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.,16728978,Allis,C David,CD,None,2006,Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.,16728978,Patel,Dinshaw J,DJ,None,2006,Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.,16512664,Denis,Gerald V,GV,"Pharmacology and Medicine, Cancer Research Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA. gdenis@bu.edu",2006,Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.,16512664,McComb,Mark E,ME,None,2006,Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.,16512664,Faller,Douglas V,DV,None,2006,Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.,16512664,Sinha,Anupama,A,None,2006,Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.,16512664,Romesser,Paul B,PB,None,2006,Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.,16512664,Costello,Catherine E,CE,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Pantano,Sergio,S,"International School for Advanced Studies, INFM-DEMOCRITOS Modeling Center for Research in Atomistic Simulation, Trieste, Italy.",2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Marcello,Alessandro,A,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Ferrari,Aldo,A,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Gaudiosi,Daniele,D,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,<lastname>SabÌ_</lastname>,Arianna,A,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Pellegrini,Vittorio,V,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Beltram,Fabio,F,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Giacca,Mauro,M,None,2006,Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.,16362936,Carloni,Paolo,P,None,2006,ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance.,17189189,Parish,Joanna L,JL,"Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.",2006,ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance.,17189189,Bean,Angela M,AM,None,2006,ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance.,17189189,Park,Regina B,RB,None,2006,ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance.,17189189,Androphy,Elliot J,EJ,None,2006,Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle.,16537635,Ilves,Ivar,I,"Institute of Technology, University of Tartu, Tartu 50411, Estonia.",2006,Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle.,16537635,<lastname>MÌ_emets</lastname>,Kristina,K,None,2006,Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle.,16537635,Silla,Toomas,T,None,2006,Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle.,16537635,Janikson,Kadri,K,None,2006,Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle.,16537635,Ustav,Mart,M,None,2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Santillan,Donna A,DA,"Molecular Biology Program, Loyola University Medical Center, Maywood, Illinois 60153, USA.",2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Theisler,Catherine M,CM,None,2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Ryan,Amanda S,AS,None,2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Popovic,Relja,R,None,2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Stuart,Tara,T,None,2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Zhou,Ming-Ming,MM,None,2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Alkan,Serhan,S,None,2006,Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.,17047066,Zeleznik-Le,Nancy J,NJ,None,2006,Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.,16928766,Ottinger,Matthias,M,"<affiliation>Institut fÌ_r Virologie, Medizinische Hochschule Hannover, Carl-Neuberg Str. 1, 30625 Hannover, Germany.</affiliation>",2006,Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.,16928766,Christalla,Thomas,T,None,2006,Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.,16928766,Nathan,Kavita,K,None,2006,Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.,16928766,Brinkmann,Melanie M,MM,None,2006,Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.,16928766,Viejo-Borbolla,Abel,A,None,2006,Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.,16928766,Schulz,Thomas F,TF,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Wysocka,Joanna,J,Laboratory of Chromatin Biology.,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Swigut,Tomek,T,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Xiao,Hua,H,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Milne,Thomas A,TA,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Kwon,So Yeon,SY,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Landry,Joe,J,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Kauer,Monika,M,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Tackett,Alan J,AJ,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Chait,Brian T,BT,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Badenhorst,Paul,P,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Wu,Carl,C,None,2006,A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.,16728976,Allis,C David,CD,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Zhou,Ming,M,"Cancer Research Institute, Central South University Xiang-Ya School of Medicine, 110 Xiang-Ya Road, Changsha, Hunan 410078, China.",2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Liu,Huaying,H,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Xu,Xiaojie,X,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Zhou,Houde,H,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Li,Xiaoling,X,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Peng,Cong,C,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Shen,Shourong,S,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Xiong,Wei,W,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Ma,Jian,J,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Zeng,Zhaoyang,Z,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Fang,Songqing,S,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Nie,Xinmin,X,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Yang,Yixin,Y,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Zhou,Jie,J,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Xiang,Juanjuan,J,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Cao,Li,L,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Peng,Shuping,S,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Li,Shufang,S,None,2006,Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.,16475162,Li,Guiyuan,G,None,2006,Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin.,16339075,Nishiyama,Akira,A,"Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2753, USA.",2006,Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin.,16339075,Dey,Anup,A,None,2006,Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin.,16339075,Miyazaki,Jun-Ichi,J,None,2006,Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin.,16339075,Ozato,Keiko,K,None,2005,The histone H3 acetylase dGcn5 is a key player in Drosophila melanogaster metamorphosis.,16135811,<lastname>CarrÌ©</lastname>,<forename>ClÌ©ment</forename>,C,"Laboratory of Drosophila Genetics and Epigenetics, Department of Developmental Biology, CNRS URA 2578, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France.",2005,The histone H3 acetylase dGcn5 is a key player in Drosophila melanogaster metamorphosis.,16135811,Szymczak,Dimitri,D,None,2005,The histone H3 acetylase dGcn5 is a key player in Drosophila melanogaster metamorphosis.,16135811,Pidoux,Josette,J,None,2005,The histone H3 acetylase dGcn5 is a key player in Drosophila melanogaster metamorphosis.,16135811,Antoniewski,Christophe,C,None,2005,Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin.,15994786,McPhillips,Maria G,MG,"Laboratory of Viral Diseases, NIAID, NIH, Building 4, Room 137, 4 Center Dr., MSC 0455, Bethesda, MD 20892-0455, USA.",2005,Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin.,15994786,Ozato,Keiko,K,None,2005,Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin.,15994786,McBride,Alison A,AA,None,2005,Proteomic and genomic characterization of chromatin complexes at a boundary.,15824130,Tackett,Alan J,AJ,"Rockefeller University, New York, NY 10021, USA.",2005,Proteomic and genomic characterization of chromatin complexes at a boundary.,15824130,Dilworth,David J,DJ,None,2005,Proteomic and genomic characterization of chromatin complexes at a boundary.,15824130,Davey,Megan J,MJ,None,2005,Proteomic and genomic characterization of chromatin complexes at a boundary.,15824130,O'Donnell,Michael,M,None,2005,Proteomic and genomic characterization of chromatin complexes at a boundary.,15824130,Aitchison,John D,JD,None,2005,Proteomic and genomic characterization of chromatin complexes at a boundary.,15824130,Rout,Michael P,MP,None,2005,Proteomic and genomic characterization of chromatin complexes at a boundary.,15824130,Chait,Brian T,BT,None,2005,Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A.,15548137,Sinha,Anupama,A,"Cancer Research Center, Boston University School of Medicine, 80 East Concord Street, K521, Boston, MA 02118, USA.",2005,Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A.,15548137,Faller,Douglas V,DV,None,2005,Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A.,15548137,Denis,Gerald V,GV,None,2005,Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.,16282494,You,Jianxin,J,"Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.",2005,Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.,16282494,Schweiger,Michal-Ruth,MR,None,2005,Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.,16282494,Howley,Peter M,PM,None,2005,Evaluation of control transcripts in real-time RT-PCR expression analysis during maritime pine embryogenesis.,16034587,<lastname>GonÌ_alves</lastname>,<forename>SÌ_nia</forename>,S,"<affiliation>Grupo Pinus, Instituto de Biologia Experimental e TecnolÌ_gica (IBET)/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (ITQB), Aptd. 12, 2781-901 Oeiras, Portugal.</affiliation>",2005,Evaluation of control transcripts in real-time RT-PCR expression analysis during maritime pine embryogenesis.,16034587,Cairney,John,J,None,2005,Evaluation of control transcripts in real-time RT-PCR expression analysis during maritime pine embryogenesis.,16034587,Maroco,<forename>JoÌ£o</forename>,J,None,2005,Evaluation of control transcripts in real-time RT-PCR expression analysis during maritime pine embryogenesis.,16034587,Oliveira,M Margarida,MM,None,2005,Evaluation of control transcripts in real-time RT-PCR expression analysis during maritime pine embryogenesis.,16034587,Miguel,<forename>CÌ©lia</forename>,C,None,2005,Ligand-induced transrepression by VDR through association of WSTF with acetylated histones.,16252006,Fujiki,Ryoji,R,"The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan.",2005,Ligand-induced transrepression by VDR through association of WSTF with acetylated histones.,16252006,Kim,Mi-sun,MS,None,2005,Ligand-induced transrepression by VDR through association of WSTF with acetylated histones.,16252006,Sasaki,Yasumasa,Y,None,2005,Ligand-induced transrepression by VDR through association of WSTF with acetylated histones.,16252006,Yoshimura,Kimihiro,K,None,2005,Ligand-induced transrepression by VDR through association of WSTF with acetylated histones.,16252006,Kitagawa,Hirochika,H,None,2005,Ligand-induced transrepression by VDR through association of WSTF with acetylated histones.,16252006,Kato,Shigeaki,S,None,2005,Corepressor CtBP1 interacts with and specifically inhibits CBP activity.,16122695,Senyuk,Vitalyi,V,"Department of Pathology, The Cancer Center, University of Illinois at Chicago, Chicago, IL, USA.",2005,Corepressor CtBP1 interacts with and specifically inhibits CBP activity.,16122695,Sinha,Kislay Kumar,KK,None,2005,Corepressor CtBP1 interacts with and specifically inhibits CBP activity.,16122695,Nucifora,Giuseppina,G,None,2005,Effector proteins for methylated histones: an expanding family.,15970672,Daniel,Jeremy A,JA,"Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.",2005,Effector proteins for methylated histones: an expanding family.,15970672,Pray-Grant,Marilyn G,MG,None,2005,Effector proteins for methylated histones: an expanding family.,15970672,Grant,Patrick A,PA,None,2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,Viejo-Borbolla,Abel,A,"Department of Virology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.",2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,Ottinger,Matthias,M,None,2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,<lastname>BrÌ_ning</lastname>,Eva,E,None,2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,<lastname>BÌ_rger</lastname>,Antje,A,None,2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,<lastname>KÌ_nig</lastname>,Regina,R,None,2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,Kati,Emrah,E,None,2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,Sheldon,Julie A,JA,None,2005,Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.,16227282,Schulz,Thomas F,TF,None,2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,Vieira,Helena L A,HL,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica (IBET), Apartado 12, 2781-901 Oeiras, Portugal.</affiliation>",2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,<lastname>EstÌ»vÌ£o</lastname>,Catarina,C,None,2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,<lastname>RoldÌ£o</lastname>,<forename>AntÌ_nio</forename>,A,None,2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,Peixoto,Cristina C,CC,None,2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,Sousa,Marcos F Q,MF,None,2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,Cruz,Pedro E,PE,None,2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,Carrondo,Manuel J T,MJ,None,2005,"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.",16023241,Alves,Paula M,PM,None,2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Raisner,Ryan M,RM,"Department of Biochemistry and Biophysics, University of California, 600 16th Street, San Francisco, California 94143, USA.",2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Hartley,Paul D,PD,None,2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Meneghini,Marc D,MD,None,2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Bao,Marie Z,MZ,None,2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Liu,Chih Long,CL,None,2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Schreiber,Stuart L,SL,None,2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Rando,Oliver J,OJ,None,2005,Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.,16239142,Madhani,Hiten D,HD,None,2005,Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.,16109377,Yang,Zhiyuan,Z,"Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA.",2005,Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.,16109377,Yik,Jasper H N,JH,None,2005,Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.,16109377,Chen,Ruichuan,R,None,2005,Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.,16109377,He,Nanhai,N,None,2005,Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.,16109377,Jang,Moon Kyoo,MK,None,2005,Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.,16109377,Ozato,Keiko,K,None,2005,Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.,16109377,Zhou,Qiang,Q,None,2005,Binding of pRB to the PHD protein RBP2 promotes cellular differentiation.,15949438,Benevolenskaya,Elizaveta V,EV,"Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.",2005,Binding of pRB to the PHD protein RBP2 promotes cellular differentiation.,15949438,Murray,Heather L,HL,None,2005,Binding of pRB to the PHD protein RBP2 promotes cellular differentiation.,15949438,Branton,Philip,P,None,2005,Binding of pRB to the PHD protein RBP2 promotes cellular differentiation.,15949438,Young,Richard A,RA,None,2005,Binding of pRB to the PHD protein RBP2 promotes cellular differentiation.,15949438,Kaelin,William G,WG,None,2005,Multisite protein modification and intramolecular signaling.,15744326,Yang,Xiang-Jiao,XJ,"Molecular Oncology Group, Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada H3A 1A1. ziang-jiao.yang@mcgill.ca",2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Haruki,N,N,"Department of Surgery, Nagoya City Hospital, Nagoya, Japan.",2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Kawaguchi,K S,KS,None,2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Eichenberger,S,S,None,2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Massion,P P,PP,None,2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Gonzalez,A,A,None,2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Gazdar,A F,AF,None,2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Minna,J D,JD,None,2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Carbone,D P,DP,None,2005,Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.,15994877,Dang,T P,TP,None,2005,Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities.,15885836,Ferreira,T B,TB,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica (IBET/ITQB), Apartado 12, P-2781-901 Oeiras, Portugal.</affiliation>",2005,Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities.,15885836,Ferreira,A L,AL,None,2005,Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities.,15885836,Carrondo,M J T,MJ,None,2005,Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities.,15885836,Alves,P M,PM,None,2005,The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.,16204849,Ma,Buyong,B,"Basic Research Program, SAIC-Frederick, Inc., Laboratory of Experimental and Computational Biology, NCI-Frederick, Frederick, MD 21702, USA. mab@ncifcrf.gov",2005,The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.,16204849,Pan,Yongping,Y,None,2005,The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.,16204849,Gunasekaran,K,K,None,2005,The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.,16204849,Keskin,Ozlem,O,None,2005,The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.,16204849,Venkataraghavan,R Babu,RB,None,2005,The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.,16204849,Levine,Arnold J,AJ,None,2005,The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.,16204849,Nussinov,Ruth,R,None,2005,The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.,16109376,Jang,Moon Kyoo,MK,"Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.",2005,The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.,16109376,Mochizuki,Kazuki,K,None,2005,The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.,16109376,Zhou,Meisheng,M,None,2005,The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.,16109376,Jeong,Ho-Sang,HS,None,2005,The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.,16109376,Brady,John N,JN,None,2005,The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.,16109376,Ozato,Keiko,K,None,2005,"Characterization of Ha29, a specific gene for Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus.",15943913,Guo,Zhong-Jian,ZJ,"Institute of Applied Entomology, Zhejiang University, Kaixuan Road 268, Hangzhou 310029, Zhejiang, China.",2005,"Characterization of Ha29, a specific gene for Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus.",15943913,An,Shi-Heng,SH,None,2005,"Characterization of Ha29, a specific gene for Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus.",15943913,Wang,Dun,D,None,2005,"Characterization of Ha29, a specific gene for Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus.",15943913,Liu,Yan-He,YH,None,2005,"Characterization of Ha29, a specific gene for Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus.",15943913,Kumar,V Shyam,VS,None,2005,"Characterization of Ha29, a specific gene for Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus.",15943913,Zhang,Chuan-Xi,CX,None,2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Zeng,Lei,L,"Structural Biology Program, Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York University, One Gustave L. Levy Place, New York, New York 10029-6574, USA.",2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Li,Jiaming,J,None,2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Muller,Michaela,M,None,2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Yan,Sherry,S,None,2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Mujtaba,Shiraz,S,None,2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Pan,Chongfeng,C,None,2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Wang,Zhiyong,Z,None,2005,Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.,15724976,Zhou,Ming-Ming,MM,None,2005,"The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.",15795266,Baxter,Michael K,MK,"Laboratory of Viral Diseases, NIAID, NIH, Building 4, Room 137, 4 Center Dr., MSC 0455, Bethesda, MD 20892-0455, USA.",2005,"The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.",15795266,McPhillips,Maria G,MG,None,2005,"The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.",15795266,Ozato,Keiko,K,None,2005,"The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.",15795266,McBride,Alison A,AA,None,2005,Quantification of Ehrlichia ruminantium by real time PCR.,15863287,Peixoto,Cristina C,CC,"IBET, Apartado 12, 2781-901 Oeiras, Portugal.",2005,Quantification of Ehrlichia ruminantium by real time PCR.,15863287,Marcelino,Isabel,I,None,2005,Quantification of Ehrlichia ruminantium by real time PCR.,15863287,<lastname>VachiÌ©ry</lastname>,Nathalie,N,None,2005,Quantification of Ehrlichia ruminantium by real time PCR.,15863287,Bensaid,Albert,A,None,2005,Quantification of Ehrlichia ruminantium by real time PCR.,15863287,Martinez,Dominique,D,None,2005,Quantification of Ehrlichia ruminantium by real time PCR.,15863287,Carrondo,Manuel J T,MJ,None,2005,Quantification of Ehrlichia ruminantium by real time PCR.,15863287,Alves,Paula M,PM,None,2005,The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing.,16085498,Zhou,Yonggang,Y,"Division of Molecular Biology of the Cell II, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.",2005,The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing.,16085498,Grummt,Ingrid,I,None,2005,Crystal structure of the proximal BAH domain of the polybromo protein.,15839835,Oliver,Antony W,AW,"CR-UK DNA Repair Enzymes Group, Section of Structural Biology, The Institute of Cancer Research, 237 Fulham Road, Chelsea, London SW3 6JB, UK. antony.oliver@icr.ac.uk",2005,Crystal structure of the proximal BAH domain of the polybromo protein.,15839835,Jones,Sarah A,SA,None,2005,Crystal structure of the proximal BAH domain of the polybromo protein.,15839835,Roe,Stephen Mark,SM,None,2005,Crystal structure of the proximal BAH domain of the polybromo protein.,15839835,Matthews,Steve,S,None,2005,Crystal structure of the proximal BAH domain of the polybromo protein.,15839835,Goodwin,Graham H,GH,None,2005,Crystal structure of the proximal BAH domain of the polybromo protein.,15839835,Pearl,Laurence H,LH,None,2005,Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein.,15710895,Brannon,Angela R,AR,"Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0455, USA.",2005,Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein.,15710895,Maresca,Julia A,JA,None,2005,Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein.,15710895,Boeke,Jef D,JD,None,2005,Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein.,15710895,Basrai,Munira A,MA,None,2005,Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein.,15710895,McBride,Alison A,AA,None,2005,Use of adenoviral vectors as veterinary vaccines.,16231058,Ferreira,T B,TB,"<affiliation>Instituto de Biologia Experimental e TecnolÌ_gica/Instituto de Tecnologia QuÌ_mica e BiolÌ_gica IBET/ITQB, Oeiras, Portugal.</affiliation>",2005,Use of adenoviral vectors as veterinary vaccines.,16231058,Alves,P M,PM,None,2005,Use of adenoviral vectors as veterinary vaccines.,16231058,Aunins,J G,JG,None,2005,Use of adenoviral vectors as veterinary vaccines.,16231058,Carrondo,M J T,MJ,None,2005,The bromodomain protein GTE6 controls leaf development in Arabidopsis by histone acetylation at ASYMMETRIC LEAVES1.,16166385,Chua,Yii Leng,YL,"Department of Plant Sciences, University of Cambridge, Cambridge CB2 3EA, UK.",2005,The bromodomain protein GTE6 controls leaf development in Arabidopsis by histone acetylation at ASYMMETRIC LEAVES1.,16166385,<lastname>ChanneliÌ¬re</lastname>,<forename>StÌ©phanie</forename>,S,None,2005,The bromodomain protein GTE6 controls leaf development in Arabidopsis by histone acetylation at ASYMMETRIC LEAVES1.,16166385,Mott,Ellie,E,None,2005,The bromodomain protein GTE6 controls leaf development in Arabidopsis by histone acetylation at ASYMMETRIC LEAVES1.,16166385,Gray,John C,JC,None,2005,Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary.,16079223,Jambunathan,Nithya,N,"Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana 70803, USA.",2005,Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary.,16079223,Martinez,Adam W,AW,None,2005,Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary.,16079223,Robert,Elizabeth C,EC,None,2005,Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary.,16079223,Agochukwu,Nneamaka B,NB,None,2005,Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary.,16079223,Ibos,Megan E,ME,None,2005,Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary.,16079223,Dugas,Sandra L,SL,None,2005,Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary.,16079223,Donze,David,D,None,2005,CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.,15834423,Kim,Jae-Hwan,JH,"Department of Biochemistry and Molecular Biology, Cancer Research Institute, Interdisciplinary Program in Genetic Engineering, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea.",2005,CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.,15834423,Cho,Eun-Jung,EJ,None,2005,CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.,15834423,Kim,Seong-Tae,ST,None,2005,CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.,15834423,Youn,Hong-Duk,HD,None,2005,Do protein motifs read the histone code?,15666348,de la Cruz,Xavier,X,"<affiliation>Institut CatalÌÊ per la Recerca i Estudis AvanÌ_ats, Barcelona, Spain.</affiliation>",2005,Do protein motifs read the histone code?,15666348,Lois,Sergio,S,None,2005,Do protein motifs read the histone code?,15666348,<lastname>SÌÁnchez-Molina</lastname>,Sara,S,None,2005,Do protein motifs read the histone code?,15666348,<lastname>MartÌ_nez-BalbÌÁs</lastname>,Marian A,MA,None,2005,Characterization of Ehrlichia ruminantium replication and release kinetics in endothelial cell cultures.,16139967,Marcelino,Isabel,I,"Animal Cell Biotechnology Lab, IBET, Apartado 12, 2781-901 Oeiras, Portugal.",2005,Characterization of Ehrlichia ruminantium replication and release kinetics in endothelial cell cultures.,16139967,<lastname>VerÌ_ssimo</lastname>,<forename>CÌ©lia</forename>,C,None,2005,Characterization of Ehrlichia ruminantium replication and release kinetics in endothelial cell cultures.,16139967,Sousa,Marcos F Q,MF,None,2005,Characterization of Ehrlichia ruminantium replication and release kinetics in endothelial cell cultures.,16139967,Carrondo,Manuel J T,MJ,None,2005,Characterization of Ehrlichia ruminantium replication and release kinetics in endothelial cell cultures.,16139967,Alves,Paula M,PM,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Gashaw,I,I,"Medical Faculty of the University Duisburg-Essen, Institute for Anatomy, Hufelandstr. 55, 45122, Essen, Germany.",2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,<lastname>GrÌ_mmer</lastname>,R,R,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Klein-Hitpass,L,L,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Dushaj,O,O,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Bergmann,M,M,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Brehm,R,R,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Grobholz,R,R,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Kliesch,S,S,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Neuvians,T P,TP,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Schmid,K W,KW,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,von Ostau,C,C,None,2005,Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4.,16158187,Winterhager,E,E,None,2005,Differentially expressed genes in endothelial differentiation.,16008511,Ishii,Hideshi,H,"Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan. hishiiAms.jichi.ac.jp",2005,Differentially expressed genes in endothelial differentiation.,16008511,Mimori,Koshi,K,None,2005,Differentially expressed genes in endothelial differentiation.,16008511,Mori,Masaki,M,None,2005,Differentially expressed genes in endothelial differentiation.,16008511,Vecchione,Andrea,A,None,2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Zhang,Jing-Min,JM,"Department of Pathology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.",2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Hashimoto,Mizuo,M,None,2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Kawai,Kumi,K,None,2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Murakumo,Yoshiki,Y,None,2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Sato,Tomoko,T,None,2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Ichihara,Masatoshi,M,None,2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Nakamura,Shigeo,S,None,2005,CD109 expression in squamous cell carcinoma of the uterine cervix.,15826242,Takahashi,Masahide,M,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Banting,Graham S,GS,"Department of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada.",2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Barak,Orr,O,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Ames,Tanya M,TM,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Burnham,Amanda C,AC,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Kardel,Melanie D,MD,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Cooch,Neil S,NS,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Davidson,Courtney E,CE,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Godbout,Roseline,R,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,McDermid,Heather E,HE,None,2005,"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.",15640247,Shiekhattar,Ramin,R,None,